"SEARCH QUERY","('psoriasis' and ('etanercept' or 'adalimumab' or 'infliximab' or ustekinumab or secukinumab)) and 'human'/de and [adult]/lim"-------------------------------------

"TITLE","Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis""AUTHOR NAMES","Sperry B.W.","Oldan J.D.","Hsich E.M.","Reynolds J.P.","Tamarappoo B.K.""SOURCE","Journal of Nuclear Cardiology (2015) 22:4 (840-844). Date of Publication: 19 Aug 2015"

"TITLE","Modelled analysis of serious infection risk in the treatment of psoriasis with biologics and systemic treatments in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)""AUTHOR NAMES","Kalb R.","Fiorentino D.","Lebwohl M.","Leonardi C.","Toole J.","Poulin Y.","Cohen A.","Goyal K.","Calabro S.","Langholff W.","Fakharzadeh S.""SOURCE","British Journal of Dermatology (2015) 173 SUPPL. 1 (63-64). Date of Publication: July 2015"

"TITLE","Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis""AUTHOR NAMES","Zhang M.","Brenneman S.K.","Carter C.T.","Essoi B.L.","Farahi K.","Johnson M.P.","Lee S.","Olson W.H.""SOURCE","Patient Preference and Adherence (2015) 9 (777-784). Date of Publication: 16 Jun 2015"

"TITLE","The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: Results from a nationwide prospective study""AUTHOR NAMES","Lie E.","Kristensen L.E.","Forsblad-D'Elia H.","Zverkova-Sandström T.","Askling J.","Jacobsson L.T.""SOURCE","Annals of the Rheumatic Diseases (2015) 74:6 (970-978). Date of Publication: 1 Jun 2015"

"TITLE","Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: A subset analysis of the PRISTINE trial""AUTHOR NAMES","Kemeny L.","Amaya M.","Cetkovska P.","Rajatanavin N.","Lee W.-R.","Szumski A.","Marshall L.","Mahgoub E.Y.","Aldinç E.""SOURCE","BMC Dermatology (2015) 15:1 Article Number: 9. Date of Publication: 21 May 2015"

"TITLE","Cost-effectiveness of secukinumab compared to current treatments for the treatment of moderate to severe plaque psoriasis in Canada""AUTHOR NAMES","Lee A.","Gregory V.","Gu Q.","Becker D.L.","Barbeau M.""SOURCE","Value in Health (2015) 18:3 (A182). Date of Publication: May 2015"

"TITLE","Treatment patterns associated with biologics in psoriasis patients""AUTHOR NAMES","Foster S.","Zhu B.","Guo J.","Ojeh C.","Nikai E.","Wu J.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB256). Date of Publication: May 2015"

"TITLE","Cost per responder of apremilast versus etanercept, adalimumab, and ustekinumab in patients with moderate to severe psoriasis""AUTHOR NAMES","Feldman S.R.","Tencer T.","Clancy Z.","Zhang F.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB229). Date of Publication: May 2015"

"TITLE","Frequency of increased maintenance doses of adalimumab, etanercept, and ustekinumab""AUTHOR NAMES","Kuznik A.","Natu A.","Siper K.","Auld M.","Gilra N.""SOURCE","Value in Health (2015) 18:3 (A168). Date of Publication: May 2015"

"TITLE","Weight and demographic characteristics of psoriasis patients treated with adalimumab, etanercept, or ustekinumab""AUTHOR NAMES","Meyer R.","Yeaw J.","Zhang M.","Hines D.","Wade R.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB257). Date of Publication: May 2015"

"TITLE","Impact of non-medical switching on healthcare costs: A claims database analysis""AUTHOR NAMES","Liu Y.","Skup M.","Lin J.","Chao J.""SOURCE","Value in Health (2015) 18:3 (A252). Date of Publication: May 2015"

"TITLE","Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents""AUTHOR NAMES","Kivelevitch D.","Sharma M.","Mansouri B.","Patel M.","Ryan C.","Menter A.","Obermoser G.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB31). Date of Publication: May 2015"

"TITLE","Patient reported nonadherence in psoriasis patients receiving adalimumab or

ustekinumab""AUTHOR NAMES","Goren A.","Carter C.","Lee S.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB241). Date of Publication: May 2015"

"TITLE","Psoriasis in elderly and adult population: Clinical features and management""AUTHOR NAMES","Napolitano M.","Ayala F.","Gallo L.","Schiattarella M.","Megna M.","Balato N.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB245). Date of Publication: May 2015"

"TITLE","Starting-dose trends over time in biologic-naïve and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab""AUTHOR NAMES","Guérin A.","Sundaram M.","Gauthier G.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB253). Date of Publication: May 2015"

"TITLE","Health care resource utilization, health care costs, and dose escalation in biologic-naïve psoriasis patients initiated on ustekinumab versus adalimumab""AUTHOR NAMES","Guérin A.","Sundaram M.","Gauthier G.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB236). Date of Publication: May 2015"

"TITLE","Assessing the impact of increased maintenance dosing of ADA limumab and Etanercept on managed ca re costs""AUTHOR NAMES","Kuznik A.","Natu A.","Siper K.","Auld M.","Gilra N.""SOURCE","Value in Health (2015) 18:3 (A185). Date of Publication: May 2015"

"TITLE","AMAGINE-3: A phase 3 study of efficacy and safety of brodalumab compared with placebo and ustekinumab in moderate to severe plaque psoriasis subjects""AUTHOR NAMES","Strober B.","Langley R.","Blicharski T.","Paul C.","Lacour J.-P.","Tyring S.","Kircik L.","Chimenti S.","Duffin K.C.","Bagel J.","Koo J.","Aras G.","Shi Y.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB224). Date of Publication: May 2015"

"TITLE","Safety and efficacy of ustekinumab in adolescent patients with moderate to severe plaque psoriasis: Results through 1 year of the phase 3 CADMUS trial""AUTHOR NAMES","Landells I.","Marano C.","Hsu M.-C.","Li S.","Eichenfield L.","Hoeger P.","Menter A.","Paller A.","Taieb A.","Randazzo B.","Szapary P.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB202). Date of Publication: May 2015"

"TITLE","Ustekinumab treatment of psoriatics infected with hepatitis B and/or hepatitis C virus""AUTHOR NAMES","Siegel S.","Naugler S.","Winthrop K.","Ehst B.D.""SOURCE","Journal of Investigative Dermatology (2015) 135 SUPPL. 1 (S44). Date of Publication: May 2015"

"TITLE","Long-term improvements in physical function are associated with improvements in dactylitis, enthesitis, tender and swollen joint counts, and psoriasis skin involvement: Results from a phase 3 study of ustekinumab in psoriatic arthritis patients""AUTHOR NAMES","Gottlieb A.","Puig L.","Kavanaugh A.","Ritchlin C.","Li S.","You Y.","Mendelsohn A.M.","Song M.","Rahman P.","McInnes I.B.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB239). Date of Publication: May 2015"

"TITLE","ESPRIT: 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent cardiovascular events at 5-year interim analysis""AUTHOR NAMES","Wu J.","Reich K.","Bereswill M.","Ghorayeb E.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB234). Date of Publication: May 2015"

"TITLE","ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent malignancies at 5-year interim analysis""AUTHOR NAMES","Thac¸i D.","Leonardi C.","Bereswill M.","Ghorayeb E.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB235). Date of Publication: May 2015"

"TITLE","ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent serious infections at 5-year interim analysis""AUTHOR NAMES","Papp K.","Menter A.","Bereswill M.","Teixeira H.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB235). Date of Publication: May 2015"

"TITLE","Five-year interim results from the ESPRIT 10-year post marketing surveillance registry of adalimumab for moderate to severe psoriasis""AUTHOR NAMES","Thac¸i D.","Kerdel F.","Bereswill M.","Williams D."

"SOURCE","Journal of the American Academy of Dermatology (2015) 72:5 SUPPL. 1 (AB236). Date of Publication: May 2015"

"TITLE","Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure""AUTHOR NAMES","Ungar B.","Haj-Natour O.","Kopylov U.","Yavzori M.","Fudim E.","Picard O.","Loebstein R.","Lahat A.","Maor Y.","Avidan B.","Lang A.","Weiss B.","Chowers Y.","Eliakim R.","Ben-Horin S.""SOURCE","Medicine (2015) 94:18 (e673). Date of Publication: 1 May 2015"

"TITLE","Occurrence of keratoacanthoma five years after development of malignant melanoma during long term treatment of psoriasis with TNF-alpha-antagonists""AUTHOR NAMES","Kowalzick L.","Eickenscheidt L.""SOURCE","Tumor Diagnostik und Therapie (2015) 36:3 (162-164). Date of Publication: 1 Apr 2015"

"TITLE","Clinical features of psoriatic uveitis in Japanese patients""AUTHOR NAMES","Tanaka R.","Takamoto M.","Komae K.","Ohtomo K.","Fujino Y.","Kaburaki T.""SOURCE","Graefe's Archive for Clinical and Experimental Ophthalmology (2015) 253:7 (1175-1180). Date of Publication: 1 Mar 2015"

"TITLE","Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry""AUTHOR NAMES","Carretero G.","Ferrandiz C.","Dauden E.","Vanaclocha Sebastián F.","Gómez-García F.J.","Herrera-Ceballos E.","De La Cueva-Dobao P.","Belinchón I.","Sánchez-Carazo J.L.","Alsina-Gibert M.","López-Estebaranz J.L.","Ferrán M.","Torrado R.","Carrascosa J.M.","Carazo C.","Rivera R.","Jiménez-Puya R.","García-Doval I.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:1 (156-163). Date of Publication: 1 Jan 2015"

"TITLE","Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study""AUTHOR NAMES","Kim W.B.","Marinas J.E.C.","Qiang J.","Shahbaz A.","Greaves S.","Yeung J.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:2 (237-241). Date of Publication: 1 Aug 2015"

"TITLE","Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice""AUTHOR NAMES","Armesto S.","Coto-Segura P.","Mayorga J.","Illaro A.","Santos-Juanes J.""SOURCE","Journal of Dermatological Treatment (2015) 26:1 (49-53). Date of Publication: 1 Feb 2015"

"TITLE","The use of a reliable, ubiquitous, inexpensive, and user-friendly tablet-based system to track target lesion improvements in subjects with plaque psoriasis treated with clobetasol propionate 0.05% spray""AUTHOR NAMES","Wiser T.H.","Meckfessel M.H.","Winkelman W.""SOURCE","Journal of Drugs in Dermatology (2015) 14:3 (236-241). Date of Publication: 1 Mar 2015"

"TITLE","Occurrence of adverse events in patients with JIA receiving biologic agents: Long-term follow-up in a real-life setting""AUTHOR NAMES","Tarkiainen M.","Tynjälä P.","Vähäsalo P.","Lahdenne P.""SOURCE","Rheumatology (United Kingdom) (2015) 54:7 (1170-1176) Article Number: keu457. Date of Publication: 1 Jul 2015"

"TITLE","Treatment of coexistent psoriasis and lupus erythematosus""AUTHOR NAMES","Varada S.","Gottlieb A.B.","Merola J.F.","Saraiya A.R.","Tintle S.J.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:2 (253-260). Date of Publication: 2015"

"TITLE","Long-term efficacy, safety and drug survival of ustekinumab in a spanish cohort of patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Puig L.","Ruiz-Salas V.""SOURCE","Dermatology (2015) 230:1 (46-54). Date of Publication: 17 Feb 2015"

"TITLE","Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: An observational study from national BIOBADADERM registry""AUTHOR NAMES","Medina C.","Carretero G.","Ferrandiz C.","Dauden E.","Vanaclocha F.","Gómez-García F.J.","Herrera-Ceballos E.","De La Cueva-Dobao P.","Belinchón I.","Sánchez-Carazo J.L.","Alsina M.","López-Estebaranz J.L.","Ferrán M.","Carrascosa J.M.","Torrado R.","Argila D.","Rivera R.","Jiménez-Puya R.","García-Doval I.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:5 (858-864). Date of Publication: 1 May 2015"

"TITLE","Combined biologic therapy for the treatment of psoriasis and psoriatic arthritis: A case report"

"AUTHOR NAMES","Babalola O.","Lakdawala N.","Strober B.E.""SOURCE","JAAD Case Reports (2015) 1:1 (3-4). Date of Publication: 2015"

"TITLE","Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial""AUTHOR NAMES","Thaçi D.","Blauvelt A.","Reich K.","Tsai T.-F.","Vanaclocha F.","Kingo K.","Ziv M.","Pinter A.","Hugot S.","You R.","Milutinovic M.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:3 (400-409). Date of Publication: 1 Sep 2015"

"TITLE","Epidemiology of psoriasis and palmoplantar pustulosis: A nationwide study using the Japanese national claims database""AUTHOR NAMES","Kubota K.","Kamijima Y.","Sato T.","Ooba N.","Koide D.","Iizuka H.","Nakagawa H.""SOURCE","BMJ Open (2015) 5:1 Article Number: e006450. Date of Publication: 2015"

"TITLE","Impact of smoking on response to systemic treatment in patients with psoriasis: A retrospective case-control study""AUTHOR NAMES","Kinahan C.E.","Mazloom S.","Fernandez A.P.""SOURCE","British Journal of Dermatology (2015) 172:2 (428-436). Date of Publication: 1 Feb 2015"

"TITLE","Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: The experience of an outpatient dermatological clinic for psoriasis""AUTHOR NAMES","Graceffa D.","Maiani E.","Sperduti I.","Ceralli F.","Bonifati C.""SOURCE","Clinical and Experimental Dermatology (2015) 40:2 (136-141). Date of Publication: 1 Mar 2015"

"TITLE","Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida""AUTHOR NAMES","Medina-Gil C.","Dehesa L.","Vega A.","Kerdel F.""SOURCE","International Journal of Dermatology (2015) 54:7 (846-852). Date of Publication: 1 Jul 2015"

"TITLE","Systemic therapy for psoriasis and the risk of herpes zoster: A 500000 person-year study""AUTHOR NAMES","Shalom G.","Zisman D.","Bitterman H.","Harman-Boehm I.","Greenberg-Dotan S.","Dreiher J.","Feldhamer I.","Moser H.","Hammerman A.","Cohen Y.","Cohen A.D.""SOURCE","JAMA Dermatology (2015) 151:5 (533-538). Date of Publication: 1 May 2015"

"TITLE","Risk of myocardial infarction in psoriasis patients: A retrospective cohort study""AUTHOR NAMES","Wu J.J.","Choi Y.M.","Bebchuk J.D.""SOURCE","Journal of Dermatological Treatment (2015) 26:3 (230-234). Date of Publication: 1 Jun 2015"

"TITLE","Factors associated with the prescription of ""traditional"" or ""biological"" systemic treatment in psoriasis""AUTHOR NAMES","Tabolli S.","Paradisi A.","Giannantoni P.","Gubinelli E.","Abeni D.""SOURCE","Journal of Dermatological Treatment (2015) 26:1 (37-40). Date of Publication: 1 Feb 2015"

"TITLE","Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: A prospective study""AUTHOR NAMES","Acquacalda E.","Albert C.","Montaudie H.","Fontas E.","Danre A.","Roux C.H.","Breuil V.","Lacour J.P.","Passeron T.","Ziegler L.E.""SOURCE","Joint Bone Spine (2015) 82:4 (267-271). Date of Publication: 1 Jul 2015"

"TITLE","Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome""AUTHOR NAMES","Skiveren J.","Philipsen P.","Therming G.""SOURCE","Clinical and Experimental Dermatology (2015) 40:6 (600-604). Date of Publication: 1 Aug 2015"

"TITLE","Cardiovascular risk factors influence response to biological therapies in psoriasis""AUTHOR NAMES","Batalla A.","González-Fernández D.","González-Lara L.","Abalde T.","Salgado-Boquete L.","Queiro-Silva R.","Coto E.","Coto-Segura P.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:2 (327-329). Date of Publication: 1 Aug 2015"

"TITLE","Mortality in American veterans with the HLA-B27 gene""AUTHOR NAMES","Walsh J.A.","Zhou X.","Clegg D.O.","Teng C.","Cannon G.W.","Sauer B.""SOURCE","Journal of Rheumatology (2015) 42:4 (638-644). Date of Publication: 1 Apr 2015"

"TITLE","Histoplasmosis Complicating Tumor Necrosis Factor-α Blocker Therapy: A Retrospective Analysis of 98 Cases""AUTHOR NAMES","Vergidis P.","Avery R.K.","Wheat L.J.","Dotson J.L.","Assi M.A.","Antoun

S.A.","Hamoud K.A.","Burdette S.D.","Freifeld A.G.","McKinsey D.S.","Money M.E.","Myint T.","Andes D.R.","Hoey C.A.","Kaul D.A.","Dickter J.K.","Liebers D.E.","Miller R.A.","Muth W.E.","Prakash V.","Steiner F.T.","Walker R.C.","Hage C.A.""SOURCE","Clinical Infectious Diseases (2015) 61:3 (409-417). Date of Publication: 1 Aug 2015"

"TITLE","Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis""AUTHOR NAMES","Molina-Leyva A.","Almodovar-Real A.","Carrascosa J.C.-R.","Molina-Leyva I.","Naranjo-Sintes R.","Jimenez-Moleon J.J.""SOURCE","Anais Brasileiros de Dermatologia (2015) 90:3 (338-345). Date of Publication: 7 Jul 2015"

"TITLE","Clearance of Psoriasis: The impact of private versus public insurance""AUTHOR NAMES","Buzney C.D.","Peterman C.","Saraiya A.","Au S.-C.","Dumont N.","Mansfield R.","Gottlieb A.B.""SOURCE","Journal of Drugs in Dermatology (2015) 14:2 (119-125). Date of Publication: 1 Feb 2015"

"TITLE","Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis""AUTHOR NAMES","Feldman S.R.","Zhao Y.","Navaratnam P.","Friedman H.S.","Lu J.","Tran M.H.""SOURCE","Journal of Managed Care Pharmacy (2015) 21:3 (201-209). Date of Publication: 2015"

"TITLE","Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register""AUTHOR NAMES","Iskandar I.Y.K.","Ashcroft D.M.","Warren R.B.","Yiu Z.Z.N.","Mcelhone K.","Lunt M.","Barker J.N.W.N.","Burden A.D.","Ormerod A.D.","Reynolds N.J.","Smith C.H.","Griffiths C.E.M.""SOURCE","British Journal of Dermatology (2015). Date of Publication: 2015"

"TITLE","Prevalence and clinical characteristics of psoriatic arthritis in Japan""AUTHOR NAMES","Ohara Y.","Kishimoto M.","Takizawa N.","Yoshida K.","Okada M.","Eto H.","Deshpande G.A.","Ritchlin C.T.","Tanaka A.","Higashiyama M.","Matsui K.","Tsuji S.""SOURCE","Journal of Rheumatology (2015) 42:8 (1439-1442). Date of Publication: 1 Aug 2015"

"TITLE","Acrodermatitis continua of hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra""AUTHOR NAMES","Saunier J.","Debarbieux S.","Jullien D.","Garnier L.","Dalle S.","Thomas L.""SOURCE","Dermatology (2015) 230:2 (97-100). Date of Publication: 6 Mar 2015"

"TITLE","Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure""AUTHOR NAMES","Kusakari Y.","Yamasaki K.","Takahashi T.","Tsuchiyama K.","Shimada-Omori R.","Nasu-Tamabuchi M.","Aiba S.""SOURCE","Journal of Dermatology (2015) 42:7 (727-730). Date of Publication: 1 Jul 2015"

"TITLE","Acute systemic sarcoidosis complicating ustekinumab therapy for chronic plaque psoriasis""AUTHOR NAMES","Powell J.B.","Matthews P.","Rattehalli R.","Woodhead F.","Perkins P.","Powell G.","Szczecinska W.","Gach J.E.""SOURCE","British Journal of Dermatology (2015) 172:3 (834-836). Date of Publication: 1 Mar 2015"

"TITLE","Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers""AUTHOR NAMES","Wang T.-C.","Chiu H.-Y.","Wang T.-S.","Tsai T.-F.""SOURCE","Dermatologica Sinica (2015) 33:1 (5-10). Date of Publication: 1 Mar 2015"

"TITLE","Psoriasis-associated IgA nephropathy under infliximab therapy""AUTHOR NAMES","Kluger N.","Du-Thanh A.","Bessis D.","Servel M.-F.","Mourad G.""SOURCE","International Journal of Dermatology (2015) 54:3 (e79-e80). Date of Publication: 1 Mar 2015"

"TITLE","Vitamin D<inf>3</inf> levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis""AUTHOR NAMES","Kincse G.","Bhattoa P.H.","Herédi E.","Varga J.","Szegedi A.","Kéri J.","Gaál J.""SOURCE","Journal of Dermatology (2015) 42:7 (679-684). Date of Publication: 1 Jul 2015"

"TITLE","Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis""AUTHOR NAMES","Cao Z.","Carter C.","Wilson K.L.","Schenkel B.""SOURCE","Journal of Dermatological Treatment (2015) 26:2 (113-120). Date of Publication: 1 Apr 2015"

"TITLE","Apremilast and adalimumab: A novel combination therapy for recalcitrant psoriasis""AUTHOR NAMES","Danesh M.J.","Beroukhim K.","Nguyen C.","Levin E.","Koo J.""SOURCE","Dermatology Online Journal (2015) 21:6. Date of Publication: 2015"

"TITLE","Homocysteine plasma levels in psoriasis patients: Our experience and review of the literature""AUTHOR NAMES","Giannoni M.","Consales V.","Campanati A.","Ganzetti G.","Giuliodori K.","Postacchini V.","Liberati G.","Azzaretto L.","Vichi S.","Guanciarossa F.","Offidani A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:9 (1781-1785). Date of Publication: 1 Sep 2015"

"TITLE","Treatment patterns with topicals, traditional systemics and biologics in psoriasis - A Swedish database analysis""AUTHOR NAMES","Svedbom A.","Dalén J.","Mamolo C.","Cappelleri J.C.","Petersson I.F.","Ståhle M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:2 (215-223). Date of Publication: 1 Feb 2015"

"TITLE","Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics""AUTHOR NAMES","Sator P.","Richter L.","Saxinger W.","Vasiljevic M.","Stingl G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:9 (1742-1749). Date of Publication: 1 Sep 2015"

"TITLE","Intracranial hypertension and memory loss in a patient treated with ustekinumab""AUTHOR NAMES","Abdelnabi M.","Short J.","Khoromi S.","Ehrlich A.""SOURCE","Australasian Journal of Dermatology (2015) 56:2 (146-147). Date of Publication: 1 May 2015"

"TITLE","Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate""AUTHOR NAMES","Philippe L.","Badie J.","Faller J.P.","Krattinger É.","Deconinck E.","Aubin F.""SOURCE","Acta Dermato-Venereologica (2015) 95:4 (495-496). Date of Publication: 1 Apr 2015"

"TITLE","An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors""AUTHOR NAMES","Van Lümig P.P.M.","Menting S.P.","Van Den Reek J.M.P.A.","Spuls P.I.","Van Riel P.L.C.M.","Van De Kerkhof P.C.M.","Fransen J.","Kievit W.","De Jong E.M.G.J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:4 (752-760). Date of Publication: 1 Apr 2015"

"TITLE","The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents""AUTHOR NAMES","Ergun T.","Seckin D.","Baskan Bulbul E.","Onsun N.","Ozgen Z.","Unalan P.","Alpsoy E.","Karakurt S.""SOURCE","International Journal of Dermatology (2015) 54:5 (594-599). Date of Publication: 1 May 2015"

"TITLE","Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long-term treatment with efalizumab, but not with anti-TNF-α treatments or ustekinumab""AUTHOR NAMES","Vilarrasa E.","Puig L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:3 (609-611). Date of Publication: 1 Mar 2015"

"TITLE","Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry""AUTHOR NAMES","Gisondi P.","Cazzaniga S.","Chimenti S.","MacCarone M.","Picardo M.","Girolomoni G.","Naldi L.""SOURCE","British Journal of Dermatology (2015) 172:6 (1613-1620). Date of Publication: 1 Jun 2015"

"TITLE","Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis""AUTHOR NAMES","Julià A.","Ferrandiz C.","Dauden E.","Fonseca E.","Fernandez-Lopez E.","Sanchez-Carazo J.L.","Vanaclocha F.","Puig L.","Moreno-Ramirez D.","Lopez-Estebaranz J.L.","Herrera E.","De La Cueva P.","Avila G.","Alonso A.","Tortosa R.","Lopez-Lasanta M.","Marsal S.""SOURCE","Pharmacogenomics Journal (2015) 15:4 (322-325). Date of Publication: 25 Aug 2015"

"TITLE","The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients""AUTHOR NAMES","Batalla A.","Coto E.","González-Fernández D.","González-Lara L.","Gómez J.","Santos-Juanes J.","Queiro R.","Coto-Segura P.""SOURCE","Pharmacogenetics and Genomics (2015) 25:6 (313-316). Date of Publication: 15 May

2015"

"TITLE","Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: A case series of 10 patients""AUTHOR NAMES","Barak E.C.","Kerner M.","Rozenman D.","Ziv M.""SOURCE","Dermatologic Therapy (2015) 28:3 (126-130). Date of Publication: 1 May 2015"

"TITLE","The SAPHO syndrome: A single-center study of 41 adult patients""AUTHOR NAMES","Aljuhani F.","Tournadre A.","Tatar Z.","Couderc M.","Mathieu S.","Malochet-Guinamand S.","Soubrier M.","Dubost J.-J.""SOURCE","Journal of Rheumatology (2015) 42:2 (329-334). Date of Publication: 1 Feb 2015"

"TITLE","Risk of drug-induced liver injury from tumor necrosis factor antagonists""AUTHOR NAMES","Björnsson E.S.","Gunnarsson B.I.","Gröndal G.","Jonasson J.G.","Einarsdottir R.","Ludviksson B.R.","Gudbjörnsson B.","Olafsson S.""SOURCE","Clinical Gastroenterology and Hepatology (2015) 13:3 (602-608). Date of Publication: 1 Mar 2015"

"TITLE","Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis""AUTHOR NAMES","Zisapel M.","Zisman D.","Madar-Balakirski N.","Arad U.","Padova H.","Matz H.","Maman-Sarvagyl H.","Kaufman I.","Paran D.","Feld J.","Litinsky I.","Wigler I.","Caspi D.","Elkayam O.""SOURCE","Journal of Rheumatology (2015) 42:1 (73-78). Date of Publication: 1 Jan 2015"

"TITLE","Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: Report on 17 cases""AUTHOR NAMES","Wilsmann-Theis D.","Frambach Y.","Philipp S.","Weyergraf A.J.","Jacobi A.","Mössner R.","Gerdes S.""SOURCE","Dermatology (2015) 230:2 (119-127). Date of Publication: 6 Mar 2015"

"TITLE","Concomitant use of Azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions""AUTHOR NAMES","Soh J.S.","Yun W.J.","Kim K.-J.","Won C.H.","Park S.H.","Yang D.-H.","Ye B.D.","Byeon J.-S.","Myung S.-J.","Yang S.-K.","Kim J.-H.""SOURCE","Inflammatory Bowel Diseases (2015) 21:4 (832-839). Date of Publication: 6 Mar 2015"

"TITLE","Clinical outcomes and progression to orthopedic surgery in Juvenile- Versus adult-onset ankylosing spondylitis""AUTHOR NAMES","Jadon D.R.","Shaddick G.","Jobling A.","Ramanan A.V.","Sengupta R.""SOURCE","Arthritis Care and Research (2015) 67:5 (651-657). Date of Publication: 1 May 2015"

"TITLE","Severe dilated cardiomyopathy induced by adalimumab and ustekinumab""AUTHOR NAMES","Membrillo De Novales F.J.","Ávila Jiménez A.","Merino Meléndez L.","Torres León J.","López Soberón E.","Fe Marqués A.","Pérez Mochales J.F.""SOURCE","Journal of Clinical Rheumatology (2015) 21:3 (171-173). Date of Publication: 9 Apr 2015"

"TITLE","Complete primary treatment failure of adalimumab in a patient with photoaggravated psoriasis""AUTHOR NAMES","Kulapatrapa C.","Rünger T.M.""SOURCE","Photodermatology Photoimmunology and Photomedicine (2015) 31:2 (104-106). Date of Publication: 1 Mar 2015"

"TITLE","Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting""AUTHOR NAMES","Fonseca E.","Iglesias R.","Paradela S.","Fernández-Torres R.M.","Elberdín L.""SOURCE","Journal of Dermatological Treatment (2015) 26:3 (217-222). Date of Publication: 1 Jun 2015"

"TITLE","Efficacy, tolerability and safety of switching from etanercept to infliximab for the treatment of moderate-to-severe psoriasis: A multicenter, open-label trial (TANGO)""AUTHOR NAMES","Ayala F.","Lambert J.""SOURCE","Journal of Dermatological Treatment (2015) 26:4 (304-311). Date of Publication: 4 Jul 2015"

"TITLE","Effects of mud-bath therapy in psoriatic arthritis patients treated with TNF inhibitors. Clinical evaluation and assessment of synovial inflammation by contrast-enhanced ultrasound (CEUS)""AUTHOR NAMES","Cozzi F.","Raffeiner B.","Beltrame V.","Ciprian L.","Coran A.","Botsios C.","Perissinotto E.","Grisan E.","Ramonda R.","Oliviero F.","Stramare R.","Punzi L.""SOURCE","Joint Bone Spine (2015) 82:2 (104-108). Date of Publication: 1 Mar 2015"

"TITLE","Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab""AUTHOR NAMES","Korta D.Z.","Ochieng P.","Fishman D.","Katz S.E.""SOURCE","Dermatology Online Journal (2015) 21:1. Date of Publication: 1 Jan 2015"

"TITLE","Squamous cell neoplasm of the ocular surface in a patient with psoriasis treated with tumor necrosis factor-alpha inhibitors""AUTHOR NAMES","Lezcano Carduz V.P.","Mingo Botín D.","Durán Poveda S.P.""SOURCE","Cornea (2015) 34:7 (833-834). Date of Publication: 7 Apr 2015"

"TITLE","Efficacy and safety of adalimumab 80 mg weekly in luminal crohn's disease""AUTHOR NAMES","Bouguen G.","Laharie D.","Nancey S.","Hebuterne X.","Flourie B.","Filippi J.","Roblin X.","Trang C.","Bourreille A.","Babouri A.","Bretagne J.-F.","Siproudhis L.","Peyrin-Biroulet L.""SOURCE","Inflammatory Bowel Diseases (2015) 21:5 (1047-1053). Date of Publication: 3 Mar 2015"

"TITLE","Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: Experience from a psoriasis referral center""AUTHOR NAMES","Fotiadou C.","Lazaridou E.","Kemanetzi C.","Kyrmanidou E.","Ioannides D.""SOURCE","International Journal of Dermatology (2015) 54:9 (1105-1108). Date of Publication: 1 Sep 2015"

"TITLE","Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: Two challenging cases""AUTHOR NAMES","Singh G.K.","Chatterjee M.""SOURCE","Indian Journal of Dermatology (2015) 60:2 (194-197). Date of Publication: 1 Apr 2015"

"TITLE","Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab""AUTHOR NAMES","Vestita M.","Guida S.","Mazzoccoli S.","Loconsole F.","Foti C.""SOURCE","European Journal of Dermatology (2015) 25:3 (272-273). Date of Publication: 1 May 2015"

"TITLE","Humanized anti-IFN-γ (HuZAF) in the treatment of psoriasis""AUTHOR NAMES","Harden J.L.","Johnson-Huang L.M.","Chamian M.F.","Lee E.","Pearce T.","Leonardi C.L.","Haider A.","Lowes M.A.","Krueger J.G.""SOURCE","Journal of Allergy and Clinical Immunology (2015) 135:2 (553-556). Date of Publication: 1 Feb 2015"

"TITLE","Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development""AUTHOR NAMES","Kawakami H.","Maeda T.","Abe N.","Matsumoto Y.","Mitsuhashi Y.","Tsuboi R.","Okubo Y.""SOURCE","Journal of Dermatology (2015) 42:1 (94-95). Date of Publication: 1 Jan 2015"

"TITLE","Hypocomplementemic urticarial vasculitis syndrome possibly secondary to etanercept use""AUTHOR NAMES","Fadahunsi A.W.","Garcia-Rosell M.","Pattanaik D.""SOURCE","Journal of Clinical Rheumatology (2015) 21:5 (274-275). Date of Publication: 6 Aug 2015"

"TITLE","Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with infliximab""AUTHOR NAMES","Bulur I.","Keseroglu H.O.","Saracoglu Z.N.","Gönül M.""SOURCE","Journal of Dermatological Case Reports (2015) 9:1 (12-14). Date of Publication: 31 Mar 2015"

"TITLE","Cutaneous histoplasmosis as a complication after anti-TNF use - Case report""AUTHOR NAMES","Zattar G.A.","Cardoso F.","Nakandakari S.","Soares C.T.""SOURCE","Anais Brasileiros de Dermatologia (2015) 90:3 Supplement 1 (S104-S107). Date of Publication: 1 Jun 2015"

"TITLE","Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease""AUTHOR NAMES","Navarrete-Dechent C.","Majerson D.","Torres M.","Armijo D.","Patel M.","Menter A.","de la Cruz C.""SOURCE","Anais Brasileiros de Dermatologia (2015) 90:3 Supplement 1 (S171-S174). Date of Publication: 1 Jun 2015"

"TITLE","Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: Results of a retrospective analysis""AUTHOR NAMES","Campanati A.","Ganzetti G.","Giuliodori K.","Marra M.","Bonfigli A.","Testa R.","Offidani A.""SOURCE","International Journal of Dermatology (2015) 54:7 (839-845). Date of Publication: 1 Jul 2015"

"TITLE","Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)"

"AUTHOR NAMES","Mrowietz U.","Leonardi C.L.","Girolomoni G.","Toth D.","Morita A.","Balki S.A.","Szepietowski J.C.","Regnault P.","Thurston H.","Papavassilis C.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:1 (27-36). Date of Publication: 1 Jul 2015"

"TITLE","Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: A randomized, controlled trial (JUNCTURE)""AUTHOR NAMES","Paul C.","Lacour J.-P.","Tedremets L.","Kreutzer K.","Jazayeri S.","Adams S.","Guindon C.","You R.","Papavassilis C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:6 (1082-1090). Date of Publication: 1 Jun 2015"

"TITLE","Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis""AUTHOR NAMES","Reich K.","Papp K.A.","Matheson R.T.","Tu J.H.","Bissonnette R.","Bourcier M.","Gratton D.","Kunynetz R.A.","Poulin Y.","Rosoph L.A.","Stingl G.","Bauer W.M.","Salter J.M.","Falk T.M.","Blödorn-Schlicht N.A.","Hueber W.","Sommer U.","Schumacher M.M.","Peters T.","Kriehuber E.","Lee D.M.","Wieczorek G.A.","Kolbinger F.","Bleul C.C.""SOURCE","Experimental Dermatology (2015) 24:7 (529-535). Date of Publication: 1 Jul 2015"

"TITLE","Risk factor analysis for the immunogenicity of adalimumab associated with decreased clinical response in Chinese patients with psoriasis""AUTHOR NAMES","Chiu H.-Y.","Wang T.-S.","Chan C.-C.","Lin S.-J.","Tsai T.-F.""SOURCE","Acta Dermato-Venereologica (2015) 95:6 (711-716). Date of Publication: 2015"

"TITLE","Systemic autoimmune, rheumatic diseases and coinciding psoriasis: Data from a large single-centre registry and review of the literature""AUTHOR NAMES","Bazsó A.","Szodoray P.","Szappanos Á.","Korda J.","Pálfi P.","Kiss E.","Poór G.""SOURCE","Mediators of Inflammation (2015) 2015 Article Number: 657907. Date of Publication: 2015"

"TITLE","Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and -9 in psoriatic plaques""AUTHOR NAMES","Vageli D.P.","Exarchou A.","Zafiriou E.","Doukas P.G.","Doukas S.","Roussaki-Schulze A.""SOURCE","Experimental and Therapeutic Medicine (2015) 10:4 (1573-1577). Date of Publication: 1 Oct 2015"

"TITLE","Secukinumab: First global approval""AUTHOR NAMES","Sanford M.","McKeage K.""SOURCE","Drugs (2015) 75:3 (329-338). Date of Publication: February 2015"

"TITLE","Adverse reactions of biological therapy for psoriasis""AUTHOR NAMES","Brănişteanu D.E.","Voicu C.M.","Creţu A.","Dimitriu A.","Luca M.C.","Sălăvăstru C.M.""SOURCE","Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i (2015) 119:1 (38-44). Date of Publication: 1 Jan 2015"

"TITLE","Secukinumab administration by pre-filled syringe: Efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)""AUTHOR NAMES","Blauvelt A.","Prinz J.C.","Gottlieb A.B.","Kingo K.","Sofen H.","Ruer-Mulard M.","Singh V.","Pathan R.","Papavassilis C.","Cooper S.""SOURCE","British Journal of Dermatology (2015) 172:2 (484-493). Date of Publication: 1 Feb 2015"

"TITLE","Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up""AUTHOR NAMES","Langley R.G.","Lebwohl M.","Krueger G.G.","Szapary P.O.","Wasfi Y.","Chan D.","Hsu M.C.","You Y.","Poulin Y.","Korman N.","Prinz J.C.","Reich K.""SOURCE","British Journal of Dermatology (2015) 172:5 (1371-1383). Date of Publication: 1 May 2015"

"TITLE","Metastatic Crohn's disease: a diagnostic and therapeutic challenge""AUTHOR NAMES","Lang N.","Hartschuh W.","Enk A.","Toberer F.""SOURCE","JDDG - Journal of the German Society of Dermatology (2015) 13:6 (571-574). Date of Publication: 1 Jun 2015"

"TITLE","Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis""AUTHOR NAMES","Sunbul M.","Cagman Z.","Gerin F.","Ozgen Z.","Durmus E.","Seckin D.","Ahmad S.","Uras F.","Agirbasli M.""SOURCE","Cardiovascular Therapeutics (2015) 33:2 (56-61). Date of Publication: 1 Apr 2015"

"TITLE","Ustekinumab treatment in patients with psoriasis undergoing hemodialysis""AUTHOR NAMES","Umezawa Y.","Hayashi M.","Kikuchi S.","Fukuchi O.","Yanaba K.","Ito

T.","Asahina A.","Saeki H.","Nakagawa H.""SOURCE","Journal of Dermatology (2015) 42:7 (731-734). Date of Publication: 1 Jul 2015"

"TITLE","Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis""AUTHOR NAMES","Pescitelli L.","Dini V.","Gisondi P.","Loconsole F.","Piaserico S.","Piccirillo A.","Stinco G.","Errichetti E.","Talamonti M.","Tripo L.","Volpi W.","Prignano F.""SOURCE","Journal of Dermatological Science (2015) 78:2 (149-151). Date of Publication: 1 May 2015"

"TITLE","Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: A phase 3 randomised non-inferiority trial""AUTHOR NAMES","Bachelez H.","Van De Kerkhof P.C.M.","Strohal R.","Kubanov A.","Valenzuela F.","Lee J.-H.","Yakusevich V.","Chimenti S.","Papacharalambous J.","Proulx J.","Gupta P.","Tan H.","Tawadrous M.","Valdez H.","Wolk R.""SOURCE","The Lancet (2015) 386:9993 (552-561). Date of Publication: 8 Aug 2015"

"TITLE","Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis A portion of the data in this manuscript was presented in at the Fall European Academy of Dermatology and Venereology 23rd Congress in Amsterdam on October 8, 2014.""AUTHOR NAMES","Menter A.","Thaçi D.","Papp K.A.","Wu J.J.","Bereswill M.","Teixeira H.D.","Rubant S.","Williams D.A.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:3 (410-419.e6). Date of Publication: 1 Sep 2015"

"TITLE","Successful use of the excimer laser for generalized psoriasis in an ustekinumab non-responder""AUTHOR NAMES","Malakouti M.","Brown G.E.","Sorenson E.","Leon A.","Koo J.","Levin E.""SOURCE","Dermatology Online Journal (2015) 21:3. Date of Publication: 2015"

"TITLE","A phase 2 trial of guselkumab versus adalimumab for plaque psoriasis""AUTHOR NAMES","Gordon K.B.","Duffin K.C.","Bissonnette R.","Prinz J.C.","Wasfi Y.","Li S.","Shen Y.-K.","Szapary P.","Randazzo B.","Reich K.""SOURCE","New England Journal of Medicine (2015) 373:2 (136-144). Date of Publication: 9 Jul 2015"

"TITLE","A randomized, blinded assessor study to evaluate the efficacy and safety of etanercept 50 mg once weekly plus as needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)""AUTHOR NAMES","Papp K.A.","Barber K.","Bissonnette R.","Bourcier M.","Lynde C.W.","Poulin Y.","Shelton J.","Toole J.","Vieira A.","Poulin-Costello M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:2 (361-366). Date of Publication: 1 Feb 2015"

"TITLE","Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate""AUTHOR NAMES","Teoh Y.-L.","Tay Y.-K.""SOURCE","JAAD Case Reports (2015) 1:2 (51-53). Date of Publication: 2015"

"TITLE","Pregnancy during Ustekinumab Treatment for Severe Psoriasis""AUTHOR NAMES","Da Rocha K.","Piccinin M.C.","Kalache L.F.","Reichert-Faria A.","Silva De Castro C.C.""SOURCE","Dermatology (2015) 231:2 (103-104). Date of Publication: 20 Aug 2015"

"TITLE","Linear psoriasis following the typical distribution of the sciatic nerve""AUTHOR NAMES","Galluzzo M.","Talamonti M.","Di Stefani A.","Chimenti S.""SOURCE","Journal of Dermatological Case Reports (2015) 9:1 (6-11). Date of Publication: 31 Mar 2015"

"TITLE","Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials""AUTHOR NAMES","Griffiths C.E.M.","Reich K.","Lebwohl M.","Van De Kerkhof P.","Paul C.","Menter A.","Cameron G.S.","Erickson J.","Zhang L.","Secrest R.J.","Ball S.","Braun D.K.","Osuntokun O.O.","Heffernan M.P.","Nickoloff B.J.","Papp K.""SOURCE","The Lancet (2015) 386:9993 (541-551). Date of Publication: 8 Aug 2015"

"TITLE","Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption""AUTHOR NAMES","Gordon K.B.","Gottlieb A.B.","Langely R.G.","Van De Kerkhof P.","Belasco K.T.","Sundaram M.","Okun M.","Serra L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:4 (767-776). Date of Publication: 1 Apr 2015"

"TITLE","Ustekinumab in adolescent patients age 12 to 17years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study"

"AUTHOR NAMES","Landells I.","Marano C.","Hsu M.-C.","Li S.","Zhu Y.","Eichenfield L.F.","Hoeger P.H.","Menter A.","Paller A.S.","Taieb A.","Philipp S.","Szapary P.","Randazzo B.""SOURCE","Journal of the American Academy of Dermatology (2015). Date of Publication: 2015"

"TITLE","Infliximab treatment-induced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction""AUTHOR NAMES","Ishii-Osai Y.","Yoneta A.","Mizugaki N.","Takahashi H.","Yamashita T.""SOURCE","JAAD Case Reports (2015) 1:4 (230-233). Date of Publication: 2015"

"TITLE","Developing a therapeutic range of adalimumab serum concentrations in management of psoriasis a step toward personalized treatment""AUTHOR NAMES","Menting S.P.","Coussens E.","Pouw M.F.","Van Den Reek J.M.P.A.","Temmerman L.","Boonen H.","De Jong E.M.G.J.","Spuls P.I.","Lambert J.""SOURCE","JAMA Dermatology (2015) 151:6 (616-622). Date of Publication: 1 Jun 2015"

"TITLE","Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice""AUTHOR NAMES","Echarri A.","Ollero V.","Barreiro-de Acosta M.","Fernández-Villaverde A.","Hernández V.","Lorenzo A.","Pereira S.","Carpio D.","Castro J.""SOURCE","European Journal of Gastroenterology and Hepatology (2015) 27:4 (430-435). Date of Publication: 15 Mar 2015"

"TITLE","Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis""AUTHOR NAMES","Puig L.","Strohal R.","Husni M.E.","Tsai T.-F.","Noppakun N.","Szumski A.","Yang S.","Robertson D.","Boggs R.","Koenig A.S.""SOURCE","Journal of Dermatological Treatment (2015) 26:1 (7-15). Date of Publication: 1 Feb 2015"

"TITLE","IL36RN gene analysis of two Japanese patients with generalized pustular psoriasis""AUTHOR NAMES","Shiratori T.","Fukai K.","Yasumizu M.","Taguchi R.","Tsuruta D.","Abe Y.","Hozumi Y.","Suzuki T.""SOURCE","International Journal of Dermatology (2015) 54:2 (e60-e62). Date of Publication: 1 Feb 2015"

"TITLE","Association between skin and joint involvement in patients with psoriatic arthritis treated with adalimumab: Analysis of data from a German non-interventional study""AUTHOR NAMES","Thaçi D.","Behrens F.","Greger G.","Burkhardt H.","Gnann H.","Schopf R.","Wittig B.M.""SOURCE","Dermatology (2015) 230:3 (213-221). Date of Publication: 19 Mar 2015"

"TITLE","Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: A 6-month prospective study""AUTHOR NAMES","Pina T.","Armesto S.","Lopez-Mejias R.","Genre F.","Ubilla B.","Gonzalez-Lopez M.A.","Gonzalez-Vela M.C.","Corrales A.","Blanco R.","Garcia-Unzueta M.T.","Hernandez J.L.","Llorca J.","Gonzalez-Gay M.A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:7 (1325-1330). Date of Publication: 1 Jul 2015"

"TITLE","Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab""AUTHOR NAMES","Belyaeva E.A.","Elenitsas R.","Roth R.","Miller C.","Gelfand J.M.""SOURCE","JAAD Case Reports (2015) 1:5 (272-273). Date of Publication: 2015"

"TITLE","LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment""AUTHOR NAMES","Kamleh M.A.","Snowden S.G.","Grapov D.","Blackburn G.J.","Watson D.G.","Xu N.","Ståhle M.","Wheelock C.E.""SOURCE","Journal of Proteome Research (2015) 14:1 (557-566). Date of Publication: 2 Jan 2015"

"TITLE","Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk""AUTHOR NAMES","Chiricozzi A.","Bianchi L.","Zangrilli A.","Bavetta M.","Giunta A.","Chimenti S.","Saraceno R.""SOURCE","European Journal of Dermatology (2015) 25:1 (64-69). Date of Publication: 2015"

"TITLE","Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: Long-term results from the Bio-CAPTURE registry""AUTHOR NAMES","Van Den Reek J.M.P.A.","Tummers M.","Zweegers J.","Seyger M.M.B.","Van Lümig P.P.M.","Driessen R.J.B.","Van De Kerkhof P.C.M.","Kievit W.","De Jong E.M.G.J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:3 (560-565). Date of Publication: 1 Mar 2015"

"TITLE","Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: A multicenter international cohort"

"AUTHOR NAMES","Juillerat P.","Sokol H.","Froehlich F.","Yajnik V.","Beaugerie L.","Lucci M.","Burnand B.","Macpherson A.J.","Cosnes J.","Korzenik J.R.""SOURCE","Inflammatory Bowel Diseases (2015) 21:1 (60-70). Date of Publication: 1 Jan 2015"

"TITLE","First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis""AUTHOR NAMES","Turashvili G.","Farmer P.""SOURCE","Journal of Dermatological Treatment (2015) 26:2 (124-127). Date of Publication: 1 Apr 2015"

"TITLE","Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients - A randomized placebo-controlled trial""AUTHOR NAMES","Faurschou A.","Gyldenløve M.","Rohde U.","Thyssen J.P.","Zachariae C.","Skov L.","Knop F.K.","Vilsbøll T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:3 (555-559). Date of Publication: 1 Mar 2015"

"TITLE","TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients""AUTHOR NAMES","De Simone C.","Farina M.","Maiorino A.","Fanali C.","Perino F.","Flamini A.","Caldarola G.","Sgambato A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:9 (1786-1790). Date of Publication: 1 Sep 2015"

"TITLE","Development of lichen striatus in a psoriasis patient treated with adalimumab""AUTHOR NAMES","Lin I.-C.","Wang T.-S.","Chiu H.-Y.","Tsai T.-F.""SOURCE","Dermatologica Sinica (2015) 33:1 (41-42). Date of Publication: 1 Mar 2015"

"TITLE","Frequent office visits for injections may reduce adalimumab survival rate in patients with psoriasis""AUTHOR NAMES","Ohata C.","Shintani T.","Arakawa M.","Yoshimura K.","Ohyama B.","Ishii N.","Ono F.","Hamada T.","Karashima T.","Furumura M.""SOURCE","Journal of Dermatological Treatment (2015) 26:4 (312-313). Date of Publication: 4 Jul 2015"

"TITLE","Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: Etanercept, vascular function and endothelial progenitor cells in psoriasis""AUTHOR NAMES","Hayek S.S.","Neuman R.","Kavtaradze N.","Sher S.","Jones D.","Li Q.","Zhao L.","Chen S.C.","Waller E.","Quyyumi A.""SOURCE","International Journal of Cardiology (2015) 182 (387-389). Date of Publication: 1 Mar 2015"

"TITLE","Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept""AUTHOR NAMES","Griffiths C.E.M.","Sterry W.","Brock F.","Dilleen M.","Stefanidis D.","Germain J.M.","Mallbris L.""SOURCE","British Journal of Dermatology (2015) 172:1 (230-238). Date of Publication: 1 Jan 2015"

"TITLE","Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: Results from the CRYSTEL study""AUTHOR NAMES","Griffiths C.E.M.","Luger T.A.","Brault Y.","Germain J.M.","Mallbris L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:3 (468-473). Date of Publication: 1 Mar 2015"

"TITLE","Homozygous missense mutation in IL36RN in generalized pustular dermatosiswith intraoral involvement compatiblewith both AGEP and generalized pustular psoriasis""AUTHOR NAMES","Navarini A.A.","Simpson M.A.","Borradori L.","Yawalkar N.","Schlapbach C.""SOURCE","JAMA Dermatology (2015) 151:4 (452-453). Date of Publication: 1 Apr 2015"

"TITLE","CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin""AUTHOR NAMES","Brunner P.M.","Glitzner E.","Reininger B.","Klein I.","Stary G.","Mildner M.","Uhrin P.","Sibilia M.","Stingl G.""SOURCE","Experimental Dermatology (2015) 24:7 (522-528). Date of Publication: 1 Jul 2015"

"TITLE","Pruritus and quality of life in moderate-to-severe plaque psoriasis: Post hoc explorative analysis from the PRISTINE study""AUTHOR NAMES","Mrowietz U.","Chouela E.N.","Mallbris L.","Stefanidis D.","Marino V.","Pedersen R.","Boggs R.L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2015) 29:6 (1114-1120). Date of Publication: 1 Jun 2015"

"TITLE","Pustular psoriasis-like lesions associated with hereditary lactate dehydrogenase M subunit deficiency without interleukin-36 receptor antagonist mutation: Long-term follow-up of two cases"

"AUTHOR NAMES","Ito T.","Aoshima M.","Sugiura K.","Fujiyama T.","Ito N.","Sakabe J.I.","Akiyama M.","Maekawa M.","Tokura Y.""SOURCE","British Journal of Dermatology (2015) 172:6 (1674-1676). Date of Publication: 1 Jun 2015"

"TITLE","PsAPASH: A new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition""AUTHOR NAMES","Saraceno R.","Babino G.","Chiricozzi A.","Zangrilli A.","Chimenti S.""SOURCE","Journal of the American Academy of Dermatology (2015) 72:1 (e42-e44). Date of Publication: 1 Jan 2015"

"TITLE","Absence of varicella zoster virus reactivation after infliximab administration for plaque psoriasis""AUTHOR NAMES","El Hayderi L.","Bontems S.","Meex C.","Nikkels A.F.""SOURCE","Dermatology (2015) 230:3 (282-284). Date of Publication: 19 Mar 2015"

"TITLE","Rapidly developed neurosyphilis in a psoriasis patient under treatment with infliximab: A case report""AUTHOR NAMES","Kase K.","Ishii-Osai Y.","Sumikawa Y.","Yoneta A.","Himeno D.","Kakutani Y.","Yamashita T.""SOURCE","Acta Dermato-Venereologica (2015) 95:3 (351-352). Date of Publication: 2015"

"TITLE","Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: A nationwide survey""AUTHOR NAMES","Rossi-Semerano L.","Fautrel B.","Wendling D.","Hachulla E.","Galeotti C.","Semerano L.","Touitou I.","Koné-Paut I.""SOURCE","Orphanet Journal of Rare Diseases (2015) 10:1 Article Number: 19. Date of Publication: 2015"

"TITLE","Cervical screening uptake in a dermatology cohort on immunosuppressive agents""AUTHOR NAMES","Clowry J.","Callanan I.","Eustace K.","Collins P.","Kirby B.","Lally A.""SOURCE","British Journal of Dermatology (2015) 172:6 (1682-1683). Date of Publication: 1 Jun 2015"

"TITLE","Etanercept in the treatment of SAPHO syndrome""AUTHOR NAMES","Sáez-Martín L.-C.","Gómez-Castro S.","Román-Curto C.","Palacios-Álvarez I.","Fernández-López E.""SOURCE","International Journal of Dermatology (2015) 54:6 (e206-e208). Date of Publication: 1 Jun 2015"

"TITLE","Calcific uraemic arteriolopathy in a patient with end-stage renal failure and chronic plaque psoriasis: Could TNF-α inhibition help ameliorate disease progression?""AUTHOR NAMES","Robinson A.J.","Nicolopoulos J.","Pedagogos E.","Radulski B.","Varigos G.A.""SOURCE","Australasian Journal of Dermatology (2015) 56:1 (68-69). Date of Publication: 1 Feb 2015"

"TITLE","Cutaneous sarcoidosis masquerading as psoriatic plaques""AUTHOR NAMES","Argraves M.","Sloan S.B.","Dadras S.S.""SOURCE","Dermatology Online Journal (2015) 21:4 Article Number: 3. Date of Publication: 1 Apr 2015"

"TITLE","Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis""AUTHOR NAMES","Mease P.","Sieper J.","Van Den Bosch F.","Rahman P.","Karunaratne P.M.","Pangan A.L.""SOURCE","Arthritis and Rheumatology (2015) 67:4 (914-923). Date of Publication: 1 Apr 2015"

"TITLE","Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: Evaluation with a magnetic resonance imaging scoring system""AUTHOR NAMES","Yanaba K.","Sadaoka A.","Yonenaga T.","Saeki H.","Umezawa Y.","Tojo S.","Ito T.","Kikuchi S.","Fukuda K.","Nakagawa H.""SOURCE","Journal of Dermatology (2015). Date of Publication: 2015"

"TITLE","Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: Findings from the etanercept PRESTA trial""AUTHOR NAMES","Kirkham B.","de Vlam K.","Li W.","Boggs R.","Mallbris L.","Nab H.W.","Tarallo M.""SOURCE","Clinical and Experimental Rheumatology (2015) 33:1 (11-19). Date of Publication: 2015"

"TITLE","Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations""AUTHOR NAMES","Van Den Bosch F.","Kavanaugh A.","Kron M.","Kupper H.","Mease P.J.""SOURCE","Journal of Rheumatology (2015) 42:6 (952-959). Date of Publication: 1 Jun 2015"

"TITLE","Myasthenia gravis onset during rheumatic disease: A new paradoxical effect of anti-TNF

alpha therapy?""AUTHOR NAMES","Bruzzese V.","Marrese C.","Scolieri P.","Hassan C.","Lorenzetti R.","Zullo A.""SOURCE","International Journal of Rheumatic Diseases (2015) 18:3 (375-376). Date of Publication: 1 Mar 2015"

"TITLE","Successful treatment of palmoplantar pustulosis with isotretinoin""AUTHOR NAMES","Wilken R.","Sharma A.","Patel F.","Maverakis E.""SOURCE","Dermatology Online Journal (2015) 21:8 Article Number: 14. Date of Publication: 1 Aug 2015"

"TITLE","Linear IgA Bullous Dermatosis Secondary to Infliximab Therapy in a Patient with Ulcerative Colitis""AUTHOR NAMES","Hoffmann J.","Hadaschik E.","Enk A.","Stremmel W.","Gauss A.""SOURCE","Dermatology (2015) 231:2 (112-115). Date of Publication: 20 Aug 2015"

"TITLE","Alopecia secondary to anti-tumor necrosis factor-alpha therapy""AUTHOR NAMES","Ribeiro L.B.P.","Rego J.C.G.","Duque Estrada B.","Bastos P.R.","Maceira J.M.P.","Sodré C.T.""SOURCE","Anais Brasileiros de Dermatologia (2015) 90:2 (232-235). Date of Publication: 2015"

"TITLE","Should self-destructive behavior affect a patient's access to scarce medical resources?""AUTHOR NAMES","Yang C.S.","Kroumpouzos G.","Bercovitch L.""SOURCE","Journal of the American Academy of Dermatology (2015) 73:1 (154-157). Date of Publication: 1 Jul 2015"

"TITLE","The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients""AUTHOR NAMES","González-Lara L.","Batalla A.","Coto E.","Gómez J.","Eiris N.","Santos-Juanes J.","Queiro R.","Coto-Segura P.""SOURCE","Archives of Dermatological Research (2015) 307:5 (405-412). Date of Publication: 24 Dec 2014"

"TITLE","Increased subclinical atherosclerosis in patients with chronic plaque psoriasis""AUTHOR NAMES","Evensen K.","Slevolden E.","Skagen K.","Rønning O.M.","Brunborg C.","Krogstad A.-L.","Russell D.""SOURCE","Atherosclerosis (2014) 237:2 (499-503). Date of Publication: 1 Dec 2014"

"TITLE","Cost-Effectiveness of Biologic Agents in the Treatment of Moderate-to-Severe Psoriasis: A Brazilian Public Health Service Perspective""AUTHOR NAMES","Riveros B.S.","Ziegelmann P.K.","Correr C.J.""SOURCE","Value in Health Regional Issues (2014) 5 (65-72). Date of Publication: 1 Dec 2014"

"TITLE","Increased subclinical atherosclerosis in patients with chronic plaque psoriasis""AUTHOR NAMES","Evensen K.","Slevolden E.","Skagen K.","Rønning O.M.","Brunborg C.","Krogstad A.-L.","Russell D.""SOURCE","Atherosclerosis (2014) 237:2 (499-503). Date of Publication: 1 Dec 2014"

"TITLE","Case report: Minimal change nephrotic syndrome associated with adalimumab therapy in a pediatric patient with crohn's disease""AUTHOR NAMES","James B.","Anupama C.","Robert W.","Kathleen U.","Grace G.""SOURCE","Inflammatory Bowel Diseases (2014) 20 SUPPL. 1 (S77). Date of Publication: December 2014"

"TITLE","Immune signatures of psoriasis""AUTHOR NAMES","Kivelevitch D.","Sharma M.","Mansouri B.","Patel M.","Ryan C.","Menter A.","Obermoser G.""SOURCE","British Journal of Dermatology (2014) 171:6 (e114). Date of Publication: December 2014"

"TITLE","Recovery of the response to biological treatments using narrow band ultraviolet-B in patients with moderate to severe psoriasis: a retrospective study of 17 patients""AUTHOR NAMES","Belinchón I.","Arribas M.P.","Soro P.","Betlloch I.""SOURCE","Photodermatology, photoimmunology & photomedicine (2014) 30:6 (316-322). Date of Publication: 1 Dec 2014"

"TITLE","A step towards personalized treatment in psoriasis: The therapeutic range of adalimumab serum concentrations established by means of a prospective daily practice cohort study""AUTHOR NAMES","Coussens E.","Menting S.","Pouw M.","Van Den Reek J.","Lambert J.","Spuls Ph.""SOURCE","British Journal of Dermatology (2014) 171:6 (e115). Date of Publication: December 2014"

"TITLE","Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment""AUTHOR NAMES","Puig L.","Strohal R.","Fuiman J.","Pedersen R.","Szumski A.","Koenig

A.S.","Robertson D.","Drexel H.""SOURCE","Journal of Dermatological Treatment (2014) 25:6 (470-481). Date of Publication: December 2014"

"TITLE","Five-year interim results from the ESPRIT 10-year postmarketing surveillance registry of adalimumab for moderate-to-severe psoriasis""AUTHOR NAMES","Thac¸i D.","Kerdel F.","Bereswill M.","Williams D.A.""SOURCE","British Journal of Dermatology (2014) 171:6 (e171). Date of Publication: December 2014"

"TITLE","Acrodermatitis continua of Hallopeau (ACH): Two cases successfully treated with adalimumab""AUTHOR NAMES","Di Costanzo L.","Napolitano M.","Patruno C.","Cantelli M.","Balato N.""SOURCE","Journal of Dermatological Treatment (2014) 25:6 (489-494). Date of Publication: December 2014"

"TITLE","Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up""AUTHOR NAMES","Vogelzang E.H.""SOURCE","Annals of the rheumatic diseases (2014) 73:12 (2178-2182). Date of Publication: 1 Dec 2014"

"TITLE","Cost utility analysis of ustekinumab for the treatment of moderate to severe chronic plaque psoriasis in Thailand""AUTHOR NAMES","Tangwongsiri D.","Leartsakulpanitch J.""SOURCE","Value in Health (2014) 17:7 (A782-A783). Date of Publication: November 2014"

"TITLE","Immune signatures of psoriasis: Comparison of gene expression profiles in psoriasis patients after therapy with biological agents""AUTHOR NAMES","Kivelevitch D.","Sharma M.","Mansouri B.","Patel M.","Ryan C.","Menter A.","Obermoser G.""SOURCE","Experimental Dermatology (2014) 23 SUPPL. 2 (7). Date of Publication: November 2014"

"TITLE","Treatment persistence with subcutaneous biologic therapies in patients with psoriatic arthritis (PSA)""AUTHOR NAMES","Lyu R.","Ding Q.","Govoni M.","Fan T.""SOURCE","Value in Health (2014) 17:7 (A384-A385). Date of Publication: November 2014"

"TITLE","Observational cases report of a group of severe plaque type psoriasis patients treated with ustekinumab""AUTHOR NAMES","Serirat O.""SOURCE","Journal of the Medical Association of Thailand = Chotmaihet thangphaet (2014) 97 Supplement 11 (S150-S153). Date of Publication: 1 Nov 2014"

"TITLE","Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy""AUTHOR NAMES","Rosenberg A.","Fan H.","Chiu Y.G.","Bolce R.","Tabechian D.","Barrett R.","Moorehead S.","Baribaud F.","Liu H.","Peffer N.","Shealy D.","Schwarz E.M.","Ritchlin C.T.""SOURCE","PLoS ONE (2014) 9:10 Article Number: e110657. Date of Publication: 21 Oct 2014"

"TITLE","The biosimilar landscape: A systematic review of its current status""AUTHOR NAMES","Goel N.","Charnce K.""SOURCE","Arthritis and Rheumatology (2014) 66 SUPPL. 10 (S662). Date of Publication: October 2014"

"TITLE","Subcutaneous merkel cell carcinoma in a psoriatic patient treated with methotrexate and TNF-α inhibitors""AUTHOR NAMES","Kucinskiene V.","Vilkickaite V.","Makstiene J.","Silling S.","Valiukeviciene S.""SOURCE","Aktuelle Dermatologie (2014) 40:10 (404-407). Date of Publication: 1 Oct 2014"

"TITLE","Secukinumab, a human anti-interleukin-17a monoclonal antibody, significantly reduces psoriasis burden in patients with psoriatic arthritis: Results from a phase 3 randomized controlled trial""AUTHOR NAMES","Gottlieb A.B.","Mease P.","McInnes I.B.","Kirkham B.","Kavanaugh A.","Rahman P.","Nash P.","Pricop L.","Yuan J.","Richards H.","Mpofu S.""SOURCE","Arthritis and Rheumatology (2014) 66 SUPPL. 10 (S233). Date of Publication: October 2014"

"TITLE","Secukinumab, a human anti-interleukin-17a monoclonal antibody, improves active psoriatic arthritis and inhibits radiographic progression: Efficacy and safety data from a phase 3 randomized, multicenter, double-blind, placebo-controlled study""AUTHOR NAMES","Mease P.","McInnes I.B.","Kirkham B.","Kavanaugh A.","Rahman P.","Van Der Heijde D.","Landewé R.","Nash P.","Pricop L.","Yuan J.","Richards H.","Mpofu S.""SOURCE","Arthritis and Rheumatology (2014) 66 SUPPL. 10 (S423-S424). Date of Publication:

October 2014"

"TITLE","Adalimumab therapy improves insulin sensitivity in non-diabetic psoriatic patients: A 6-month prospective study""AUTHOR NAMES","Pina Murcia T.","López-Mejías R.","Genre F.","Ubilla B.","Armesto S.","González-López M.A.","Del Carmen Gonzalez-Vela M.","Llorca J.","Blanco R.","González-Gay M.A.""SOURCE","Arthritis and Rheumatology (2014) 66 SUPPL. 10 (S960). Date of Publication: October 2014"

"TITLE","Long term improvements in physical function are associated with improvements in dactylitis, enthesitis, tender and swollen joint counts, and psoriasis skin involvement: Results from a phase 3 study of ustekinumab in psoriatic arthritis patients""AUTHOR NAMES","Kavanaugh A.","Sanz L.P.","Gottlieb A.B.","Ritchlin C.T.","Li S.","You Y.","Mendelsohn A.M.","Song M.","Rahman P.","McInnes I.B.""SOURCE","Arthritis and Rheumatology (2014) 66 SUPPL. 10 (S688). Date of Publication: October 2014"

"TITLE","Efficacy of infliximab in pediatric ulcerative colitis""AUTHOR NAMES","Scorrano M.C.","Iuliano S.","Salerno A.","Gaiani F.","Calzolari F.","Cavirani B.","Ghiselli A.","Bizzarri B.","Luigi de'Angelis G.""SOURCE","Digestive and Liver Disease (2014) 46 SUPPL. 3 (e121). Date of Publication: 30 Sep 2014"

"TITLE","Adherence and resource use among patients treated with biologic drugs: Findings from BEETLE study""AUTHOR NAMES","Esposti L.D.","Sangiorgi D.","Perrone V.","Radice S.","Clementi E.","Perone F.","Buda S.""SOURCE","ClinicoEconomics and Outcomes Research (2014) 6 (401-407). Date of Publication: 18 Sep 2014"

"TITLE","Periodic fever syndromes and autoinflammatory diseases: A case series from an Italian centre""AUTHOR NAMES","Firinu D.","Murgia G.","Mura M.N.","Peralta M.M.","Torrazza M.","Frau A.","Manconi P.E.","Del Giacco S.R.""SOURCE","Allergy: European Journal of Allergy and Clinical Immunology (2014) 69 SUPPL. 99 (68). Date of Publication: September 2014"

"TITLE","Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment""AUTHOR NAMES","Boggs R.L.","Ka´rpa´ti S.","Li W.","Williams T.","Pedersen R.","Mallbris L.","Gniadecki R.""SOURCE","BMC Dermatology (2014) 14:1 Article Number: 14. Date of Publication: 5 Aug 2014"

"TITLE","Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: A retrospective cohort study""AUTHOR NAMES","Wu N.","Lee Y.-C.","Shah N.","Harrison D.J.""SOURCE","Clinical Therapeutics (2014) 36:8 (1231-1241.e3). Date of Publication: 1 Aug 2014"

"TITLE","Newer agents for psoriasis in adults""AUTHOR NAMES","Jabbar-Lopez Z.K.","Wu K.C.P.","Reynolds N.J.""SOURCE","BMJ (Online) (2014) 349 Article Number: g4026. Date of Publication: 9 Jul 2014"

"TITLE","Etanercept-induced cystic acne""AUTHOR NAMES","Kashat M.","Caretti K.","Kado J.""SOURCE","Cutis (2014) 94:1 (31-32). Date of Publication: 1 Jul 2014"

"TITLE","Pustular psoriasis complicated with acute generalized exanthematous pustulosis""AUTHOR NAMES","Abbas M.","Holfeld K.","Desjardins D.","Zimmer J.""SOURCE","Journal of Dermatological Case Reports (2014) 8:2 (42-45). Date of Publication: 30 Jun 2014"

"TITLE","Adalimumab for Crohn’s disease in New Zealand—a prospective multicentre experience""AUTHOR NAMES","Thomas G.R.","Lewis-Morris T.","Rowbotham D.","Whiteside C.","Joyce S.","Inns S.","Schultz M.","Gearry R.B.""SOURCE","New Zealand Medical Journal (2014) 127:1396 (23-33). Date of Publication: 20 Jun 2014"

"TITLE","Course of biotherapies in a large cohort of juvenile idiopathic arthritis at adulthood""AUTHOR NAMES","Wipff J.","Le S.","Viguier F.","Kahan A.","Deslandre C.""SOURCE","Annals of the Rheumatic Diseases (2014) 73 SUPPL. 2. Date of Publication: June 2014"

"TITLE","The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series""AUTHOR NAMES","Afzali A.","Wheat C.L.","Hu J.K.","Olerud J.E.","Lee S.D."

"SOURCE","Journal of Crohn's and Colitis (2014) 8:6 (480-488). Date of Publication: 1 Jun 2014"

"TITLE","Health-Related Quality of Life Worsens Disproportionately to Objective Signs of Psoriasis After Withdrawal of Adalimumab Therapy""AUTHOR NAMES","Poulin Y.","Sheth P.","Gu Y.","Teixeira H.D.""SOURCE","Dermatology and Therapy (2014) 4:1 (33-42). Date of Publication: 1 Jun 2014"

"TITLE","Psoriasis (PsO) treatment patterns in patients newly initiating or continuing biologics in a pharmacy benefit management setting""AUTHOR NAMES","Shah N.","Harrison D.","Wu N.","Lee Y.-C.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB179). Date of Publication: May 2014"

"TITLE","Higher health care costs and dose escalation rates in psoriasis patients treated with ustekinumab compared to adalimumab""AUTHOR NAMES","Guérin A.","Wang K.","Sundaram M.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB171). Date of Publication: May 2014"

"TITLE","Cost per treated patient for etanercept and ustekinumab in patients treated for moderate to severe plaque psoriasis""AUTHOR NAMES","Shah N.","Harrison D.","Wu N.","Lee Y.-C.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB166). Date of Publication: May 2014"

"TITLE","Study design and baseline characteristics from a phase 3, randomized, double-blind study of adalimumab versus methotrexate treatment in pediatric patients with chronic plaque psoriasis""AUTHOR NAMES","Papp K.","Williams D.","Thaci D.","Landells I.","Unnebrink K.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB190). Date of Publication: May 2014"

"TITLE","Paediatric psoriasis: Co-morbidities and complex management""AUTHOR NAMES","Paller A.S.""SOURCE","Australasian Journal of Dermatology (2014) 55 SUPPL. 1 (7). Date of Publication: May 2014"

"TITLE","Pregnancy outcomes in women exposed to ustekinumab in the psoriasis clinical development program""AUTHOR NAMES","Schaufelberg B.W.","Horn E.","Cather J.C.","Rahawi K.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB178). Date of Publication: May 2014"

"TITLE","ESPRIT: Year to year safety over 4 years of interim results from a 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis""AUTHOR NAMES","Menter A.","Williams D.A.","Thac¸i D.","Teixeira H.","Bereswill M.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB169). Date of Publication: May 2014"

"TITLE","Fourth-year interim safety and patient outcomes from ESPRIT, a 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis""AUTHOR NAMES","Thaci D.","Williams D.","Kerdel F.","Wu J.","Bereswill M.","Sundaram M.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:5 SUPPL. 1 (AB170). Date of Publication: May 2014"

"TITLE","Impact of patient weight on adalimumab efficacy in crohn's disease-a pilot study""AUTHOR NAMES","Al-Taweel T.","Kopylov U.","Strohl M.","Paradis-Surprenant L.","Almaimani M.K.","Martel M.","Bitton A.","Afif W.","Bessissow T.","Seidman E.G.""SOURCE","Gastroenterology (2014) 146:5 SUPPL. 1 (S-459). Date of Publication: May 2014"

"TITLE","Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis""AUTHOR NAMES","Li Y.","Zhou H.","Cai B.","Kahler K.H.","Tian H.","Gabriel S.","Arcona S.""SOURCE","ClinicoEconomics and Outcomes Research (2014) 6:1 (197-208). Date of Publication: 10 Apr 2014"

"TITLE","Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment""AUTHOR NAMES","Tillack C.","Ehmann L.M.","Friedrich M.","Laubender R.P.","Papay P.","Vogelsang H.","Stallhofer J.","Beigel F.","Bedynek A.","Wetzke M.","Maier H.","Koburger M.","Wagner J.","Glas J.","Diegelmann J.","Koglin S.","Dombrowski Y.","Schauber J.","Wollenberg A.","Brand S.""SOURCE","Gut (2014) 63:4 (567-577). Date of Publication: April 2014"

"TITLE","Increased expression of heat shock protein 90 in keratinocytes and mast cells in

patients with psoriasis""AUTHOR NAMES","Kakeda M.","Arock M.","Schlapbach C.","Yawalkar N.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:4 (683-690). Date of Publication: April 2014"

"TITLE","Psoriatic uveitis responding to adalimumab therapy""AUTHOR NAMES","Ermertcan A.T.","Emre S.","Öztürk F.","Gençoǧlan G.","Gündüz K.""SOURCE","International Journal of Dermatology (2014) 53:4 (e271-e273). Date of Publication: April 2014"

"TITLE","Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression?""AUTHOR NAMES","Scaldaferri F.","Petito V.","Papa A.","Cesarini M.","Arena V.","Lopetuso L.R.","Corbi M.","Perino F.","Caldarola G.","Carbone A.","Corazziari E.","Sgambato A.","Gasbarrini A.","De Simone C.""SOURCE","Gut (2014) 63:4 (699-701). Date of Publication: April 2014"

"TITLE","Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis""AUTHOR NAMES","Villanova F.","Flutter B.","Tosi I.","Grys K.","Sreeneebus H.","Perera G.K.","Chapman A.","Smith C.H.","Di Meglio P.","Nestle F.O.""SOURCE","Journal of Investigative Dermatology (2014) 134:4 (984-991). Date of Publication: April 2014"

"TITLE","Clinical and contrast-enhanced ultrasound echography outcomes in psoriatic arthritis patients after one year of continuous therapy with anti-TNF drugs""AUTHOR NAMES","Bonifati C.","Elia F.","Graceffa D.","Ceralli F.","Maiani E.","De Mutiis C.","Solivetti F.M.""SOURCE","ISRN Dermatology (2014) 2014 Article Number: 932721. Date of Publication: 2014"

"TITLE","A case of mycosis fungoides with large cell transformation associated with infliximab treatment""AUTHOR NAMES","Suga H.","Sugaya M.","Toyama T.","Sumida H.","Fujita H.","Kogure A.","Igarashi A.","Sato S.""SOURCE","Acta Dermato-Venereologica (2014) 94:2 (233-234). Date of Publication: 2014"

"TITLE","Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice""AUTHOR NAMES","Callis Duffin K.","Yeung H.","Takeshita J.","Krueger G.G.","Robertson A.D.","Troxel A.B.","Shin D.B.","Van Voorhees A.S.","Gelfand J.M.""SOURCE","British Journal of Dermatology (2014) 170:3 (672-680). Date of Publication: March 2014"

"TITLE","Diet and physical exercise in psoriasis: A randomized controlled trial""AUTHOR NAMES","Naldi L.","Conti A.","Cazzaniga S.","Patrizi A.","Pazzaglia M.","Lanzoni A.","Veneziano L.","Pellacani G.","Miglietta R.","Padalino C.","Giannetti A.","Santoro S.","Satolli F.","Donelli S.","Savoia F.","Di Lernia V.","Virgili A.","Borghi A.","Alessandrini F.","Di Crecchio R.""SOURCE","British Journal of Dermatology (2014) 170:3 (634-642). Date of Publication: 1 Mar 2014"

"TITLE","Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: Is it safe and efficacious?""AUTHOR NAMES","Sánchez-Moya A.I.","Dauden E.""SOURCE","International Journal of Dermatology (2014) 53:3 (e211-e212). Date of Publication: March 2014"

"TITLE","The effect of adalimumab on key drivers in the pathogenesis of psoriasis""AUTHOR NAMES","Hendriks A.G.M.","Van Der Velden H.M.J.","Wolberink E.A.W.","Seyger M.M.B.","Schalkwijk J.","Zeeuwen P.L.J.M.","De Jong E.M.G.J.","Pasch M.C.","Van Erp P.E.J.","Van De Kerkhof P.C.M.""SOURCE","British Journal of Dermatology (2014) 170:3 (571-580). Date of Publication: March 2014"

"TITLE","Induction of atopic dermatitis under ustekinumab-therapy in psoriasis vulgaris""AUTHOR NAMES","Kroll K.","Spornraft-Ragaller P.","Schild M.","Laske J.","Beissert S.""SOURCE","Aktuelle Dermatologie (2014) 40:3 (81-83). Date of Publication: March 2014"

"TITLE","Ulcerative keratitis in psoriasis: A rare variant of psoriatic ocular inflammatory disease""AUTHOR NAMES","Herbert V.G.","Lögering B.","Von Gruben V.","Filev F.","Klemm M.","Reich K.""SOURCE","British Journal of Dermatology (2014) 170:3 (746-748). Date of Publication: March 2014"

"TITLE","Long-term durability and dose escalation patterns in infliximab therapy for psoriasis""AUTHOR NAMES","Luber A.J.","Tsui C.L.","Heinecke G.M.","Lebwohl M.G.","Levitt J.O."

"SOURCE","Journal of the American Academy of Dermatology (2014) 70:3 (525-532). Date of Publication: March 2014"

"TITLE","Mycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by QuantiFERON(®)-TB test""AUTHOR NAMES","Kaneko S.","Seishima M.","Asano Y.","Chinuki Y.","Morita E.""SOURCE","International Journal of Dermatology (2014) 53:3 (e187-e189). Date of Publication: March 2014"

"TITLE","The role of sterol-C4-methyl oxidase in epidermal biology""AUTHOR NAMES","He M.","Smith L.D.","Chang R.","Li X.","Vockley J.""SOURCE","Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids (2014) 1841:3 (331-335). Date of Publication: March 2014"

"TITLE","Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis""AUTHOR NAMES","Dicaro D.","Bowen C.","Dalton S.R.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:3 (e64-e65). Date of Publication: March 2014"

"TITLE","Anti-TNF-α therapy prevents the recurrence of joint bleeding in haemophilia and arthritis""AUTHOR NAMES","Melchiorre D.","Morfini M.","Linari S.","Zignego A.L.","Innocenti M.","Cerinic M.M.""SOURCE","Rheumatology (United Kingdom) (2014) 53:3 (576-578) Article Number: ket280. Date of Publication: March 2014"

"TITLE","Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: What are the risks?""AUTHOR NAMES","Subramaniam K.","Yeung D.","Grimpen F.","Joseph J.","Fay K.","Buckland M.","Talaulikar D.","Elijah J.","Clarke A.C.","Pavli P.","Moore J.""SOURCE","Internal Medicine Journal (2014) 44:3 (287-290). Date of Publication: March 2014"

"TITLE","Predictors of biologic treatment of psoriasis: A non-interventional study""AUTHOR NAMES","Puig L.","Fan T.","Ding Q.","Smith N.E.""SOURCE","ClinicoEconomics and Outcomes Research (2014) 6:1 (93-100). Date of Publication: 17 Feb 2014"

"TITLE","Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy""AUTHOR NAMES","Varley C.D.","Deodhar A.A.","Ehst B.D.","Bakke A.","Blauvelt A.","Vega R.","Yamashita S.","Winthrop K.L.""SOURCE","Rheumatology (United Kingdom) (2014) 53:2 (332-337) Article Number: ket351. Date of Publication: February 2014"

"TITLE","Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis""AUTHOR NAMES","Van Den Reek J.M.P.A.","Van Lümig P.P.M.","Driessen R.J.B.","Van De Kerkhof P.C.M.","Seyger M.M.B.","Kievit W.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2014) 170:2 (415-424). Date of Publication: February 2014"

"TITLE","Infliximab Treatment of Psoriasis in Supervised Infusion Centers: Case Management Experience""AUTHOR NAMES","Campos Muñoz L.","de Unamuno Bustos B.","Herranz Pinto P.","El Ahmed H.H.","Ruiz-Villaverde R.","Taberner Ferrer R.""SOURCE","American Journal of Clinical Dermatology (2014) 15:1 (17-24). Date of Publication: 1 Feb 2014"

"TITLE","Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers""AUTHOR NAMES","Viguier M.","Livideanu C.","Beylot-Barry M.","Richard M.-A.","Paul C.","Bachelez H.","Aubin F.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (75-77). Date of Publication: February 2014"

"TITLE","Risk of herpes zoster in psoriatic patients undergoing biologic treatment""AUTHOR NAMES","Umezawa Y.","Fukuchi O.","Ito T.","Saeki H.","Nakagawa H.""SOURCE","Journal of Dermatology (2014) 41:2 (168-170). Date of Publication: February 2014"

"TITLE","Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: A retrospective study""AUTHOR NAMES","Di Lernia V.","Ricci C.","Lallas A.","Ficarelli E.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (73-74). Date of Publication: February 2014"

"TITLE","Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09""AUTHOR NAMES","Kimball A.B.","Schenfeld J.","Accortt N.A.","Anthony M.S.","Rothman K.J.","Pariser D.""SOURCE","British Journal of Dermatology (2014) 170:2 (366-373). Date of Publication: February 2014"

"TITLE","Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England""AUTHOR NAMES","Khalid J.M.","Fox K.M.","Globe G.","Maguire A.","Chau D.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (67-72). Date of Publication: February 2014"

"TITLE","Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: A multicentre, cross-sectional study""AUTHOR NAMES","Mahé E.","Reguiai Z.","Barthelemy H.","Quiles-Tsimaratos N.","Chaby G.","Girard C.","Estève E.","MacCari F.","Descamps V.","Schmutz J.-L.","Begon E.","Bravard P.","Maillard H.","Boyé T.","Beauchet A.","Sigal M.-L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:2 (151-159). Date of Publication: February 2014"

"TITLE","Occurrence of keratoacanthoma five years after development of malignant melanoma during long term treatment of psoriasis with TNF-alpha-antagonists""AUTHOR NAMES","Kowalzick L.","Eickenscheidt L.""SOURCE","Aktuelle Dermatologie (2014) 40:1-2 (44-46). Date of Publication: February 2014"

"TITLE","Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry""AUTHOR NAMES","Piaserico S.","Cazzaniga S.","Chimenti S.","Giannetti A.","MacCarone M.","Picardo M.","Peserico A.","Naldi L.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:2 (257-262). Date of Publication: February 2014"

"TITLE","Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis""AUTHOR NAMES","Foulkes A.C.","Griffiths C.E.M.","Chinoy H.","Warren R.B.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (61-62). Date of Publication: February 2014"

"TITLE","Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: A randomized clinical trial (TRANSIT)""AUTHOR NAMES","Paul C.","Puig L.","Kragballe K.","Luger T.","Lambert J.","Chimenti S.","Girolomoni G.","Nicolas J.-F.","Rizova E.","Lavie F.","Mistry S.","Bergmans P.","Barker J.","Reich K.""SOURCE","British Journal of Dermatology (2014) 170:2 (425-434). Date of Publication: February 2014"

"TITLE","MCP-1 in psoriatic patients: Effect of biological therapy""AUTHOR NAMES","Lembo S.","Capasso R.","Balato A.","Cirillo T.","Flora F.","Zappia V.","Balato N.","Ingrosso D.","Ayala F.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (83-86). Date of Publication: February 2014"

"TITLE","One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: The TRANSIT randomized trial in moderate-to-severe plaque psoriasis""AUTHOR NAMES","Reich K.","Puig L.","Paul C.","Kragballe K.","Luger T.","Lambert J.","Chimenti S.","Girolomoni G.","Nicolas J.-F.","Rizova E.","Brunori M.","Mistry S.","Bergmans P.","Barker J.""SOURCE","British Journal of Dermatology (2014) 170:2 (435-444). Date of Publication: February 2014"

"TITLE","Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: A retrospective observational multicenter study on 15 patients""AUTHOR NAMES","Costa L.","Caso F.","Atteno M.","Giannitti C.","Spadaro A.","Ramonda R.","Vezzù M.","Del Puente A.","Morisco F.","Fiocco U.","Galeazzi M.","Punzi L.","Scarpa R.""SOURCE","Clinical Rheumatology (2014) 33:2 (273-276). Date of Publication: February 2014"

"TITLE","Concurrent treatment of chronic psoriasis and asthma with ustekinumab""AUTHOR NAMES","Amarnani A.","Rosenthal K.S.","Mercado J.M.","Brodell R.T.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (63-66). Date of Publication: February 2014"

"TITLE","Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: Results from PHOENIX 1""AUTHOR NAMES","Rich P.","Bourcier M.","Sofen H.","Fakharzadeh S.","Wasfi Y.","Wang

Y.","Kerkmann U.","Ghislain P.-D.","Poulin Y.""SOURCE","British Journal of Dermatology (2014) 170:2 (398-407). Date of Publication: February 2014"

"TITLE","Current therapeutic approaches of psoriasis are affected by age at disease onset""AUTHOR NAMES","Di Lernia V.","Ficarelli E.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (15-17). Date of Publication: February 2014"

"TITLE","Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: A randomized controlled trial""AUTHOR NAMES","Maari C.","Bolduc C.","Nigen S.","Marchessault P.","Bissonnette R.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (57-60). Date of Publication: February 2014"

"TITLE","A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis""AUTHOR NAMES","Mohanan S.","Ramassamy S.","Chandrashekar L.","Thappa D.M.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (50-53). Date of Publication: February 2014"

"TITLE","Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%""AUTHOR NAMES","Routt E.T.","Levitt J.O.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:2 (e37-e38). Date of Publication: February 2014"

"TITLE","Long-term response to etanercept monotherapy in moderate to severe psoriasis: Assessment in daily practice by the maintenance of low values of PASI and BSA""AUTHOR NAMES","Fernández-Torres R.M.","Paradela S.","Fonseca E.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (54-56). Date of Publication: February 2014"

"TITLE","Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers""AUTHOR NAMES","Saraceno R.","Specchio F.","Chiricozzi A.","Sarmati L.","Amicosante M.","Chimenti M.S.","Chimenti S.""SOURCE","Expert Opinion on Biological Therapy (2014) 14:2 (151-156). Date of Publication: February 2014"

"TITLE","Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: Results from the PRISTINE trial""AUTHOR NAMES","Husni M.E.","Qureshi A.A.","Koenig A.S.","Pedersen R.","Robertson D.""SOURCE","Journal of Dermatological Treatment (2014) 25:1 (90-95). Date of Publication: February 2014"

"TITLE","Treatment patterns and annual drug costs of biologic therapies across indications from the humana commercial database""AUTHOR NAMES","Howe A.","Eyck L.T.","Dufour R.","Shah N.","Harrison D.J.""SOURCE","Journal of Managed Care Pharmacy (2014) 20:12 (1236-1244). Date of Publication: 2014"

"TITLE","Partial clinical response to anakinra in severe palmoplantar pustular psoriasis""AUTHOR NAMES","Tauber M.","Viguier M.","Alimova E.","Petit A.","Lioté F.","Smahi A.","Bachelez H.""SOURCE","British Journal of Dermatology (2014) 171:3 (646-649). Date of Publication: 1 Sep 2014"

"TITLE","Generalised pustular psoriasis - A case report and review of therapeutic approaches""AUTHOR NAMES","Osmola-Mańkowska A.""SOURCE","Przeglad Dermatologiczny (2014) 101:6 (473-476). Date of Publication: 2014"

"TITLE","Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: Results of a prospective longitudinal observational study""AUTHOR NAMES","Montaudié H.","Albert-Sabonnadière C.","Acquacalda E.","Fontas E.","Danré A.","Roux C.","Ortonne J.P.","Lacour J.P.","Euller-Ziegler L.","Passeron T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:9 (1186-1191). Date of Publication: 2014"

"TITLE","German psoriasis registry PsoBest: Objectives, methodology and baseline data""AUTHOR NAMES","Augustin M.","Spehr C.","Radtke M.A.","Boehncke W.-H.","Luger T.","Mrowietz U.","Reusch M.","Strömer K.","Wozel G.","Kiedrowski R.V.","Rustenbach S.J.","Purwins S.","Reich K.""SOURCE","JDDG - Journal of the German Society of Dermatology (2014) 12:1 (48-57). Date of Publication: January 2014"

"TITLE","Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: A single-centre database analysis""AUTHOR NAMES","Menting S.P.","Sitaram A.S.","Bonnerjee-Van Der Stok H.M.","De Rie M.A.","Hooft L.","Spuls P.I.""SOURCE","British Journal of Dermatology (2014) 171:4 (875-883). Date of Publication: 1 Oct 2014"

"TITLE","Suicide and depression in a patient with psoriasis receiving adalimumab: The role of the dermatologist""AUTHOR NAMES","Ellard R.","Ahmed A.","Shah R.","Bewley A.""SOURCE","Clinical and Experimental Dermatology (2014) 39:5 (624-627). Date of Publication: July 2014"

"TITLE","Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample""AUTHOR NAMES","Yeaw J.","Watson C.","Fox K.M.","Schabert V.F.","Goodman S.","Gandra S.R.""SOURCE","Advances in Therapy (2014) 31:4 (410-425). Date of Publication: April 2014"

"TITLE","Comparing treatment goals for psoriasis with treatment decisions in daily practice: Results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE""AUTHOR NAMES","Zweegers J.","Van Den Reek J.M.P.A.","Van De Kerkhof P.C.M.","Otero M.E.","Ossenkoppele P.M.","Njoo M.D.","Mommers J.M.","Koetsier M.I.A.","Arnold W.P.","Sybrandy-Fleuren B.A.M.","Kuijpers A.L.A.","Andriessen M.P.M.","Kievit W.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2014) 171:5 (1091-1098). Date of Publication: 1 Nov 2014"

"TITLE","What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice""AUTHOR NAMES","Talamonti M.","Galluzzo M.","Bianchi L.","Boca A.N.","Costanzo A.","Chimenti S.""SOURCE","Dermatology (2014) 229:4 (324-332). Date of Publication: 22 May 2014"

"TITLE","Efficacy, safety, and out-of-pocket costs are the most important factors to patients in choosing a psoriasis therapy""AUTHOR NAMES","Secrest A.M.","Matinrazm A.","Ferris L.K.""SOURCE","Journal of Clinical and Aesthetic Dermatology (2014) 7:12 (30-33). Date of Publication: 1 Dec 2014"

"TITLE","Intensification therapy with golimumab: A new treatment strategy for moderate-severe refractory psoriasis""AUTHOR NAMES","Torregrosa Calatayud J.L.","Garcías Ladaria J.","Sánchez Carazo J.L.","Pérez-Ferriols A.","Oliver Martínez V.","Calvo Catalá J.","Alegre de Miquel V.""SOURCE","International Journal of Dermatology (2014) 53:12 (e585-e587). Date of Publication: 1 Dec 2014"

"TITLE","Patch test results in psoriasis patients on biologics""AUTHOR NAMES","Kim N.","Notik S.","Gottlieb A.B.","Scheinman P.L.""SOURCE","Dermatitis (2014) 25:4 (182-190). Date of Publication: 2014"

"TITLE","Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis""AUTHOR NAMES","Dang L.J.","Lubel J.S.","Gunatheesan S.","Hosking P.","Su J.""SOURCE","Australasian Journal of Dermatology (2014) 55:1 (75-79). Date of Publication: February 2014"

"TITLE","Satisfaction of treatment with biologics is high in psoriasis: Results from the Bio-CAPTURE network""AUTHOR NAMES","Van Den Reek J.M.P.A.","Van Lüumig P.P.M.","Otero M.E.","Zweegers J.","Van De Kerkhof P.C.M.","Ossenkoppele P.M.","Njoo M.D.","Mommers J.M.","Koetsier M.I.A.","Arnold W.P.","Sybrandy-Fleuren B.A.M.","Kuijpers A.L.A.","Andriessen M.P.M.","Seyger M.M.B.","Kievit W.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2014) 170:5 (1158-1165). Date of Publication: May 2014"

"TITLE","Monoclonal gammopathy of undetermined significance in patients with psoriasis: Is it really a side effect of biological therapy?""AUTHOR NAMES","Conti A.","Esposito I.","Lasagni C.","Miglietta R.","Padalino C.","Fabiano A.","Pellacani G.""SOURCE","Drug Development Research (2014) 75:S1 (S35-S37). Date of Publication: 1 Nov 2014"

"TITLE","The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: A randomized controlled prospective trial""AUTHOR NAMES","Al-Mutairi N.","Nour T.""SOURCE","Expert Opinion on Biological Therapy (2014) 14:6 (749-756). Date of Publication: June 2014"

"TITLE","Infliximab treatment of psoriasis in supervised infusion centers: Case management experience""AUTHOR NAMES","Campos Muñoz L.","De Unamuno Bustos B.","Herranz Pinto P.","El Ahmed H.H.","Ruiz-Villaverde R.","Taberner Ferrer R.""SOURCE","American Journal of Clinical Dermatology (2014) 15:SUPPL. 1 (S17-S24). Date of Publication: February 2014"

"TITLE","Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: A cohort analysis in the French insurance database""AUTHOR NAMES","Le Moigne M.","Sommet A.","Lapeyre-Mestre M.","Bourrel R.","Molinier L.","Paul C.","Montastruc J.-.L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:9 (1235-1244). Date of Publication: 2014"

"TITLE","Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)""AUTHOR NAMES","Kimball A.B.","Leonardi C.","Stahle M.","Gulliver W.","Chevrier M.","Fakharzadeh S.","Goyal K.","Calabro S.","Langholff W.","Menter A.""SOURCE","British Journal of Dermatology (2014) 171:1 (137-147). Date of Publication: 2014"

"TITLE","The psychophysiological stress response in psoriasis and rheumatoid arthritis""AUTHOR NAMES","De Brouwer S.J.M.","Van Middendorp H.","Stormink C.","Kraaimaat F.W.","Sweep F.C.G.J.","De Jong E.M.G.J.","Schalkwijk J.","Eijsbouts A.","Donders A.R.T.","Van De Kerkhof P.C.M.","Van Riel P.L.C.M.","Evers A.W.M.""SOURCE","British Journal of Dermatology (2014) 170:4 (824-831). Date of Publication: 2014"

"TITLE","The risk of deep fungal infections during biologic therapy for psoriasis""AUTHOR NAMES","Jourabchi N.","Adelzadeh L.","Wu J.J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:10 (1277-1285). Date of Publication: 1 Oct 2014"

"TITLE","National survey of psoriasis flares after 2009 monovalent H<inf>1</inf> N<inf>1</inf> / seasonal vaccines""AUTHOR NAMES","Sbidian E.","Eftekahri P.","Viguier M.","Laroche L.","Chosidow O.","Gosselin P.","Trouche F.","Bonnet N.","Arfi C.","Tubach F.","Bachelez H.""SOURCE","Dermatology (2014) 229:2 (130-135). Date of Publication: 19 Nov 2014"

"TITLE","Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis""AUTHOR NAMES","Larquey M.","Poreaux C.","Cuny J.-F.","Barbaud A.","Schmutz J.-L.""SOURCE","European Journal of Dermatology (2014) 24:5 (618-619). Date of Publication: 1 Sep 2014"

"TITLE","Cost-of-illness in patients with moderate to severe psoriasis: A cross-sectional survey in Hungarian dermatological centres""AUTHOR NAMES","Balogh O.","Brodszky V.","Gulácsi L.","Herédi E.","Herszényi K.","Jókai H.","Kárpáti S.","Baji P.","Remenyik É.","Szegedi A.","Holló P.""SOURCE","European Journal of Health Economics (2014) 15:SUPPL. 1 (S101-S109). Date of Publication: May 2014"

"TITLE","Real-world outcome analysis of continuously and intermittently treated patients with moderate to severe psoriasis after switching to a biologic agent""AUTHOR NAMES","Hjalte F.","Steen Carlsson K.","Schmitt-Egenolf M.""SOURCE","Dermatology (2014) 230:4 (347-353). Date of Publication: 28 May 2015"

"TITLE","Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy""AUTHOR NAMES","Gisondi P.","Pezzolo E.","Lo Cascio G.","Girolomoni G.""SOURCE","British Journal of Dermatology (2014) 171:4 (884-890). Date of Publication: 1 Oct 2014"

"TITLE","Efficacy of Tumor Necrosis Factor Inhibitors in Patients with Ankylosing Spondylitis""AUTHOR NAMES","Dülgeroğlu Erdoğdu D.","Bal A.","Karaahmet Ö.","Erkoç S.","Yalçin T.","Çakci A.""SOURCE","Turkish Journal of Rheumatology (2014) 29:4 (257-266). Date of Publication: 2014"

"TITLE","Management of patients with psoriasis treated with biological drugs needing a surgical treatment""AUTHOR NAMES","Fabiano A.","De Simone C.","Gisondi P.","Piaserico S.","Lasagni C.","Pellacani G.","Conti A.""SOURCE","Drug Development Research (2014) 75:S1 (S24-S26). Date of Publication: 1 Nov 2014"

"TITLE","Happy drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: Results from the BioCAPTURE network""AUTHOR NAMES","Van Den Reek J.M.P.A.","Zweegers J.","Kievit W.","Otero M.E.","Van Lümig P.P.M.","Driessen R.J.B.","Ossenkoppele P.M.","Njoo M.D.","Mommers J.M.","Koetsier

M.I.A.","Arnold W.P.","Sybrandy-Fleuren B.A.M.","Kuijpers A.L.A.","Andriessen M.P.M.","Van De Kerkhof P.C.M.","Seyger M.M.B.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2014) 171:5 (1189-1196). Date of Publication: 1 Nov 2014"

"TITLE","Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies""AUTHOR NAMES","Gottlieb A.B.","Kalb R.E.","Langley R.G.","Krueger G.G.","De Jong E.M.G.J.","Guenther L.","Goyal K.","Fakharzadeh S.","Chevrier M.","Calabro S.","Langholff W.","Menter A.""SOURCE","Journal of Drugs in Dermatology (2014) 13:12 (1441-1448). Date of Publication: 1 Dec 2014"

"TITLE","Some clinical factors affecting quality of the response to ustekinumab for psoriasis""AUTHOR NAMES","Umezawa Y.","Saeki H.","Nakagawa H.""SOURCE","Journal of Dermatology (2014) 41:8 (690-696). Date of Publication: August 2014"

"TITLE","Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting""AUTHOR NAMES","Takeshita J.","Wang S.","Shin D.B.","Callis Duffin K.","Krueger G.G.","Kalb R.E.","Weisman J.D.","Sperber B.R.","Stierstorfer M.B.","Brod B.A.","Schleicher S.M.","Robertson A.D.","Linn K.A.","Shinohara R.T.","Troxel A.B.","Van Voorhees A.S.","Gelfand J.M.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:6 (1167-1175). Date of Publication: 1 Dec 2014"

"TITLE","Biologics are more potent than other treatment modalities for improvement of quality of life in psoriasis patients""AUTHOR NAMES","Takahashi H.","Iinuma S.","Tsuji H.","Honma M.","Iizuka H.""SOURCE","Journal of Dermatology (2014) 41:8 (686-689). Date of Publication: August 2014"

"TITLE","Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: A retrospective analysis""AUTHOR NAMES","Chiu H.-Y.","Wang T.-S.","Chan C.-C.","Cheng Y.-P.","Lin S.-J.","Tsai T.-F.""SOURCE","British Journal of Dermatology (2014) 171:5 (1181-1188). Date of Publication: 1 Nov 2014"

"TITLE","Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: Expanding the spectrum of neurological disease associated with TNF-inhibitors""AUTHOR NAMES","Birnbaum J.","Bingham C.O.""SOURCE","Seminars in Arthritis and Rheumatism (2014) 43:5 (638-647). Date of Publication: April 2014"

"TITLE","Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis""AUTHOR NAMES","Foulkes A.C.","Wheeler L.","Gosal D.","Griffiths C.E.M.","Warren R.B.""SOURCE","British Journal of Dermatology (2014) 170:1 (206-209). Date of Publication: January 2014"

"TITLE","Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis""AUTHOR NAMES","Gulyas K.","Bodnar N.","Nagy Z.","Szamosi S.","Horvath A.","Vancsa A.","Vegh E.","Szabo Z.","Szucs G.","Szekanecz Z.","Szanto S.""SOURCE","European Journal of Health Economics (2014) 15:SUPPL. 1 (S93-S100). Date of Publication: May 2014"

"TITLE","Treatment-related restoration of langerhans cell migration in psoriasis""AUTHOR NAMES","Shaw F.L.","Mellody K.T.","Ogden S.","Dearman R.J.","Kimber I.","Griffiths C.E.M.""SOURCE","Journal of Investigative Dermatology (2014) 134:1 (268-271). Date of Publication: January 2014"

"TITLE","Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis""AUTHOR NAMES","Commons R.J.","Grivas R.","Currie B.J.""SOURCE","Internal Medicine Journal (2014) 44:12 (1245-1246). Date of Publication: 1 Dec 2014"

"TITLE","Anti-TNFα therapy in the management of psoriasis: Experience of a state referral center""AUTHOR NAMES","Silva L.M.A.","Rocha B.O.","Nobre A.C.P.","Rêgo V.R.P.A.","Follador I.","de Oliveira M.F.S.P.""SOURCE","Anais Brasileiros de Dermatologia (2014) 89:3 (436-440). Date of Publication: May/June 2014"

"TITLE","Golimumab in patients affected by moderate to severe psoriatic arthritis: An open-label study in thirty-two patients previously treated with other biologics""AUTHOR NAMES","Chimenti M.S.","Teoli M.","Saraceno R.","Dattola A.","Ventura A.","Chiricozzi

A.","Chiaramonte C.","Perricone R.","Chimenti S.""SOURCE","Dermatology (2014) 227:4 (305-310). Date of Publication: January 2014"

"TITLE","Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept""AUTHOR NAMES","Tichy M.","Hercogova J.""SOURCE","Dermatologic Therapy (2014) 27:4 (211-214). Date of Publication: July-August 2014"

"TITLE","Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil""AUTHOR NAMES","Lopes L.C.","Silveira M.S.D.N.","De Camargo M.C.","De Camargo I.A.","Luz T.C.B.","Osorio-De-Castro C.G.S.","Barberato-Filho S.","Del Fiol F.D.S.","Guyatt G.""SOURCE","Expert Opinion on Drug Safety (2014) 13:9 (1155-1163). Date of Publication: September 2014"

"TITLE","Resistant palmoplantar lesions in patients of psoriasis: Evaluation of the causes and comparison of the frequency of delayed-type hypersensitivity in patients without palm and sole lesions""AUTHOR NAMES","Al-Mutairi N.","Abdalla T.O.","Nour T.M.""SOURCE","Medical Principles and Practice (2014) 23:6 (561-567). Date of Publication: 19 Nov 2014"

"TITLE","Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis""AUTHOR NAMES","Capo A.","di Nicola M.","Auriemma M.","Piaserico S.","Cuccurullo C.","Santilli F.","Davi G.","Amerio P.""SOURCE","European Journal of Dermatology (2014) 24:1 (133-135). Date of Publication: January-February 2014"

"TITLE","Secukinumab in plaque psoriasis - Results of two phase 3 trials""AUTHOR NAMES","Langley R.G.","Elewski B.E.","Lebwohl M.","Reich K.","Griffiths C.E.M.","Papp K.","Puig L.","Nakagawa H.","Spelman L.","Sigurgeirsson B.","Rivas E.","Tsai T.-F.","Wasel N.","Tyring S.","Salko T.","Hampele I.","Notter M.","Karpov A.","Helou S.","Papavassilis C.""SOURCE","New England Journal of Medicine (2014) 371:4 (326-338). Date of Publication: 2014"

"TITLE","Autoantibodies in psoriatic patients treated with anti-TNF-α therapy""AUTHOR NAMES","Bardazzi F.","Odorici G.","Virdi A.","Antonucci V.A.","Tengattini V.","Patrizi A.","Balestri R.""SOURCE","JDDG - Journal of the German Society of Dermatology (2014) 12:5 (401-406). Date of Publication: May 2014"

"TITLE","Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-tumour necrosis factor-α therapy""AUTHOR NAMES","Kelsen J.","Dige A.","Christensen M.","D'Amore F.","Iversen L.""SOURCE","Clinical and Experimental Immunology (2014) 177:1 (142-148). Date of Publication: July 2014"

"TITLE","Drug survival of fumaric acid esters for psoriasis: A retrospective study""AUTHOR NAMES","Ismail N.","Collins P.","Rogers S.","Kirby B.","Lally A.""SOURCE","British Journal of Dermatology (2014) 171:2 (397-402). Date of Publication: 2014"

"TITLE","Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: A randomized control clinical trial""AUTHOR NAMES","Guida B.","Napoleone A.","Trio R.","Nastasi A.","Balato N.","Laccetti R.","Cataldi M.""SOURCE","Clinical Nutrition (2014) 33:3 (399-405). Date of Publication: June 2014"

"TITLE","Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs""AUTHOR NAMES","Perrotta F.M.","Addimanda O.","Ramonda R.","D’Angelo S.","Lubrano E.","Marchesoni A.","Olivieri I.","Punzi L.","Salvarani C.","Spadaro A.""SOURCE","Reumatismo (2014) 66:3 (208-214). Date of Publication: 2014"

"TITLE","Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker""AUTHOR NAMES","Villani A.P.","Weiler L.","Jullien D.","Chapurlat R.","Confavreux C.""SOURCE","Joint Bone Spine (2014) 81:5 (455-463). Date of Publication: 2014"

"TITLE","HLA-G 14-bp polymorphism: A possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study""AUTHOR NAMES","Borghi A.","Rizzo R.","Corazza M.","Bertoldi A.M.","Bortolotti D.","Sturabotti G.","Virgili A.","Di Luca D.""SOURCE","Dermatologic Therapy (2014) 27:5 (284-289). Date of Publication: 1 Sep 2014"

"TITLE","Occurrence of psoriatic plaques on previous adalimumab injection sites during disease relapse in a patient with pustular psoriasis""AUTHOR NAMES","Wang T.-S.","Tsai T.-F.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:1 (e24-e26). Date of Publication: July 2014"

"TITLE","Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience""AUTHOR NAMES","Kopylov U.","Afif W.","Cohen A.","Bitton A.","Wild G.","Bessissow T.","Wyse J.","Al-Taweel T.","Szilagyi A.","Seidman E.""SOURCE","Journal of Crohn's and Colitis (2014) 8:11 (1516-1522). Date of Publication: 2014"

"TITLE","The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in ITALY""AUTHOR NAMES","Spandonaro F.","Ayala F.","Berardesca E.","Chimenti S.","Girolomoni G.","Martini P.","Peserico A.","Polistena B.","Puglisi Guerra A.","Vena G.A.","Altomare G.","Calzavara Pinton P.""SOURCE","BioDrugs (2014) 28:3 (285-295). Date of Publication: June 2014"

"TITLE","Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14""AUTHOR NAMES","Eytan O.","Sarig O.","Sprecher E.","Van Steensel M.A.M.""SOURCE","British Journal of Dermatology (2014) 171:2 (420-422). Date of Publication: 2014"

"TITLE","Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis""AUTHOR NAMES","Navarro R.","Concha-Garzón M.J.","Castaño C.","Casal C.","Guiu A.","Daudén E.""SOURCE","International Journal of Dermatology (2014) 53:7 (909-911). Date of Publication: July 2014"

"TITLE","Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy""AUTHOR NAMES","Gutiérrez-González E.","Batalla A.","de La Mano D.""SOURCE","Dermatology Online Journal (2014) 20:4. Date of Publication: 2014"

"TITLE","Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit. A review of clinical features and new therapeutics""AUTHOR NAMES","Varman K.M.","Namias N.","Schulman C.I.","Pizano L.R.""SOURCE","Burns (2014) 40:4 (e35-e39). Date of Publication: June 2014"

"TITLE","Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy""AUTHOR NAMES","Hay R.A.S.","Pan J.Y.""SOURCE","Clinical and Experimental Dermatology (2014) 39:6 (751-752). Date of Publication: August 2014"

"TITLE","Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options""AUTHOR NAMES","Sylwestrzak G.","Liu J.","Stephenson J.J.","Ruggieri A.P.","DeVries A.""SOURCE","American Health and Drug Benefits (2014) 7:2 (71-81). Date of Publication: April 2014"

"TITLE","TNF-α gene polymorphisms: Association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis""AUTHOR NAMES","Murdaca G.","Gulli R.","Spanò F.","Lantieri F.","Burlando M.","Parodi A.","Mandich P.","Puppo F.""SOURCE","Journal of Investigative Dermatology (2014) 134:10 (2503-2509). Date of Publication: 1 Jan 2014"

"TITLE","Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases""AUTHOR NAMES","Saraceno R.","Talamonti M.","Galluzzo M.","Chiricozzi A.","Costanzo A.","Chimenti S.""SOURCE","Case Reports in Dermatology (2014) 5:3 (254-258). Date of Publication: 2014"

"TITLE","Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study""AUTHOR NAMES","Tauber M.","Buche S.","Reygagne P.","Berthelot J.-M.","Aubin F.","Ghislain P.-D.","Cohen J.-D.","Coquerelle P.","Goujon E.","Jullien D.","Brixi H.","Jeudy G.","Guennoc X.","Martin A.","Brénaut E.","Hoppé E.","Bertolotti A.","Bardin T.","Delaporte E.","Allez M.","Bachelez H.","Seneschal J.","Viguier M.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:6 (1146-1149). Date of Publication: June 2014"

"TITLE","The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection""AUTHOR NAMES","Atteno M.","Costa L.","Matarese A.","Caso F.","Del Puente A.","Cantarini

L.","Bocchino M.L.","Sanduzzi A.","Scarpa R.""SOURCE","Clinical Rheumatology (2014) 33:4 (543-547). Date of Publication: April 2014"

"TITLE","Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: A retrospective investigation of 146 psoriasis patients""AUTHOR NAMES","Hoffmann J.H.O.","Knoop C.","Enk A.H.","Hadaschik E.N.""SOURCE","Journal of Dermatological Science (2014) 76:3 (180-185). Date of Publication: 1 Dec 2014"

"TITLE","Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients""AUTHOR NAMES","Włodarczyk M.","Sobolewska A.","Wójcik B.","Loga K.","Fichna J.","Wiśniewska-Jarosińska M.""SOURCE","World Journal of Gastroenterology (2014) 20:22 (7019-7026). Date of Publication: 2014"

"TITLE","Retrospective cohort study of anti-tumor necrosis factor agent use in a Veteran Population""AUTHOR NAMES","Bounthavong M.","Madkour N.","Kazerooni R.""SOURCE","PeerJ (2014) 2014:1 Article Number: e385. Date of Publication: 2014"

"TITLE","Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis""AUTHOR NAMES","Escalas J.","Knöpfel N.","Martin-Santiago A.","Calles C.""SOURCE","Journal of the American Academy of Dermatology (2014) 70:1 (e17-e18). Date of Publication: January 2014"

"TITLE","Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis""AUTHOR NAMES","Eder L.","Thavaneswaran A.","Chandran V.","Gladman D.D.""SOURCE","Annals of the Rheumatic Diseases (2014) 73:6 (1007-1011). Date of Publication: June 2014"

"TITLE","Multiple halo naevi associated with tocilizumab""AUTHOR NAMES","Kuet K.","Goodfield M.""SOURCE","Clinical and Experimental Dermatology (2014) 39:6 (717-719). Date of Publication: August 2014"

"TITLE","Survival rate of etanercept for psoriasis in real life: A multicentre observational study""AUTHOR NAMES","Herrera-Acosta E.","Suárez-Pérez J.A.","Aguilera J.","Gómez-Garcĺa F.","Jiménez-Puya R.","Guimeŕa F.","Mendiola M.V.","Herreraceballos E.""SOURCE","European Journal of Dermatology (2014) 24:5 (619-620). Date of Publication: 1 Sep 2014"

"TITLE","Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis""AUTHOR NAMES","Baert F.","Vande Casteele N.","Tops S.","Noman M.","Van Assche G.","Rutgeerts P.","Gils A.","Vermeire S.","Ferrante M.""SOURCE","Alimentary Pharmacology and Therapeutics (2014) 40:11-12 (1324-1332). Date of Publication: 1 Dec 2014"

"TITLE","Letter: Dermatological complications with therapy for inflammatory bowel disease""AUTHOR NAMES","Mihály E.","Székely H.","Herszényi L.","Wikonkál N.","Tulassay Z.""SOURCE","Alimentary Pharmacology and Therapeutics (2014) 39:2 (232-233). Date of Publication: January 2014"

"TITLE","Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis""AUTHOR NAMES","Ryan C.","Kelleher J.","Fagan M.F.","Rogers S.","Collins P.","Barker J.N.W.N.","Allen M.","Hagan R.","Renfro L.","Kirby B.""SOURCE","Clinical and Experimental Dermatology (2014) 39:4 (519-524). Date of Publication: June 2014"

"TITLE","Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease""AUTHOR NAMES","Seirafi M.","De Vroey B.","Amiot A.","Seksik P.","Roblin X.","Allez M.","Peyrin-Biroulet L.","Marteau P.","Cadiot G.","Laharie D.","Boureille A.","De Vos M.","Savoye G.","Rahier J.-F.","Carbonnel F.","Bonaz B.","Colombel J.-F.","Bouhnik Y.""SOURCE","Alimentary Pharmacology and Therapeutics (2014) 40:4 (363-373). Date of Publication: August 2014"

"TITLE","Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis""AUTHOR NAMES","Bito T.","Nishikawa R.","Hatakeyama M.","Kikusawa A.","Kanki H.","Nagai H.","Sarayama Y.","Ikeda T.","Yoshizaki H.","Seto H.","Adachi A.","Horikawa T.","Oka

M.","Nishigori C.""SOURCE","British Journal of Dermatology (2014) 170:4 (922-929). Date of Publication: 2014"

"TITLE","Induction or exacerbation of psoriasis in patients with Crohn's Disease under treatment with anti-TNF antibodies""AUTHOR NAMES","Barthel C.","Biedermann L.","Frei P.","Vavricka S.R.","Kündig T.","Fried M.","Rogler G.","Scharl M.""SOURCE","Digestion (2014) 89:3 (209-215). Date of Publication: 2014"

"TITLE","Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester""AUTHOR NAMES","Sheeran C.","Nicolopoulos J.""SOURCE","Australasian Journal of Dermatology (2014) 55:3 (235-236). Date of Publication: August 2014"

"TITLE","Central retinal vein occlusion and subsequent neovascular glaucoma after adalimumab treatment for psoriasis""AUTHOR NAMES","Hsu C.-K.","Cheng C.-Y.","Hung J.-H.","Li M.L.","Huang F.-C.","Yang W.-L.","Lee J.Y.-Y.""SOURCE","Clinical and Experimental Dermatology (2014) 39:1 (72-73). Date of Publication: January 2014"

"TITLE","Low-dose methotrexate - A therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris""AUTHOR NAMES","Wilsmann-Theis D.","Fronhoffs K.","Ehler L.-K.","Wenzel J.","Bieber T.","Klingmueller K.""SOURCE","Dermatologic Therapy (2014) 27:1 (55-59). Date of Publication: January-February 2014"

"TITLE","Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study""AUTHOR NAMES","Ohtsuki M.","Morita A.","Abe M.","Takahashi H.","Seko N.","Karpov A.","Shima T.","Papavassilis C.","Nakagawa H.""SOURCE","Journal of Dermatology (2014) 41:12 (1039-1046). Date of Publication: 1 Dec 2014"

"TITLE","Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy""AUTHOR NAMES","Strober B.E.","Poulin Y.","Teller C.","Wang Y.","Williams D.A.","Goldblum O.M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:12 (1701-1706). Date of Publication: 1 Dec 2014"

"TITLE","Two cases of renal cell cancer during immunobiologic therapy for psoriasis""AUTHOR NAMES","Zarur F.P.","d’Almeida L.F.V.","Mafort M.S.P.","de Gusmão P.R.","Avelleira J.C.R.""SOURCE","Anais Brasileiros de Dermatologia (2014) 89:6 (1017-1018). Date of Publication: 1 Nov 2014"

"TITLE","Immunologic biomarkers for clinical and therapeutic management of psoriasis""AUTHOR NAMES","Cordiali-Fei P.","Bianchi L.","Bonifati C.","Trento E.","Ruzzetti M.","Francesconi F.","Bultrini S.","D'Agosto G.","Bordignon V.","Francavilla V.","Tripiciano A.","Chiricozzi A.","Campione E.","Cavallotti C.","Orlandi A.","Berardesca E.","Di Carlo A.","Chimenti S.","Ensoli F.""SOURCE","Mediators of inflammation (2014) 2014 (236060). Date of Publication: 2014"

"TITLE","Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: Implications for pharmacovigilance""AUTHOR NAMES","Blake K.V.","Zaccaria C.","Domergue F.","La Mache E.","Saint-Raymond A.","Hidalgo-Simon A.""SOURCE","Pediatric Drugs (2014) 16:4 (309-319). Date of Publication: August 2014"

"TITLE","Disease Control for Patients with Psoriasis Receiving Continuous Versus Interrupted Therapy with Adalimumab or Etanercept: A Clinical Practice Study""AUTHOR NAMES","Moreno-Ramírez D.","Ojeda-Vila T.","Ferrándiz L.""SOURCE","American Journal of Clinical Dermatology (2014) 15:6 (543-549). Date of Publication: 21 Nov 2014"

"TITLE","Cutaneous actinomycosis associated with anti-TNF-alpha therapy: Report of two cases""AUTHOR NAMES","Breton A.L.","Lamblin G.","Pariset C.","Jullien D.""SOURCE","Dermatology (2014) 228:2 (112-114). Date of Publication: March 2014"

"TITLE","The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center""AUTHOR NAMES","Koskinas J.S.","Deutsch M.","Adamidi S.","Skondra M.","Tampaki M.","Alexopoulou A.","Manolakopoulos S.","Pectasides D.""SOURCE","European Journal of Internal Medicine (2014) 25:8 (768-771). Date of Publication: 1 Oct 2014"

"TITLE","Cutaneous actinomycosis associated with anti-TNF-alpha therapy: Report of two cases"

"AUTHOR NAMES","Breton A.L.","Lamblin G.","Pariset C.","Jullien D.""SOURCE","Dermatology (2014) 228:2 (112-114). Date of Publication: 2014"

"TITLE","Evaluation of body composition parameters in patients with psoriasis""AUTHOR NAMES","Engin B.","Kutlubay Z.","Yardimci G.","Vehid H.E.","Ambarcioğlu P.","Serdaroğlu S.","Tüzün Y.""SOURCE","International Journal of Dermatology (2014) 53:12 (1468-1473). Date of Publication: 1 Dec 2014"

"TITLE","The risk of skin cancer in psoriasis patients treated with UVB therapy""AUTHOR NAMES","Osmancevic A.","Gillstedt M.","Wennberg A.-M.","Larkö O.""SOURCE","Acta Dermato-Venereologica (2014) 94:4 (425-430). Date of Publication: July 2014"

"TITLE","Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasis""AUTHOR NAMES","Piaserico S.","Sandini E.","Saldan A.","Abate D.""SOURCE","Drug Development Research (2014) 75:S1 (S73-S76). Date of Publication: 1 Nov 2014"

"TITLE","Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebocontrolled, randomised PSUMMIT 2 trial""AUTHOR NAMES","Ritchlin C.","Rahman P.","Kavanaugh A.","McInnes I.B.","Puig L.","Li S.","Wang Y.","Shen Y.-K.","Doyle M.K.","Mendelsohn A.M.","Gottlieb A.B.""SOURCE","Annals of the Rheumatic Diseases (2014) 73:6 (990-999). Date of Publication: June 2014"

"TITLE","The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients""AUTHOR NAMES","Ganzetti G.","Campanati A.","Scocco V.","Brugia M.","Tocchini M.","Liberati G.","Giuliodori K.","Brisigotti V.","Offidani A.""SOURCE","Acta Dermato-Venereologica (2014) 94:6 (715-717). Date of Publication: 2014"

"TITLE","Factors influencing seasonal patterns of relapse in anti-TNF psoriatic responders after temporary drug discontinuation""AUTHOR NAMES","Ruano J.","Velez A.","Casas E.","Rodriguez-Martin A.","Salido R.","Isla-Tejera B.","Espejo-Alvarez J.","Gómez F.","Jiménez-Puya R.","Moreno-Giménez J.C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:4 (516-518). Date of Publication: 2014"

"TITLE","Abdominal aortitis in HLA-B27+ spondyloarthritis: Case report with 5-year follow-up and literature review""AUTHOR NAMES","Grewal G.S.","Leipsic J.","Klinkhoff A.V.""SOURCE","Seminars in Arthritis and Rheumatism (2014) 44:3 (305-308). Date of Publication: 1 Dec 2014"

"TITLE","Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: A retrospective study of three cases from a single centre and literature review""AUTHOR NAMES","Calvo-Río V.","de la Hera D.","Blanco R.","Beltrán-Catalán E.","Loricera J.","Cañal J.","Ventosa J.","Cifrián J.M.","Ortiz-Sanjuán F.","Rueda-Gotor J.","González-Vela M.C.","González-López M.","González-Gay M.A.""SOURCE","Clinical and Experimental Rheumatology (2014) 32:6 (864-868). Date of Publication: 2014"

"TITLE","Prevalence of past and reactivated viral infections and efficacy of cyclosporine a as monotherapy or in combination in patients with psoriatic arthritis - Synergy study: A longitudinal observational study""AUTHOR NAMES","Colombo D.","Chimenti S.","Grossi P.","Marchesoni A.","Di Nuzzo S.","Griseta V.","Gargiulo A.","Parodi A.","Simoni L.","Bellia G.""SOURCE","BioMed Research International (2014) 2014 Article Number: 941767. Date of Publication: 2014"

"TITLE","Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations""AUTHOR NAMES","Hüffmeier U.","Wätzold M.","Mohr J.","Schön M.P.","Mössner R.""SOURCE","British Journal of Dermatology (2014) 170:1 (202-204). Date of Publication: January 2014"

"TITLE","Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis""AUTHOR NAMES","Guidelli G.","Tenti S.","Fioravanti A.""SOURCE","Indian Journal of Dermatology, Venereology and Leprology (2014) 80:2 (187-189). Date of Publication: March-April 2014"

"TITLE","Comparative effectiveness of infliximab and adalimumab for crohn's disease""AUTHOR NAMES","Osterman M.T.","Haynes K.","Delzell E.","Zhang J.","Bewtra M.","Brensinger

C.","Chen L.","Xie F.","Curtis J.R.","Lewis J.D.""SOURCE","Clinical Gastroenterology and Hepatology (2014) 12:5 (811-817). Date of Publication: May 2014"

"TITLE","Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Two-year efficacy and safety findings from AMPLE trial""AUTHOR NAMES","Schiff M.","Weinblatt M.E.","Valente R.","Van Der Heijde D.","Citera G.","Elegbe A.","Maldonado M.","Fleischmann R.""SOURCE","Annals of the Rheumatic Diseases (2014) 73:1 (86-94). Date of Publication: January 2014"

"TITLE","Ustekinumab induces fast response and maintenance of very severe refractory scalp psoriasis: Results in two Greek patients from the psoriasis hospital-based clinic""AUTHOR NAMES","Papadavid E.","Ferra D.","Koumaki D.","Dalamaga M.","Stamou C.","Theodoropoulos K.","Rigopoulos D.""SOURCE","Dermatology (2014) 228:2 (107-111). Date of Publication: 2014"

"TITLE","Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: Subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial""AUTHOR NAMES","Paul C.","Reich K.","Gottlieb A.B.","Mrowietz U.","Philipp S.","Nakayama J.","Harfst E.","Guettner A.","Papavassilis C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:12 (1670-1675). Date of Publication: 1 Dec 2014"

"TITLE","Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; Results from a randomised controlled trial""AUTHOR NAMES","Bissonnette R.","Nigen S.","Langley R.G.","Lynde C.W.","Tan J.","Fuentes-Duculan J.","Krueger J.G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:10 (1298-1305). Date of Publication: 1 Oct 2014"

"TITLE","Five-year history of pruritic plaques""AUTHOR NAMES","Chapman J.C.","Murina A.","Boh E.""SOURCE","International Journal of Dermatology (2014) 53:1 (e33-e35). Date of Publication: January 2014"

"TITLE","Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients""AUTHOR NAMES","Koike T.","Harigai M.","Ishiguro N.","Inokuma S.","Takei S.","Takeuchi T.","Yamanaka H.","Haruna S.","Ushida N.","Kawana K.","Tanaka Y.""SOURCE","Modern Rheumatology (2014) 24:3 (390-398). Date of Publication: May 2014"

"TITLE","Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis""AUTHOR NAMES","Bertelsen T.","Kragballe K.","Johansen C.","Iversen L.""SOURCE","International Journal of Dermatology (2014) 53:10 (e464-e466). Date of Publication: 2014"

"TITLE","Ustekinumab improves psoriasis without suppressing tumor antigen-specific cytotoxic T lymphocytes""AUTHOR NAMES","Narita M.","Nishizawa Y.","Iwaya S.","Oiwa E.","Iwabuchi M.","Uchiyama T.","Matsuyama A.","Masuko M.","Takahashi M.""SOURCE","International Archives of Allergy and Immunology (2014) 165:1 (52-60). Date of Publication: 27 Nov 2014"

"TITLE","Ustekinumab induces fast response and maintenance of very severe refractory scalp psoriasis: Results in two greek patients from the psoriasis hospital-based clinic""AUTHOR NAMES","Papadavid E.","Ferra D.","Koumaki D.","Dalamaga M.","Stamou C.","Theodoropoulos K.","Rigopoulos D.""SOURCE","Dermatology (2014) 228:2 (107-111). Date of Publication: March 2014"

"TITLE","Ustekinumab in severe complicated erythrodermic psoriasis: Rapid clearing, safety, and sustained remission""AUTHOR NAMES","Koutsoukou X.-A.","Papadavid E.","Theodoropoulos K.","Rigopoulos D.""SOURCE","Dermatologic Therapy (2014) 27:5 (257-259). Date of Publication: 1 Sep 2014"

"TITLE","Extent and consequences of antibody formation against adalimumab in patients with psoriasis one-year follow-up""AUTHOR NAMES","Menting S.P.","Van Lümig P.P.M.","De Vries A.-C.Q.","Van Den Reek J.M.P.A.","Van Der Kleij D.","De Jong E.M.G.J.","Spuls P.I.","Lecluse L.L.A.""SOURCE","JAMA Dermatology (2014) 150:2 (130-136). Date of Publication: February 2014"

"TITLE","Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice"

"AUTHOR NAMES","Shear N.H.","Hartmann M.","Toledo-Bahena M.","Katsambas A.","Connors L.","Chang Q.","Yao R.","Nograles K.","Popmihajlov Z.""SOURCE","British Journal of Dermatology (2014) 171:3 (631-641). Date of Publication: 1 Sep 2014"

"TITLE","Real-world dosing and utilization of ustekinumab among patients with psoriasis""AUTHOR NAMES","Cai Q.","Carter C.","Abu A.","Schenkel B.","Jones M.","Tan H.""SOURCE","American Journal of Pharmacy Benefits (2014) 6:3 (129-136). Date of Publication: May/June 2014"

"TITLE","Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients""AUTHOR NAMES","Yanaba K.","Umezawa Y.","Ito T.","Hayashi M.","Kikuchi S.","Fukuchi O.","Saeki H.","Nakagawa H.""SOURCE","Archives of Dermatological Research (2014) 306:10 (921-925). Date of Publication: 2014"

"TITLE","The use of ustekinumab in a patient with severe psoriasis and positive HBV serology""AUTHOR NAMES","Steglich R.B.","Cheinquer H.","Meneghello L.P.","Muller F.M.","de Carvalho A.V.E.","Reginatto F.P.""SOURCE","Anais Brasileiros de Dermatologia (2014) 89:4 (652-654). Date of Publication: July-August 2014"

"TITLE","Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient""AUTHOR NAMES","Lindsey S.F.","Weiss J.","Lee E.S.","Romanelli P.""SOURCE","Journal of Drugs in Dermatology (2014) 13:7 (869-871). Date of Publication: July 2014"

"TITLE","Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling""AUTHOR NAMES","Johnston A.","Guzman A.M.","Swindell W.R.","Wang F.","Kang S.","Gudjonsson J.E.""SOURCE","British Journal of Dermatology (2014) 171:1 (97-107). Date of Publication: 2014"

"TITLE","Psoriasis associated with idiopathic CD4+ T-cell lymphopenia: A regulatory T-cell defect?""AUTHOR NAMES","Baroudjian B.","Viguier M.","Battistella M.","Beneton N.","Pagès C.","Gener G.","Bégon E.","Bachelez H.""SOURCE","British Journal of Dermatology (2014) 171:1 (186-189). Date of Publication: 2014"

"TITLE","Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, Despite isoniazid chemoprophylaxis""AUTHOR NAMES","Errichetti E.","Piccirillo A.""SOURCE","European Journal of Dermatology (2014) 24:4 (508-509). Date of Publication: 1 Jul 2014"

"TITLE","Infective endocarditis complicating adalimumab therapy for psoriasis""AUTHOR NAMES","Haque Hussain S.S.","Wallace M.","Belham M.","Rusk R.","Carmichael A.J.","Wells F.C.","Burrows N.P.""SOURCE","Clinical and Experimental Dermatology (2014) 39:4 (555-556). Date of Publication: June 2014"

"TITLE","Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: Post hoc analysis of REACH""AUTHOR NAMES","Poulin Y.","Crowley J.J.","Langley R.G.","Unnebrink K.","Goldblum O.M.","Valdecantos W.C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:7 (882-890). Date of Publication: 2014"

"TITLE","Zastosowanie ustekinumabu u pacjentów z łuszczycą zwykłą oraz współistniejącymi zaburzeniami czynnoßci nerek lub wątroby - Opis dwóch przypadków""AUTHOR NAMES","Arasiewicz H.","Brzezińska-Wcisło L.","Miziołek B.","Michalska-Bańkowska A.""SOURCE","Przeglad Dermatologiczny (2014) 101:5 (405-408). Date of Publication: 2014"

"TITLE","Regulated genes in psoriatic skin during treatment with fumaric acid esters""AUTHOR NAMES","Onderdijk A.J.","Balak D.M.W.","Baerveldt E.M.","Florencia E.F.","Kant M.","Laman J.D.","Van Ijcken W.F.J.","Racz E.","De Ridder D.","Thio H.B.","Prens E.P.""SOURCE","British Journal of Dermatology (2014) 171:4 (732-741). Date of Publication: 1 Oct 2014"

"TITLE","Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept""AUTHOR NAMES","Jin H.","Cho H.-H.","Kim W.-J.","Mun J.-H.","Song M.","Kim H.-S.","Ko H.-C.","Kim M.-B.","Kim B.-S.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:4 (e152-e153). Date of

Publication: 2014"

"TITLE","Psoriatic erythroderma successfully treated with ustekinumab""AUTHOR NAMES","Mazur M.","Torz M.","Neneman-Hirsch A.","Adamski Z.""SOURCE","Dermatologia Kliniczna (2014) 15:3 (115-119). Date of Publication: 2014"

"TITLE","Disease characteristics in patients with and without psoriatic arthritis treated with etanercept""AUTHOR NAMES","Papp K.","Poulin Y.","Vieira A.","Shelton J.","Poulin-Costello M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:5 (581-589). Date of Publication: May 2014"

"TITLE","Severe plaque psoriasis with coexisting cicatricial alopecia treated with adalimumab - Case report""AUTHOR NAMES","Krasowska D.","Adamczyk M.","Michalska-Jakubus M.","Pietrzak A.""SOURCE","Przeglad Dermatologiczny (2014) 101:1 (46-49). Date of Publication: 2014"

"TITLE","A case of inverse psoriasis successfully treated with adalimumab""AUTHOR NAMES","Ješe R.","Perdan-Pirkmajer K.","Dolenc-Voljč M.","Tomšič M.""SOURCE","Acta Dermatovenerologica Alpina, Pannonica et Adriatica (2014) 23:1 (21-23). Date of Publication: 2014"

"TITLE","Acute severe methotrexate toxicity in patients with psoriasis: A case series and discussion""AUTHOR NAMES","Yélamos O.","Català A.","Vilarrasa E.","Roé E.","Puig L.""SOURCE","Dermatology (2014) 229:4 (306-309). Date of Publication: 22 May 2014"

"TITLE","Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis""AUTHOR NAMES","Yayli S.","Irla N.","Yawalkar N.""SOURCE","Case Reports in Dermatology (2014) 5:3 (332-335). Date of Publication: 2014"

"TITLE","Hypertrigyceridemia during infliximab therapy""AUTHOR NAMES","Javot L.","Pere P.","Got I.","Petitpain N.","Peyrin-Biroulet L.","Gillet P.""SOURCE","Joint Bone Spine (2014) 81:1 (94-96). Date of Publication: January 2014"

"TITLE","Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: ANALYSIS of 102 cases seen in a tertiary hospital in Johor, Malaysia""AUTHOR NAMES","Choon S.E.","Lai N.M.","Mohammad N.A.","Nanu N.M.","Tey K.E.","Chew S.F.""SOURCE","International Journal of Dermatology (2014) 53:6 (676-684). Date of Publication: June 2014"

"TITLE","Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening""AUTHOR NAMES","Gin A.","Dolianitis C.""SOURCE","Australasian Journal of Dermatology (2014) 55:2 (140-141). Date of Publication: May 2014"

"TITLE","Clinical markers predictive of primary inefficacy: A ""real life"" retrospective study in psoriatic patients treated with etanercept""AUTHOR NAMES","Giunta A.","Babino G.","Manetta S.","Mazzotta A.","Chimenti S.","Esposito M.""SOURCE","Drug Development Research (2014) 75:S1 (S27-S30). Date of Publication: 1 Nov 2014"

"TITLE","Deep vein thrombosis and lung cancer in a patient with psoriasis under anti-tumor necrosis factor treatment: A case study""AUTHOR NAMES","Tatarkova I.","Cetkovska P.""SOURCE","Dermatologic Therapy (2014) 27:1 (39-42). Date of Publication: January-February 2014"

"TITLE","Rosacea associated with etanercept""AUTHOR NAMES","Yazici A.","Akturk A.S.","Cefle A.","Bayramgurler D.","Yildiz K.D.""SOURCE","Joint Bone Spine (2014) 81:3 (274-275). Date of Publication: May 2014"

"TITLE","Hepatotoxicity due to etanercept abated after dose reduction in a patient with pustular psoriasis and without compromised efficacy""AUTHOR NAMES","Li Z.","Xiao S.","Ren J.","Zhang Y.","Tu C.","Ji F.""SOURCE","Revista Espanola de Enfermedades Digestivas (2014) 106:7 (492-493). Date of Publication: 2014"

"TITLE","Etanercept for Psoriasis and Psoriatic Arthritis in a Patient with Charcot-Marie-Tooth Disease""AUTHOR NAMES","Guarneri C.","Russo M.","Mazzeo A.","Cannavò S.P.""SOURCE","Annals of Pharmacotherapy (2014) 48:4 (550-551). Date of Publication: April 2014"

"TITLE","Systemic corticosteroids are frequently prescribed for psoriasis""AUTHOR NAMES","Al-Dabagh A.","Al-Dabagh R.","Davis S.A.","Taheri A.","Lin H.-C.","Balkrishnan R.","Feldman S.R.""SOURCE","Journal of Cutaneous Medicine and Surgery (2014) 18:3 (195-199). Date of Publication:

May-June 2014"

"TITLE","Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction""AUTHOR NAMES","Nakamizo S.","Miyachi Y.","Kabashima K.""SOURCE","Indian Journal of Dermatology (2014) 59:5 (522-523). Date of Publication: 1 Sep 2014"

"TITLE","The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients""AUTHOR NAMES","Protic M.","Seibold F.","Schoepfer A.","Radojicic Z.","Juillerat P.","Bojic D.","Mwinyi J.","Mottet C.","Jojic N.","Beglinger C.","Vavricka S.","Rogler G.","Frei P.""SOURCE","Journal of Crohn's and Colitis (2014) 8:11 (1427-1437). Date of Publication: 2014"

"TITLE","Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy""AUTHOR NAMES","Kawaguchi T.","Kawazoe Y.","Kamoi K.","Miyanaga M.","Takase H.","Sugita S.","Mochizuki M.""SOURCE","Japanese Journal of Ophthalmology (2014) 58:1 (75-80). Date of Publication: January 2014"

"TITLE","Destructive thyroiditis followed by hypothyroidism associated with infliximab therapy""AUTHOR NAMES","Ozkan C.","Altinova A.E.","Cerit E.T.","Yalcin M.M.","Toruner F.B.","Akturk M.","Cakir N.""SOURCE","Endocrine Practice (2014) 20:11 (e207-e210). Date of Publication: 1 Nov 2014"

"TITLE","Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis""AUTHOR NAMES","Armuzzi A.","Pugliese D.","Danese S.","Rizzo G.","Felice C.","Marzo M.","Andrisani G.","Fiorino G.","Nardone O.M.","De Vitis I.","Papa A.","Rapaccini G.L.","Guidi L.""SOURCE","Inflammatory Bowel Diseases (2014) 20:8 (1368-1374). Date of Publication: August 2014"

"TITLE","Clinical features of the SAPHO syndrome and their role in choosing the therapeutic approach: Report of four patients and review of the literature""AUTHOR NAMES","Anić B.","Padjen I.","Mayer M.","Bosnić D.","Cerovec M.""SOURCE","Acta Dermatovenerologica Croatica (2014) 22:3 (180-188). Date of Publication: 2014"

"TITLE","A case of nail psoriasis-associated psoriatic arthritis successfully treated with adalimumab""AUTHOR NAMES","Ikumi N.","Kitamura N.","Shiraiwa H.","Inomata H.","Nozaki T.","Kuwana Y.","Matsukawa Y.","Hayama T.","Sawada S.","Takei M.","Ochiai T.""SOURCE","Acta Dermatovenerologica Croatica (2014) 22:1 (65-66). Date of Publication: 2014"

"TITLE","Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: Results from a pilot observational study""AUTHOR NAMES","Vaughn B.P.","Martinez-Vazquez M.","Patwardhan V.R.","Moss A.C.","Sandborn W.J.","Cheifetz A.S.""SOURCE","Inflammatory Bowel Diseases (2014) 20:11 (1996-2003). Date of Publication: 1 Nov 2014"

"TITLE","Erythrodermic psoriasis""AUTHOR NAMES","Mumoli N.","Vitale J.","Gambaccini L.","Sabatini S.","Brondi B.","Cei M.""SOURCE","QJM (2014) 107:4 (315) Article Number: hct139. Date of Publication: April 2014"

"TITLE","Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris""AUTHOR NAMES","Ohtsuka T.""SOURCE","Journal of Dermatology (2014) 41:4 (354-355). Date of Publication: April 2014"

"TITLE","Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: Personal experience and literature review""AUTHOR NAMES","Chimenti M.S.","Spinelli F.R.","Giunta A.","Martinelli F.","Saraceno R.","Conti F.","Perricone R.","Valesini G.""SOURCE","Drug Development Research (2014) 75:S1 (S61-S63). Date of Publication: 1 Nov 2014"

"TITLE","Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy""AUTHOR NAMES","Kusumoto S.","Kajihara I.","Nagamoto E.","Makino K.","Ichihara A.","Aoi J.","Johno T.","Makino T.","Fukushima S.","Jinnin M.","Ihn H.""SOURCE","British Journal of Dermatology (2014) 171:5 (1259-1261). Date of Publication: 1 Nov 2014"

"TITLE","Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: Results from the PRISTINE trial""AUTHOR NAMES","Thaçi D.","Galimberti R.","Amaya-Guerra M.","Rosenbach T.","Robertson

D.","Pedersen R.","Yang S.","Kuligowski M.","Boggs R.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:7 (900-906). Date of Publication: 2014"

"TITLE","Pustular psoriasis occurring after total colectomy for ulcerative colitis and relieved by administration of infliximab""AUTHOR NAMES","Saito K.","Ito A.","Ishikawa K.","Shimada H.","Takeo N.","Hatano Y.","Sugiura K.","Akiyama M.","Inomata M.","Kitano S.","Fujiwara S.""SOURCE","Journal of Dermatology (2014) 41:11 (1033-1034). Date of Publication: 1 Nov 2014"

"TITLE","Rosacea associated with etanercept""AUTHOR NAMES","Yazici A.","Akturk A.S.","Cefle A.","Bayramgurler D.","Yildiz K.D.""SOURCE","Joint Bone Spine (2014) 81:3 (274-275). Date of Publication: 2014"

"TITLE","Appearance of de novo dysplastic spitzoid compound naevus in an adalimumab-treated psoriatic patient: Case report and review of the possible causal relationship with TNF-α blockers""AUTHOR NAMES","Sousa M.","Freitas J.P.","Antunes J.","Soares-De-Almeida L.","Filipe P.L.""SOURCE","Australasian Journal of Dermatology (2014) 55:2 (156-157). Date of Publication: May 2014"

"TITLE","Killing two birds with one stone: Oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis""AUTHOR NAMES","Craiglow B.G.","King B.A.""SOURCE","Journal of Investigative Dermatology (2014) 134:12 (2988-2990). Date of Publication: 13 Dec 2014"

"TITLE","Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis""AUTHOR NAMES","Ortigosa L.C.M.","Silva L.C.R.","Duarte A.J.S.","Takahashi M.D.F.","Benard G.""SOURCE","Acta Dermato-Venereologica (2014) 94:1 (26-31). Date of Publication: 2014"

"TITLE","Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment""AUTHOR NAMES","Moustou A.E.","Alexandrou P.","Stratigos A.J.","Giannopoulou I.","Vergou T.","Katsambas A.","Antoniou C.""SOURCE","Anais Brasileiros de Dermatologia (2014) 89:6 (891-897). Date of Publication: 1 Nov 2014"

"TITLE","Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment""AUTHOR NAMES","De Simone C.","Caldarola G.","Coco V.","Palumbo S.","Pocino K.","Sgambato A.","Maiorino A.","Corbi M.","Sandri M.T.","Vendittelli F.","Capoluongo E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2014) 28:5 (590-596). Date of Publication: May 2014"

"TITLE","Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab""AUTHOR NAMES","Jacks S.M.","Taylor B.R.","Rogers R.P.","Ralston J.S.","Metcalf J.S.","Lazarchick J.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:3 (e86-e87). Date of Publication: September 2014"

"TITLE","How would you diagnose the rash on her trunk and extremities?""SOURCE","Consultant (2014) 54:6 (478+480). Date of Publication: June 2014"

"TITLE","Erythrodermic CD81 pseudolymphoma during infliximab treatment in a patient with psoriasis: Use of cyclosporine as a rescue therapy""AUTHOR NAMES","Safa G.","Luce K.","Darrieux L.","Tisseau L.","Ortonne N.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:4 (e149-e150). Date of Publication: 2014"

"TITLE","Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils""AUTHOR NAMES","Yamanaka K.","Umezawa Y.","Yamagiwa A.","Saeki H.","Kondo M.","Gabazza E.C.","Nakagawa H.","Mizutani H.""SOURCE","Journal of Dermatology (2014) 41:8 (679-685). Date of Publication: August 2014"

"TITLE","An evolving plaque in an immunosuppressed patient with psoriasis""AUTHOR NAMES","Seminario-Vidal L.","Baddley J.W.","Sami N.""SOURCE","Journal of the American Academy of Dermatology (2014) 72:3 (e77-e78). Date of Publication: 1 Mar 2015"

"TITLE","A 52-year-old man with bullous pemphigoid and bullous cystitis""AUTHOR NAMES","Launhardt A.","Thiyanaratnam J.","Fernandez K.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:3 (e102-e103). Date of

Publication: September 2014"

"TITLE","Psoriasis in pregnancy""AUTHOR NAMES","Rajab K.","Sanad W.","Kumar V.""SOURCE","Bahrain Medical Bulletin (2014) 36:3. Date of Publication: 2014"

"TITLE","Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: A novel approach with anti-TNF therapy. Systematic review""AUTHOR NAMES","Marí A.","Morla A.","Melero M.","Schiavone R.","Rodríguez J.""SOURCE","Journal of Cranio-Maxillofacial Surgery (2014) 42:8 (1990-1996). Date of Publication: 1 Dec 2014"

"TITLE","Cutaneous pseudolymphoma: A rare side effect of cyclosporine""AUTHOR NAMES","Foley C.","Leonard N.","Wynne B.""SOURCE","Journal of the American Academy of Dermatology (2014) 72:3 (e85-e86). Date of Publication: 1 Mar 2015"

"TITLE","Woronoff ring associated with adalimumab therapy for psoriasis""AUTHOR NAMES","Park K.K.","Swan J.W.","Eilers D.","Tung R.","Koo J.""SOURCE","Cutis (2014) 93:2 (E1-E2). Date of Publication: February 2014"

"TITLE","Ophthalmic cyclosporine for the treatment of psoriatic conjunctivitis""AUTHOR NAMES","Habeshian K.A.","Levitt J.O.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:2 (e43-e44). Date of Publication: August 2014"

"TITLE","A case of psoriasis accompanied by arthritis after delivery""AUTHOR NAMES","Kanemaru H.","Jinnin M.","Asao K.","Ichihara A.","Makino K.","Kajihara I.","Fujisawa A.","Fukushima S.","Ihn H.""SOURCE","BioScience Trends (2014) 8:1 (64-67). Date of Publication: 2014"

"TITLE","Analysis of trial data for infliximab and golimumab: Baseline c-reactive protein level and prediction of therapeutic response in patients with psoriatic arthritis""AUTHOR NAMES","Au S.-C.","Ramirez-Fort M.K.","Gottlieb A.B.""SOURCE","Arthritis Care and Research (2014) 66:7 (1114-1118). Date of Publication: July 2014"

"TITLE","Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy.""AUTHOR NAMES","Safa G.","Luce K.","Darrieux L.","Tisseau L.","Ortonne N.""SOURCE","Journal of the American Academy of Dermatology (2014) 71:4 (e149-150). Date of Publication: Oct 2014"

"TITLE","Health-related quality of life in psoriatic arthritis patients in Spain""AUTHOR NAMES","Gratacós J.","Daudén E.","Gómez-Reino J.","Moreno J.C.","Casado M.T.","Rodríguez-Valverde V.""SOURCE","Reumatologia Clinica (2014) 10:1 (25-31). Date of Publication: January 2014"

"TITLE","Psoriatic rheumatism. Inflammatory arthropathy.""AUTHOR NAMES","Macovei L.","Brujbu I.""SOURCE","Revista medico-chirurgicalǎ̌ a Societǎ̌ţii de Medici ş̧i Naturaliş̧ti din Iaş̧i (2014) 118:1 (45-51). Date of Publication: 2014 Jan-Mar"

"TITLE","Pityriasis rubra pilaris : Failure of treatment with infliximab""AUTHOR NAMES","Masuda K.","Miyawaki S.","Hanakawa Y.","Shirakata Y.","Murakami S.","Sayama K.","Minami M.""SOURCE","Nishinihon Journal of Dermatology (2014) 76:4 (349-352). Date of Publication: 2014"

"TITLE","PReS-FINAL-2238: PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome: Results from the Eurofever registry""AUTHOR NAMES","Caorsi R.","Insalaco A.","Marotto D.","Frenkel J.","Martini A.","De benedetti F.","Gattorno M.""SOURCE","Pediatric Rheumatology (2013) 11 SUPPL. 2. Date of Publication: 5 Dec 2013"

"TITLE","Successful management of ustekinumab-induced pustular psoriasis without therapy discontinuation""AUTHOR NAMES","Caca-Biljanovska N.","V'lckova-Laskoska M.","Laskoski D.""SOURCE","Acta Dermatovenerologica Croatica (2013) 21:3 (202-204). Date of Publication: 2013"

"TITLE","Drug survival rates in patients with psoriasis after treatment with biologics""AUTHOR NAMES","Umezawa Y.","Nobeyama Y.","Hayashi M.","Fukuchi O.","Ito T.","Saeki H.","Nakagawa H.""SOURCE","Journal of Dermatology (2013) 40:12 (1008-1013). Date of Publication: December 2013"

"TITLE","Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis-A multinational cross-sectional study""AUTHOR NAMES","Nast A.","Mrowietz U.","Kragballe K.","De Jong E.M.G.J.","Puig L.","Reich

K.","Warren R.B.","Werner R.","Kopkow C.","Schmitt J.""SOURCE","Archives of Dermatological Research (2013) 305:10 (899-907). Date of Publication: 2013"

"TITLE","Risk of myocardial infarction in Canadian patients with psoriasis: A retrospective cohort study""AUTHOR NAMES","Levesque A.","Lachaine J.","Bissonnette R.""SOURCE","Journal of Cutaneous Medicine and Surgery (2013) 17:6 (398-403). Date of Publication: December 2013"

"TITLE","Ustekinumab associated with flares of psoriatic arthritis""AUTHOR NAMES","Stamell E.F.","Kutner A.","Viola K.","Cohen S.R.""SOURCE","JAMA Dermatology (2013) 149:12 (1410-1413). Date of Publication: December 2013"

"TITLE","Abatacept in psoriatic arthritis: Case report and short review""AUTHOR NAMES","Ursini F.","Naty S.","Russo E.","Grembiale R.""SOURCE","Journal of Pharmacology and Pharmacotherapeutics (2013) 4:SUPPL.1 (S29-S32). Date of Publication: December 2013"

"TITLE","Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab""AUTHOR NAMES","Andrisani G.","Marzo M.","Celleno L.","Guidi L.","Papa A.","Gasbarrini A.","Armuzzi A.""SOURCE","European Review for Medical and Pharmacological Sciences (2013) 17:20 (2831-2836). Date of Publication: 2013"

"TITLE","Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin""AUTHOR NAMES","Gallo E.","Llamas-Velasco M.","Daudén E.","García-Diez A.""SOURCE","International Journal of Dermatology (2013) 52:12 (1610-1611). Date of Publication: December 2013"

"TITLE","Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study""AUTHOR NAMES","Kimball A.B.","Papp K.A.","Wasfi Y.","Chan D.","Bissonnette R.","Sofen H.","Yeilding N.","Li S.","Szapary P.","Gordon K.B.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:12 (1535-1545). Date of Publication: December 2013"

"TITLE","Infliximab in psoriasis and psoriatic arthritis""AUTHOR NAMES","Papoutsaki M.","Osório F.","Morais P.","Torres T.","Magina S.","Chimenti S.","Costanzo A.""SOURCE","BioDrugs (2013) 27:SUPPL. 1 (13-23). Date of Publication: 2013"

"TITLE","An embarrassing rash""AUTHOR NAMES","Paget S.""SOURCE","Prescriber (2013) 24:23-24 (10-12). Date of Publication: December 2013"

"TITLE","Serological markers in psoriatic arthritis: Promising tools""AUTHOR NAMES","Ramonda R.","Modesti V.","Ortolan A.","Scanu A.","Bassi N.","Oliviero F.","Punzi L.""SOURCE","Experimental Biology and Medicine (2013) 238:12 (1431-1436). Date of Publication: December 2013"

"TITLE","PW02-009-PAPA syndrome: Results from the Euroefever registry""AUTHOR NAMES","Caorsi R.","Insalaco A.","Marotto D.","Frenkel J.","Martini A.","De Benedetti F.","Gattorno M.""SOURCE","Pediatric Rheumatology (2013) 11 SUPPL. 1. Date of Publication: 8 Nov 2013"

"TITLE","P02-007-Childhood autoinflammatory disorders in Qatar""AUTHOR NAMES","Aladbe B.","Aly A.","Taha R.","Elshanti H.","Moussa T.","Al Amry F.","Fathalla B.""SOURCE","Pediatric Rheumatology (2013) 11 SUPPL. 1. Date of Publication: 8 Nov 2013"

"TITLE","Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis""AUTHOR NAMES","Tan E.","Baker C.","Foley P.""SOURCE","Australasian Journal of Dermatology (2013) 54:4 (259-263). Date of Publication: November 2013"

"TITLE","A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis""AUTHOR NAMES","Bardazzi F.","Antonucci V.A.","Tengattini V.","Odorici G.","Balestri R.","Patrizi A.""SOURCE","JDDG - Journal of the German Society of Dermatology (2013) 11:11 (1065-1072). Date of Publication: November 2013"

"TITLE","Latent tuberculosis infection and active tuberculosis in patients with psoriasis: A study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry""AUTHOR NAMES","Sánchez-Moya A.I.","García-Doval I.","Carretero G.","Sánchez-Carazo J.","Ferrandiz C.","Herrera Ceballos E.","Alsina M.","Ferrán M.","Lõpez-Estebaranz J.-L.","Gõmez-García F.","De La Cueva Dobao P.","Carrascosa J.-M.","Vanaclocha F.","Belinchõn I.","Peral F.","Dauden E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:11 (1366-1374). Date of Publication: November 2013"

"TITLE","Indirect comparison of the effect of biologics in patients with psoriasis; A meta-analysis of randomized, double blind clinical trials in bayesian framework""AUTHOR NAMES","Brodszky V.","Mo M.","Gulacsi L.","Baji P.","Balogh O.","Péntek M.""SOURCE","Value in Health (2013) 16:7 (A501-A502). Date of Publication: November 2013"

"TITLE","Direct health care costs of patients switching biologic therapies in chronic plaque psoriasis""AUTHOR NAMES","Qureshi A.","Mallya U.","Zhang X.","Li L.","Lahoz R.""SOURCE","Value in Health (2013) 16:7 (A727). Date of Publication: November 2013"

"TITLE","Interdigital psoriasis of the feet (Psoriasis Alba): Not a distinct form of psoriasis""AUTHOR NAMES","Bardazzi F.","Antonucci V.A.","Patrizi A.","Alessandrini A.","Tengattini V.","Odorici G.","Balestri R.""SOURCE","Dermatology (2013) 227:2 (130-133). Date of Publication: November 2013"

"TITLE","Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population""AUTHOR NAMES","Abreu C.","Magro F.","Santos-Antunes J.","Pilão A.","Rodrigues-Pinto E.","Bernardes J.","Bernardo A.","Magina S.","Vilas-Boas F.","Lopes S.","Macedo G.","Sarmento A.""SOURCE","Journal of Crohn's and Colitis (2013) 7:10 (e486-e492). Date of Publication: 1 Nov 2013"

"TITLE","Increased permeability of cutaneous lymphatic capillaries and enhanced blood flow in psoriatic plaques""AUTHOR NAMES","Meier T.O.","Kovacicova L.","Huggenberger R.","Navarini A.A.","Gitzelmann G.","Amann-Vesti B.R.""SOURCE","Dermatology (2013) 227:2 (118-125). Date of Publication: November 2013"

"TITLE","Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab""AUTHOR NAMES","Vilaça S.","Torres T.","Selores M.""SOURCE","European Journal of Dermatology (2013) 23:6 (897-898). Date of Publication: November-December 2013"

"TITLE","Frequency and spectrum of myopathies in patients with psoriasis""AUTHOR NAMES","Liewluck T.","Ernste F.C.","Tracy J.A.""SOURCE","Muscle and Nerve (2013) 48:5 (716-721). Date of Publication: November 2013"

"TITLE","Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: In vivo and in vitro analysis""AUTHOR NAMES","Sauzullo I.","Mengoni F.","Marocco R.","Potenza C.","Skroza N.","Tieghi T.","Lichtner M.","Vullo V.","Mastroianni C.M.""SOURCE","British Journal of Dermatology (2013) 169:5 (1133-1140). Date of Publication: November 2013"

"TITLE","Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis""AUTHOR NAMES","Jo K.-W.","Hong Y.","Jung Y.J.","Yoo B.","Lee C.-K.","Kim Y.-G.","Yang S.-K.","Byeon J.-S.","Kim K.J.","Ye B.D.","Lee S.-D.","Kim W.S.","Kim D.S.","Shim T.S.""SOURCE","Respiratory Medicine (2013) 107:11 (1797-1802). Date of Publication: November 2013"

"TITLE","Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab""AUTHOR NAMES","Husein-ElAhmed H.","Molina-Leyva A.","Garrido-TorresPuchol V.","Ruiz-Carrascosa J.""SOURCE","Annals of Saudi Medicine (2013) 33:6 (632-633). Date of Publication: November-December 2013"

"TITLE","Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)(+) dendritic cells and macrophages""AUTHOR NAMES","Brunner P.M.","Koszik F.","Reininger B.","Kalb M.L.","Bauer W.","Stingl G.""SOURCE","Journal of Allergy and Clinical Immunology (2013) 132:5 (1184-1193.e8). Date of Publication: November 2013"

"TITLE","Adalimumab for the treatment of psoriasis in real life: A retrospective cohort of 119 patients at a single Spanish centre""AUTHOR NAMES","Lõpez-Ferrer A.","Vilarrasa E.","Gich I.J.","Puig L."

"SOURCE","British Journal of Dermatology (2013) 169:5 (1141-1147). Date of Publication: November 2013"

"TITLE","Treating psoriatic arthritis with biological disease modifying antirheumatic drugs: Systematic review and meta-analysis to evaluate efficacy and safety""AUTHOR NAMES","Lemos L.L.P.","Reis C.A.L.","Barbosa M.M.","Oliveira H.","Almeida A.M.","Acurcio F.A.""SOURCE","Value in Health (2013) 16:7 (A715). Date of Publication: November 2013"

"TITLE","An observational, prospective study of monthly adalimumab therapy for disease maintenance in psoriasis patients: A possible new therapeutic option for good responders to the initial induction treatment""AUTHOR NAMES","Taniguchi T.","Noda S.","Takahashi N.","Yoshimura H.","Mizuno K.","Adachi M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:11 (1444-1447). Date of Publication: November 2013"

"TITLE","Alopecia areata developing during ustekinumab therapy: Report of two cases""AUTHOR NAMES","Tauber M.","Beneton N.","Reygagne P.","Bachelez H.","Viguier M.""SOURCE","European Journal of Dermatology (2013) 23:6 (912-913). Date of Publication: November-December 2013"

"TITLE","Clinical and economic impact of etanercept in real-life: A prospective, non-interventional study of etanercept in the treatment of patients with moderate to severe plaque psoriasis in private dermatologist settings (ESTHER)""AUTHOR NAMES","Larsen C.G.","Andersen P.H.","Lorentzen H.","Zachariae C.","Huldt-Nystrøm T.","Dotterud L.K.","Lindkvist R.-M.","Qvitzau S.""SOURCE","European Journal of Dermatology (2013) 23:6 (774-781). Date of Publication: November-December 2013"

"TITLE","The use of extemporaneously compounded 1% tetracaine to improve adherence with clotrimazole 1% topical solution in the treatment of ear infection: A case report""AUTHOR NAMES","Kolling W.M.","McPherson T.B.","McJunkin J.L.""SOURCE","American Journal of Otolaryngology - Head and Neck Medicine and Surgery (2013) 34:6 (757-758). Date of Publication: November-December 2013"

"TITLE","Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin""AUTHOR NAMES","Naruse H.","Nagashima Y.","Maekawa R.","Etoh T.","Hida A.","Shimizu J.","Kaida K.-I.","Shiio Y.""SOURCE","Journal of Clinical Neuroscience (2013) 20:11 (1618-1619). Date of Publication: November 2013"

"TITLE","Respiratory failure due to infliximab induced interstitial lung disease""AUTHOR NAMES","Kakavas S.","Balis E.","Lazarou V.","Kouvela M.","Tatsis G.""SOURCE","Heart and Lung: Journal of Acute and Critical Care (2013) 42:6 (480-482). Date of Publication: November 2013"

"TITLE","Optic neuritis due to immunobiologics: First brazilian case report""AUTHOR NAMES","da Silva L.G.M.","Sasso L.S.","Nelli C.J.","Filho F.B.","de Abreu M.A.M.M.""SOURCE","Anais Brasileiros de Dermatologia (2013) 88:6 SUPPL.1 (162-165). Date of Publication: November/December 2013"

"TITLE","Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: Is it the first case?""AUTHOR NAMES","Patruno C.","Balato N.","Cirillo T.","Napolitano M.","Ayala F.""SOURCE","Dermatologic Therapy (2013) 26:6 (493-495). Date of Publication: November-December 2013"

"TITLE","Biological agents: Investigation into leprosy and other infectious diseases before indication""AUTHOR NAMES","António J.R.","Paschoal V.D.A.","Travolo A.R.F.","Soubhia R.M.C.","Amarante C.F.""SOURCE","Anais Brasileiros de Dermatologia (2013) 88:6 SUPPL.1 (23-25). Date of Publication: November/December 2013"

"TITLE","Clinical and capillaroscopic modifications of the psoriatic plaque during therapy: Observations with oral acitretin""AUTHOR NAMES","Stinco G.","Buligan C.","Errichetti E.","Valent F.","Patrone P.""SOURCE","Dermatology Research and Practice (2013) 2013 Article Number: 781942. Date of Publication: 2013"

"TITLE","Comorbidity profiles among adult patients with juvenile idiopathic arthritis: Results of a biologic register""AUTHOR NAMES","Raab A.","Sengler C.","Niewerth M.","Klotsche J.","Horneff G.","Zink A.","Girschick H.","Weber K.","Minden K.""SOURCE","Clinical and Experimental Rheumatology (2013) 31:5 (796-802). Date of Publication:

2013"

"TITLE","Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy""AUTHOR NAMES","Steinke S.I.B.","Peitsch W.K.","Ludwig A.","Goebeler M.""SOURCE","PLoS ONE (2013) 8:10 Article Number: e78152. Date of Publication: 23 Oct 2013"

"TITLE","Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population""AUTHOR NAMES","Schabert V.F.","Watson C.","Joseph G.J.","Iversen P.","Burudpakdee C.","Harrison D.J.""SOURCE","Journal of Managed Care Pharmacy (2013) 19:8 (621-630). Date of Publication: 2013"

"TITLE","Autoimmune hepatitis triggered by anti-TNF- α therapy""AUTHOR NAMES","Nakayama S.""SOURCE","Case Reports in Medicine (2013) 2013 Article Number: 561748. Date of Publication: 2013"

"TITLE","Risk of moderate to advanced kidney disease in patients with psoriasis: Population based cohort study""AUTHOR NAMES","Wan J.","Wang S.","Haynes K.","Denburg M.R.","Shin D.B.","Gelfand J.M.""SOURCE","BMJ (Online) (2013) 347 Article Number: f5961. Date of Publication: 15 Oct 2013"

"TITLE","Mycobacterium porferae infection in a psoriasis patient on anti-tnf-a therapy""AUTHOR NAMES","Laquer V.T.","Ta T.","Nguyen T.","Tan B.""SOURCE","Dermatology Online Journal (2013) 19:9. Date of Publication: 2013"

"TITLE","Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan""AUTHOR NAMES","Igarashi A.","Kuwabara H.","Fahrbach K.","Schenkel B.""SOURCE","Journal of Dermatological Treatment (2013) 24:5 (351-355). Date of Publication: October 2013"

"TITLE","Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting""AUTHOR NAMES","Bonafede M.","Johnson B.H.","Fox K.M.","Watson C.","Gandra S.R.""SOURCE","Journal of Dermatological Treatment (2013) 24:5 (369-373). Date of Publication: October 2013"

"TITLE","Childhood-onset psoriasis: Association with future cardiovascular and metabolic comorbidities""AUTHOR NAMES","Mahé E.","MacCari F.","Beauchet A.","Lahfa M.","Barthelemy H.","Reguiaï Z.","Beneton N.","Estève E.","Chaby G.","Ruer-Mulard M.","Steiner H.-G.","Pauwels C.","Avenel-Audran M.","Goujon-Henry C.","Descamps V.","Begon E.","Sigal M.-L.""SOURCE","British Journal of Dermatology (2013) 169:4 (889-895). Date of Publication: October 2013"

"TITLE","Paradoxical psoriasis: Experience of a biological therapy monographic unit""AUTHOR NAMES","Vivar M.L.G.","Barrio S.P.","Agirregoikoa E.G.","Arango C.G.","Llorente J.F.G.","Belloso R.I.","Lucea E.R.","Salaberri I.T.","Alzaga J.M.C.""SOURCE","Arthritis and Rheumatism (2013) 65 SUPPL. 10 (S661). Date of Publication: October 2013"

"TITLE","Combination use of ustekinumab with other systemic therapies: A retrospective study in a tertiary referral center""AUTHOR NAMES","Heinecke G.M.","Luber A.J.","Levitt J.O.","Lebwohl M.G.""SOURCE","Journal of Drugs in Dermatology (2013) 12:10 (1098-1102). Date of Publication: October 2013"

"TITLE","Remission in ankylosing spondylitis treated with anti-TNF-α drugs: A national multicentre study""AUTHOR NAMES","Spadaro A.","Lubrano E.","Marchesoni A.","D'Angelo S.","Ramonda R.","Addimanda O.","Perrotta F.M.","Olivieri I.","Punzi L.","Salvarani C.""SOURCE","Rheumatology (United Kingdom) (2013) 52:10 (1914-1919) Article Number: ket249. Date of Publication: October 2013"

"TITLE","Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis""AUTHOR NAMES","Shimauchi T.","Hirakawa S.","Suzuki T.","Yasuma A.","Majima Y.","Tatsuno K.","Yagi H.","Ito T.","Tokura Y.""SOURCE","Journal of Dermatology (2013) 40:10 (805-812). Date of Publication: October 2013"

"TITLE","Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the National Psoriasis Foundation Surveys, 2003-2011""AUTHOR NAMES","Armstrong A.W.","Robertson A.D.","Wu J.","Schupp C.","Lebwohl M.G."

"SOURCE","JAMA Dermatology (2013) 149:10 (1180-1185). Date of Publication: October 2013"

"TITLE","Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study""AUTHOR NAMES","Jókai H.","Szakonyi J.","Kontár O.","Marschalkó M.","Szalai K.","Kárpáti S.","Holló P.""SOURCE","Journal of the American Academy of Dermatology (2013) 69:4 (523-529). Date of Publication: October 2013"

"TITLE","Psoriasiform reactions to anti-tumor necrosis factor α therapy""AUTHOR NAMES","Nguyen K.","Vleugels R.A.","Velez N.F.","Merola J.F.","Qureshi A.A.""SOURCE","Journal of Clinical Rheumatology (2013) 19:7 (377-381). Date of Publication: October 2013"

"TITLE","The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: A case-control study""AUTHOR NAMES","Gallo E.","Cabaleiro T.","Román M.","Solano-López G.","Abad-Santos F.","García-Díez A.","Daudén E.""SOURCE","British Journal of Dermatology (2013) 169:4 (819-829). Date of Publication: October 2013"

"TITLE","Cost consideration for biologics for patients with rheumatoid arthritis in a pharmacy benefit management setting""AUTHOR NAMES","Wu N.","Lee Y.-C.","Shah N.","Harrison D.J.""SOURCE","Arthritis and Rheumatism (2013) 65 SUPPL. 10 (S426-S427). Date of Publication: October 2013"

"TITLE","Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: A validation study using the medical records of rheumatologists""AUTHOR NAMES","Widdifield J.","Bernatsky S.","Paterson J.M.","Tu K.","Ng R.","Thorne J.C.","Pope J.E.","Bombardier C.""SOURCE","Arthritis Care and Research (2013) 65:10 (1582-1591). Date of Publication: October 2013"

"TITLE","Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome""AUTHOR NAMES","García-Bosch O.","Gisbert J.P.","Cañas-Ventura À.","Merino O.","Cabriada J.L.","García-Sánchez V.","Gutiérrez A.","Nos P.","Peñalva M.","Hinojosa J.","García-Planella E.","Muñoz F.","Calvet X.","Panés J.""SOURCE","Journal of Crohn's and Colitis (2013) 7:9 (717-722). Date of Publication: 1 Oct 2013"

"TITLE","Widespread psoriasis induced by rituximab in a patient with rheumatoid arthritis: An unexpected adverse reaction""AUTHOR NAMES","Ozen G.","Ergun T.","Oner S.Y.","Demirkesen C.","Inanc N.""SOURCE","Joint Bone Spine (2013) 80:5 (541-555). Date of Publication: October 2013"

"TITLE","Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use""AUTHOR NAMES","Brodmerkel C.","Wadman E.","Langley R.G.","Papp K.A.","Bourcier M.","Poulin Y.","Ho V.","Guenther L.","Kunynetz R.","Nigen S.","Vender R.","Wasel N.","Hsu M.-C.","Szapary P.""SOURCE","Journal of Drugs in Dermatology (2013) 12:10 (1122-1129). Date of Publication: October 2013"

"TITLE","Adherence to ustekinumab in psoriasis patients""AUTHOR NAMES","Sandoval L.F.","Huang K.E.","Feldman S.R.""SOURCE","Journal of Drugs in Dermatology (2013) 12:10 (1090-1092). Date of Publication: October 2013"

"TITLE","Suspected rapid-onset neutropenia following etanercept use: Disproved following rechallenge and lessons to be learned""AUTHOR NAMES","Sachdev A.","Shwayder T.""SOURCE","International Journal of Dermatology (2013) 52:10 (1287-1288). Date of Publication: October 2013"

"TITLE","Effectiveness of adalimumab dose escalation, combination therapy of adalimumab with methotrexate, or both in patients with psoriasis in daily practice""AUTHOR NAMES","Van Den Reek J.M.","Van Lümig P.P.","Kievit W.","Zweegers J.","Van De Kerkhof P.C.","Seyger M.M.","Jong E.M.D.""SOURCE","Journal of Dermatological Treatment (2013) 24:5 (361-368). Date of Publication: October 2013"

"TITLE","Pharmacokinetics and pharmacodynamics of ustekinumab in two phase 3 studies in patients with active psoriatic arthritis""AUTHOR NAMES","Zhu Y.","Comisar C.","Hu C.","Zong A.","Marini J.C.","Li S.","Mendelsohn A.","Song M.","Davis H.M.","Zhou H."

"SOURCE","Clinical Pharmacology in Drug Development (2013) 2 SUPPL. 1 (31). Date of Publication: October 2013"

"TITLE","Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient""AUTHOR NAMES","Gupta R.","Wu J.J.","Levin E.C.","Koo J.Y.M.","Liao W.""SOURCE","Journal of Drugs in Dermatology (2013) 12:10 (1089). Date of Publication: October 2013"

"TITLE","Immunogenicity and clinical relevance of ustekinumab in two phase 3 studies in patients with active psoriatic arthritis""AUTHOR NAMES","Zhu Y.","Keen M.","Gunn G.","Schantz A.","Li S.","Mendelsohn A.","Song M.","Davis H.M.","Zhou H.""SOURCE","Clinical Pharmacology in Drug Development (2013) 2 SUPPL. 1 (32). Date of Publication: October 2013"

"TITLE","Maintenance of efficacy and safety of ustekinumab in patients with active psoriatic arthritis despite prior conventional nonbiologic and anti-tnf biologic therapy: 1-year results of a phase 3, multicenter, double-blind, placebo-controlled trial""AUTHOR NAMES","Ritchlin C.T.","McInnes I.B.","Kavanaugh A.","Puig L.","Rahman P.","Brodmerkel C.","Li S.","Shen Y.-K.","Doyle M.K.","Mendelsohn A.M.","Gottlieb A.B.""SOURCE","Arthritis and Rheumatism (2013) 65 SUPPL. 10 (S127-S128). Date of Publication: October 2013"

"TITLE","Psoriasis onset with tocilizumab""AUTHOR NAMES","Grasland A.","Mahé E.","Raynaud E.","Mahé I.""SOURCE","Joint Bone Spine (2013) 80:5 (541-555). Date of Publication: October 2013"

"TITLE","What causes her psoriasis?""SOURCE","Consultant (2013) 53:10 (734). Date of Publication: October 2013"

"TITLE","Biological therapy for Crohn's disease in a liver transplant patient""AUTHOR NAMES","Bendezú García R.A.","Rodríguez Manrique M.A.","Hernández Martínez A.","Lázaro Sáez M.","Patrón Román G.O.","Amat Alcaraz S.","Vega Sáenz J.L.""SOURCE","Journal of Digestive Diseases (2013) 14:10 (564-566). Date of Publication: October 2013"

"TITLE","A case of persistent fever""AUTHOR NAMES","Lopes C.A.","Real A.","Adelino L.","Pimenta F.","Gonc¸alves C.""SOURCE","European Journal of Internal Medicine (2013) 24 SUPPL. 1 (e124-e125). Date of Publication: October 2013"

"TITLE","The reported adverse effects related to biological agents used for the treatment of rheumatic diseases in Turkey""AUTHOR NAMES","Kiliç E.","Kiliç G.","Akgül O.","Akgöl G.","Özgöçmen S.""SOURCE","Turkish Journal of Rheumatology (2013) 28:3 (149-162). Date of Publication: 2013"

"TITLE","Psoriasis treated successfully with ustekinumab in a cocaine-addicted patient""AUTHOR NAMES","Rallis E.","Korfitis C.","Katoulis A.","Katsarou A.""SOURCE","Journal of Dermatological Case Reports (2013) 7:3 (82-83). Date of Publication: 30 Sep 2013"

"TITLE","Health plan utilization and costs of specialty drugs within 4 chronic conditions""AUTHOR NAMES","Gleason P.P.","Alexander G.C.","Starner C.I.","Ritter S.T.","Van Houten H.K.","Gunderson B.W.","Shah N.D.""SOURCE","Journal of Managed Care Pharmacy (2013) 19:7 (542-548). Date of Publication: 2013"

"TITLE","Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial""AUTHOR NAMES","McInnes I.B.","Kavanaugh A.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.","Brodmerkel C.","Li S.","Wang Y.","Mendelsohn A.M.","Doyle M.K.","Aelion J.","Akovbyan G.","Andersone D.","Bakulev A.","Basijokiene V.","Beaulieu A.","Birbara C.","Boh E.","Bourcier M.","Braun J.","Brzezicki J.","Buchanan R.","Budd J.","Bukauskiene L.","Burnette M.","Crespillo J.C.","Carey W.","Chattapadhyay C.","Chudzik D.","Cooper R.","Drescher E.","Dudek A.","Dutz J.","El-Kadi H.","Erlacher L.","Fretzin S.A.","Garcia Meijide J.A.","George E.","Gilchrist N.","Gladstein G.","Gow P.","Graninger W.","Griffin Jr. R.M.","Guenther L.","Gulliver W.","Hall S.","Halter D.G.","Hobbs K.","Ilivanova E.","Jarvinen P.","Jeka S.","Jones P.","Khraishi M.","Kokhan M.","Kovacs A.","Kovacs L.","Kubanov A.","Kunynetz R.","Langley R.","Lee S.","Leonardi C.L.","Lessard C.","Lietuvininkiene V.","Lizzul P.","Martin A.","Maslyanskiy A.","Matheson R.T.","Mikazane H.","Murphy F.T.","Nash P.","Nasonov E.","Sarabia F.N.","Orlov-Morozov A.","Paimela L.","Palmer W.","Papp K.","Pileckyte M.","Poor G.","Poulin Y.","Silva R.Q.","Rapoport R.","Rebrov A.","Rell-Bakalarska M.","Rich P.","Rischmueller M.","Rojkovich B.","Rosen C.","Rosoph L.","Scheinecker C.","Schopf R.","Sebastian M.","Seigel S.","Shaikh S.","Sheeran T.","Shergy W.J.","Shirinsky V.","Siegel E.L.","Sofen H.","Sterry W.","Supronik J.","Szabo Z.","Szanyo F.","Tahir H.","Tan J.","Taylor W.","Temnikov V.","Thaci D.","Toth D.","Újfalussy I.","Valleala H.","Vender R.","Wasel N.","Willans M.","Wollenhaupt J.","Zamani

O.","Zanetakis E.","Zonova E.","Zoschke D.","Zubrzycka-Sienkiewicz A.""SOURCE","The Lancet (2013) 382:9894 (780-789). Date of Publication: 2013"

"TITLE","Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis""AUTHOR NAMES","Bonafede M.","Joseph G.J.","Princic N.","Harrison D.J.""SOURCE","Journal of Medical Economics (2013) 16:9 (1120-1128). Date of Publication: September 2013"

"TITLE","Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: A multicentre observational study""AUTHOR NAMES","Esposito M.","Gisondi P.","Cassano N.","Ferrucci G.","Del Giglio M.","Loconsole F.","Giunta A.","Vena G.A.","Chimenti S.","Girolomoni G.""SOURCE","British Journal of Dermatology (2013) 169:3 (666-672). Date of Publication: September 2013"

"TITLE","Blaschko-linear manifestations of polygenic inflammatory diseases: Analysis of 17 cases""AUTHOR NAMES","Lenormand C.","Cribier B.","Lipsker D.""SOURCE","European Journal of Dermatology (2013) 23:5 (671-676). Date of Publication: September-October 2013"

"TITLE","Effectiveness of systemic treatment agents on psoriatic nails: A comparative study""AUTHOR NAMES","Demirsoy E.O.","Kiran R.","Salman S.","Çaǧlayan Ç.","Aktürk A.Ş.","Bayramgurler D.","Bilen N.""SOURCE","Journal of Drugs in Dermatology (2013) 12:9 (1039-1043). Date of Publication: September 2013"

"TITLE","The role of Fcγ receptor polymorphisms in the response to anti-tumor necrosis factor therapy in psoriasis: A pharmacogenetic study""AUTHOR NAMES","Julià M.","Guilabert A.","Lozano F.","Suarez-Casasús B.","Moreno N.","Carrascosa J.M.","Ferrándiz C.","Pedrosa E.","Alsina-Gibert M.","Mascaró Jr. J.M.""SOURCE","JAMA Dermatology (2013) 149:9 (1033-1039). Date of Publication: September 2013"

"TITLE","Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases""AUTHOR NAMES","Saraceno R.","Talamonti M.","Galluzzo M.","Chiricozzi A.","Costanzo A.","Chimenti S.""SOURCE","Case Reports in Dermatology (2013) 5:3 (254-258). Date of Publication: September-December 2013"

"TITLE","Cost effectiveness of moderate to severe psoriasis therapy with etanercept and ustekinumab in the united states""AUTHOR NAMES","Villacorta R.","Hay J.W.","Messali A.""SOURCE","PharmacoEconomics (2013) 31:9 (823-839). Date of Publication: September 2013"

"TITLE","Psoriasis and risk of cardiovascular disease: Case report and discussion""AUTHOR NAMES","Maybury C.","Smith C.H.""SOURCE","Heart and Metabolism (2013) :60 (30-33). Date of Publication: September 2013"

"TITLE","Nodal melanoma metastasis under infliximab therapy in a patient with nevoid melanoma first misdiagnosed as benign nevus: A potentially dangerous diagnostic pitfall in the era of biologic therapies""AUTHOR NAMES","Safa G.","Fromentoux S.","Darrieux L.","Hogenhuis J.-A.","Tisseau L.""SOURCE","Case Reports in Dermatology (2013) 5:3 (290-294). Date of Publication: September-December 2013"

"TITLE","A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Lebwohl M.G.","Kircik L.","Callis Duffin K.","Pariser D.","Hooper M.","Wenkert D.","Thompson E.H.Z.","Yang J.","Kricorian G.","Koo J.""SOURCE","Journal of the American Academy of Dermatology (2013) 69:3 (385-392). Date of Publication: September 2013"

"TITLE","Item-level psychometric properties for a new patient-reported psoriasis symptom diary""AUTHOR NAMES","Strober B.E.","Nyirady J.","Mallya U.G.","Guettner A.","Papavassilis C.","Gottlieb A.B.","Elewski B.E.","Turner-Bowker D.M.","Shields A.L.","Gwaltney C.J.","Lebwohl M.""SOURCE","Value in Health (2013) 16:6 (1014-1022). Date of Publication: September-October 2013"

"TITLE","Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy""AUTHOR NAMES","Pivarcsi A.","Meisgen F.","Xu N.","Sonkoly E.""SOURCE","British Journal of Dermatology (2013) 169:3 (563-570). Date of Publication: September 2013"

"TITLE","Integrated assessment in dermatology: A case report""AUTHOR NAMES","Vari C.","Velotti P.","Giancristoforo S.","Richetta A.G.","Zavattini G.C.""SOURCE","Psychotherapy and Psychosomatics (2013) 82 SUPPL. 1 (120). Date of Publication: September 2013"

"TITLE","Mycobacterium poriferae infection in a psoriasis patient on anti-TNF-α therapy""AUTHOR NAMES","Laquer V.","Ta T.","Nguyen T.","Tan B.""SOURCE","Dermatology online journal (2013) 19:9 (19609). Date of Publication: 1 Sep 2013"

"TITLE","Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis""AUTHOR NAMES","Yayli S.","Irla N.","Yawalkar N.""SOURCE","Case Reports in Dermatology (2013) 5:3 (332-335). Date of Publication: September-December 2013"

"TITLE","Foreword""AUTHOR NAMES","Giele J.Z.""SOURCE","Current Problems in Dermatology (Switzerland) (2013) 44 (VII-VIII). Date of Publication: 2013"

"TITLE","Patients' narratives""AUTHOR NAMES","Foulkes A.C.","Warren R.B.""SOURCE","Current Problems in Dermatology (Switzerland) (2013) 44 (145-157). Date of Publication: 2013"

"TITLE","Safety of long-term therapy with biological drugs in psoriatic patients treated for latent tuberculosis infection: A retrospective study""AUTHOR NAMES","Conti A.","Galdo G.","Gisondi P.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S82-S84). Date of Publication: August 2013"

"TITLE","Different immune modulation with new biological agents for psoriasis""AUTHOR NAMES","Diani M.","Altomare A.","Bosè F.","Reali E.","Molteni S.","Petti L.","Altomare G.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S65-S67). Date of Publication: August 2013"

"TITLE","Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation""AUTHOR NAMES","Mansouri B.","Patel M.","Menter A.""SOURCE","British Journal of Dermatology (2013) 169:2 (481-483). Date of Publication: August 2013"

"TITLE","Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: Case report and review of 142 cases""AUTHOR NAMES","Famenini S.","Wu J.J.""SOURCE","Journal of Drugs in Dermatology (2013) 12:8 (939-943). Date of Publication: August 2013"

"TITLE","Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis""AUTHOR NAMES","Bosè F.","Petti L.","Diani M.","Moscheni C.","Molteni S.","Altomare A.","Rossi R.L.","Talarico D.","Fontana R.","Russo V.","Altomare G.","Reali E.""SOURCE","American Journal of Pathology (2013) 183:2 (413-421). Date of Publication: August 2013"

"TITLE","Psoriasis and alexithymia""AUTHOR NAMES","Auriemma M.","Gambi F.","Carlo R.","Giuseppe F.","Sapede G.","Di Giannantonio M.","Amerio P.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S86-S88). Date of Publication: August 2013"

"TITLE","Risk of nocardial infections with anti-tumor necrosis factor therapy""AUTHOR NAMES","Ali T.","Chakraburtty A.","Mahmood S.","Bronze M.S.""SOURCE","American Journal of the Medical Sciences (2013) 346:2 (166-168). Date of Publication: August 2013"

"TITLE","Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers""AUTHOR NAMES","Atteno M.","Costa L.","Caso F.","Sfriso P.","Puente A.D.","Scarpa R.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S103-S104). Date of Publication: August 2013"

"TITLE","Influence of polymorphism at position-308 of the tumour necrosis factor alpha gene on the expression of high mobility group box-1 protein in rheumatoid arthritis and spondyloarthritis patient""AUTHOR NAMES","Bagnato G.","Talotta R.","Bagnato G.","Bitto A.","Atteritano M.","Sangari

D.","Altavilla D.","Squadrito F.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S106-S108). Date of Publication: August 2013"

"TITLE","Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy""AUTHOR NAMES","Russell E.","Luk F.","Manocha S.","Ho T.","O'Connor C.","Hussain H.""SOURCE","Seminars in Arthritis and Rheumatism (2013) 43:1 (119-124). Date of Publication: August 2013"

"TITLE","Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: A single-centre, cohort study""AUTHOR NAMES","Mahil S.K.","Arkir Z.","Richards G.","Lewis C.M.","Barker J.N.","Smith C.H.""SOURCE","British Journal of Dermatology (2013) 169:2 (306-313). Date of Publication: August 2013"

"TITLE","Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: Results from the PSUNRISE trial""AUTHOR NAMES","Kalb R.E.","Blauvelt A.","Sofen H.L.","Chevrier M.","Amato D.","Calabro S.","Wang J.","Schenkel B.","Gottlieb A.B.""SOURCE","Journal of Drugs in Dermatology (2013) 12:8 (874-880). Date of Publication: August 2013"

"TITLE","Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab""AUTHOR NAMES","Talamonti M.","Botti E.","Galluzzo M.","Teoli M.","Spallone G.","Bavetta M.","Chimenti S.","Costanzo A.""SOURCE","British Journal of Dermatology (2013) 169:2 (458-463). Date of Publication: August 2013"

"TITLE","Assessment of psoriatic arthritis by means of functional infrared imaging: A pilot study""AUTHOR NAMES","Capo A.","Merla A.","Mattei P.","Auriemma M.","Panarese F.","Celletti E.","Abate M.","Romani G.L.","Amerio P.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S90-S91). Date of Publication: August 2013"

"TITLE","Long-term safety and efficacy of etanercept in patients with moderate-to-severe psoriasis: 5-years data experience""AUTHOR NAMES","Conti A.","Galdo G.","Greco M.","Borsari S.","Lasagni C.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S84-S86). Date of Publication: August 2013"

"TITLE","A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions""AUTHOR NAMES","Bhutani T.","Patel T.","Koo B.","Nguyen T.","Hong J.","Koo J.""SOURCE","Journal of the American Academy of Dermatology (2013) 69:2 (e79-e88). Date of Publication: August 2013"

"TITLE","Videocapillaroscopic findings in the microcirculation of the psoriatic plaque during etanercept therapy""AUTHOR NAMES","Stinco G.","Buligan C.","Maione V.","Valent F.","Patrone P.""SOURCE","Clinical and Experimental Dermatology (2013) 38:6 (633-637). Date of Publication: August 2013"

"TITLE","Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept""AUTHOR NAMES","Günther C.","Blau K.","Förster U.","Viehweg A.","Wozel G.","Schäkel K.""SOURCE","Experimental Dermatology (2013) 22:8 (535-540). Date of Publication: August 2013"

"TITLE","Antinuclear antibodies do not predict anti-infliximab antibody induction in sarcoidosis""AUTHOR NAMES","Vorselaars A.D.M.","Hijdra D.","Van Moorsel C.H.M.","Claessen A.M.E.","Grutters J.C.""SOURCE","Journal of the American Academy of Dermatology (2013) 69:2 (312-314). Date of Publication: August 2013"

"TITLE","Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infections""AUTHOR NAMES","Ku J.H.","Winthrop K.L.","Varley C.D.","Sullivan A.","Ehst B.D.","Blauvelt A.","Deodhar A.A.""SOURCE","JAMA Dermatology (2013) 149:8 (986-989). Date of Publication: August 2013"

"TITLE","Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study"

"AUTHOR NAMES","Chimenti M.S.","Graceffa D.","Di Muzio G.","Ballanti E.","Rinaldi M.","Perricone R.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S122-S125). Date of Publication: August 2013"

"TITLE","Personality, alexithymic and autonomic aspects in psoriatic patients: A preliminary study""AUTHOR NAMES","Di Nuzzo S.","Ercolini E.","Carrozzo E.","Fante C.","Casanova D.","Pruneti C.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S88-S90). Date of Publication: August 2013"

"TITLE","Evaluation of endothelial dysfunction in psoriatic patients by different techniques""AUTHOR NAMES","De Simone C.","Caldarola G.","Capizzi R.","Tassone F.","Vendittelli F.","Tondi P.","Santoliquido A.","Capoluongo E.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S91-S93). Date of Publication: August 2013"

"TITLE","Colour doppler ultrasonography in the diagnosis and management of giant cell arteritis""AUTHOR NAMES","Ciancio G.","Farina I.","Bortoluzzi A.","Giacuzzo S.","Bruschi M.","Occhionorelli S.","Vanini A.","Govoni M.""SOURCE","Clinical Drug Investigation (2013) 33:SUPPL.2 (S110-S112). Date of Publication: August 2013"

"TITLE","Psoriasis patients' knowledge about the disease and treatments""AUTHOR NAMES","Wahl A.K.","Moum T.","Robinson H.S.","Langeland E.","Larsen M.H.","Krogstad A.L.""SOURCE","Dermatology Research and Practice (2013) 2013 Article Number: 921737. Date of Publication: 2013"

"TITLE","Biologic therapy and tuberculosis: Our experience and review of literature""AUTHOR NAMES","Fabroni C.","D'Erme A.M.","Lotti T.""SOURCE","Psoriasis: Targets and Therapy (2013) 3 (25-29). Date of Publication: 3 Jul 2013"

"TITLE","A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients""AUTHOR NAMES","Park K.K.","Wu J.J.","Koo J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:7 (899-906). Date of Publication: July 2013"

"TITLE","Evaluation of renal function in patients with psoriasis using immunobiologicals""AUTHOR NAMES","Melgäo S.S.C.","da Silva Junior G.B.","Dantas A.M.M.","Vasconcelos A.M.A.","de Siqueira V.R.","Vieira A.P.F.","De Francesco Daher E.""SOURCE","Anais Brasileiros de Dermatologia (2013) 88:4 (667-669). Date of Publication: July/August 2013"

"TITLE","New onset of psoriasis in a patient with rheumatoid arthritis treated with rituximab""AUTHOR NAMES","Toussirot E.""SOURCE","Journal of Rheumatology (2013) 40:7 (1230-1231). Date of Publication: July 2013"

"TITLE","The predictive factors of adverse events in psoriatic arthritis patients treated with anti-TNF drugs""AUTHOR NAMES","Atzeni F.","Ricci C.","Ventura D.","Caporali R.","Cavagna L.","Saccardo F.","Pellerito R.","Gorla R.","Marchesoni A.","Sarzi-Puttini P.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27 SUPPL. 4 (5). Date of Publication: July 2013"

"TITLE","Study design and baseline characteristics from a phase 3, randomized, double-blind study of adalimumab versus methotrexate treatment in pediatric patients with chronic plaque psoriasis""AUTHOR NAMES","Papp K.","Thac¸i D.","Landells I.","Unnebrink K.","Williams D.A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27 SUPPL. 4 (27-28). Date of Publication: July 2013"

"TITLE","Multiple myeloma in a patient under ustekinumab - Are they related?""AUTHOR NAMES","Pinto-Almeida T.","Torres T.","Selores M.""SOURCE","European Journal of Dermatology (2013) 23:4 (567). Date of Publication: July - August 2013"

"TITLE","Continued improvement of signs and symptoms in ustekinumabtreated patients with active psoriatic arthritis: Week 52 results of a phase 3, multicenter, double-blind, placebo-controlled study""AUTHOR NAMES","Puig L.","Kavanaugh A.","McInnes I.B.","Gottlieb A.B.","Rahman P.","Ritchlin C.","Li S.","Wang Y.","Doyle M.K.","Mendelsohn A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27 SUPPL. 4

(53). Date of Publication: July 2013"

"TITLE","The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis""AUTHOR NAMES","Campanati A.","Ganzetti G.","Sario A.D.","Damiani A.","Sandroni L.","Rosa L.","Benedetti A.","Offidani A.""SOURCE","Journal of Gastroenterology (2013) 48:7 (839-846). Date of Publication: July 2013"

"TITLE","Sarcoidosis and psoriasis: A case series and review of the literature exploring co-incidence vs coincidence""AUTHOR NAMES","Wanat K.A.","Schaffer A.","Richardson V.","Van Voorhees A.","Rosenbach M.""SOURCE","JAMA Dermatology (2013) 149:7 (848-852). Date of Publication: July 2013"

"TITLE","Cutaneous leishmaniasis in a patient receiving infliximab""AUTHOR NAMES","Hernández-Torres A.","García-Vázquez E.","Frías-Iniesta J.","Herrero-Martínez J.A.","Gómez-Gómez J.""SOURCE","Scandinavian Journal of Infectious Diseases (2013) 45:7 (567-569). Date of Publication: July 2013"

"TITLE","Plasma YKL-40: A potential biomarker for psoriatic arthritis?""AUTHOR NAMES","Jensen P.","Wiell C.","Milting K.","Poggenborg R.P.","Østergaard M.","Johansen J.S.","Skov L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:7 (815-819). Date of Publication: July 2013"

"TITLE","Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab""AUTHOR NAMES","Lora V.","Bonaguri C.","Gisondi P.","Sandei F.","Battistelli L.","Russo A.","Melegari A.","Trenti T.","Lippi G.","Girolomoni G.""SOURCE","Immunologic Research (2013) 56:2-3 (382-389). Date of Publication: July 2013"

"TITLE","Fourth-year interim results from esprit, a 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis""AUTHOR NAMES","Kerdel F.","Thac¸i D.","Bereswill M.","Williams D.A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27 SUPPL. 4 (68). Date of Publication: July 2013"

"TITLE","Acitretin prescribing patterns in women of childbearing potential""AUTHOR NAMES","Davis S.A.","Yentzer B.A.","Feldman S.R.""SOURCE","Journal of Drugs in Dermatology (2013) 12:7 (799-802). Date of Publication: July 2013"

"TITLE","Psoriatic arthritis mutilans: Case series and literature review""AUTHOR NAMES","Bruzzese V.","Marrese C.","Ridola L.","Zullo A.""SOURCE","Journal of Rheumatology (2013) 40:7 (1233-1236). Date of Publication: July 2013"

"TITLE","Use of TNFα antagonists in refractory AIH: Revealing the unforeseen""AUTHOR NAMES","Saitis A.","Gatselis N.","Zachou K.","Dalekos G.N.""SOURCE","Journal of Hepatology (2013) 59:1 (197-198). Date of Publication: July 2013"

"TITLE","Hair regrowth following TNF-α blockade in coexisting psoriasis vulgaris and alopecia areata""AUTHOR NAMES","Ono S.","Miyachi Y.","Arakawa A.""SOURCE","European Journal of Dermatology (2013) 23:4 (537). Date of Publication: July - August 2013"

"TITLE","Fissured tongue responding to biologics during the treatment of psoriasis: The importance of detecting oral involvement of psoriasis""AUTHOR NAMES","D'Erme A.M.","Agnoletti A.F.","Prignano F.""SOURCE","Dermatologic Therapy (2013) 26:4 (364-366). Date of Publication: July-August 2013"

"TITLE","Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment""AUTHOR NAMES","Bandinelli F.","Bonacci E.","Matucci-Cerinic M.""SOURCE","Clinical and Experimental Rheumatology (2013) 31:3 (440-442). Date of Publication: 2013"

"TITLE","Evaluation of risk factors for body weight gain in psoriatic patients on infliximab: A multicentre, cross-sectional study""AUTHOR NAMES","Mahe E.","Reguiai Z.","Barthelemy H.","Quiles-Tsimaratos N.","Chaby G.","Girard C.","Estève E.","Maccari F.","Descamps V.","Schmutz J.-L.","Begon E.","Bravard P.","Maillard H.","Boyé T.","Beauchet A.","Sigal M.-L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27 SUPPL. 4 (16). Date of Publication: July 2013"

"TITLE","Remission of psoriatic arthritis after etanercept discontinuation: Analysis of

patients' clinical characteristics leading to disease relapse""AUTHOR NAMES","Chimenti M.S.","Esposito M.","Giunta A.","Graceffa D.","Babino G.","Teoli M.","Mazzotta A.","Perricone R.","Chimenti S.""SOURCE","International Journal of Immunopathology and Pharmacology (2013) 26:3 (833-838). Date of Publication: July-September 2013"

"TITLE","Differential diagnosis of a patient with low back and toe pain""AUTHOR NAMES","Wahl E.C.","Smith D.","Sesto M.","Boissonnault W.""SOURCE","Journal of Manual and Manipulative Therapy (2013) 21:2 (81-89). Date of Publication: 2013"

"TITLE","Striae: A potential precipitating factor for Koebner phenomenon in psoriasis?""AUTHOR NAMES","Morais P.","Oliveira M.","Matos J.""SOURCE","Dermatology Online Journal (2013) 19:5. Date of Publication: 2013"

"TITLE","Tumor necrosis factor inhibition and glucose homeostasis""AUTHOR NAMES","Larsen A.J.","Clarke J.T.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:6 (e182-e183). Date of Publication: June 2013"

"TITLE","Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review""AUTHOR NAMES","Solovan C.","Chiticariu E.""SOURCE","Infectious Diseases and Therapy (2013) 2:1 (59-73). Date of Publication: June 2013"

"TITLE","Acute treatment of generalized pustular psoriasis of von Zumbusch with single-dose infliximab""AUTHOR NAMES","Smith N.","Harms K.L.","Hines A.C.","Harms P.W.","Gudjonsson J.E.","Hristov A.C.","Wang F.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:6 (e187-e189). Date of Publication: June 2013"

"TITLE","Cost per treated patient for biologics for rheumatoid arthritis (RA) using us claims data""AUTHOR NAMES","Schabert V.F.","Korn J.","Bilir S.P.","Dekoven M.","Harrison D.J.","Joseph G.J.""SOURCE","Annals of the Rheumatic Diseases (2013) 72 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis""AUTHOR NAMES","Chandran V.","Shen H.","Pollock R.A.","Pellett F.J.","Carty A.","Cook R.J.","Gladman D.D.""SOURCE","Journal of Rheumatology (2013) 40:6 (866-871). Date of Publication: June 2013"

"TITLE","Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: A two-case series""AUTHOR NAMES","Jensen J.D.","Huynh T.","Cafardi J.","Sami N.""SOURCE","Journal of Drugs in Dermatology (2013) 12:6 (710-711). Date of Publication: June 2013"

"TITLE","Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis""AUTHOR NAMES","Koga M.","Terawaki S.","Tatsukawa R.","Fujita M.","Imafuku S.","Nakayama J.""SOURCE","Journal of Dermatology (2013) 40:6 (476-477). Date of Publication: June 2013"

"TITLE","Persistency with subcutaneous anti-TNF therapy for treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis patients""AUTHOR NAMES","Tandon N.","Haas S.","Waters H.C.","Olson W.","Bolge S.","Gunnarsson C.""SOURCE","Annals of the Rheumatic Disease (2013) 71 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Tumor necrosis factor-α antagonists and alopecia areata: A class-wide adverse effect""AUTHOR NAMES","Griffith J.L.","Ledet J.J.","Elewski B.E.""SOURCE","Journal of Drugs in Dermatology (2013) 12:6 (713-714). Date of Publication: June 2013"

"TITLE","Tumor necrosis factor (TNF)-inhibitor dose escalation in rheumatoid arthritis (RA) patients in a united states (US) pharmacy benefits management (PBM) setting""AUTHOR NAMES","Blume S.W.","Fox K.M.","Joseph G.","Chuang C.-C.","Thomas J.","Gandra S.R.""SOURCE","Annals of the Rheumatic Disease (2013) 71 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Psoriasis is associated with an increased risk of parkinsonism: A population-based 5-year follow-up study""AUTHOR NAMES","Sheu J.-J.","Wang K.-H.","Lin H.-C.","Huang C.-C.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:6 (992-999). Date of Publication: June 2013"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit i study""AUTHOR NAMES","Rahman P.","Kavanaugh A.","Gottlieb A.","Puig L.","Ritchlin C.","McInnes I.","Li S.","Wang Y.","Mendelsohn A.","Doyle M.""SOURCE","Journal of Rheumatology (2013) 40:6 (983). Date of Publication: June 2013"

"TITLE","Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: Results of a randomized, long-term extension trial (RESTORE2)""AUTHOR NAMES","Reich K.","Wozel G.","Zheng H.","Van Hoogstraten H.J.F.","Flint L.","Barker J.""SOURCE","British Journal of Dermatology (2013) 168:6 (1325-1334). Date of Publication: June 2013"

"TITLE","Etanercept use for psoriasis in Taiwan: A case series study""AUTHOR NAMES","Chiu H.-Y.","Wang T.-S.","Cho Y.-T.","Tsai T.-F.""SOURCE","International Journal of Dermatology (2013) 52:6 (673-680). Date of Publication: June 2013"

"TITLE","Efficacy and safety of etanercept in the treatment of recalcitrant psoriasis: An open-label, retrospective, observational study in Taiwan""AUTHOR NAMES","Wu Y.-F.","Shin Y.-C.","Yang C.-H.","Huang Y.-H.""SOURCE","Dermatologica Sinica (2013) 31:2 (49-53). Date of Publication: June 2013"

"TITLE","Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases""AUTHOR NAMES","Afshar M.","Martinez A.D.","Gallo R.L.","Hata T.R.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:6 (771-778). Date of Publication: June 2013"

"TITLE","Continued improvement of signs and symptoms in ustekinumab-treated patients with active psoriatic arthritis: Week 52 results of a phase 3, multicenter, double-blind, placebo-controlled study""AUTHOR NAMES","Kavanaugh A.","McInnes I.B.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.","Li S.","Wang Y.","Doyle M.","Mendelsohn A.""SOURCE","Annals of the Rheumatic Diseases (2013) 72 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study""AUTHOR NAMES","McInnes I.B.","Kavanaugh A.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.","Li S.","Wang Y.","Mendelsohn A.M.","Doyle M.K.""SOURCE","Annals of the Rheumatic Disease (2013) 71 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Successful treatment of psoriasis with interrupted adalimumab use: A case report""AUTHOR NAMES","Sakamoto S.","Kawada A.","Oiso N.""SOURCE","Journal of Dermatology (2013) 40:6 (477-478). Date of Publication: June 2013"

"TITLE","Maintenance of efficacy and safety of ustekinumab in patients with active psoriatic arthritis despite prior conventional nonbiologic and anti-TNF biologic therapy: 1 yr results of the psummit 2 trial""AUTHOR NAMES","Ritchlin C.","McInnes I.","Kavanaugh A.","Puig L.","Rahman P.","Li S.","Shen Y.","Doyle M.","Mendelsohn A.","Gottlieb A.""SOURCE","Annals of the Rheumatic Diseases (2013) 72 SUPPL. 3. Date of Publication: June 2013"

"TITLE","Bullae and psoriasiform hyperkeratosis after treatment with golimumab""AUTHOR NAMES","Madigan L.M.","Kaffenberger B.H.","Wong H.K.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:6 (e195-e196). Date of Publication: June 2013"

"TITLE","Anti-TNF agents and nail psoriasis: A single-center, retrospective, comparative study""AUTHOR NAMES","Kyriakou A.","Patsatsi A.","Sotiriadis D.""SOURCE","Journal of Dermatological Treatment (2013) 24:3 (162-168). Date of Publication: 2013"

"TITLE","Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: Results of a European cross-sectional observational study""AUTHOR NAMES","Christophers E.","Segaert S.","Milligan G.","Molta C.T.","Boggs R.""SOURCE","Journal of Dermatological Treatment (2013) 24:3 (193-198). Date of Publication: 2013"

"TITLE","Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis""AUTHOR NAMES","Au S.-C.","Goldminz A.M.","Kim N.","Dumont N.","Michelon M.","Volf E.","Hession M.","Lizzul P.F.","Andrews I.D.","Kerensky T.","Wang A.","Yaniv S.","Gottlieb A.B.""SOURCE","Journal of Dermatological Treatment (2013) 24:3 (179-187). Date of Publication: 2013"

"TITLE","The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)"

"AUTHOR NAMES","Strohal R.","Puig L.","Chouela E.","Tsai T.-F.","Melin J.","Freundlich B.","Molta C.T.","Fuiman J.","Pedersen R.","Robertson D.""SOURCE","Journal of Dermatological Treatment (2013) 24:3 (169-178). Date of Publication: 2013"

"TITLE","Adalimumab therapy for psoriasis in real-world practice: Efficacy, safety and results in biologic-naïve vs. non-naïve patients""AUTHOR NAMES","Van Lümig P.P.M.","Van De Kerkhof P.C.M.","Boezeman J.B.M.","Driessen R.J.B.","De Jong E.M.G.J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:5 (593-600). Date of Publication: May 2013"

"TITLE","Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: A prospective cohort study""AUTHOR NAMES","Gisondi P.","Conti A.","Galdo G.","Piaserico S.","De Simone C.","Girolomoni G.""SOURCE","British Journal of Dermatology (2013) 168:5 (1124-1127). Date of Publication: May 2013"

"TITLE","Cost per treated patient for biologics across adult indications using claims data""AUTHOR NAMES","Schabert V.F.","Korn J.","Bilir P.","DeKoven M.","Harrison D.J.","Joseph G.""SOURCE","Value in Health (2013) 16:3 (A220). Date of Publication: May 2013"

"TITLE","Onychomycosis in patients of nail psoriasis on biologic therapy: A randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab""AUTHOR NAMES","Al-Mutairi N.","Nour T.","Al-Rqobah D.""SOURCE","Expert Opinion on Biological Therapy (2013) 13:5 (625-629). Date of Publication: May 2013"

"TITLE","Cost-effectiveness analysis of biological therapies for the treatment of moderate and severe psoriasis in institutional market in ecuador""AUTHOR NAMES","Torres Toala F.G.","Albuja Riofrio M.F.","Mould Quevedo J.F.","Estévez C.""SOURCE","Value in Health (2013) 16:3 (A118). Date of Publication: May 2013"

"TITLE","Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?""AUTHOR NAMES","Bhalme M.","Sharma A.","Keld R.","Willert R.","Campbell S.""SOURCE","European Journal of Gastroenterology and Hepatology (2013) 25:5 (543-549). Date of Publication: May 2013"

"TITLE","Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: A single centre, cohort study""AUTHOR NAMES","Mahil S.K.","Arkir Z.","Richards G.","Barker J.N.","Smith C.H.""SOURCE","Journal of Investigative Dermatology (2013) 133 SUPPL. 1 (S159). Date of Publication: May 2013"

"TITLE","Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: Report of two cases""AUTHOR NAMES","Matsumoto Y.","Maeda T.","Tsuboi R.","Okubo Y.""SOURCE","Journal of Dermatology (2013) 40:5 (389-392). Date of Publication: May 2013"

"TITLE","Alopecia areata during treatment with adalimumab: Therapy with an alternative TNF-alpha inhibitor is possible""AUTHOR NAMES","Zschoche C.","Bidier M.","Hadaschik E.""SOURCE","JDDG - Journal of the German Society of Dermatology (2013) 11:5 (450-454). Date of Publication: May 2013"

"TITLE","OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis""AUTHOR NAMES","Kimball A.B.","Pariser D.","Yamauchi P.S.","Menter A.","Teller C.F.","Shi Y.","Yong M.","Creamer K.","Hooper M.","Aras G.","Kricorian G.","Gelfand J.M.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:5 (756-764). Date of Publication: May 2013"

"TITLE","Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response""AUTHOR NAMES","Baerveldt E.M.","Onderdijk A.J.","Kurek D.","Kant M.","Florencia E.F.","Ijpma A.S.","Van Der Spek P.J.","Bastiaans J.","Jansen P.A.","Van Kilsdonk J.W.J.","Laman J.D.","Prens E.P.""SOURCE","British Journal of Dermatology (2013) 168:5 (990-998). Date of Publication: May 2013"

"TITLE","High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires""AUTHOR NAMES","Haroon M.","Kirby B.","FitzGerald O.""SOURCE","Annals of the Rheumatic Diseases (2013) 72:5 (736-740). Date of Publication: May 2013"

"TITLE","Paradoxical reaction to etanercept: Development of pyoderma gangraenosum during

therapy of psoriasis arthritis""AUTHOR NAMES","Kowalzick L.","Bertolini J.","Baumann C.","Walther B.","Truhm B.","Eickenscheidt L.""SOURCE","JDDG - Journal of the German Society of Dermatology (2013) 11:5 (447-449). Date of Publication: May 2013"

"TITLE","Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: Subanalysis of REVEAL and the open-label extension study""AUTHOR NAMES","Papp K.","Menter A.","Poulin Y.","Gu Y.","Sasso E.H.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:5 (634-642). Date of Publication: May 2013"

"TITLE","A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis""AUTHOR NAMES","Ortonne J.P.","Paul C.","Berardesca E.","Marino V.","Gallo G.","Brault Y.","Germain J.M.""SOURCE","British Journal of Dermatology (2013) 168:5 (1080-1087). Date of Publication: May 2013"

"TITLE","Long-term management of HIV/hepatitis C virus associated psoriasis with etanercept""AUTHOR NAMES","Di Lernia V.","Zoboli G.","Ficarelli E.""SOURCE","Indian Journal of Dermatology, Venereology and Leprology (2013) 79:3 (444). Date of Publication: May-Jun 2013"

"TITLE","Adalimumab modulates angiogenesis in psoriatic skin""AUTHOR NAMES","Campanati A.","Moroncini G.","Ganzetti G.","Pozniak K.N.","Goteri G.","Giuliano A.","Martina E.","Liberati G.","Ricotti F.","Gabrielli A.","Offidani A.""SOURCE","European Journal of Inflammation (2013) 11:2 (489-498). Date of Publication: May-August 2013"

"TITLE","Oxidative stress and psoriasis: The effect of antitumour necrosis factor-α inhibitor treatment""AUTHOR NAMES","Bacchetti T.","Campanati A.","Ferretti G.","Simonetti O.","Liberati G.","Offidani A.M.""SOURCE","British Journal of Dermatology (2013) 168:5 (984-989). Date of Publication: May 2013"

"TITLE","Hepatitis and lupus-like syndrome during infliximab therapy for psoriasis""AUTHOR NAMES","Riad H.","Abu Shaikha S.","Al Ansari H.","Al Naama K.","Al Sada H.","Al Mansoori M.""SOURCE","Case Reports in Dermatology (2013) 5:2 (219-224). Date of Publication: May-August 2013"

"TITLE","Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis""AUTHOR NAMES","Sauder M.B.","Glassman S.J.""SOURCE","International Journal of Dermatology (2013) 52:5 (624-628). Date of Publication: May 2013"

"TITLE","Altered redox status in the blood of psoriatic patients: Involvement of NADPH oxidase and role of anti-TNF-α therapy""AUTHOR NAMES","Barygina V.V.","Becatti M.","Soldi G.","Prignano F.","Lotti T.","Nassi P.","Wright D.","Taddei N.","Fiorillo C.""SOURCE","Redox Report (2013) 18:3 (100-106). Date of Publication: May 2013"

"TITLE","Application and modifications of minimal disease activity measures for patients with psoriatic arthritis treated with adalimumab: Subanalyses of ADEPT""AUTHOR NAMES","Mease P.J.","Heckaman M.","Kary S.","Kupper H.""SOURCE","Journal of Rheumatology (2013) 40:5 (647-652). Date of Publication: May 2013"

"TITLE","Effects of adalimumab therapy on musculoskeletal manifestations and health-related quality of life in patients with active psoriatic arthritis""AUTHOR NAMES","Tsuji S.","Higashiyama M.","Inaoka M.","Tomita T.","Yokomi A.","Satoh A.","Hirano A.","Hayashi M.","Tsuji M.","Kunugiza Y.","Hamada M.","Yoshikawa H.""SOURCE","Modern Rheumatology (2013) 23:3 (529-537). Date of Publication: May 2013"

"TITLE","Effectiveness of infliximab in pityriasis rubra pilaris is associated with pro-inflammatory cytokine inhibition""AUTHOR NAMES","Adnot-Desanlis L.","Antonicelli F.","Tabary T.","Bernard P.","Reguiaï Z.""SOURCE","Dermatology (2013) 226:1 (41-46). Date of Publication: May 2013"

"TITLE","Adalimumab-induced psoriasis in a patient with Crohn's disease""AUTHOR NAMES","Korkmaz U.","Duman A.E.","Dindar G.","Yilmaz H.","Dursun I.H.","Celebi A.","Senturk O.","Hulagu S.""SOURCE","Indian Journal of Gastroenterology (2013) 32:2 (135-136). Date of Publication: 2013"

"TITLE","The TICOPA protocol (tight control of psoriatic arthritis): A randomised controlled

trial to compare intensive management versus standard care in early psoriatic arthritis""AUTHOR NAMES","Coates L.C.","Navarro-Coy N.","Brown S.R.","Browan S.","McParland L.","Collier H.","Skinner E.","Law J.","Moverley A.","Pavitt S.","Hulme C.","Emery P.","Conaghan P.G.","Helliwell P.S.""SOURCE","BMC Musculoskeletal Disorders (2013) 14 Article Number: 101. Date of Publication: 2013"

"TITLE","Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis""AUTHOR NAMES","Kirson N.Y.","Rao S.","Birnbaum H.G.","Kantor E.","Wei R.S.","Cifaldi M.""SOURCE","Journal of Medical Economics (2013) 16:4 (479-489). Date of Publication: 2013"

"TITLE","Crusted scabies complicates etanercept therapy in a patient with severe psoriasis""AUTHOR NAMES","Saillard C.","Darrieux L.","Safa G.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 (e138-e139). Date of Publication: 2013"

"TITLE","Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis""AUTHOR NAMES","Morales-Múnera C.","Vilarrasa E.","Puig L.""SOURCE","British Journal of Dermatology (2013) 168:4 (820-824). Date of Publication: April 2013"

"TITLE","Association between anti-TNF-α therapy and interstitial lung disease""AUTHOR NAMES","Herrinton L.J.","Harrold L.R.","Liu L.","Raebel M.A.","Taharka A.","Winthrop K.L.","Solomon D.H.","Curtis J.R.","Lewis J.D.","Saag K.G.""SOURCE","Pharmacoepidemiology and Drug Safety (2013) 22:4 (394-402). Date of Publication: April 2013"

"TITLE","Effect of tumor necrosis factorealfa inhibitor and methotrexate therapy on total cholesterol, high-density lipoprotein, and low-density lipoprotein in psoriasis/psoriatic arthritis and rheumatoid arthritis patients""AUTHOR NAMES","Wu J.","Xiang A.","Rowan C.","Poon K.-Y.","Anthony M.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB199). Date of Publication: April 2013"

"TITLE","Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: Final results from 5 years of follow-up""AUTHOR NAMES","Papp K.A.","Griffiths C.E.M.","Gordon K.","Lebwohl M.","Szapary P.O.","Wasfi Y.","Chan D.","Hsu M.-C.","Ho V.","Ghislain P.D.","Strober B.","Reich K.""SOURCE","British Journal of Dermatology (2013) 168:4 (844-854). Date of Publication: April 2013"

"TITLE","Treatment patterns in the first year for biologic-naive psoriasis patients starting on etanercept and adalimumab in a pharmacy benefit management setting""AUTHOR NAMES","Joseph G.J.","Harrison D.J.","Thomas J.","Blume S.W.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB216). Date of Publication: April 2013"

"TITLE","Ustekinumab in nail psoriasis: An open-label, uncontrolled, nonrandomized study""AUTHOR NAMES","Patsatsi A.","Kyriakou A.","Sotiriadis D.""SOURCE","Journal of Dermatological Treatment (2013) 24:2 (96-100). Date of Publication: April 2013"

"TITLE","US treatment patterns in psoriasis pts newly initiated on etanercept or adalimumab""AUTHOR NAMES","Kimball A.B.","Zhang F.","Li S.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB217). Date of Publication: April 2013"

"TITLE","Cost of etanercept and adalimumab in patients with psoriatic diseases with employer-provided health insurance""AUTHOR NAMES","Bonafede M.","Watson C.","Joseph G.J.","Princic N.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB196). Date of Publication: April 2013"

"TITLE","Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug usation data in a US managed care population""AUTHOR NAMES","Schabert V.F.","Burudpakdee C.","Watson C.","Harrison D.J.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB196). Date of Publication: April 2013"

"TITLE","Pityriasis rubra pilaris and arthritis: Is there a link?""AUTHOR NAMES","Levin J.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB57). Date of Publication: April 2013"

"TITLE","Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and

non-Chinese healthy male subjects across two phase 1 studies""AUTHOR NAMES","Zhu Y.","Wang Q.","Frederick B.","Bouman-Thio E.","Marini J.C.","Keen M.","Petty K.J.","Davis H.M.","Zhou H.""SOURCE","Clinical Drug Investigation (2013) 33:4 (291-301). Date of Publication: April 2013"

"TITLE","Adalimumab: Long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease""AUTHOR NAMES","Burmester G.R.","Panaccione R.","Gordon K.B.","McIlraith M.J.","Lacerda A.P.M.""SOURCE","Annals of the Rheumatic Diseases (2013) 72:4 (517-524). Date of Publication: April 2013"

"TITLE","Successful long-term triple disease control by ustekinumab in a patient with Behçet's disease, psoriasis and hidradenitis suppurativa""AUTHOR NAMES","Baerveldt E.M.","Kappen J.H.","Thio H.B.","Van Laar J.A.M.","Martin Van Hagen P.","Prens E.P.""SOURCE","Annals of the Rheumatic Diseases (2013) 72:4 (626-627). Date of Publication: April 2013"

"TITLE","Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?""AUTHOR NAMES","Bartalesi F.","Salomoni E.","Cavallo A.","Corti G.","Pimpinelli N.","Bartoloni A.","Taliani G.""SOURCE","Scandinavian Journal of Infectious Diseases (2013) 45:4 (320-323). Date of Publication: April 2013"

"TITLE","Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab""AUTHOR NAMES","Gisondi P.","Lora V.","Bonauguri C.","Russo A.","Lippi G.","Girolomoni G.""SOURCE","British Journal of Dermatology (2013) 168:4 (749-755). Date of Publication: April 2013"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT i study""AUTHOR NAMES","Gottlieb A.","Kavanaugh A.","McInnes I.","Puig L.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB218). Date of Publication: April 2013"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: results of the phase iii, multicentre, double-blind, placebo-controlled psummit i study.""AUTHOR NAMES","McInnes I.","Kavanaugh A.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.","Li S.","Wang Y.","Mendelsohn A.","Doyle M.""SOURCE","Rheumatology (United Kingdom) (2013) 52 SUPPL. 1 (i164). Date of Publication: April 2013"

"TITLE","Safety and efficacy of adding topical clobetasol propionate to etanercept in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Lebwohl M.G.","Pariser D.","Kricorian G.","Koo J.","Duffin K.C.","Kircik L.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB211). Date of Publication: April 2013"

"TITLE","A 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis: Third-year interim results of ESPRIT""AUTHOR NAMES","Kerdel F.A.","Williams D.A.","Thac¸i D.","Wang Y.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB191). Date of Publication: April 2013"

"TITLE","Incremental medical service costs associated with escalating methotrexate dosage versus switching to adalimumab in patients with psoriasis""AUTHOR NAMES","Reich K.","Guerin A.","Kaminsky M.","Sundaram M.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB203). Date of Publication: April 2013"

"TITLE","Double-dosing payment in psoriasis patients newly initiated on etaner-cept in US""AUTHOR NAMES","Zhang F.","Li S.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1 (AB198). Date of Publication: April 2013"

"TITLE","Infliximab-induced discoid lupus erythematosus""AUTHOR NAMES","Cemil B.C.","Atas H.","Canpolat F.","Akca Y.","Sasmaz R.""SOURCE","Lupus (2013) 22:5 (515-518). Date of Publication: April 2013"

"TITLE","The risk of herpes zoster in the anti-TNF-α era: A case report and review of the literature""AUTHOR NAMES","Di Costanzo L.","Ayala F.","Megna M.","Gaudiello F.","Patrì A.","Balato N.""SOURCE","Journal of Dermatological Case Reports (2013) 7:1 (1-4). Date of Publication: 30 Mar

2013"

"TITLE","Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris""AUTHOR NAMES","Di Stefani A.","Galluzzo M.","Talamonti M.","Chiricozzi A.","Costanzo A.","Chimenti S.""SOURCE","Journal of Dermatological Case Reports (2013) 7:1 (5-9). Date of Publication: 30 Mar 2013"

"TITLE","T cell costimulation blockade may prevent tumour necrosis factor alpha inhibitor-induced palmoplantar pustulosis""AUTHOR NAMES","Rodenhausen S.","Dan D.","Caliezi G.","Möller B.""SOURCE","Aktuelle Rheumatologie (2013) 38:1 (55-58). Date of Publication: 2013"

"TITLE","Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn's disease: A case report and review of the hypothetical association between TNF-α blockers and cancer""AUTHOR NAMES","Kouklakis G.","Efremidou E.I.","Pitiakoudis M.","Liratzopoulos N.","Polychronidis A.C.""SOURCE","Drug Design, Development and Therapy (2013) 7 (195-199). Date of Publication: 26 Mar 2013"

"TITLE","Serum cytokines correlated with the disease severity of generalized pustular psoriasis""AUTHOR NAMES","Yamamoto M.","Imai Y.","Sakaguchi Y.","Haneda T.","Yamanishi K.""SOURCE","Disease Markers (2013) 34:3 (153-161). Date of Publication: 2013"

"TITLE","Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster""AUTHOR NAMES","Winthrop K.L.","Baddley J.W.","Chen L.","Liu L.","Grijalva C.G.","Delzell E.","Beukelman T.","Patkar N.M.","Xie F.","Saag K.G.","Herrinton L.J.","Solomon D.H.","Lewis J.D.","Curtis J.R.""SOURCE","JAMA - Journal of the American Medical Association (2013) 309:9 (887-895). Date of Publication: 6 Mar 2013"

"TITLE","Switch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practice""AUTHOR NAMES","Norlin J.M.","Steen Carlsson K.","Persson U.","Schmitt-Egenolf M.""SOURCE","Dermatology (2012) 225:4 (326-332). Date of Publication: March 2013"

"TITLE","Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: A retrospective, multicentre study in a clinical setting""AUTHOR NAMES","Navarro R.","Vilarrasa E.","Herranz P.","Puig L.","Bordas X.","Carrascosa J.M.","Taberner R.","Ferrán M.","Garćia-Bustinduy M.","Romero-Maté A.","Pedragosa R.","Garćia-Diez A.","Daudén E.""SOURCE","British Journal of Dermatology (2013) 168:3 (609-616). Date of Publication: March 2013"

"TITLE","Psoriasis treated with ustekinumab in a patient with hepatitis C""AUTHOR NAMES","Abuchar A.","Vitiello M.","Kerdel F.A.""SOURCE","International Journal of Dermatology (2013) 52:3 (381-382). Date of Publication: March 2013"

"TITLE","Does anti-tumour necrosis factor-alpha increase oral candida colonization? A case-control study in psoriatic patients""AUTHOR NAMES","Corazza M.","Zauli S.","Ricci M.","Borghi A.","Rossi R.","Virgili A.""SOURCE","Acta Dermato-Venereologica (2013) 93:3 (352-353). Date of Publication: March 2013"

"TITLE","Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept""AUTHOR NAMES","Wang T.-S.","Tsai T.-F.""SOURCE","Dermatologica Sinica (2013) 31:1 (11-18). Date of Publication: March 2013"

"TITLE","Tolerability of one hour 10mg/kg infliximab infusions in patients with inflammatory bowel disease""AUTHOR NAMES","Babouri A.","Buisson A.","Bigard M.-A.","Peyrin-Biroulet L.""SOURCE","Journal of Crohn's and Colitis (2013) 7:2 (129-133). Date of Publication: 1 Mar 2013"

"TITLE","Lichen planus under anti TNF therapy for ankylosing spondylitis""AUTHOR NAMES","Wendling D.","Biver-Dalle C.","Vidon C.","Prati C.","Aubin F.""SOURCE","Joint Bone Spine (2013) 80:2 (227-228). Date of Publication: March 2013"

"TITLE","Adverse cutaneous drug reactions among hospitalized patients: Five year surveillance""AUTHOR NAMES","Turk B.G.","Gunaydin A.","Ertam I.","Ozturk G.""SOURCE","Cutaneous and Ocular Toxicology (2013) 32:1 (41-45). Date of Publication: March 2013"

"TITLE","Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for crohn's disease""AUTHOR NAMES","Kawashima K.","Ishihara S.","Yamamoto A.","Ohno Y.","Fukuda K.","Onishi K.","Kinoshita Y.""SOURCE","Inflammatory Bowel Diseases (2013) 19:3 (E33-E34). Date of Publication: March 2013"

"TITLE","IL-20, IL-21 and p40: Potential biomarkers of treatment response for ustekinumab""AUTHOR NAMES","Gedebjerg A.","Johansen C.","Kragbale K.","Iversen L.""SOURCE","Acta Dermato-Venereologica (2013) 93:2 (150-155). Date of Publication: March 2013"

"TITLE","One-Year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a canadian population""AUTHOR NAMES","Vender R.","Lynde C.","Gilbert M.","Ho V.","Sapra S.","Poulin-Costello M.""SOURCE","Journal of Cutaneous Medicine and Surgery (2013) 17:2 (129-138). Date of Publication: March-April 2013"

"TITLE","Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient""AUTHOR NAMES","Koskinas J.","Tampaki M.","Doumba P.P.","Rallis E.""SOURCE","British Journal of Dermatology (2013) 168:3 (679-680). Date of Publication: March 2013"

"TITLE","Combination therapy of infiximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis""AUTHOR NAMES","Fujisawa T.","Moriya C.","Shibuya Y.","Kanoh H.","Seishima M.""SOURCE","Acta Dermato-Venereologica (2013) 93:3 (364-365). Date of Publication: March 2013"

"TITLE","The changes in expression of Ki-67, and CD31 in psoriatic lesions before and after etanercept treatment""AUTHOR NAMES","Tursen B.","Kara T.","Tursen U.","Apa D.D.","Gubur O.","Kaya T.I.""SOURCE","Hong Kong Journal of Dermatology and Venereology (2013) 21:1 (5-13). Date of Publication: Spring 2013"

"TITLE","Entecavir and intermittent etanercept therapy in a patient with concurrent hepatitis B virus infection and psoriasis""AUTHOR NAMES","Babino G.","Esposito M.","Mazzotta A.","Chimenti S.","Giunta A.""SOURCE","Acta Dermato-Venereologica (2013) 93:3 (373-374). Date of Publication: March 2013"

"TITLE","Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation""AUTHOR NAMES","Johnston A.","Fritz Y.","Dawes S.M.","Diaconu D.","Al-Attar P.M.","Guzman A.M.","Chen C.S.","Fu W.","Gudjonsson J.E.","McCormick T.S.","Ward N.L.""SOURCE","Journal of Immunology (2013) 190:5 (2252-2262). Date of Publication: 1 Mar 2013"

"TITLE","B-cell lymphoma in a psoriatic patient treated with infliximab""AUTHOR NAMES","Bardazzi F.","Antonucci V.A.","Alessandrini A.M.","Baraldi C.","Tengattini V.","Patrizi A.""SOURCE","European Journal of Dermatology (2013) 23:2 (264-265). Date of Publication: March/April 2013"

"TITLE","A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: Effects of adalimumab treatment on lesional and nonlesional skin""AUTHOR NAMES","De Groot M.","Picavet D.I.","Van Kuijk A.W.R.","Tak P.P.","Bos J.D.","De Rie M.A.","Teunissen M.B.M.""SOURCE","Dermatology (2012) 225:4 (298-303). Date of Publication: March 2013"

"TITLE","Prediction of treatment response in psoriasis with measurement of serum levels of adalimumab, etanercept, and antidrug antibodies: A pilot study""AUTHOR NAMES","Mahil S.K.","Arkir Z.","Richards G.","Barker J.N.","Smith C.H.""SOURCE","The Lancet (2013) 381 SUPPL. 1 (S69). Date of Publication: 27 Feb 2013"

"TITLE","Lower extremity swelling in a patient with psoriatic arthritis""AUTHOR NAMES","Condit R.","Fiocco G.""SOURCE","Rheumatology Reports (2013) 5:1 (1-3). Date of Publication: 2013"

"TITLE","Distinct immunologic and radiographic patterns in etanercept-induced lung injury""AUTHOR NAMES","Serban K.","Muzoora M.","Hage C.A.","Lahm T.""SOURCE","Respiratory Medicine Case Reports (2013) 8:1 (18-20). Date of Publication: 2013"

"TITLE","Ustekinumab for resistant psoriatic arthritis""AUTHOR NAMES","Wallis D.E.J.","Waldron N.M.","Korendowych E.""SOURCE","Journal of Rheumatology (2013) 40:2 (207). Date of Publication: February 2013"

"TITLE","Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population"

"AUTHOR NAMES","Chastek B.","Fox K.M.","Watson C.","Kricorian G.","Gandra S.R.""SOURCE","Journal of Dermatological Treatment (2013) 24:1 (25-33). Date of Publication: February 2013"

"TITLE","Demyelination during tumour necrosis factor antagonist therapy for psoriasis: A case report and review of the literature""AUTHOR NAMES","Mahil S.K.","Andrews T.C.","Brierley C.","Barker J.N.","Smith C.H.""SOURCE","Journal of Dermatological Treatment (2013) 24:1 (38-49). Date of Publication: February 2013"

"TITLE","Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study""AUTHOR NAMES","Rich P.","Sigurgeirsson B.","Thaci D.","Ortonne J.-P.","Paul C.","Schopf R.E.","Morita A.","Roseau K.","Harfst E.","Guettner A.","MacHacek M.","Papavassilis C.""SOURCE","British Journal of Dermatology (2013) 168:2 (402-411). Date of Publication: February 2013"

"TITLE","How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center""AUTHOR NAMES","Kamangar F.","Isip L.","Bhutani T.","Dennis M.","Heller M.M.","Lee E.S.","Nie H.","Liao W.""SOURCE","Journal of Dermatological Treatment (2013) 24:1 (13-24). Date of Publication: February 2013"

"TITLE","Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study""AUTHOR NAMES","Papp K.A.","Langley R.G.","Sigurgeirsson B.","Abe M.","Baker D.R.","Konno P.","Haemmerle S.","Thurston H.J.","Papavassilis C.","Richards H.B.""SOURCE","British Journal of Dermatology (2013) 168:2 (412-421). Date of Publication: February 2013"

"TITLE","TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease""AUTHOR NAMES","Ciccacci C.","Biancone L.","Di Fusco D.","Ranieri M.","Condino G.","Giardina E.","Onali S.","Lepre T.","Pallone F.","Novelli G.","Borgiani P.""SOURCE","Journal of Crohn's and Colitis (2013) 7:1 (44-52). Date of Publication: February 2013"

"TITLE","Severe infliximab-induced psoriasis treated with adalimumab switching""AUTHOR NAMES","Faillace C.","Duarte G.V.","Cunha R.S.","De Carvalho J.F.""SOURCE","International Journal of Dermatology (2013) 52:2 (234-238). Date of Publication: February 2013"

"TITLE","Psoriasiform skin lesions induced by anti-TNF antibodies in IBD patients""AUTHOR NAMES","Pernat C.""SOURCE","Journal of Crohn's and Colitis (2013) 7 SUPPL.1 (S81-S82). Date of Publication: February 2013"

"TITLE","Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease""AUTHOR NAMES","Desai A.","Zator Z.A.","De Silva P.","Nguyen D.D.","Korzenik J.","Yajnik V.","Ananthakrishnan A.N.""SOURCE","Inflammatory Bowel Diseases (2013) 19:2 (309-315). Date of Publication: February 2013"

"TITLE","Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: Results from a phase 3 clinical trial (LOTUS)""AUTHOR NAMES","Zhu X.","Zheng M.","Song M.","Shen Y.-K.","Chan D.","Szapary P.O.","Wang B.""SOURCE","Journal of Drugs in Dermatology (2013) 12:2 (166-174). Date of Publication: February 2013"

"TITLE","Crohn's disease diagnosis during adalimumab treatment""AUTHOR NAMES","Fernández Salazar L.","Barrio Andrés J.","González Hernández J.M.""SOURCE","Scandinavian Journal of Gastroenterology (2013) 48:2 (254-255). Date of Publication: February 2013"

"TITLE","Body weight increment in patients treated with infliximab for plaque psoriasis""AUTHOR NAMES","Florin V.","Cottencin A.C.","Delaporte E.","Staumont-Sallé D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:2 (e186-e190). Date of Publication: February 2013"

"TITLE","Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis""AUTHOR NAMES","Aslam A.","Green R.L.","Motta L.","Ghrew M.","Griffiths C.E.M.","Warren R.B.""SOURCE","British Journal of Dermatology (2013) 168:2 (446-447). Date of Publication: February 2013"

"TITLE","Reflectance confocal microscopy characteristics of eight cases of pustular eruptions and histopathological correlations""AUTHOR NAMES","Debarbieux S.","Depaepe L.","Poulalhon N.","Dalle S.","Balme B.","Thomas L.""SOURCE","Skin Research and Technology (2013) 19:1 (e444-e452). Date of Publication: February 2013"

"TITLE","Patients' narratives""AUTHOR NAMES","Foulkes A.C.","Warren R.B.""SOURCE","Current Problems in Dermatology (Switzerland) (2013) 44 (145-157). Date of Publication: 2013"

"TITLE","The costs of psoriasis medications""AUTHOR NAMES","Mustonen A.","Mattila K.","Leino M.","Koulu L.","Tuominen R.""SOURCE","Dermatology and Therapy (2013) 3:2 (169-177). Date of Publication: 2013"

"TITLE","TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis""AUTHOR NAMES","Saraceno R.","Pietroleonardo L.","Mazzotta A.","Zangrilli A.","Bianchi L.","Chimenti S.""SOURCE","Expert Opinion on Biological Therapy (2013) 13:4 (469-473). Date of Publication: April 2013"

"TITLE","Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis""AUTHOR NAMES","Yeung H.","Wan J.","Van Voorhees A.S.","Callis Duffin K.","Krueger G.G.","Kalb R.E.","Weisman J.D.","Sperber B.R.","Brod B.A.","Schleicher S.M.","Bebo Jr. B.F.","Shin D.B.","Troxel A.B.","Gelfand J.M.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:1 (64-72). Date of Publication: January 2013"

"TITLE","Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry""AUTHOR NAMES","Gisondi P.","Cazzaniga S.","Chimenti S.","Giannetti A.","MacCarone M.","Picardo M.","Girolomoni G.","Naldi L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2013) 27:1 (e30-e41). Date of Publication: January 2013"

"TITLE","Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases""AUTHOR NAMES","Haynes K.","Beukelman T.","Curtis J.R.","Newcomb C.","Herrinton L.J.","Graham D.J.","Solomon D.H.","Griffin M.R.","Chen L.","Liu L.","Saag K.G.","Lewis J.D.""SOURCE","Arthritis and Rheumatism (2013) 65:1 (48-58). Date of Publication: January 2013"

"TITLE","Interdigital psoriasis of the feet (Psoriasis Alba): Not a distinct form of psoriasis""AUTHOR NAMES","Bardazzi F.","Antonucci V.A.","Patrizi A.","Alessandrini A.","Tengattini V.","Odorici G.","Balestri R.""SOURCE","Dermatology (2013) 227:2 (130-133). Date of Publication: 2013"

"TITLE","Hepatitis and lupus-like syndrome during infliximab therapy for psoriasis""AUTHOR NAMES","Riad H.","Abu Shaikha S.","Al Ansari H.","Al Naama K.","Al Sada H.","Al Mansoori M.""SOURCE","Case Reports in Dermatology (2013) 5:2 (219-224). Date of Publication: 2013"

"TITLE","The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C""AUTHOR NAMES","Chiu H.-Y.","Chen C.-H.","Wu M.-S.","Cheng Y.-P.","Tsai T.-F.""SOURCE","British Journal of Dermatology (2013) 169:6 (1295-1303). Date of Publication: December 2013"

"TITLE","Inflammatory arthritis following ustekinumab treatment for psoriasis: A report of two cases""AUTHOR NAMES","De Souza A.","Ali-Shaw T.","Reddy S.M.","Fiorentino D.","Strober B.E.""SOURCE","British Journal of Dermatology (2013) 168:1 (210-212). Date of Publication: January 2013"

"TITLE","Mycobacterial diseases and antitumour necrosis factor therapy in USA""AUTHOR NAMES","Winthrop K.L.","Baxter R.","Liu L.","Varley C.D.","Curtis J.R.","Baddley J.W.","McFarland B.","Austin D.","Radcliffe L.","Suhler E.B.","Choi D.","Rosenbaum J.T.","Herrinton L.J.""SOURCE","Annals of the Rheumatic Diseases (2013) 72:1 (37-42). Date of Publication: January 2013"

"TITLE","Neutrophilic cholangitis in psoriasis vulgaris and psoriatic arthritis""AUTHOR NAMES","Dieude P.","Sbidian E.","Viguier M.","Zafrani E.","De Bazelaire C.","Dawidowicz K.","Adle-Biassette H.","Allez M.","Petit A.","Richette P.","Bachelez H."

"SOURCE","British Journal of Dermatology (2013) 168:1 (216-218). Date of Publication: January 2013"

"TITLE","Dynamic QuantiFERON response in psoriasis patients taking long-term biologic therapy""AUTHOR NAMES","Drago L.","Nicola L.","Signori V.","Palazzi E.","Garutti C.","Spadino S.","Altomare G.""SOURCE","Dermatology and Therapy (2013) 3:1 (73-81). Date of Publication: 2013"

"TITLE","Initiation of anti-TNF therapy and the risk of optic neuritis: From the safety assessment of biologic ThERapy (SABER) study""AUTHOR NAMES","Winthrop K.L.","Chen L.","Fraunfelder F.W.","Ku J.H.","Varley C.D.","Suhler E.","Hills W.L.","Gattey D.","Baddley J.W.","Liu L.","Grijalva C.G.","Delzell E.","Beukelman T.","Patkar N.M.","Xie F.","Herrinton L.J.","Fraunfelder F.T.","Saag K.G.","Lewis J.D.","Solomon D.H.","Curtis J.R.""SOURCE","American Journal of Ophthalmology (2013) 155:1 (183-189). Date of Publication: January 2013"

"TITLE","Detection of antibodies to anti-TNF agents in psoriatic patients: A preliminary study""AUTHOR NAMES","Cozzani E.","Burlando M.","Parodi A.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2013) 148:2 (171-174). Date of Publication: April 2013"

"TITLE","Long-term cost-effectiveness analysis of etanercept and adalimumab for plaque psoriasis not associated with arthritis""AUTHOR NAMES","Ruano J.","Isla-Tejera B.","Jiménez-Puya R.","Rodriguez-Martin A.","Cárdenas M.","Gómez F.","Vélez A.A.","del Prado-Llergo J.R.","Moreno-Giménez J.C.""SOURCE","Dermatology and Therapy (2013) 3:2 (131-142). Date of Publication: 2013"

"TITLE","The combinational treatment with TNF-α inhibitors of the patient suffering from psoriatic arthritis with the need of tuberculosis prophylaxis""AUTHOR NAMES","Feliksik-Skrobich K.","Mazur M.","Adamski Z.""SOURCE","Dermatologia Kliniczna (2013) 15:1 (32-36). Date of Publication: 2013"

"TITLE","Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study""AUTHOR NAMES","Weinblatt M.E.","Schiff M.","Valente R.","Van Der Heijde D.","Citera G.","Zhao C.","Maldonado M.","Fleischmann R.""SOURCE","Arthritis and Rheumatism (2013) 65:1 (28-38). Date of Publication: January 2013"

"TITLE","Late reaction to ustekinumab infusion""AUTHOR NAMES","Morais M.R.","Meneghello L.P.","de Oliveira C.F.","Carvalho A.V.E.""SOURCE","Dermatology Reports (2013) 5:1 Article Number: e2. Date of Publication: 2013"

"TITLE","Efficacy and safety of clinical use of etanercept for the treatment of moderate-to-severe psoriasis in Spain: Results of a multicentric prospective study at 12 months follow-up""AUTHOR NAMES","Puig L.","Camacho Martínez F.M.","Gimeno Carpio E.","López-Ávila A.","García-Calvo C.""SOURCE","Dermatology (2012) 225:3 (220-230). Date of Publication: January 2013"

"TITLE","Squamous cell carcinoma of the lip associated with adalimumab therapy for ankylosing spondylitis: A case report and review of TNF-α inhibitors and cutaneous carcinoma risk""AUTHOR NAMES","Zitelli K.B.","Zedek D.","Ranganathan P.","Amerson E.H.""SOURCE","Cutis (2013) 92:1 (35-39). Date of Publication: 2013"

"TITLE","Prevalence and management of panic attacks during infliximab infusion in psoriatic patients""AUTHOR NAMES","Saraceno R.","Faleri S.","Ruzzetti M.","Centonze D.","Chimenti S.""SOURCE","Dermatology (2012) 225:3 (236-241). Date of Publication: January 2013"

"TITLE","Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis""AUTHOR NAMES","Calzavara-Pinton P.G.","Sala R.","Arisi M.","Rossi M.T.","Venturini M.","Ortel B.""SOURCE","British Journal of Dermatology (2013) 169:1 (130-136). Date of Publication: July 2013"

"TITLE","Generalized pustular psoriasis triggered by infliximab in two patients with Crohn's disease""AUTHOR NAMES","Kato Y.","Yamamoto T.""SOURCE","Journal of Dermatology (2013) 40:11 (932-933). Date of Publication: November 2013"

"TITLE","Mutation Analysis of the IL36RN Gene in 14 Japanese Patients with Generalized Pustular Psoriasis""AUTHOR NAMES","Farooq M.","Nakai H.","Fujimoto A.","Fujikawa H.","Matsuyama A.","Kariya N.","Aizawa A.","Fujiwara H.","Ito M.","Shimomura Y.""SOURCE","Human Mutation (2013) 34:1 (176-183). Date of Publication: January 2013"

"TITLE","Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: Results of a randomized controlled trial""AUTHOR NAMES","Bissonnette R.","Tardif J.-C.","Harel F.","Pressacco J.","Bolduc C.","Guertin M.-C.""SOURCE","Circulation: Cardiovascular Imaging (2013) 6:1 (83-90). Date of Publication: January 2013"

"TITLE","Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice""AUTHOR NAMES","Van Lümig P.P.M.","Driessen R.J.B.","Kievit W.","Boezeman J.B.M.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","Journal of the American Academy of Dermatology (2013) 68:1 (57-63). Date of Publication: January 2013"

"TITLE","A case of postpartum severe generalized pustular psoriasis treated with infliximab""AUTHOR NAMES","Tsutsumi R.","Adachi K.","Yoshida Y.","Yamamoto O.""SOURCE","Nishinihon Journal of Dermatology (2013) 75:6 (504-507). Date of Publication: 2013"

"TITLE","Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy""AUTHOR NAMES","Mishra V.","Daniel R.C.","Elmets C.A.","Levin A.","Elewski B.E.""SOURCE","Journal of Drugs in Dermatology (2013) 12:1 (16-17). Date of Publication: January 2013"

"TITLE","Blocking T helper 1/T helper 17 pathways has no effect on patch testing""AUTHOR NAMES","Nosbaum A.","Rozieres A.","Balme B.","Goujon C.","Nicolas J.-F.","Bérard F.""SOURCE","Contact Dermatitis (2013) 68:1 (58-59). Date of Publication: January 2013"

"TITLE","Psoriasis triggered by infliximab in a patient with Behçet's disease""AUTHOR NAMES","Kawazoe Y.","Sugita S.","Yamada Y.","Akino A.","Miura K.","Mochizuki M.""SOURCE","Japanese Journal of Ophthalmology (2013) 57:1 (95-97). Date of Publication: January 2013"

"TITLE","High density cholesterol level as predictor of clinical response to anti-TNF-alpha therapy in psoriatic patients""AUTHOR NAMES","Saraceno R.","Rizza S.","Faleri S.","Federici M.","Nisticò S.P.","Copetti M.","Chimenti S.""SOURCE","Journal of Biological Regulators and Homeostatic Agents (2013) 27:3 (903-908). Date of Publication: 2013"

"TITLE","Spontaneous resolution of lupus nephritis following withdrawal of etanercept""AUTHOR NAMES","Yahya T.M.","Dhanyamraju S.","Harrington T.M.","Prichard J.W.""SOURCE","Annals of Clinical and Laboratory Science (2013) 43:4 (447-449). Date of Publication: 2013"

"TITLE","Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment""AUTHOR NAMES","Skroza N.","Proietti I.","Bernardini N.","La Viola G.","Nicolucci F.","Pampena R.","Tolino E.","Zuber S.","Mancini M.T.","Soccodato V.","Balduzzi V.","Potenza C.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2013) 148:6 (661-665). Date of Publication: December 2013"

"TITLE","Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept""AUTHOR NAMES","Nin M.","Tokunaga D.","Ishii N.","Komai A.","Hashimoto T.","Katoh N.""SOURCE","Journal of Dermatology (2013) 40:1 (55-56). Date of Publication: January 2013"

"TITLE","Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis""AUTHOR NAMES","Yeremenko N.","Noordenbos T.","Cantaert T.","Van Tok M.","Van De Sande M.","Cañete J.D.","Tak P.P.","Baeten D.""SOURCE","Arthritis and Rheumatism (2013) 65:1 (174-185). Date of Publication: January 2013"

"TITLE","Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis""AUTHOR NAMES","Park J.-H.","Lee J.","Lee J.H.","Lee D.-Y.","Koh E.-M.""SOURCE","Dermatology (2012) 225:3 (259-263). Date of Publication: January 2013"

"TITLE","Effectiveness of infliximab in pityriasis rubra pilaris is associated with pro-inflammatory cytokine inhibition""AUTHOR NAMES","Adnot-Desanlis L.","Antonicelli F.","Tabary T.","Bernard P.","Reguiaï Z.""SOURCE","Dermatology (2013) 226:1 (41-46). Date of Publication: 2013"

"TITLE","Nodular fasciitis: A possible side effect of etanercept?""AUTHOR NAMES","Vine K.","Dacko A.","Weinberg J.M."

"SOURCE","Cutis (2013) 92:4 (199-202). Date of Publication: October 2013"

"TITLE","The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: A 5-year prospective analysis""AUTHOR NAMES","Machado N.P.","dos Reis Neto E.T.","Soares M.R.M.P.","Freitas D.S.","Porro A.","Ciconelli R.M.","Pinheiro M.M.""SOURCE","Clinics (2013) 68:9 (1189-1196). Date of Publication: 2013"

"TITLE","Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: A parallel randomized trial""AUTHOR NAMES","Kimball A.B.","Kerdel F.","Adams D.","Mrowietz U.","Gelfand J.M.","Gniadecki R.","Prens E.P.","Schlessinger J.","Zouboulis C.C.","van der Zee H.H.","Rosenfeld M.","Mulani P.","Gu Y.","Paulson S.","Okun M.","Jemec G.B.E.""SOURCE","Annals of Internal Medicine (2012) 157:12 (846-855). Date of Publication: 18 Dec 2012"

"TITLE","Differences between the Glycosylation Patterns of Haptoglobin Isolated from Skin Scales and Plasma of Psoriatic Patients""AUTHOR NAMES","Maresca B.","Cigliano L.","Spagnuolo M.S.","Dal Piaz F.","Corsaro M.M.","Balato N.","Nino M.","Balato A.","Ayala F.","Abrescia P.""SOURCE","PLoS ONE (2012) 7:12 Article Number: e52040. Date of Publication: 18 Dec 2012"

"TITLE","Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: Is it really a paradoxical side effect?""AUTHOR NAMES","Joyau C.","Veyrac G.","Dixneuf V.","Jolliet P.""SOURCE","Clinical and Experimental Rheumatology (2012) 30:5 (700-706). Date of Publication: 2012"

"TITLE","Anti-TNF-α-induced lupus erythematosus in a patient with psoriasis - Diagnostic controversy""AUTHOR NAMES","Sobjanek M.","Wilkowska A.","Sokołowska-Wojdłyo M.","Michajołwski I.","Roszkiewicz J.""SOURCE","Przeglad Dermatologiczny (2012) 99:5 (605-610). Date of Publication: 2012"

"TITLE","Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease""AUTHOR NAMES","Malickova K.","Duricova D.","Bortlik M.","Komarek V.","Machkova N.","Komarek A.","Janatkova I.","Lukáš M.""SOURCE","Gastroenterologie a Hepatologie (2012) 66:1 (23-31). Date of Publication: 2012"

"TITLE","Comparison of ustekinumab with other biological agents for the treatment of moderate to severe plaque psoriasis: A bayesian network meta-analysis""AUTHOR NAMES","Lin V.W.","Ringold S.","Devine E.B.""SOURCE","Archives of Dermatology (2012) 148:12 (1403-1410). Date of Publication: December 2012"

"TITLE","Psoriasis and psoriasiform lesions induced by TNFα antagonists: The experience of a tertiary care hospital from northern Spain""AUTHOR NAMES","López-Robles A.","Queiro R.","Alperi M.","Alonso S.","Riestra J.L.","Ballina J.""SOURCE","Rheumatology International (2012) 32:12 (3779-3783). Date of Publication: December 2012"

"TITLE","Ustekinumab for the treatment of HIV psoriasis""AUTHOR NAMES","Paparizos V.","Rallis E.","Kirsten L.","Kyriakis K.""SOURCE","Journal of Dermatological Treatment (2012) 23:6 (398-399). Date of Publication: December 2012"

"TITLE","Cutaneous pseudolymphoma caused by tumor necrosis factor-α inhibitors was not induced by ustekinumab""AUTHOR NAMES","Imafuku S.","Tatsukawa R.","Ito K.","Nakayama J.""SOURCE","Journal of Dermatology (2012) 39:12 (1070). Date of Publication: December 2012"

"TITLE","Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: A prospective, observational study""AUTHOR NAMES","Garcovich S.","Ruggeri A.","D'Agostino M.","Ardito F.","De Simone C.","Delogu G.","Fadda G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:12 (1572-1576). Date of Publication: December 2012"

"TITLE","Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis""AUTHOR NAMES","Di Lernia V.","Tasin L.","Pellicano R.","Zumiani G.","Albertini G.""SOURCE","Journal of Dermatological Treatment (2012) 23:6 (404-409). Date of Publication: December 2012"

"TITLE","Rituximab treatment for spondyloarthritis. A nationwide series: Data from the AIR registry of the French Society of Rheumatology""AUTHOR NAMES","Wendling D.","Dougados M.","Berenbaum F.","Brocq O.","Schaeverbeke T.","Mazieres B.","Marcelli C.","LeParc J.-M.","Bertin P.","Robin M.","Sibilia J.","Lafforgue P.","Prati C.","Combe B.","Gottenberg J.-E.""SOURCE","Journal of Rheumatology (2012) 39:12 (2327-2331). Date of Publication: December 2012"

"TITLE","Association between anti-TNF-α therapy and all-cause mortality""AUTHOR NAMES","Herrinton L.J.","Liu L.","Chen L.","Harrold L.R.","Raebel M.A.","Curtis J.R.","Griffin M.R.","Solomon D.H.","Saag K.G.","Lewis J.D.""SOURCE","Pharmacoepidemiology and Drug Safety (2012) 21:12 (1311-1320). Date of Publication: December 2012"

"TITLE","Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: Preliminary results""AUTHOR NAMES","Nardis C.","Anzivino E.","Bellizzi A.","Rodio D.M.","De Pità O.","Chiarini F.","Pietropaolo V.""SOURCE","Journal of Cellular Physiology (2012) 227:12 (3796-3802). Date of Publication: December 2012"

"TITLE","Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: Results from PROGRESS, an open-label Phase IIIB trial""AUTHOR NAMES","Strober B.E.","Sobell J.M.","Duffin K.C.","Bao Y.","Guérin A.","Yang H.","Goldblum O.","Okun M.M.","Mulani P.M.""SOURCE","British Journal of Dermatology (2012) 167:6 (1374-1381). Date of Publication: December 2012"

"TITLE","Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis""AUTHOR NAMES","De Masson A.","Ben Said B.","Parier J.","Begon E.","Augey F.","Goujon C.","Dahel K.","Nicolas J.-F.","Bérard F.","Bachelez H.","Bagot M.","Bouaziz J.-D.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:6 (e280-e282). Date of Publication: December 2012"

"TITLE","Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's disease""AUTHOR NAMES","de Greef E.","Hoffman I.","D'Haens G.","van Biervliet S.","Smets F.","Scaillon M.","Dewit O.","Peeters H.","Paquot I.","Alliet P.","Arts W.","Hauser B.","Vermeire S.","van Gossum A.","Rahier J.F.","Etienne I.","Louis E.","Coche J.C.","Mahachie John J.","van Steen K.","Veereman G.""SOURCE","Acta Gastro-Enterologica Belgica (2012) 75:4 (425-431). Date of Publication: 2012"

"TITLE","Posterior spondylitis of costovertebral joints in a patient with psoriatic arthritis""AUTHOR NAMES","Yachoui R.","Han B.K.","Kolasinski S.L.""SOURCE","Journal of Clinical Rheumatology (2012) 18:8 (450). Date of Publication: December 2012"

"TITLE","Epidermal-type FABP is a predictive marker of clinical response to systemic treatment and ultraviolet therapy in psoriatic skin lesions""AUTHOR NAMES","Miyake T.","Ogawa E.","Mikoshiba A.","Kobayashi A.","Hosoe H.","Kashiwabara S.","Uhara H.","Owada Y.","Okuyama R.""SOURCE","Journal of Dermatological Science (2012) 68:3 (199-202). Date of Publication: December 2012"

"TITLE","Cost effectiveness of golimumab for the treatment of active psoriatic arthritis""AUTHOR NAMES","Cummins E.","Asseburg C.","Prasad M.","Buchanan J.","Punekar Y.S.""SOURCE","European Journal of Health Economics (2012) 13:6 (801-809). Date of Publication: December 2012"

"TITLE","Treatment of psoriasis with etanercept: An experience from South Kuwait""AUTHOR NAMES","Al-Abdulrazzaq A.","Zadeh V.B.","Al-Otaibi S.","Tarrab S.","Najem N.""SOURCE","Journal of Pakistan Association of Dermatologists (2012) 22:2 (136-145). Date of Publication: 2012"

"TITLE","Two cases of hepatitis B in patients with moderate to severe psoriasis treated with ustekinumab""AUTHOR NAMES","Opel D.","Economidi A.","Chan D.","Wasfi Y.","Mistry S.","Vergou T.","Antoniou C.","Sofen H.""SOURCE","Journal of Drugs in Dermatology (2012) 11:12 (1498-1501). Date of Publication: December 2012"

"TITLE","Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: Subanalysis of the BELIEVE study""AUTHOR NAMES","Paul C.","Van De Kerkhof P.","Puig L.","Unnebrink K.","Goldblum O.","Thaçi D.""SOURCE","European Journal of Dermatology (2012) 22:6 (762-769). Date of Publication: December

2012"

"TITLE","Etanercept downregulates the th17 pathway and decreases the IL-17 (+)/IL-10(+) cell ratio in patients with psoriasis vulgaris""AUTHOR NAMES","Antiga E.","Volpi W.","Cardilicchia E.","Maggi L.","Filì L.","Manuelli C.","Parronchi P.","Fabbri P.","Caproni M.""SOURCE","Journal of Clinical Immunology (2012) 32:6 (1221-1232). Date of Publication: December 2012"

"TITLE","Primary cutaneous aspergillosis complicating tumor necrosis factor-α blockade therapy in a patient with psoriasis""AUTHOR NAMES","Osório F.","Magina S.","Azevedo F.""SOURCE","Actas Dermo-Sifiliograficas (2012) 103:10 (939-941). Date of Publication: December 2012"

"TITLE","Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis""AUTHOR NAMES","Kimura U.","Kinoshita A.","Sekigawa I.","Takamori K.","Suga Y.""SOURCE","Journal of Dermatology (2012) 39:12 (1071-1072). Date of Publication: December 2012"

"TITLE","Continued improvement of signs and symptoms in patients with active psoriatic arthritis: Week 52 results of a phase 3, multicenter, double-blind, placebo-controlled study""AUTHOR NAMES","Kavanaugh A.","McInnes I.B.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.T.","Li S.","Wang Y.","Doyle M.K.","Mendelsohn A.M.""SOURCE","Arthritis and Rheumatism (2012) 64:12 (4168). Date of Publication: December 2012"

"TITLE","Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's disease""AUTHOR NAMES","Carter C.T.","Waters H.C.","Smith D.B.""SOURCE","Patient Preference and Adherence (2012) 6 (417-426). Date of Publication: 2012"

"TITLE","The trend in newly diagnosed Crohn's disease and extraintestinal manifestations of Crohn's disease in central China: A retrospective study of a single center""AUTHOR NAMES","Yi F.","Chen M.","Huang M.","Li J.","Zhao J.","Li L.","Xia B.""SOURCE","European Journal of Gastroenterology and Hepatology (2012) 24:12 (1424-1429). Date of Publication: December 2012"

"TITLE","Neurologiske symptomer som bivirkning af infliximab""AUTHOR NAMES","M. Bebe A.C.","Harboe K.M.","Nøjgaard C.""SOURCE","Ugeskrift for Laeger (2012) 174:40 (2388-2390). Date of Publication: 2012"

"TITLE","A multicentre study on high-frequency ultrasound evaluation of the skin and joints in patients with psoriatic arthritis treated with infliximab""AUTHOR NAMES","De Agustín J.J.","Moragues C.","De Miguel E.","Möller I.","Acebes C.","Naredo E.","Uson J.","Rejón E.","Mayordomo L.","Garrido J.""SOURCE","Clinical and Experimental Rheumatology (2012) 30:6 (879-885). Date of Publication: 2012"

"TITLE","Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome""AUTHOR NAMES","Burgemeister L.T.","Baeten D.L.P.","Tas S.W.""SOURCE","Netherlands Journal of Medicine (2012) 70:10 (444-449). Date of Publication: December 2012"

"TITLE","Treatment of thalidomide resistant pyoderma gangrenosum with etenercept""AUTHOR NAMES","Guedes R.","Moreira A.","Menezes N.","Baptista A.","Varela P.""SOURCE","Acta Dermatovenerologica Croatica (2012) 20:3 (175-180). Date of Publication: 2012"

"TITLE","Etanercept-induced asthma in a psoriatic patient resolving with transition to ustekinumab""AUTHOR NAMES","Torres T.","Vilaç S.","Velho G.","Selores M.""SOURCE","European Journal of Dermatology (2012) 22:5 (696-697). Date of Publication: 2012"

"TITLE","Lentigines in previous psoriatic plaques in a patient treated with infliximab""AUTHOR NAMES","Bardazzi F.","Magnano M.","Antonucci A.V.","Balestri R.","Sgubbi P.","Patrizi A.""SOURCE","European Journal of Dermatology (2012) 22:5 (698-699). Date of Publication: 2012"

"TITLE","Combination of adalimumab with traditional systemic antipsoriatic drugs - A report of 39 cases""AUTHOR NAMES","Philipp S.","Wilsmann-Theis D.","Weyergraf A.","Rotterdam S.","Frambach Y.","Gerdes S.","Mössner R.""SOURCE","JDDG - Journal of the German Society of Dermatology (2012) 10:11 (821-838). Date of Publication: November 2012"

"TITLE","Development of MGUS in psoriatic patients: A possible undiagnosed event during anti-TNF-α-treatment"

"AUTHOR NAMES","Prignano F.","Pescitelli L.","Ricceri F.","Ermini A.","Lotti T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:11 (1444-1448). Date of Publication: November 2012"

"TITLE","Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis""AUTHOR NAMES","Wu J.J.","Poon K.-Y.T.","Channual J.C.","Shen A.Y.-J.""SOURCE","Archives of Dermatology (2012) 148:11 (1244-1250). Date of Publication: November 2012"

"TITLE","Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment""AUTHOR NAMES","Sánchez-Moya A.I.","Daudén E.""SOURCE","Archives of Dermatology (2012) 148:11 (1332-1333). Date of Publication: November 2012"

"TITLE","Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.""AUTHOR NAMES","Shmidt E.","Wetter D.A.","Ferguson S.B.","Pittelkow M.R.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:5 (e179-185). Date of Publication: Nov 2012"

"TITLE","Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: Report of five cases and review of the literature""AUTHOR NAMES","Osório F.","Magro F.","Lisboa C.","Lopes S.","MacEdo G.","Bettencourt H.","Azevedo F.","Magina S.""SOURCE","Dermatology (2012) 225:2 (163-167). Date of Publication: November 2012"

"TITLE","Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C""AUTHOR NAMES","Wu M.-C.","Lee J.Y.-Y.""SOURCE","Australasian Journal of Dermatology (2012) 53:4 (e69-e72). Date of Publication: November 2012"

"TITLE","A case of psoriasis verrucosa successfully treated with adalimumab""AUTHOR NAMES","Katayama C.","Maejima H.","Watarai A.","Nishiyama H.","Katsuoka K.""SOURCE","Journal of Drugs in Dermatology (2012) 11:11 (e74-e75). Date of Publication: November 2012"

"TITLE","Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient""AUTHOR NAMES","Brokalaki E.I.","Voshege N.","Witzke O.","Kribben A.","Schadendorf D.","Hillen U.""SOURCE","Transplantation Proceedings (2012) 44:9 (2776-2777). Date of Publication: November 2012"

"TITLE","Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens""AUTHOR NAMES","Gniadecki R.","Robertson D.","Molta C.T.","Freundlich B.","Pedersen R.","Li W.","Boggs R.","Zbrozek A.S.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:11 (1436-1443). Date of Publication: November 2012"

"TITLE","Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice""AUTHOR NAMES","Vender R.","Lynde C.","Gilbert M.","Ho V.","Sapra S.","Poulin-Costello M.""SOURCE","Journal of Cutaneous Medicine and Surgery (2012) 16:6 (407-416). Date of Publication: November-December 2012"

"TITLE","Erythroderma: A clinical and prognostic study""AUTHOR NAMES","Li J.","Zheng H.-Y.""SOURCE","Dermatology (2012) 225:2 (154-162). Date of Publication: November 2012"

"TITLE","Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists""AUTHOR NAMES","Lamrock E.","Brown P.""SOURCE","Australasian Journal of Dermatology (2012) 53:4 (e87-e90). Date of Publication: November 2012"

"TITLE","Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema""AUTHOR NAMES","Umegaki N.","Kira M.","Horiuchi T.","Itoi S.","Tani M.","Yokomi A.","Tanemura A.","Miyahara H.","Hatanaka M.","Kitamura H.","Kitano E.","Katayama I.""SOURCE","Modern Rheumatology (2012) 22:6 (928-930). Date of Publication: November 2012"

"TITLE","Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia"

"AUTHOR NAMES","Palmsten K.","Hernández-Díaz S.","Kuriya B.","Solomon D.H.","Setoguchi S.""SOURCE","Arthritis Care and Research (2012) 64:11 (1730-1738). Date of Publication: November 2012"

"TITLE","Rituximabin psoriatic arthritis: An exploratory evaluation""AUTHOR NAMES","Jimenez-Boj E.","Stamm T.A.","Sadlonova M.","Rovensky J.","Raffayová H.","Leeb B.","Machold K.P.","Graninger W.B.","Smolen J.S.""SOURCE","Annals of the Rheumatic Diseases (2012) 71:11 (1868-1871). Date of Publication: November 2012"

"TITLE","A retrospective epidemiological study of rheumatology patients admitted in a tertiary care private centre in Northern India""AUTHOR NAMES","Jain S.","Jain N.","Duggal L.""SOURCE","Indian Journal of Rheumatology (2012) 7 SUPPL. 1 (S44). Date of Publication: November 2012"

"TITLE","Efficacy of additional methotrexate as a maintenance treatment in a Japanese patient with psoriatic arthritis refractory to infliximab monotherapy""AUTHOR NAMES","Nonomura Y.","Otsuka A.","Miyachi Y.","Kabashima K.","Tanioka M.""SOURCE","Journal of Dermatology (2012) 39:11 (954-955). Date of Publication: November 2012"

"TITLE","Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept""AUTHOR NAMES","Tresh A.","Smith V.H.","Parslew R.A.G.""SOURCE","Libyan Journal of Medicine (2012) 7:1. Date of Publication: 2012"

"TITLE","Trends in lipid profiles in patients with psoriasis: a population-based analysis""AUTHOR NAMES","Akkara Veetil B.M.","Matteson E.L.","Maradit-Kremers H.","McEvoy M.T.","Crowson C.S.""SOURCE","BMC Dermatology (2012) 12 Article Number: 20. Date of Publication: 30 Oct 2012"

"TITLE","Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: A long-term follow-up study""AUTHOR NAMES","Cantini F.","Niccoli L.","Cassarà E.","Kaloudi O.","Nannini C.""SOURCE","Biologics: Targets and Therapy (2012) 6 (201-206). Date of Publication: 2012"

"TITLE","Treatment of severe psoriasis with ustekinumab during pregnancy""AUTHOR NAMES","Andrulonis R.","Ferris L.K.""SOURCE","Journal of Drugs in Dermatology (2012) 11:10 (1240-1241). Date of Publication: October 2012"

"TITLE","Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: Case report and review""AUTHOR NAMES","Puig L.","Morales-Múnera C.E.","López-Ferrer A.","Geli C.""SOURCE","Dermatology (2012) 225:1 (14-17). Date of Publication: October 2012"

"TITLE","Adalimumab for psoriasis in Greece: Clinical experience in a tertiary referral centre""AUTHOR NAMES","Fotiadou C.","Lazaridou E.","Sotiriou E.","Ioannides D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:10 (1298-1303). Date of Publication: October 2012"

"TITLE","Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists""AUTHOR NAMES","Carlesimo M.","La Pietra M.","Arcese A.","Di Russo P.P.","Mari E.","Gamba A.","Orsini D.","Camplone G.""SOURCE","International Journal of Dermatology (2012) 51:10 (1234-1236). Date of Publication: October 2012"

"TITLE","Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: A nationwide series""AUTHOR NAMES","Toussirot É.","Houvenagel É.","Goëb V.","Fouache D.","Martin A.","Le Dantec P.","Dernis E.","Wendling D.","Ansemant T.","Berthelot J.-M.","Bader-Meunier B.","Kantelip B.""SOURCE","Joint Bone Spine (2012) 79:5 (457-463). Date of Publication: October 2012"

"TITLE","Attitude to treatment of patients with psoriasis attending SPA center""AUTHOR NAMES","Gisondi P.","Farina S.","Giordano M.V.","Zanoni M.","Girolomoni G.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2012) 147:5 (483-489). Date of Publication: October 2012"

"TITLE","The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study""AUTHOR NAMES","Gottlieb A.B.","Kalb R.E.","Blauvelt A.","Heffernan M.P.","Sofen H.L.","Ferris L.K.","Kerdel F.A.","Calabro S.","Wang J.","Kerkmann U.","Chevrier M.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:4 (642-650). Date of Publication: October 2012"

"TITLE","Tumor Necrosis Factor-associated Palmoplantar Pustular Psoriasis Treated with Interleukin 6 Blocker""AUTHOR NAMES","Younis S.","Rimar D.","Slobodin G.","Rosner I.""SOURCE","Journal of Rheumatology (2012) 39:10 (2055-2056). Date of Publication: October 2012"

"TITLE","Cost of etanercept, adalimumab, and infliximab in patients with rheumatoid arthritis with employer provided health insurance""AUTHOR NAMES","Bonafede M.","Watson C.","Joseph G.","Princic N.","Harrison D.J.""SOURCE","Arthritis and Rheumatism (2012) 64 SUPPL. 10 (S778). Date of Publication: October 2012"

"TITLE","Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: A case series""AUTHOR NAMES","Sadlier M.","Lally A.","Kirby B.""SOURCE","British Journal of Dermatology (2012) 167:4 (937-938). Date of Publication: October 2012"

"TITLE","Comparison of rheumatoid arthritis-related health care resource use and comorbidities among patients with rheumatoid arthritis treated with adalimumab vs etanercept""AUTHOR NAMES","Xie J.","Ganguli A.","Yang H.","Parikh K.","Wu E.Q.","Cifaldi M.""SOURCE","Arthritis and Rheumatism (2012) 64 SUPPL. 10 (S211). Date of Publication: October 2012"

"TITLE","An inflammatory verrucous epidermal nevus concomitant with psoriasis: Treatment with adalimumab""AUTHOR NAMES","Özdemir M.","Balevi A.","Esen H.""SOURCE","Dermatology Online Journal (2012) 18:10 (11). Date of Publication: October 2012"

"TITLE","Ustekinumab associated thrombotic thrombocytopenic purpura""AUTHOR NAMES","Huang S.H.S.","Xenocostas A.","Moist L.M.","Crowther M.","Moore J.C.","Clark W.F.""SOURCE","Transfusion and Apheresis Science (2012) 47:2 (185-188). Date of Publication: October 2012"

"TITLE","Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab""AUTHOR NAMES","Becker J.G.","Mundi J.P.","Newlove T.","Mones J.","Shupack J.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:4 (e150-e151). Date of Publication: October 2012"

"TITLE","Acute pain management in an unusual case of psoriasis""AUTHOR NAMES","Eipe N.","Penning J.""SOURCE","Canadian Journal of Anesthesia (2012) 59:10 (999-1000). Date of Publication: October 2012"

"TITLE","Minimal-change disease secondary to etanercept""AUTHOR NAMES","Koya M.","Pichler R.","Jefferson J.A.""SOURCE","Clinical Kidney Journal (2012) 5:5 (420-423). Date of Publication: October 2012"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study""AUTHOR NAMES","Kavanaugh A.","McInnes I.B.","Gottlieb A.B.","Puig L.","Rahman P.","Ritchlin C.T.","Li S.","Wang Y.","Mendelsohn A.","Doyle M.K.""SOURCE","Arthritis and Rheumatism (2012) 64 SUPPL. 10 (S1083-S1084). Date of Publication: October 2012"

"TITLE","Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis""AUTHOR NAMES","Rueda-Gotor J.","González-Gay M.A.","Blanco Alonso R.","Gonzalez-Vela C.","Lopez-Obregon C.","González-López M.A.""SOURCE","Joint Bone Spine (2012) 79:5 (510-513). Date of Publication: October 2012"

"TITLE","Anti-TNF-α therapy in membranous glomerulonephritis""AUTHOR NAMES","Santoro D.","Postorino A.","Costantino G.","Savica V.","Bellinghieri G.""SOURCE","Clinical Kidney Journal (2012) 5:5 (487-488). Date of Publication: October 2012"

"TITLE","Serum angiogenin levels are decreased in patients with psoriasis""AUTHOR NAMES","Miyagaki T.","Sugaya M.","Kamata M.","Suga H.","Morimura S.","Tatsuta A.","Uwajima Y.","Yamamoto M.","Shibata S.","Fujita H.","Asano Y.","Kadono T.","Sato S.","Tada Y.""SOURCE","Clinical and Experimental Dermatology (2012) 37:7 (792-793). Date of Publication: October 2012"

"TITLE","Safety and efficacy of Adalimumab in the treatment of moderate to severe palmo-plantar psoriasis: an open label study.""AUTHOR NAMES","Richetta A.G.","Mattozzi C.","Giancristoforo S.","D'Epiro S.","Cantisani

C.","Macaluso L.","Salvi M.","Calvieri S.""SOURCE","La Clinica terapeutica (2012) 163:2 (e61-66). Date of Publication: 2012"

"TITLE","Atypical erythematous lesions in the course of biological therapy of generalized pustular psoriasis""AUTHOR NAMES","Słowińska M.","Czuwara J.","Rakowska A.","Sicińska J.","Warszawik O.","Kardynał A.","Kurzeja M.","Kłujszo E.""SOURCE","Przeglad Dermatologiczny (2012) 99:3 (216-221). Date of Publication: 2012"

"TITLE","Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: Results from a 1-year, multicentre, open-label, single-arm study in a clinical setting""AUTHOR NAMES","Vender R.","Lynde C.","Ho V.","Chau D.","Poulin-Costello M.""SOURCE","Applied Health Economics and Health Policy (2012) 10:5 (343-353). Date of Publication: 2012"

"TITLE","Improvement of anti-TNFα antibody-induced pustular psoriasis by azathioprine""AUTHOR NAMES","Kayama T.","Otsuka A.","Miyachi Y.","Kabashima K.""SOURCE","European Journal of Dermatology (2012) 22:4 (565-566). Date of Publication: 2012"

"TITLE","Musculoskeletal involvement of syphilis - A forgotten lesson""AUTHOR NAMES","Gomez J.V.","Molnar S.L.","Val S.M.","Arnal R.G.""SOURCE","BMJ Case Reports (2012). Date of Publication: 2012"

"TITLE","Pityriasis versicolor during anti-TNF-α monoclonal antibody therapy: Therapeutic considerations""AUTHOR NAMES","Balestri R.","Rech G.","Piraccini B.M.","Antonucci A.","Ismaili A.","Patrizi A.","Bardazzi F.""SOURCE","Mycoses (2012) 55:5 (444-446). Date of Publication: September 2012"

"TITLE","Risk of Herpes zoster in patients with psoriasis treated with biologic drugs""AUTHOR NAMES","Dreiher J.","Kresch F.S.","Comaneshter D.","Cohen A.D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:9 (1127-1132). Date of Publication: September 2012"

"TITLE","A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Gottlieb A.B.","Langley R.G.","Strober B.E.","Papp K.A.","Klekotka P.","Creamer K.","Thompson E.H.Z.","Hooper M.","Kricorian G.""SOURCE","British Journal of Dermatology (2012) 167:3 (649-657). Date of Publication: September 2012"

"TITLE","Effects of anti-tumor necrosis factor therapy on body composition and insulin sensitivity in patients with psoriasis""AUTHOR NAMES","Kofoed K.","Clemmensen A.","Mikkelsen U.R.","Simonsen L.","Andersen O.","Gniadecki R.""SOURCE","Archives of Dermatology (2012) 148:9 (1089-1091). Date of Publication: September 2012"

"TITLE","Systemic interventions in pediatric pustular psoriasis: Systematic review""AUTHOR NAMES","Posso-De Los Rios C.J.","Pope E.","Lara-Corrales I.""SOURCE","Pediatric Dermatology (2012) 29:5 (690). Date of Publication: September-October 2012"

"TITLE","Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial""AUTHOR NAMES","Nakagawa H.","Schenkel B.","Kato M.","Kato T.","Igarashi A.""SOURCE","Journal of Dermatology (2012) 39:9 (761-769). Date of Publication: September 2012"

"TITLE","Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: Results from an open-label study""AUTHOR NAMES","Leonardi C.","Sobell J.M.","Crowley J.J.","Mrowietz U.","Bao Y.","Mulani P.M.","Gu Y.","Okun M.M.""SOURCE","British Journal of Dermatology (2012) 167:3 (658-667). Date of Publication: September 2012"

"TITLE","Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab""AUTHOR NAMES","Romero-Maté A.","Martínez-Sánchez D.","Tardío J.C.","Moreno-Torres A.","García-Donoso C.","Aguado-Lobo M.","Espinosa-Lara P.","Borbujo J.""SOURCE","Dermatology Online Journal (2012) 18:9. Date of Publication: September 2012"

"TITLE","Aortitis in a patient with psoriatic arthritis""AUTHOR NAMES","Tufan A.","Tezcan M.E.","Kaya A.","Mercan R.","Oner Y.","Ozturk M.A.""SOURCE","Modern Rheumatology (2012) 22:5 (774-777). Date of Publication: September 2012"

"TITLE","Ethical considerations when prescribing biologics in dermatology""AUTHOR NAMES","Santoro F.A.","Rothe M.J.","Strober B.E.""SOURCE","Clinics in Dermatology (2012) 30:5 (492-495). Date of Publication: September 2012"

"TITLE","New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette-Guerin""AUTHOR NAMES","Hung C.-T.","Wang W.-M.","Tsao C.-W.","Chiang C.-P.""SOURCE","Dermatologica Sinica (2012) 30:3 (108-111). Date of Publication: September 2012"

"TITLE","Intermediate to long-term efficacy and safety of etanercept: Report from the psoriasis registry Austria""AUTHOR NAMES","Inzinger M.","Roschatt I.","Weger W.","Salmhofer W.","Wolf P.""SOURCE","Journal of Investigative Dermatology (2012) 132 SUPPL. 2 (S60). Date of Publication: September 2012"

"TITLE","Etanercept therapy for psoriatic arthritis in the presence of recurrent nonyhodgkin lymphoma""AUTHOR NAMES","Pai S.","Rosenstein E.D.","Kramer N.""SOURCE","Journal of Clinical Rheumatology (2012) 18:6 (301-303). Date of Publication: September 2012"

"TITLE","Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.""AUTHOR NAMES","Vine K.","Votava H.J.","Smith B.L.""SOURCE","Cutis; cutaneous medicine for the practitioner (2012) 90:3 (132-136). Date of Publication: Sep 2012"

"TITLE","Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association?""AUTHOR NAMES","Florit E.A.","Úbeda-Aranda I.","Delgado-Conde P.","Rodríguez-Cubillo B.","Monzón-Vázquez T.","de la Flor-Merino J.C.","Valga-Amado F.","Barrientos-Guzmán A.""SOURCE","Nefrologia (2012) 32:2 (228-232). Date of Publication: 2012"

"TITLE","Management of moderate to severe psoriasis with systemic immunomodulatory therapies: A 5-year experience from two departments of dermatology of Northern France""AUTHOR NAMES","Staumont-Sallé D.","Florin V.","Cottencin A.C.","Chaby G.","Delaporte E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:8 (1038-1039). Date of Publication: August 2012"

"TITLE","Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings""AUTHOR NAMES","Bonafede M.","Fox K.M.","Watson C.","Princic N.","Gandra S.R.""SOURCE","Advances in Therapy (2012) 29:8 (664-674). Date of Publication: August 2012"

"TITLE","Efficacy and safety of biologics in erythrodermic psoriasis: A multicentre, retrospective study""AUTHOR NAMES","Viguier M.","Pagès C.","Aubin F.","Delaporte E.","Descamps V.","Lok C.","Beylot-Barry M.","Séneschal J.","Dubertret L.","Morand J.-J.","Dréno B.","Bachelez H.""SOURCE","British Journal of Dermatology (2012) 167:2 (417-423). Date of Publication: August 2012"

"TITLE","Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: Results of PRIDE, an open-label, multicentre, phase IIIb study""AUTHOR NAMES","Papp K.","Ho V.","Teixeira H.D.","Guerette B.","Chen K.","Lynde C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:8 (1007-1013). Date of Publication: August 2012"

"TITLE","Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study""AUTHOR NAMES","Lesuis N.","Befrits R.","Nyberg F.","van Vollenhoven R.F.""SOURCE","BMC Medicine (2012) 10 Article Number: 82. Date of Publication: 1 Aug 2012"

"TITLE","Treatment of severe psoriasis""AUTHOR NAMES","Puig L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:SUPPL. 5 (17-18). Date of Publication: August 2012"

"TITLE","Utilization of biologic therapy for psoriasis in the U.S.A.""AUTHOR NAMES","Jabbar-Lopez Z.","Landon J.","Schneeweiss S.""SOURCE","British Journal of Dermatology (2012) 167:2 (e12). Date of Publication: August 2012"

"TITLE","Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome""AUTHOR NAMES","Talamonti M.","Galluzzo M.","Chiricozzi A.","Teoli M.","Bavetta M.","Costanzo A.","Chimenti S.""SOURCE","Journal of Drugs in Dermatology (2012) 11:8 (1000-1002). Date of Publication: August

2012"

"TITLE","Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre""AUTHOR NAMES","Wee J.S.","Petrof G.","Jackson K.","Barker J.N.W.N.","Smith C.H.""SOURCE","British Journal of Dermatology (2012) 167:2 (411-416). Date of Publication: August 2012"

"TITLE","Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies""AUTHOR NAMES","Castiñeiras I.","Fernández-Diaz L.","Juárez Y.","Lueiro M.""SOURCE","Journal of Dermatology (2012) 39:8 (730-731). Date of Publication: August 2012"

"TITLE","Case presentation of moderate-severe psoriasis""AUTHOR NAMES","Salmhofer W.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:SUPPL. 5 (19-20). Date of Publication: August 2012"

"TITLE","The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis""AUTHOR NAMES","Chiu H.-Y.","Wang T.-S.","Chang C.-Y.","Tsai T.-F.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:8 (991-998). Date of Publication: August 2012"

"TITLE","Pityriasis amiantacea: A distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy""AUTHOR NAMES","Ettler J.","Wetter D.A.","Pittelkow M.R.""SOURCE","Clinical and Experimental Dermatology (2012) 37:6 (639-641). Date of Publication: August 2012"

"TITLE","Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy""AUTHOR NAMES","Buommino E.","De Filippis A.","Gaudiello F.","Balato A.","Balato N.","Tufano M.A.","Ayala F.""SOURCE","Archives of Dermatological Research (2012) 304:6 (481-485). Date of Publication: August 2012"

"TITLE","Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus""AUTHOR NAMES","Winchester D.","Duffin K.C.","Hansen C.""SOURCE","Lupus (2012) 21:9 (1007-1010). Date of Publication: August 2012"

"TITLE","Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: Results from the PEARL trial""AUTHOR NAMES","Tsai T.-F.","Song M.","Shen Y.-K.","Schenkel B.","Choe Y.-B.","Kim N.-I.","Lee J.-H.","Lee J.-H.","Song H.-J.","Youn J.-I.""SOURCE","Journal of Drugs in Dermatology (2012) 11:8 (943-949). Date of Publication: August 2012"

"TITLE","Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis""AUTHOR NAMES","Pariser D.M.","Leonardi C.L.","Gordon K.","Gottlieb A.B.","Tyring S.","Papp K.A.","Li J.","Baumgartner S.W.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:2 (245-256). Date of Publication: August 2012"

"TITLE","A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept""AUTHOR NAMES","Lynde C.W.","Gupta A.K.","Guenther L.","Poulin Y.","Levesque A.","Bissonnette R.""SOURCE","Journal of Dermatological Treatment (2012) 23:4 (261-267). Date of Publication: August 2012"

"TITLE","Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: A case series""AUTHOR NAMES","Wong J.W.","Nguyen T.V.","Bhutani T.","Koo J.Y.M.""SOURCE","Journal of Drugs in Dermatology (2012) 11:8 (994-996). Date of Publication: August 2012"

"TITLE","Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasis""AUTHOR NAMES","Abuchar A.","Vitiello M.","Ricotti C.","Grant A.","Dehesa L.","Kerdel F.""SOURCE","Journal of Drugs in Dermatology (2012) 11:8 (950-954). Date of Publication: August 2012"

"TITLE","Immunosuppressant and Infliximab-Resistant Generalized Pustular Psoriasis Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis""AUTHOR NAMES","Furusawa K.","Hasegawa T.","Ikeda S.""SOURCE","Therapeutic Apheresis and Dialysis (2012) 16:4 (379-380). Date of Publication: August 2012"

"TITLE","Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection""AUTHOR NAMES","Dragonas C.","Ehrenstein B.","Fleck M.""SOURCE","Rheumatology (United Kingdom) (2012) 51:8 (1520-1521) Article Number: kes051. Date of Publication: August 2012"

"TITLE","Long-term outcome of patients with jia treated with etanercept, results of the biologic register jumbo""AUTHOR NAMES","Minden K.","Niewerth M.","Zink A.","Seipelt E.","Foeldvari I.","Girschick H.","Ganser G.","Horneff G.""SOURCE","Rheumatology (United Kingdom) (2012) 51:8 (1407-1415) Article Number: kes019. Date of Publication: August 2012"

"TITLE","Trends in older adult psoriasis outpatient health care practices in the united states""AUTHOR NAMES","Wong J.W.","Davis S.A.","Feldman S.R.","Koo J.Y.M.""SOURCE","Journal of Drugs in Dermatology (2012) 11:8 (957-962). Date of Publication: August 2012"

"TITLE","Psoriasis and Down syndrome: A report of three cases and a potential pathophysiologic link""AUTHOR NAMES","Marmon S.","De Souza A.","Strober B.E.""SOURCE","Dermatology Online Journal (2012) 18:6 (13). Date of Publication: 2012"

"TITLE","Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors""AUTHOR NAMES","Meyer M.W.","Zachariae C.","Bendtzen K.","Skov L.""SOURCE","Acta Dermato-Venereologica (2012) 92:4 (362-364). Date of Publication: 2012"

"TITLE","Differential response of chronic plaque psoriasis to briakinumab vs. ustekinumab""AUTHOR NAMES","Inzinger M.","Weger W.","Salmhofer W.","Wolf P.""SOURCE","Acta Dermato-Venereologica (2012) 92:4 (357-358). Date of Publication: 2012"

"TITLE","Dose-creep of infliximab during psoriasis treatment: An observational study""AUTHOR NAMES","Mehren C.R.","Gniadecki R.""SOURCE","Acta Dermato-Venereologica (2012) 92:4 (355-356). Date of Publication: 2012"

"TITLE","Successful treatment of lichen planus with adalimumab""AUTHOR NAMES","Holló P.","Szakonyi J.","Kiss D.","Jokai H.","Horváth A.","Kárpáti S.""SOURCE","Acta Dermato-Venereologica (2012) 92:4 (385-386). Date of Publication: 2012"

"TITLE","Association between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection among Older Patients with Selected Immune-Mediated Diseases""AUTHOR NAMES","Zhang J.","Xie F.","Delzell E.","Chen L.","Winthrop K.L.","Lewis J.D.","Saag K.G.","Baddley J.W.","Curtis J.R.""SOURCE","JAMA - Journal of the American Medical Association (2012) 308:1 (43-49). Date of Publication: 4 Jul 2012"

"TITLE","Managing psoriasis: What's best for your patient?""AUTHOR NAMES","Uhlenhake E.E.","Mehregan D.A.""SOURCE","Journal of Family Practice (2012) 61:7 (402-409+451). Date of Publication: July 2012"

"TITLE","Letter: Alopecia areata during ustekinumab administration: Coexistence or an adverse reaction?""AUTHOR NAMES","Verros C.","Rallis E.","Crowe M.""SOURCE","Dermatology Online Journal (2012) 18:7. Date of Publication: July 2012"

"TITLE","Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa""AUTHOR NAMES","Gulliver W.P.","Jemec G.B.E.","Baker K.A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:7 (911-914). Date of Publication: July 2012"

"TITLE","Transient blood eosinophilia during treatment with Adalimumab""AUTHOR NAMES","Vester K.","Rüger R.D.","Harth W.","Simon J.C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:7 (924-925). Date of Publication: July 2012"

"TITLE","Development of a preliminary US power Doppler composite score for monitoring treatment in PsA""AUTHOR NAMES","Gutierrez M.","Di geso L.","Salaffi F.","Bertolazzi C.","Tardella M.","Filosa

G.","Filippucci E.","Grassi W.""SOURCE","Rheumatology (United Kingdom) (2012) 51:7 (1261-1268) Article Number: kes014. Date of Publication: July 2012"

"TITLE","Considerations in the study of TNF-alpha inhibitor and methotrexate therapy on metabolic factors in psoriasis/psoriatic arthritis and rheumatoid arthritis patients""AUTHOR NAMES","Wu J.","Rowan C.","Poon K.-Y.","Anthony M.","Xiang A.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S24). Date of Publication: July 2012"

"TITLE","Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis""AUTHOR NAMES","Campanati A.","Orciani M.","Gorbi S.","Regoli F.","Di Primio R.","Offidani A.""SOURCE","British Journal of Dermatology (2012) 167:1 (68-76). Date of Publication: July 2012"

"TITLE","Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept""AUTHOR NAMES","Bagel J.","Lynde C.","Tyring S.","Kricorian G.","Shi Y.","Klekotka P.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:1 (86-92). Date of Publication: July 2012"

"TITLE","Effect of secukinumab treatment on ACR50, HAQ-DI and EULAR remission rates in patients with rheumatoid arthritis""AUTHOR NAMES","Genovese M.","Kellner H.","Durez P.","Codding C.E.","Ligozio G.","Richards H.B.","Escrig C.","Mpofu S.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S45-S46). Date of Publication: July 2012"

"TITLE","Secukinumab treatment has no effect on the lipid profile in patients with rheumatoid arthritis: Results from a randomized, double-blind, placebocontrolled, phase II study""AUTHOR NAMES","Durez P.","Genovese M.","Kellner H.","Codding C.","Ligozio G.","Richards H.","Escrig C.","Mpofu S.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S47-S48). Date of Publication: July 2012"

"TITLE","Health-related quality of life (HRQOL) improvement with secukinumab in patients with rheumatoid arthritis: Results from a dosefinding study""AUTHOR NAMES","Vibeke S.","Genovese M.","Mallya U.G.","Richards H.","Mpofu S.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S54). Date of Publication: July 2012"

"TITLE","Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis""AUTHOR NAMES","Kimball A.B.","Szapary P.","Mrowietz U.","Reich K.","Langley R.G.","You Y.","Hsu M.-C.","Yeilding N.","Rader D.J.","Mehta N.N.""SOURCE","Journal of the American Academy of Dermatology (2012) 67:1 (76-85). Date of Publication: July 2012"

"TITLE","Topical treatment habits in psoriasis patients receiving adalimumab""AUTHOR NAMES","Kolios A.G.A.","Rusca F.","Reisenbauer K.","Cozzio A.","French L.E.","Navarini A.A.""SOURCE","Dermatology (2012) 224:3 (228-230). Date of Publication: July 2012"

"TITLE","Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment""AUTHOR NAMES","Strand V.","Sharp V.","Koenig A.S.","Park G.","Shi Y.","Wang B.","Zack D.J.","Fiorentino D.""SOURCE","Annals of the Rheumatic Diseases (2012) 71:7 (1143-1150). Date of Publication: July 2012"

"TITLE","Use of modern psychometric techniques to demonstrate improvement in fatigue in RA patients treated with secukinumab""AUTHOR NAMES","Gnanasakthy A.","Kosinski M.","Durez P.","Mallya U.G.","Mpofu S.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S43). Date of Publication: July 2012"

"TITLE","Evaluation of high and low intensity physical functioning in secukinumab treated RA patients: An application of IRT methodology""AUTHOR NAMES","Gnanasakthy A.","Kosinski M.","Kellner H.","Mallya U.G.","Mpofu S.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S44). Date of Publication: July 2012"

"TITLE","Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, doubleblind, placebo-controlled PSUMMIT I study""AUTHOR NAMES","McInnes I.","Kavanaugh A.","Gottlieb A.","Puig L.","Rahman P.","Ritchlin C.","Li S.","Wang Y.","Mendelsohn A.","Doyle M.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S41). Date of Publication: July 2012"

"TITLE","IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis""AUTHOR NAMES","Krueger J.G.","Fretzin S.","Suárez-Fariñas M.","Haslett P.A.","Phipps K.M.","Cameron G.S.","McColm J.","Katcherian A.","Cueto I.","White T.","Banerjee S.","Hoffman

R.W.""SOURCE","Journal of Allergy and Clinical Immunology (2012) 130:1 (145-154.e9). Date of Publication: July 2012"

"TITLE","Utilization of narrow-band UVB light therapy and etanercept for the treatment of psoriasis/characteristics of PASI responders""AUTHOR NAMES","Belaus M.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S48-S49). Date of Publication: July 2012"

"TITLE","Etanercept used for psoriasis loses efficacy with time""AUTHOR NAMES","Vladau G.","Bunn H.","Schofield J.K.","Hussain K.","Scharre K.","Hepburn N.""SOURCE","British Journal of Dermatology (2012) 167 SUPPL. 1 (66). Date of Publication: July 2012"

"TITLE","Diffuse alveolar hemorrhage and acute respiratory distress syndrome during treatment of rheumatoid arthritis with etanercept""AUTHOR NAMES","Khaja M.","Menon L.","Niazi M.","Fuentes G.D.""SOURCE","Journal of Bronchology and Interventional Pulmonology (2012) 19:3 (228-231). Date of Publication: July 2012"

"TITLE","Safety and efficacy of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Lebwohl M.G.","Kircik L.","Callis Duffin K.","Pariser D.","Hooper M.","Wenkert D.","Thompson E.H.Z.","Yang J.","John K.""SOURCE","Dermatology and Therapy (2012) 2 SUPPL. 1 (S39). Date of Publication: July 2012"

"TITLE","Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: A retrospective study""AUTHOR NAMES","Teoli M.","Zangrilli A.","Chimenti M.S.","Talamonti M.","Bavetta M.","Graceffa D.","Perricone R.","Chimenti S.""SOURCE","Clinical and Developmental Immunology (2012) 2012 Article Number: 823854. Date of Publication: 2012"

"TITLE","Erythrodermic verrucous psoriasis""AUTHOR NAMES","Curtis A.R.","Yosipovitch G.""SOURCE","Journal of Dermatological Treatment (2012) 23:3 (215-218). Date of Publication: June 2012"

"TITLE","Flare of pustular psoriasis after initiating ustekinumab therapy""AUTHOR NAMES","Wenk K.S.","Claros J.M.","Ehrlich A.""SOURCE","Journal of Dermatological Treatment (2012) 23:3 (212-214). Date of Publication: June 2012"

"TITLE","Comparison of ustekinumab with other biologic agents for treatment of moderate-to-severe psoriasis: A Bayesian mixed treatment comparison approach""AUTHOR NAMES","Lin V.","Ringold S.","Devine B.""SOURCE","Value in Health (2012) 15:4 (A99). Date of Publication: June 2012"

"TITLE","Efficacy of adalimumab in the treatment of psoriasis: A retrospective study of 15 patients in daily practice""AUTHOR NAMES","Sola-Ortigosa J.","Sánchez-Regaña M.","Umbert-Millet P.""SOURCE","Journal of Dermatological Treatment (2012) 23:3 (203-207). Date of Publication: June 2012"

"TITLE","Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases""AUTHOR NAMES","Guerra I.","Algaba A.","Pérez-Calle J.L.","Chaparro M.","Marín-Jiménez I.","García-Castellanos R.","González-Lama Y.","López-Sanromán A.","Manceñido N.","Martínez-Montiel P.","Quintanilla E.","Taxonera C.","Villafruela M.","Romero-Maté A.","López-Serrano P.","Gisbert J.P.","Bermejo F.""SOURCE","Journal of Crohn's and Colitis (2012) 6:5 (518-523). Date of Publication: June 2012"

"TITLE","Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease""AUTHOR NAMES","Riis Å.","Martinsen T.C.","Waldum H.L.","Fossmark R.""SOURCE","Scandinavian Journal of Gastroenterology (2012) 47:6 (649-657). Date of Publication: June 2012"

"TITLE","Infliximab-induced psoriasis during therapy for Crohn's disease""AUTHOR NAMES","Steinwurz F.","Denadai R.","Saad-Hossne R.","Queiroz M.L.","Teixeira F.V.","Romiti R.""SOURCE","Journal of Crohn's and Colitis (2012) 6:5 (610-616). Date of Publication: June 2012"

"TITLE","Development of metastatic Crohn's disease of the skin while on Anti-TNF biologics""AUTHOR NAMES","Patel A.V.","Jones D.M.","Hill J.C.","MacDermott R.P.""SOURCE","Inflammatory Bowel Diseases (2012) 18:6 (1188-1190). Date of Publication: June 2012"

"TITLE","Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease""AUTHOR NAMES","Tichy Jr. M.","Tichy M.","Kopova R.","Jan S.","Ditrichova D.""SOURCE","Journal of Dermatological Treatment (2012) 23:3 (208-211). Date of Publication: June 2012"

"TITLE","Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis""AUTHOR NAMES","Gualdi G.","Monari P.","Rossi M.T.","Crotti S.","Calzavara-Pinton P.G.""SOURCE","British Journal of Dermatology (2012) 166:6 (1373-1374). Date of Publication: June 2012"

"TITLE","Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial.""AUTHOR NAMES","Yang H.Z.","Wang K.","Jin H.Z.","Gao T.W.","Xiao S.X.","Xu J.H.","Wang B.X.","Zhang F.R.","Li C.Y.","Liu X.M.","Tu C.X.","Ji S.Z.","Shen Y.","Zhu X.J.""SOURCE","Chinese medical journal (2012) 125:11 (1845-1851). Date of Publication: Jun 2012"

"TITLE","Graduated exposure, positive reinforcement, and stimulus distraction in a compliance-with-blood-draw intervention for an adult with autism""AUTHOR NAMES","Grider B.","Luiselli J.K.","Turcotte-Shamski W.""SOURCE","Clinical Case Studies (2012) 11:3 (253-260). Date of Publication: June 2012"

"TITLE","Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist""AUTHOR NAMES","Moureau C.","Pothen L.","Wilmes D.","Yombi J.C.","Coche E.","Hainaut P.""SOURCE","American Journal of Medicine (2012) 125:6 (e9-e10). Date of Publication: June 2012"

"TITLE","Determination of lymphotoxin-Alpha levels in patients with psoriatic arthritis undergoing etanercept treatment""AUTHOR NAMES","Murdaca G.","Colombo B.M.","Contini P.","Puppo F.""SOURCE","Journal of Interferon and Cytokine Research (2012) 32:6 (277-279). Date of Publication: 1 Jun 2012"

"TITLE","Joint destruction and presence of small papules on the palms and soles""AUTHOR NAMES","Meseguer-Yebra C.","Martínez-Morán C.","Romero-Maté A.","Moreno A.","Arias-Palomo D.","Borbujo J.""SOURCE","Clinical and Experimental Dermatology (2012) 37:4 (450-452). Date of Publication: June 2012"

"TITLE","Therapy of severe atopic dermatitis in adults""AUTHOR NAMES","Deleuran M.S.","Vestergaard C.""SOURCE","JDDG - Journal of the German Society of Dermatology (2012) 10:6 (399-406). Date of Publication: June 2012"

"TITLE","Efficacy of ustekinumab in sub-erythrodermic psoriasis: When TNF-blockers fail""AUTHOR NAMES","Buggiani G.","D'Erme A.M.","Krysenka A.","Pescitelli L.","Lotti T.","Prignano F.""SOURCE","Dermatologic Therapy (2012) 25:3 (283-285). Date of Publication: May-June 2012"

"TITLE","Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: Data from the French AIR registry""AUTHOR NAMES","Thomas L.","Canoui-Poitrine F.","Gottenberg J.-E.","Economu-Dubosc A.","Medkour F.","Chevalier X.","Bastuji-Garin S.","Le Louët H.","Farrenq V.","Claudepierre P.""SOURCE","Journal of Rheumatology (2012) 39:5 (893-898). Date of Publication: May 2012"

"TITLE","Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors""AUTHOR NAMES","Cathcart S.","Sami N.","Elewski B.""SOURCE","Journal of Drugs in Dermatology (2012) 11:5 (609-612). Date of Publication: May 2012"

"TITLE","Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials""AUTHOR NAMES","Lebwohl M.","Leonardi C.","Griffiths C.E.M.","Prinz J.C.","Szapary P.O.","Yeilding N.","Guzzo C.","Li S.","Hsu M.-C.","Strober B.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:5 (731-741). Date of Publication: May 2012"

"TITLE","Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease""AUTHOR NAMES","Buisson A.","Cuny J.-F.","Barbaud A.","Schmutz J.-L.","Bigard M.-A.","Guéant J.-L.","Peyrin-Biroulet L.""SOURCE","Alimentary Pharmacology and Therapeutics (2012) 35:10 (1175-1180). Date of Publication: May 2012"

"TITLE","Comparative safety of infliximab and etanercept on the risk of serious infections: Does the association vary by patient characteristics?""AUTHOR NAMES","Toh S.","Li L.","Harrold L.R.","Bayliss E.A.","Curtis J.R.","Liu L.","Chen L.","Grijalva C.G.","Herrinton L.J.""SOURCE","Pharmacoepidemiology and Drug Safety (2012) 21:5 (524-534). Date of Publication: May 2012"

"TITLE","Unexpected effect of anti-tnf therapy in membranous glomerulonephritis""AUTHOR NAMES","Santoro D.","Postorino A.","Costantino G.","Bellinghieri G.","Savica V.""SOURCE","Nephrology Dialysis Transplantation (2012) 27 SUPPL. 2 (ii417). Date of Publication: May 2012"

"TITLE","Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists.""AUTHOR NAMES","Hawryluk E.B.","Linskey K.R.","Duncan L.M.","Nazarian R.M.""SOURCE","Journal of cutaneous pathology (2012) 39:5 (481-492). Date of Publication: May 2012"

"TITLE","Adalimumab induces and maintains mucosal healing in patients with Crohn's Disease: Data from the EXTEND trial""AUTHOR NAMES","Rutgeerts P.","Van Assche G.","Sandborn W.J.","Wolf D.C.","Geboes K.","Colombel J.-F.","Reinisch W.","Kumar A.","Lazar A.","Camez A.","Lomax K.G.","Pollack P.F.","D'Haens G.""SOURCE","Gastroenterology (2012) 142:5 (1102-1111.e2). Date of Publication: May 2012"

"TITLE","Treatment of psoriasis with biologics: A survey of dermatological and rheumatological practice at Reims University Hospital""AUTHOR NAMES","Adnot-Desanlis L.","Brochot P.","Eschard J.-P.","Bernard P.","Reguiaï Z.""SOURCE","Annales de Dermatologie et de Venereologie (2012) 139:5 (355-362). Date of Publication: May 2012"

"TITLE","Combination of etanercept and twice-weekly administration of cyclosporin in psoriasis unsatisfactorily controlled by etanercept monotherapy: A retrospective analysis""AUTHOR NAMES","Vena G.A.","Mastrandrea V.","Battaglini S.","Loconsole F.","Buquicchio R.","Cassano N.""SOURCE","European Journal of Inflammation (2012) 10:2 (239-242). Date of Publication: May-August 2012"

"TITLE","Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment""AUTHOR NAMES","De Castro G.R.W.","Neves F.S.","Pereira I.A.","Souza Fialho S.C.M.","Ribeiro G.","Zimmermann A.F.""SOURCE","Rheumatology International (2012) 32:5 (1313-1316). Date of Publication: May 2012"

"TITLE","TNF-α inhibitor (adalimumab) induced psoriasis: A case report""AUTHOR NAMES","Al-Mutairi A.","Elkashlan M.","Al-Fayed H.M.","Swayed M.""SOURCE","Australasian Journal of Dermatology (2012) 53:2 (157). Date of Publication: May 2012"

"TITLE","Subjects with psoriatic arthritis have worse quality of life and greater quality-of-life improvement on Etanercept therapy than subjects with psoriasis alone: The PRISTINE trial""AUTHOR NAMES","Noppakun N.","Amaya-Guerra M.","Robertson D.","Yang S.","Witcombe D.","Thirunavukkarasu K.","Molta C.T.","Boggs R.""SOURCE","Australasian Journal of Dermatology (2012) 53 SUPPL. 1 (55). Date of Publication: May 2012"

"TITLE","The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: A retrospective long-term study""AUTHOR NAMES","Saraceno R.","Specchio F.","Torres T.","Nisticò S.P.","Rizza S.","Chimenti S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:5 (e180-e182). Date of Publication: May 2012"

"TITLE","Pharmacological undertreatment of coronary risk factors in patients with psoriasis: Observational study of the danish nationwide registries""AUTHOR NAMES","Ahlehoff O.","Skov L.","Gislason G.","Lindhardsen J.","Kristensen S.L.","Iversen L.","Lasthein S.","Gniadecki R.","Dam T.N.","Torp-Pedersen C.","Hansen P.R.""SOURCE","PLoS ONE (2012) 7:4 Article Number: e36342. Date of Publication: 30 Apr 2012"

"TITLE","Management of recalcitrant hidradenitis suppurativa with ustekinumab""AUTHOR NAMES","Sharon V.R.","Garcia M.S.","Bagheri S.","Goodarzi H.","Yang C.","Ono Y.","Maverakis E.""SOURCE","Acta Dermato-Venereologica (2012) 92:3 (320-321). Date of Publication: 2012"

"TITLE","Comparison of efficiency and adverse effects of etanercept, infliximab and adalimumab in patients with psoriasis vulgaris""AUTHOR NAMES","Şen A.P.","Onsun N.","Su Ö.","Cinkaya A.""SOURCE","Turkderm Deri Hastaliklari ve Frengi Arsivi (2012) 46:1 (11-14). Date of Publication: 2012"

"TITLE","Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: Patients ineligible vs eligible for randomized controlled trials"

"AUTHOR NAMES","Garcia-Doval I.","Carretero G.","Vanaclocha F.","Ferrandiz C.","Daudén E.","Sánchez-Carazo J.-L.","Alsina M.","Herrera-Ceballos E.","Gómez-García F.-J.","Ferrán M.","López-Estebaranz J.-L.","Hernanz J.-M.","Belinchón-Romero I.","Vilar-Alejo J.","Rivera R.","Carrascosa J.-M.","Carazo C.""SOURCE","Archives of Dermatology (2012) 148:4 (463-470). Date of Publication: April 2012"

"TITLE","Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting""AUTHOR NAMES","Gelfand J.M.","Wan J.","Callis Duffin K.","Krueger G.G.","Kalb R.E.","Weisman J.D.","Sperber B.R.","Stierstorfer M.B.","Brod B.A.","Schleicher S.M.","Bebo Jr. B.F.","Troxel A.B.","Shin D.B.","Steinemann J.M.","Goldfarb J.","Yeung H.","Van Voorhees A.S.""SOURCE","Archives of Dermatology (2012) 148:4 (487-494). Date of Publication: April 2012"

"TITLE","Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States""AUTHOR NAMES","Schabert V.F.","Watson C.","Gandra S.R.","Goodman S.","Fox K.M.","Harrison D.J.""SOURCE","Journal of Medical Economics (2012) 15:2 (264-275). Date of Publication: April 2012"

"TITLE","Real world tumor necrosis factor (TNF) blocker treatment patterns for biologic-naïve psoriasis patients in a US managed care population""AUTHOR NAMES","Smith T.","Joyce A.","Fox K.","Gandra S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB10). Date of Publication: April 2012"

"TITLE","Treatment of generalized vitiligo with anti-TNF-α agents""AUTHOR NAMES","AlGhamdi K.M.","Khurrum H.","Taïeb A.","Ezzedine K.""SOURCE","Journal of Drugs in Dermatology (2012) 11:4 (534-539). Date of Publication: April 2012"

"TITLE","Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis""AUTHOR NAMES","Pontikaki I.","Shahi E.","Frasin L.A.","Gianotti R.","Gelmetti C.","Gerloni V.","Meroni P.L.""SOURCE","Clinical Reviews in Allergy and Immunology (2012) 42:2 (131-134). Date of Publication: April 2012"

"TITLE","Costs of tumor necrosis factor blockers per treated psoriasis patient using real world data in US commercially insured population""AUTHOR NAMES","Yeaw J.","Watson C.","Fox K.","Gandra S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB189). Date of Publication: April 2012"

"TITLE","Combined clinical, videodermatoscopic, and ultrasound evaluation of psoriasis treated with biologics provides objective therapeutic response""AUTHOR NAMES","Micali G.","Santagati C.","Lacarrubba F.","Musumeci M.L.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB188). Date of Publication: April 2012"

"TITLE","Tumor necrosis factor blocker treatment patterns after discontinuation within the first year of therapy initiation in psoriatic arthritis patients in a real-world managed care setting""AUTHOR NAMES","Bonafede M.","Watson C.","Fox K.","Gandra S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB205). Date of Publication: April 2012"

"TITLE","Using real-world drug utilization to estimate tumor necrosis factor blocker cost for treated psoriasis patients in a managed care setting""AUTHOR NAMES","Bonafede M.","Watson C.","Fox K.","Gandra S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB206). Date of Publication: April 2012"

"TITLE","Cost-effectiveness of treatment with etanercept for psoriasis in Sweden""AUTHOR NAMES","Knight C.","Mauskopf J.","Ekelund M.","Singh A.","Yang S.","Boggs R.""SOURCE","European Journal of Health Economics (2012) 13:2 (145-156). Date of Publication: April 2012"

"TITLE","Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab""AUTHOR NAMES","Tammaro A.","Persechino S.","Abruzzese C.","Narcisi A.","Cortesi G.","Parisella F.R.","Lagana B.""SOURCE","International Journal of Immunopathology and Pharmacology (2012) 25:2 (499-501). Date of Publication: April-June 2012"

"TITLE","Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: Results from the PHOENIX 1 trial through up to 3 years""AUTHOR NAMES","Kimball A.B.","Gordon K.B.","Fakharzadeh S.","Yeilding N.","Szapary P.O.","Schenkel B.","Guzzo C.","Li S.","Papp K.A."

"SOURCE","British Journal of Dermatology (2012) 166:4 (861-872). Date of Publication: April 2012"

"TITLE","Long-term durability of response to adalimumab in Crohn's disease""AUTHOR NAMES","Chaparro M.","Panés J.","García V.","Merino O.","Nos P.","Domènech E.","Peñalva M.","García-Planella E.","Esteve M.","Hinojosa J.","Andreu M.","Muñoz F.","Gutiérrez A.","Mendoza J.L.","Barrio J.","Barreiro-de Acosta M.","Vera I.","Vilar P.","Cabriada J.L.","Montoro M.A.","Aldeguer X.","Saro C.","Gisbert J.P.""SOURCE","Inflammatory Bowel Diseases (2012) 18:4 (685-690). Date of Publication: April 2012"

"TITLE","Etanercept and adalimumab treatment patterns after discontinuation within the first year of therapy initiation in psoriasis (PSO) patients in a large managed care population""AUTHOR NAMES","Bonafede M.","Watson C.","Fox K.","Gandra S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB192). Date of Publication: April 2012"

"TITLE","Ustekinumab in clinical practice: Response depends on dose and previous treatment""AUTHOR NAMES","Ruiz Salas V.","Puig L.","Alomar A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:4 (508-513). Date of Publication: April 2012"

"TITLE","Human papilloma virus and molluscum contagiosum lesions related to infliximab therapy for psoriasis: A case series""AUTHOR NAMES","Georgala S.","Katoulis A.C.","Kanelleas A.","Befon A.","Georgala C.""SOURCE","Dermatology Online Journal (2012) 18:4 (9). Date of Publication: April 2012"

"TITLE","Adalimumab response is consistent across subgroups of patients with moderate to severe chronic plaque psoriasis of the hands and/or feet: Subanalysis of the “REACH” study""AUTHOR NAMES","Poulin Y.","Crowley J.J.","Unnebrink K.","Valdecantos W.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB183). Date of Publication: April 2012"

"TITLE","Patient satisfaction with injection devices: A randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis""AUTHOR NAMES","Paul C.","Stalder J.F.","Thaçi D.","Vincendon P.","Brault Y.","Kielar D.","Tebbs V.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:4 (448-455). Date of Publication: April 2012"

"TITLE","Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: The RESPOND study""AUTHOR NAMES","Baranauskaite A.","Raffayová H.","Kungurov N.V.","Kubanova A.","Venalis A.","Helmle L.","Srinivasan S.","Nasonov E.","Vastesaeger N.","Nasyrova R.","Parsik E.","Otsa K.","Butrimiene I.","Pileckyte M.","Tlustochowicz W.","Kucharz E.","Szekanecz Z.","Poor G.","Koo E.","Hodinka L.","Macejova Z.","Direskeneli H.","Akkoc N.","Kabasakal Y.","Ertenli I.","Khatib F.","Van Duuren E.M.","Spargo C.","Louw I.","Codreanu C.","Ionescu R.","Chireac R.M.","Rednic S.","Hammoudeh M.","Szechinski J.","Rell-Bakalarska M.","Avraham D.","Andersone D.","Keszthelyi P.","Suranyi P.""SOURCE","Annals of the Rheumatic Diseases (2012) 71:4 (541-548). Date of Publication: April 2012"

"TITLE","A 10-year postmarketing surveillance registry of adalimumab for moderate to severe psoriasis: Second-year interim results of ESPRIT""AUTHOR NAMES","Kerdel F.","Thaci D.","Chen K.","Goldblum O.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB181). Date of Publication: April 2012"

"TITLE","Clinical and patient-reported improvements of hand and/or foot psoriasis with adalimumab: Subanalysis of REACH""AUTHOR NAMES","Menter A.","Bagel J.","Unnebrink K.","Rozzo S.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB187). Date of Publication: April 2012"

"TITLE","Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist""AUTHOR NAMES","Wollina U.","Gemmeke A.","Koch A.""SOURCE","Journal of Clinical and Aesthetic Dermatology (2012) 5:4 (36-39). Date of Publication: April 2012"

"TITLE","Adding methotrexate to etanercept versus etanercept monotherapy in adults with moderate to severe plaque psoriasis: Efficacy and safety""AUTHOR NAMES","Gottlieb A.B.","Strober B.E.","Kricorian G.","Langley R.G.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:4 SUPPL. 1 (AB184). Date of Publication: April 2012"

"TITLE","The use of videodermoscopy for monitoring subungual hyperkeratosis in a psoriasis

patient treated with infliximab""AUTHOR NAMES","Sicińska J.","Rakowska A.","Słowińska M.","Czuwara J.","Kardynał A.","Warszawik O.","Kurzeja M.","Maj M.","Rudnicka L.""SOURCE","Przeglad Dermatologiczny (2012) 99:1 (45-51). Date of Publication: 2012"

"TITLE","Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-""AUTHOR NAMES","Puertas-Abreu E.","Polanco E.","Azocar M.","Mundarain L.","Nũez-Sotelo C.","Montão R.","Vivas F.","Noguera Z.","Marín F.","Bellorin O.","Rivas J.","Toro E.","Benzaquen E.","Rauseo M.","Gutiérrez González L.""SOURCE","International Archives of Medicine (2012) 5:1 Article Number: 7. Date of Publication: 2012"

"TITLE","Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the greek population""AUTHOR NAMES","Vasilopoulos Y.","Manolika M.","Zafiriou E.","Sarafidou T.","Bagiatis V.","Krüger-Krasagaki S.","Tosca A.","Patsatsi A.","Sotiriadis D.","Mamuris Z.","Roussaki-Schulze A.""SOURCE","Molecular Diagnosis and Therapy (2012) 16:1 (29-34). Date of Publication: 2012"

"TITLE","Safety of treatment with biologics for psoriasis in daily practice: 5-year data""AUTHOR NAMES","Van Lümig P.P.M.","Driessen R.J.B.","Berends M.A.M.","Boezeman J.B.M.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:3 (283-291). Date of Publication: March 2012"

"TITLE","Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients""AUTHOR NAMES","Wan J.","Abuabara K.","Troxel A.B.","Shin D.B.","Van Voorhees A.S.","Bebo Jr. B.F.","Krueger G.G.","Callis Duffin K.","Gelfand J.M.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:3 (376-386). Date of Publication: March 2012"

"TITLE","Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: A claims analysis""AUTHOR NAMES","Bonafede M.M.K.","Gandra S.R.","Watson C.","Princic N.","Fox K.M.""SOURCE","Advances in Therapy (2012) 29:3 (234-248). Date of Publication: March 2012"

"TITLE","Disease severity and therapy as predictors of cardiovascular risk in psoriasis: A population-based cohort study""AUTHOR NAMES","Maradit-Kremers H.","Icen M.","Ernste F.C.","Dierkhising R.A.","McEvoy M.T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:3 (336-343). Date of Publication: March 2012"

"TITLE","TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis""AUTHOR NAMES","Tejasvi T.","Stuart P.E.","Chandran V.","Voorhees J.J.","Gladman D.D.","Rahman P.","Elder J.T.","Nair R.P.""SOURCE","Journal of Investigative Dermatology (2012) 132:3 PART 1 (593-600). Date of Publication: March 2012"

"TITLE","Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community-based hospital""AUTHOR NAMES","Noda S.","Mizuno K.","Adachi M.""SOURCE","Journal of Dermatology (2012) 39:3 (265-268). Date of Publication: March 2012"

"TITLE","Eosinophilia during psoriasis treatment with TNF antagonists""AUTHOR NAMES","Malisiewicz B.","Murer C.","Pachlopnik Schmid J.","French L.E.","Schmid-Grendelmeier P.","Navarini A.A.""SOURCE","Dermatology (2011) 223:4 (311-315). Date of Publication: March 2012"

"TITLE","An update on the long-term safety experience of Ustekinumab: Results from the psoriasis clinical development program with up to four years of follow-up""AUTHOR NAMES","Reich K.","Papp K.A.","Griffiths C.E.M.","Szapary P.O.","Yeilding N.","Wasfi Y.","Ott E.","Hsu M.-C.","Lebwohl M.","Gordon K.B.""SOURCE","Journal of Drugs in Dermatology (2012) 11:3 (300-312). Date of Publication: March 2012"

"TITLE","Skin Disease Education Foundation's 36th Annual Hawaii Dermatology Seminar""SOURCE","Seminars in Cutaneous Medicine and Surgery (2012) 31:1. Date of Publication: March 2012"

"TITLE","Psoriasis onset with tocilizumab treatment for rheumatoid arthritis""AUTHOR NAMES","Wendling D.","Letho-Gyselinck H.","Guillot X.","Prati C.""SOURCE","Journal of Rheumatology (2012) 39:3 (657). Date of Publication: March 2012"

"TITLE","Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe

plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial""AUTHOR NAMES","Igarashi A.","Kato T.","Kato M.","Song M.","Nakagawa H.""SOURCE","Journal of Dermatology (2012) 39:3 (242-252). Date of Publication: March 2012"

"TITLE","Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test""AUTHOR NAMES","Silva L.C.R.","Geluk A.","Arnone M.","Romiti R.","Franken K.C.L.M.","Duarte A.J.S.","Takahashi M.D.F.","Benard G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:3 (319-324). Date of Publication: March 2012"

"TITLE","Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: An open prospective unblinded study""AUTHOR NAMES","Rigopoulos D.","Gregoriou S.","Makris M.","Ioannides D.""SOURCE","Dermatology (2011) 223:4 (325-329). Date of Publication: March 2012"

"TITLE","Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis""AUTHOR NAMES","Imafuku S.","Ito K.","Nakayama J.""SOURCE","British Journal of Dermatology (2012) 166:3 (675-678). Date of Publication: March 2012"

"TITLE","Effective treatment of etanercept and phototherapy-resistant psoriasis using the excimer laser""AUTHOR NAMES","Park K.K.","Swan J.","Koo J.""SOURCE","Dermatology Online Journal (2012) 18:3 (2). Date of Publication: March 2012"

"TITLE","Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: An analysis of Japanese clinical trials of infliximab""AUTHOR NAMES","Torii H.","Sato N.","Yoshinari T.","Nakagawa H.""SOURCE","Journal of Dermatology (2012) 39:3 (253-259). Date of Publication: March 2012"

"TITLE","Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: A case study""AUTHOR NAMES","Lee E.S.","Heller M.M.","Kamangar F.","Park Md K.K.","Koo J.Y.M.""SOURCE","Journal of Drugs in Dermatology (2012) 11:3 (413-414). Date of Publication: March 2012"

"TITLE","Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis""AUTHOR NAMES","Kimura U.","Kinoshita A.","Haruna K.","Mizuno Y.","Sekigawa I.","Takamori K.","Suga Y.""SOURCE","Journal of Dermatology (2012) 39:3 (286-288). Date of Publication: March 2012"

"TITLE","Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions""AUTHOR NAMES","Kokolakis G.","Giannikaki E.","Stathopoulos E.","Avramidis G.","Tosca A.D.","Krüger-Krasagakis S.""SOURCE","British Journal of Dermatology (2012) 166:3 (491-497). Date of Publication: March 2012"

"TITLE","Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis""AUTHOR NAMES","Mizote Y.","Nakahara T.","Mitoma C.","Nakao M.","Mitoma H.","Moroi Y.","Furue M.""SOURCE","Journal of Dermatology (2012) 39:3 (284-285). Date of Publication: March 2012"

"TITLE","Circulating dendritic cell subsets in psoriatic patients before and after biologic therapy""AUTHOR NAMES","Prignano F.","Ricceri F.","Beccatti M.","Di Gennaro P.","Fiorillo C.","Lotti T.","Taddei N.""SOURCE","Journal of Dermatology (2012) 39:3 (274-275). Date of Publication: March 2012"

"TITLE","The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis""AUTHOR NAMES","Young L.","Czarnecki D.""SOURCE","Australasian Journal of Dermatology (2012) 53:1 (57-60). Date of Publication: February 2012"

"TITLE","Drug survival rates of biologic treatments in patients with psoriasis vulgaris""AUTHOR NAMES","Brunasso A.M.G.","Puntoni M.","Massone C.""SOURCE","British Journal of Dermatology (2012) 166:2 (447-449). Date of Publication: 2012"

"TITLE","Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: A case and review of the literature"

"AUTHOR NAMES","Navarro R.","Daudén E.","Gallo E.","Sánchez-Mateos D.S.","García-Diez A.""SOURCE","Skin Pharmacology and Physiology (2012) 25:2 (107-110). Date of Publication: February 2012"

"TITLE","174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers""AUTHOR NAMES","Di Renzo L.","Bianchi A.","Saraceno R.","Calabrese V.","Cornelius C.","Iacopino L.","Chimenti S.","De Lorenzo A.""SOURCE","Pharmacogenetics and Genomics (2012) 22:2 (134-142). Date of Publication: February 2012"

"TITLE","HLA polymorphism among Chinese patients with chronic plaque psoriasis: Subgroup analysis""AUTHOR NAMES","Chiu H.Y.","Huang P.-Y.","Jee S.-H.","Hu C.-Y.","Chou C.-T.","Chang Y.-T.","Hwang C.-Y.","Tsai T.-F.""SOURCE","British Journal of Dermatology (2012) 166:2 (288-297). Date of Publication: 2012"

"TITLE","The juvenile-onset spondyloarthritis""AUTHOR NAMES","Burgos-Vargas R.""SOURCE","Rheumatology (2012) 51 SUPPL. 1 (i2). Date of Publication: February 2012"

"TITLE","Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population""AUTHOR NAMES","Papp K.A.","Poulin Y.","Bissonnette R.","Bourcier M.","Toth D.","Rosoph L.","Poulin-Costello M.","Setterfield M.","Syrotuik J.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:2 (e33-e45). Date of Publication: February 2012"

"TITLE","Long-term efficacy of etanercept for psoriasis in daily practice""AUTHOR NAMES","Van Lümig P.P.M.","Driessen R.J.B.","Boezeman J.B.M.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2012) 166:2 (445-447). Date of Publication: 2012"

"TITLE","Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL""AUTHOR NAMES","Gordon K.","Papp K.","Poulin Y.","Gu Y.","Rozzo S.","Sasso E.H.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:2 (241-251). Date of Publication: February 2012"

"TITLE","The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis""AUTHOR NAMES","Kimball A.B.","Yu A.P.","Signorovitch J.","Xie J.","Tsaneva M.","Gupta S.R.","Bao Y.","Mulani P.M.""SOURCE","Journal of the American Academy of Dermatology (2012) 66:2 (e67-e76). Date of Publication: February 2012"

"TITLE","Paradoxical pustulosis palmoplantaris caused by etanercept for suppurative hidradenitis""AUTHOR NAMES","Van Der Zee H.H.","Tjioe M.","Prens E.P.""SOURCE","Nederlands Tijdschrift voor Dermatologie en Venereologie (2012) 22:2 (124-128). Date of Publication: February 2012"

"TITLE","Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor""AUTHOR NAMES","Mas-Vidal A.","Santos-Juanes J.","Esteve-Martinez A.","Caminal-Montero L.","Coto-Segura P.""SOURCE","Australasian Journal of Dermatology (2012) 53:1 (70-72). Date of Publication: February 2012"

"TITLE","February highlights""AUTHOR NAMES","Del Rosso J.Q.","Werschler P.""SOURCE","Journal of Clinical and Aesthetic Dermatology (2012) 5:2 (10). Date of Publication: February 2012"

"TITLE","Acitretin-induced poliosis with concurrent alopecia""AUTHOR NAMES","Chappell J.A.","Chu M.B.","Martin K.","Hurley M.Y.""SOURCE","Journal of Drugs in Dermatology (2012) 11:2 (247-249). Date of Publication: February 2012"

"TITLE","Combination biologic treatment of refractory psoriasis and psoriatic arthritis""AUTHOR NAMES","Cuchacovich R.","Garcia-Valladares I.","Espinoza L.R.""SOURCE","Journal of Rheumatology (2012) 39:1 (187-193). Date of Publication: January 2012"

"TITLE","Transient improvement in chronic psoriasis after treatment of TNF-α blocker induced disseminated M. Tuberculosis infection""AUTHOR NAMES","Letada P.R.","Hitchcock E.","Steele S.L.","Winstanley D."

"SOURCE","Journal of Drugs in Dermatology (2012) 11:1 (119-120). Date of Publication: January 2012"

"TITLE","Vessel resistance to blood flow in the nailfold in patients with psoriasis: A prospective case-control echo Doppler-based study""AUTHOR NAMES","Husein El-Ahmed H.","Garrido-Pareja F.","Ruiz-Carrascosa J.-C.","Naranjo-Sintes R.""SOURCE","British Journal of Dermatology (2012) 166:1 (54-58). Date of Publication: January 2012"

"TITLE","Malignant melanoma during ustekinumab therapy of Crohn's disease""AUTHOR NAMES","Ehmann L.M.","Tillack-Schreiber C.","Brand S.","Wollenberg A.""SOURCE","Inflammatory Bowel Diseases (2012) 18:1 (E199-E200). Date of Publication: January 2012"

"TITLE","Different response rates between palmo-plantar involvement and diffuse plaque psoriasis in patients treated with infliximab""AUTHOR NAMES","Brunasso A.M.G.","Puntoni M.","Delfino C.","Massone C.""SOURCE","European Journal of Dermatology (2012) 22:1 (133-135). Date of Publication: January/February 2012"

"TITLE","Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic""AUTHOR NAMES","Velez N.F.","Wei-Passanese E.X.","Husni M.E.","Mody E.A.","Qureshi A.A.""SOURCE","Archives of Dermatological Research (2012) 304:1 (7-13). Date of Publication: January 2012"

"TITLE","Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab""AUTHOR NAMES","Ogata A.","Umegaki N.","Katayama I.","Kumanogoh A.","Tanaka T.""SOURCE","Joint Bone Spine (2012) 79:1 (85-87). Date of Publication: January 2012"

"TITLE","Reactivation of tuberculosis in three cases of psoriasis after initiation of anti-TNF therapy""AUTHOR NAMES","Abu Shaikha S.","Mansour K.","Riad H.""SOURCE","Case Reports in Dermatology (2012) 4:1 (41-46). Date of Publication: January-April 2012"

"TITLE","Practical experience of ustekinumab in the treatment of psoriasis: Experience from a multicentre, retrospective case cohort study across the U.K. and Ireland""AUTHOR NAMES","Laws P.M.","Downs A.M.","Parslew R.","Dever B.","Smith C.H.","Barker J.N.","Moriarty B.","Murphy R.","Kirby B.","Burden A.D.","McBride S.","Anstey A.V.","O'Shea S.","Ralph N.","Buckley C.","Griffiths C.E.M.","Warren R.B.""SOURCE","British Journal of Dermatology (2012) 166:1 (189-195). Date of Publication: January 2012"

"TITLE","Spontaneous abortion during ustekinumab therapy""AUTHOR NAMES","Fotiadou C.","Lazaridou E.","Sotiriou E.","Ioannides D.""SOURCE","Journal of Dermatological Case Reports (2012) 6:4 (105-107). Date of Publication: 2012"

"TITLE","Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: A randomized intraindividual trial""AUTHOR NAMES","Wolf P.","Weger W.","Legat F.J.","Posch-Fabian T.","Gruber-Wackernagel A.","Inzinger M.","Salmhofer W.","Hofer A.""SOURCE","British Journal of Dermatology (2012) 166:1 (147-153). Date of Publication: January 2012"

"TITLE","Severe cutaneous and arthritic psoriasis in patient with Aids: A good outcome with therapy using etanercept""AUTHOR NAMES","Santos M.","Rabelo R.","Mendes L.","Vilasboas V.","Talhari C.","Talhari S.""SOURCE","Anais Brasileiros de Dermatologia (2012) 87:1 (135-138). Date of Publication: January/February 2012"

"TITLE","Clinical manifestation of selective IgA deficiency during anti-TNF-α treatment in a psoriatic arthritis patient: Case report""AUTHOR NAMES","Iervolino S.","Lofrano M.","Di Minno M.N.D.","Foglia F.","Scarpa R.","Peluso R.""SOURCE","Reumatismo (2012) 64:1 (40-43). Date of Publication: 2012"

"TITLE","Occurrence of salivary gland tumours in two patients treated with biological agents""AUTHOR NAMES","Carlesimo M.","Mari E.","La Pietra M.","Orsini D.","Pranteda G.","Pranteda G.","Grimaldi M.","Arcese A.""SOURCE","International Journal of Immunopathology and Pharmacology (2012) 25:1 (297-300). Date of Publication: January-March 2012"

"TITLE","Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept""AUTHOR NAMES","Esposito M.","Giunta A.","Babino G.","Schipani C.","Marchei M.","Chimenti M.S.""SOURCE","European Journal of Dermatology (2012) 22:1 (151-152). Date of Publication: January/February 2012"

"TITLE","Psoriasis, lymphoma and etanercept: Is there a correlation?""AUTHOR NAMES","Miranda L.Q.","Bressan A.L.","Rehfeldt F.V.S.","Vasconcelos B.N.","Gripp A.C.""SOURCE","Anais Brasileiros de Dermatologia (2012) 87:1 (139-141). Date of Publication: January/February 2012"

"TITLE","Do men have more severe psoriasis than women?""AUTHOR NAMES","White D.","O'Shea S.J.","Rogers S.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2012) 26:1 (126-127). Date of Publication: January 2012"

"TITLE","Adalimumab monotherapy in a patient with psoriatic arthritis associated with chronic renal failure on hemodialysis: A case report and literature review""AUTHOR NAMES","Shimojima Y.","Matsuda M.","Ishii W.","Ikeda S.""SOURCE","Clinical Medicine Insights: Case Reports (2012) 5 (13-17). Date of Publication: 2012"

"TITLE","Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis""AUTHOR NAMES","Ahmed Z.","Powell R.","Llewelyn G.","Anstey A.""SOURCE","BMJ Case Reports (2011). Date of Publication: 2011"

"TITLE","Detecting latent tuberculosis infection during anti-tumour necrosis factor therapy""AUTHOR NAMES","Ringrose J.S.","Sanche S.E.","Taylor-Gjevre R.M.""SOURCE","Clinical and Experimental Rheumatology (2011) 29:5 (790-794). Date of Publication: 2011"

"TITLE","Initiation of tumor necrosis factor-αantagonists and the risk of hospitalization for infection in patients with autoimmune diseases""AUTHOR NAMES","Grijalva C.G.","Chen L.","Delzell E.","Baddley J.W.","Beukelman T.","Winthrop K.L.","Griffin M.R.","Herrinton L.J.","Liu L.","Ouellet-Hellstrom R.","Patkar N.M.","Solomon D.H.","Lewis J.D.","Xie F.","Saag K.G.","Curtis J.R.""SOURCE","JAMA - Journal of the American Medical Association (2011) 306:21 (2331-2339). Date of Publication: 7 Dec 2011"

"TITLE","Biological treatment in atypical forms of psoriasis: Case reports""AUTHOR NAMES","Rogowski-Tylman M.","Lesiak A.","Sysa-Jȩdrzejowska A.","Brucka-Stemkowska A.","Sobolewska D.","Narbutt J.""SOURCE","Przeglad Dermatologiczny (2011) 98:6 (506-511). Date of Publication: 2011"

"TITLE","Drug-induced bullous pemphigoid: Cases triggered by intravenous iodine and etanercept""AUTHOR NAMES","Kluk J.","Goulding J.M.R.","Bhat J.","Finch T.M.""SOURCE","Clinical and Experimental Dermatology (2011) 36:8 (871-873). Date of Publication: December 2011"

"TITLE","Management of Recurrent Cutaneous Abscesses During Therapy With Infliximab""AUTHOR NAMES","De Simone C.","Murri R.","Maiorino A.","Venier A.","Caldarola G.""SOURCE","Clinical Therapeutics (2011) 33:12 (1993-1996). Date of Publication: December 2011"

"TITLE","Switching between tumour necrosis factor blockers in spondyloarthritis: A retrospective monocentre study of 222 patients""AUTHOR NAMES","Dadoun S.","Geri G.","Paternotte S.","Dougados M.","Gossec L.""SOURCE","Clinical and Experimental Rheumatology (2011) 29:6 (1010-1013). Date of Publication: 2011"

"TITLE","Rapid response of scalp psoriasis to ustekinumab""AUTHOR NAMES","di Cesare A.","Fargnoli M.C.","Peris K.""SOURCE","European Journal of Dermatology (2011) 21:6 (993-994). Date of Publication: December 2011"

"TITLE","Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: A new series and a review of 120 cases from the literature""AUTHOR NAMES","Cullen G.","Kroshinsky D.","Cheifetz A.S.","Korzenik J.R.""SOURCE","Alimentary Pharmacology and Therapeutics (2011) 34:11-12 (1318-1327). Date of Publication: December 2011"

"TITLE","Multiple squamous cell carcinomas in the setting of psoriasis treated with etanercept: a report of four cases and review of the literature""AUTHOR NAMES","Brewer J.D.","Hoverson Schott A.R.","Roenigk R.K.""SOURCE","International Journal of Dermatology (2011) 50:12 (1555-1559). Date of Publication: December 2011"

"TITLE","Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis""AUTHOR NAMES","Tan J.Y.","Li S.","Yang K.","Ma B.","Chen W.","Zha C.","Zhang J.""SOURCE","Journal of Dermatological Treatment (2011) 22:6 (323-336). Date of Publication: December 2011"

"TITLE","The kaleidoscopic presentation of the spondyloarthritis concept in a female patient""AUTHOR NAMES","De Langhe E.","Lories R.","Maenaut K.","De Vlam K.""SOURCE","Joint Bone Spine (2011) 78:6 (638-640). Date of Publication: December 2011"

"TITLE","Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2""AUTHOR NAMES","Reich K.","Schenkel B.","Zhao N.","Szapary P.","Augustin M.","Bourcier M.","Guenther L.","Langley R.G.""SOURCE","Journal of Dermatological Treatment (2011) 22:6 (337-347). Date of Publication: December 2011"

"TITLE","Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: A retrospective cohort study""AUTHOR NAMES","Lestre S.","Diamantino F.","Veloso L.","Fidalgo A.","Ferreira A.""SOURCE","European Journal of Dermatology (2011) 21:6 (916-920). Date of Publication: December 2011"

"TITLE","Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients""AUTHOR NAMES","Baumgart D.C.","Grittner U.","Steingräber A.","Azzaro M.","Philipp S.""SOURCE","Inflammatory Bowel Diseases (2011) 17:12 (2512-2520). Date of Publication: December 2011"

"TITLE","Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction""AUTHOR NAMES","Hoffmann J.H.O.","Hartmann M.","Enk A.H.","Hadaschik E.N.""SOURCE","British Journal of Dermatology (2011) 165:6 (1355-1358). Date of Publication: December 2011"

"TITLE","Infliximab-induced intertriginous psoriasis in patient with Crohn's disease""AUTHOR NAMES","Mola F.","Motolese A.""SOURCE","Dermatology Reports (2011) 3:3 Article Number: e40. Date of Publication: 2011"

"TITLE","Etanercept in dermatological practice - Authors' own experience in the treatment of psoriasis vulgaris and psoriatic arthritis""AUTHOR NAMES","Adamski Z.","Dudziak M.","Zakrzewska K.""SOURCE","Postepy Dermatologii i Alergologii (2011) 28:6 (435-441). Date of Publication: 2011"

"TITLE","Dramatic response of nail psoriasis to infliximab""AUTHOR NAMES","Safa G.","Darrieux L.""SOURCE","Case Reports in Medicine (2011) 2011 Article Number: 107928. Date of Publication: 2011"

"TITLE","Treatment of palmoplantar psoriasis with infliximab: A randomized, double-blind placebo-controlled study""AUTHOR NAMES","Bissonnette R.","Poulin Y.","Guenther L.","Lynde C.W.","Bolduc C.","Nigen S.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:12 (1402-1408). Date of Publication: December 2011"

"TITLE","The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept""AUTHOR NAMES","Kanelleas A.","Liapi C.","Katoulis A.","Stavropoulos P.","Avgerinou G.","Georgala S.","Economopoulos T.","Stavrianeas N.G.","Katsambas A.""SOURCE","Clinical and Experimental Dermatology (2011) 36:8 (845-850). Date of Publication: December 2011"

"TITLE","Psoriasis induced by infliximab""AUTHOR NAMES","Fernandes I.C.","Torres T.","Sanches M.","Velho G.","Lago P.","Selores M.""SOURCE","Acta Medica Portuguesa (2011) 24:SUPPL.3 (709-712). Date of Publication: 2011"

"TITLE","Patients with moderate/severe psoriasis report overall work impairment, with improvement on etanercept therapy: Results from the PRISTINE study""AUTHOR NAMES","Augustin M.","Remenyik E.","Gómez Flores M.","Kuligowski M.","Pedersen R.","Robertson D.","Boggs R.""SOURCE","British Journal of Dermatology (2011) 165:6 (e38). Date of Publication: December 2011"

"TITLE","Cutaneous leukocytoclastic vasculitis associated with a fast food diet""AUTHOR NAMES","Sundhar J.","Ozbek A.B.","Modjinou D.","Mirza N.","Roppelt H."

"SOURCE","Internet Journal of Dermatology (2011) 9:1. Date of Publication: 2011"

"TITLE","A case of ALK+ Anaplastic Large T Cell Lymphoma (ALCL) with lymphomatous meningitis""AUTHOR NAMES","Rudder B.A.","Mishra N.","Braverman A.S.","Geraghty M.","Jimenez E.""SOURCE","Blood (2011) 118:21. Date of Publication: 18 Nov 2011"

"TITLE","Teledermatological monitoring of psoriasis patients on biologic therapy""AUTHOR NAMES","Koller S.","Hofmann-Wellenhof R.","Hayn D.","Weger W.","Kastner P.","Schreier G.","Salmhofer W.""SOURCE","Acta Dermato-Venereologica (2011) 91:6 (680-685). Date of Publication: 2011"

"TITLE","Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: A case series""AUTHOR NAMES","Wang T.-S.","Tsai T.-F.""SOURCE","Journal of Dermatology (2011) 38:11 (1096-1099). Date of Publication: November 2011"

"TITLE","Pneumonia due to legionella pneumophila in patients treated with tumor necrosis factor-α antagonists""AUTHOR NAMES","Sorbello A.","Diak P.","Gilbert J.","Boucher R.""SOURCE","Infectious Diseases in Clinical Practice (2011) 19:6 (399-405). Date of Publication: November 2011"

"TITLE","Neurological deficits during treatment with tumor necrosis factor-alpha antagonists""AUTHOR NAMES","Nozaki K.","Silver R.M.","Stickler D.E.","Abou-Fayssal N.G.","Giglio P.","Kamen D.L.","Daniel R.","Judson M.A.""SOURCE","American Journal of the Medical Sciences (2011) 342:5 (352-355). Date of Publication: November 2011"

"TITLE","Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families?""AUTHOR NAMES","Tadros A.","Vergou T.","Stratigos A.J.","Tzavara C.","Hletsos M.","Katsambas A.","Antoniou C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:11 (1282-1287). Date of Publication: November 2011"

"TITLE","Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor-α""AUTHOR NAMES","Javed S.","Kamili Q.-U.-A.","Mendoza N.","Tyring S.K.""SOURCE","Journal of Medical Virology (2011) 83:11 (2051-2055). Date of Publication: November 2011"

"TITLE","The effect of systemic psoriasis therapies on the incidence of myocardial infarction: A cohort study""AUTHOR NAMES","Abuabara K.","Lee H.","Kimball A.B.""SOURCE","British Journal of Dermatology (2011) 165:5 (1066-1073). Date of Publication: November 2011"

"TITLE","Costs of tumor necrosis factor blockers per treated patient across adult indications using real-world data in us commercially-insured population""AUTHOR NAMES","Schabert V.","Gandra S.R.","Watson C.","Fox K.M.","Yeaw J.","Goodman S.","Milev S.","Harrison D.J.""SOURCE","Value in Health (2011) 14:7 (A304-A305). Date of Publication: November 2011"

"TITLE","Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems""AUTHOR NAMES","Herrinton L.J.","Curtis J.R.","Chen L.","Liu L.","Delzell E.","Lewis J.D.","Solomon D.H.","Griffin M.R.","Ouellet-Hellstom R.","Beukelman T.","Grijalva C.G.","Haynes K.","Kuriya B.","Lii J.","Mitchel E.","Patkar N.","Rassen J.","Winthrop K.L.","Nourjah P.","Saag K.G.""SOURCE","Pharmacoepidemiology and Drug Safety (2011) 20:11 (1199-1209). Date of Publication: November 2011"

"TITLE","Cost of etanercept, adalimumab, and infliximab per treated patient across adult indications using real-world data""AUTHOR NAMES","Bonafede M.","Gandra S.R.","Watson C.","Princic N.","Fox K.M.""SOURCE","Value in Health (2011) 14:7 (A304). Date of Publication: November 2011"

"TITLE","Disseminated granuloma annulare: A cutaneous adverse effect of anti-TNF agents""AUTHOR NAMES","Ratnarathorn M.","Raychaudhuri S.P.","Naguwa S.""SOURCE","Indian Journal of Dermatology (2011) 56:6 (752-754). Date of Publication: November-December 2011"

"TITLE","Pilot study of sexual dysfunction in patients with psoriasis: Influence of biologic therapy""AUTHOR NAMES","Ruiz-Villaverde R.","Sánchez-Cano D.","Rodrigo J.R.","Gutierrez C.V.""SOURCE","Indian Journal of Dermatology (2011) 56:6 (694-699). Date of Publication: November-

December 2011"

"TITLE","(18)FDG PET/CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and/or psoriasis vulgaris""AUTHOR NAMES","Takata T.","Taniguchi Y.","Ohnishi T.","Kohsaki S.","Nogami M.","Nakajima H.","Kumon Y.","Terada Y.","Ogawa Y.","Tarutani M.","Sano S.""SOURCE","Journal of Dermatological Science (2011) 64:2 (144-147). Date of Publication: November 2011"

"TITLE","Efficacy and safety of infliximab vs. Methotrexate in patients with moderate-to-severe plaque psoriasis: Results of an open-label, active-controlled, randomized trial (RESTORE1)""AUTHOR NAMES","Barker J.","Hoffmann M.","Wozel G.","Ortonne J.-P.","Zheng H.","Van Hoogstraten H.","Reich K.""SOURCE","British Journal of Dermatology (2011) 165:5 (1109-1117). Date of Publication: November 2011"

"TITLE","Cutaneous infarction under IL-12/23 p40 inhibition: A cautionary note""AUTHOR NAMES","Lipsker D.","Lutz V.""SOURCE","Archives of Dermatology (2011) 147:11 (1344-1345). Date of Publication: November 2011"

"TITLE","Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: Results from a prospective 12-month nonrandomized unblinded clinical trial""AUTHOR NAMES","Karanikolas G.N.","Koukli E.-M.","Katsalira A.","Arida A.","Petrou D.","Komninou E.","Fragiadaki K.","Zacharioudaki A.","Lasithiotakis I.","Giavri E.","Vaiopoulos G.","Sfikakis P.P.""SOURCE","Journal of Rheumatology (2011) 38:11 (2466-2474). Date of Publication: November 2011"

"TITLE","Clastogenic plasma factors in psoriasis - Comparison of phototherapy and anti-TNF-α treatments""AUTHOR NAMES","Emerit I.","Antunes J.","Silva J.M.","Freitas J.","Pinheiro T.","Filipe P.""SOURCE","Photochemistry and Photobiology (2011) 87:6 (1427-1432). Date of Publication: November-December 2011"

"TITLE","Endometrium cancer in a female with psoriatic arthritis treated with TNF alpha antagonist adalimumab""AUTHOR NAMES","Erten S.""SOURCE","Rheumatology International (2011) 31:11 (1537-1538). Date of Publication: November 2011"

"TITLE","Infliximab dosing and administration patterns in patients with crohn's disease in a hospital outpatient setting""AUTHOR NAMES","Bailey R.A.","Waters H.C.","Ernst F.R.","Johnson B.H.","McKenzie R.S.""SOURCE","American Journal of Pharmacy Benefits (2011) 3:6 (e121-e126). Date of Publication: November/December 2011"

"TITLE","Inflammation in depression: Is adiposity a cause?""AUTHOR NAMES","Shelton R.C.","Miller A.H.""SOURCE","Dialogues in Clinical Neuroscience (2011) 13:1 (41-54). Date of Publication: 2011"

"TITLE","New-onset palmoplantar psoriasis during treatment of active ankylosing spondylitis with TNF-alpha blocking agent adalimumab""AUTHOR NAMES","Akgül O.","Çaliş M.","Özgöçmen S.""SOURCE","Turkish Journal of Rheumatology (2011) 26:3 (269-270). Date of Publication: 2011"

"TITLE","Letter: New-onset psoriasis associated with adalimumab: A report of two cases""AUTHOR NAMES","Glenn C.J.","Kobraei K.B.","Russo J.J.""SOURCE","Dermatology Online Journal (2011) 17:9 (15). Date of Publication: 2011"

"TITLE","Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis""AUTHOR NAMES","Safa G.","Martin A.","Darrieux L.""SOURCE","Journal of Clinical Rheumatology (2011) 17:7 (385-386). Date of Publication: October 2011"

"TITLE","Double screening for latent tuberculosis infection in patients treated with anti-tumor necrosis factor α""AUTHOR NAMES","Sempau L.","González-Sixto B.","Sánchez-Sambucetty P.","Ruiz De Morales J.M.G.","Peŕez-Bustillo A.","Rodríguez-Prieto M.A.""SOURCE","Archives of Dermatology (2011) 147:10 (1233-1234). Date of Publication: October 2011"

"TITLE","Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases""AUTHOR NAMES","Perez-Alvarez R.","Perez-de-Lis M.","Diaz-Lagares C.","Pego-Reigosa J.M.","Retamozo S.","Bove A.","Brito-Zeron P.","Bosch X.","Ramos-Casals M.""SOURCE","Seminars in Arthritis and Rheumatism (2011) 41:2 (256-264). Date of Publication:

October 2011"

"TITLE","Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: Results of a prospective longitudinal observational study""AUTHOR NAMES","Boehncke S.","Salgo R.","Garbaraviciene J.","Beschmann H.","Hardt K.","Diehl S.","Fichtlscherer S.","Thaçi D.","Boehncke W.-H.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:10 (1187-1193). Date of Publication: October 2011"

"TITLE","Tattoo sites and psoriasis""AUTHOR NAMES","Smith S.F.","Feldman S.R.""SOURCE","Journal of Drugs in Dermatology (2011) 10:10 (1199-1200). Date of Publication: October 2011"

"TITLE","Costs of tumor necrosis factor blockers per treated rheumatoid arthritis patient using real-world drug data in us commercially-insured population""AUTHOR NAMES","Schabert V.F.","Gandra S.R.","Watson C.","Yeaw J.","Goodman S.","Fox K.M.","Milev S.""SOURCE","Arthritis and Rheumatism (2011) 63:10 SUPPL. 1. Date of Publication: October 2011"

"TITLE","Anti-tumor necrosis factor dose escalation among biologic nave rheumatoid arthritis patients in commercial managed care plans in the two years following therapy initiation""AUTHOR NAMES","Bonafede M.","Fox K.M.","Wilson K.L.","Gandra S.R.""SOURCE","Arthritis and Rheumatism (2011) 63:10 SUPPL. 1. Date of Publication: October 2011"

"TITLE","Tumor necrosis factor blocker treatment patterns after discontinuation within the first year of therapy initiation in rheumatoid arthritis patients in a real-world managed care setting""AUTHOR NAMES","Bonafede M.","Watson C.","Fox K.M.","Princic N.","Gandra S.R.""SOURCE","Arthritis and Rheumatism (2011) 63:10 SUPPL. 1. Date of Publication: October 2011"

"TITLE","Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease""AUTHOR NAMES","Kiss L.S.","Szamosi T.","Molnar T.","Miheller P.","Lakatos L.","Vincze A.","Palatka K.","Barta Z.","Gasztonyi B.","Salamon A.","Horvath G.","Tõth G.T.","Farkas K.","Banai J.","Tulassay Z.","Nagy F.","Szenes M.","Veres G.","Lovasz B.D.","Vegh Z.","Golovics P.A.","Szathmari M.","Papp M.","Lakatos P.L.""SOURCE","Alimentary Pharmacology and Therapeutics (2011) 34:8 (911-922). Date of Publication: October 2011"

"TITLE","Comparing costs of tumor necrosis factor blockers per treated patient for psoriatic arthritis using real-world data in US managed care""AUTHOR NAMES","Schabert V.F.","Gandra S.R.","Watson C.","Goodman S.","Fox K.M.","Yeaw J.","Milev S.""SOURCE","Arthritis and Rheumatism (2011) 63:10 SUPPL. 1. Date of Publication: October 2011"

"TITLE","Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: Modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response""AUTHOR NAMES","Quaglino P.","Bergallo M.","Ponti R.","Barberio E.","Cicchelli S.","Buffa E.","Comessatti A.","Costa C.","Terlizzi M.E.","Astegiano S.","Novelli M.","Cavallo R.","Bernengo M.G.""SOURCE","Dermatology (2011) 223:1 (57-67). Date of Publication: October 2011"

"TITLE","Lack of effect of ustekinumab in treatment of allergic contact dermatitis""AUTHOR NAMES","Bangsgaard N.","Zachariae C.","Menné T.","Skov L.""SOURCE","Contact Dermatitis (2011) 65:4 (227-230). Date of Publication: October 2011"

"TITLE","Dose escalation among rheumatoid arthritis patients treated with infliximab or abatacept: Comparison in claims data""AUTHOR NAMES","Darkow T.","Chastek B.","Rosenblatt L.","Trivedi D.","Hebden T.","Henk H.","Liu F.""SOURCE","Arthritis and Rheumatism (2011) 63:10 SUPPL. 1. Date of Publication: October 2011"

"TITLE","Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis""AUTHOR NAMES","De Simone C.","D'Agostino M.","Capizzi R.","Capponi A.","Venier A.","Caldarola G.""SOURCE","European Journal of Dermatology (2011) 21:4 (568-572). Date of Publication: 2011"

"TITLE","Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: Clinical and virological study in three patients""AUTHOR NAMES","Zanni M.","Missale G.","Santilli D.","Di Nuzzo S.""SOURCE","European Journal of Dermatology (2011) 21:4 (564-567). Date of Publication: 2011"

"TITLE","Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis""AUTHOR NAMES","Avgerinou G.","Tousoulis D.","Siasos G.","Oikonomou E.","Maniatis K.","Papageorgiou N.","Paraskevopoulos T.","Miliou A.","Koumaki D.","Latsios G.","Therianiou A.","Trikas A.","Kampoli A.M.","Stefanadis C.""SOURCE","International Journal of Cardiology (2011) 151:3 (382-383). Date of Publication: 15 Sep 2011"

"TITLE","High-frequency ultrasonography in monitoring the effects of treatment of selected dermatoses""AUTHOR NAMES","Polańska A.","Dańczak-Pazdrowska A.","Silny W.","Sadowska A.","Jenerowicz D.","Osmola-Mańkowska A.","Olek-Hrab K.""SOURCE","Postepy Dermatologii i Alergologii (2011) 28:4 (255-260). Date of Publication: 2011"

"TITLE","Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis""AUTHOR NAMES","Onoufriadis A.","Simpson M.A.","Pink A.E.","Di Meglio P.","Smith C.H.","Pullabhatla V.","Knight J.","Spain S.L.","Nestle F.O.","Burden A.D.","Capon F.","Trembath R.C.","Barker J.N.""SOURCE","American Journal of Human Genetics (2011) 89:3 (432-437). Date of Publication: 9 Sep 2011"

"TITLE","Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: Retrospective data analysis of a patient registry""AUTHOR NAMES","Inzinger M.","Heschl B.","Weger W.","Hofer A.","Legat F.J.","Gruber-Wackernagel A.","Tilz H.","Salmhofer W.","Quehenberger F.","Wolf P.""SOURCE","British Journal of Dermatology (2011) 165:3 (640-645). Date of Publication: September 2011"

"TITLE","Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis""AUTHOR NAMES","Strober B.E.","Crowley J.J.","Yamauchi P.S.","Olds M.","Williams D.A.""SOURCE","British Journal of Dermatology (2011) 165:3 (661-668). Date of Publication: September 2011"

"TITLE","Responses to ustekinumab in the anti-TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris""AUTHOR NAMES","Clemmensen A.","Spon M.","Skov L.","Zachariae C.","Gniadecki R.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:9 (1037-1040). Date of Publication: September 2011"

"TITLE","Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: Subanalysis of BELIEVE""AUTHOR NAMES","Ortonne J.-P.","Chimenti S.","Reich K.","Gniadecki R.","Sprøgel P.","Unnebrink K.","Kupper H.","Goldblum O.","Thaçi D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:9 (1012-1020). Date of Publication: September 2011"

"TITLE","Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis""AUTHOR NAMES","Laggner U.","Di Meglio P.","Perera G.K.","Hundhausen C.","Lacy K.E.","Ali N.","Smith C.H.","Hayday A.C.","Nickoloff B.J.","Nestle F.O.""SOURCE","Journal of Immunology (2011) 187:5 (2783-2793). Date of Publication: 1 Sep 2011"

"TITLE","CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity""AUTHOR NAMES","Pedrosa E.","Carretero-Iglesia L.","Boada A.","Colobran R.","Faner R.","Pujol-Autonell I.","Palou E.","Esteve A.","Pujol-Borrell R.","Ferrándiz C.","Juan M.","Carrascosa J.-M.""SOURCE","Journal of Investigative Dermatology (2011) 131:9 (1830-1837). Date of Publication: September 2011"

"TITLE","Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients""AUTHOR NAMES","Kothary N.","Diak I.-L.","Brinker A.","Bezabeh S.","Avigan M.","Dal Pan G.""SOURCE","Journal of the American Academy of Dermatology (2011) 65:3 (546-551). Date of Publication: September 2011"

"TITLE","Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy""AUTHOR NAMES","Schnitzler F.","Fidder H.","Ferrante M.","Ballet V.","Noman M.","Van Assche G.","Spitz B.","Hoffman I.","Van Steen K.","Vermeire S.","Rutgeerts P.""SOURCE","Inflammatory Bowel Diseases (2011) 17:9 (1846-1854). Date of Publication: September 2011"

"TITLE","Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): A pilot study""AUTHOR NAMES","Mehta N.N.","Yu Y.","Saboury B.","Foroughi N.","Krishnamoorthy P.","Raper A.","Baer A.","Antigua J.","Van Voorhees A.S.","Torigian D.A.","Alavi A.","Gelfand J.M.""SOURCE","Archives of Dermatology (2011) 147:9 (1031-1039). Date of Publication: September 2011"

"TITLE","Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)""AUTHOR NAMES","Tsai T.-F.","Ho J.-C.","Song M.","Szapary P.","Guzzo C.","Shen Y.-K.","Li S.","Kim K.-J.","Kim T.-Y.","Choi J.-H.","Youn J.-I.""SOURCE","Journal of Dermatological Science (2011) 63:3 (154-163). Date of Publication: September 2011"

"TITLE","Dermatophytosis during anti-TNF-α monoclonal antibody therapy""AUTHOR NAMES","Bardazzi F.","Balestri R.","Rech G.","Antonucci A.","Patrizi A.""SOURCE","Mycoses (2011) 54:5 (e619-e620). Date of Publication: September 2011"

"TITLE","Etanercept: Effectiveness and safety data of a retrospective study""AUTHOR NAMES","Antoniou C.","Vergou T.","Dessinioti C.","Stratigos A.J.","Avgerinou G.","Stavropoulos P.","Katsambas A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:9 (1113-1115). Date of Publication: September 2011"

"TITLE","Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis""AUTHOR NAMES","Gottlieb A.B.","Leonardi C.","Kerdel F.","Mehlis S.","Olds M.","Williams D.A.""SOURCE","British Journal of Dermatology (2011) 165:3 (652-660). Date of Publication: September 2011"

"TITLE","Lack of ethnic effect on the pharmacokinetics of subcutaneous ustekinumab in adult Chinese and non-Chinese healthy male subjects""AUTHOR NAMES","Zhu Y.","Wang Q.","Frederick B.","Bouman-Thio E.","Marini J.C.","Keen M.","Petty K.","Davis H.M.","Zhou H.""SOURCE","Journal of Clinical Pharmacology (2011) 51:9 (1335-1336). Date of Publication: September 2011"

"TITLE","Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis""AUTHOR NAMES","Knudson R.M.","Tefferi A.","Pittelkow M.R.","Davis M.D.P.""SOURCE","Journal of the American Academy of Dermatology (2011) 65:3 (673-674). Date of Publication: September 2011"

"TITLE","Marked improvement in nail psoriasis during treatment with etanercept""AUTHOR NAMES","Vázquez M.G.","Ramón Navarra Amayuelas""SOURCE","Dermatologic Therapy (2011) 24:5 (498-500). Date of Publication: September-October 2011"

"TITLE","Anti-tumour-necrosis-factor-alpha agents and the heart: Beyond left ventricular systolic dysfunction?""AUTHOR NAMES","Vassiliou V.","Ntatsaki E.""SOURCE","New Zealand Medical Journal (2011) 124:1343 (76-78). Date of Publication: September 2011"

"TITLE","A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept""AUTHOR NAMES","Silpa-Archa N.","Wongpraparut C.""SOURCE","Journal of the Medical Association of Thailand (2011) 94:9 (1154-1157). Date of Publication: September 2011"

"TITLE","Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials""AUTHOR NAMES","Ryan C.","Leonardi C.L.","Krueger J.G.","Kimball A.B.","Strober B.E.","Gordon K.B.","Langley R.G.","De Lemos J.A.","Daoud Y.","Blankenship D.","Kazi S.","Kaplan D.H.","Friedewald V.E.","Menter A.""SOURCE","JAMA - Journal of the American Medical Association (2011) 306:8 (864-871). Date of Publication: August 24-31, 2011"

"TITLE","Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: Results of a prospective longitudinal pilot study""AUTHOR NAMES","Boehncke S.","Salgo R.","Garbaraviciene J.","Beschmann H.","Ackermann H.","Boehncke W.-H.","Ochsendorf F.R.""SOURCE","Archives of Dermatological Research (2011) 303:6 (417-424). Date of Publication: August 2011"

"TITLE","311nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients""AUTHOR NAMES","Wolf P.","Hofer A.","Weger W.","Posch-Fabian T.","Gruber-Wackernagel A.","Legat F.J.""SOURCE","Photodermatology Photoimmunology and Photomedicine (2011) 27:4 (186-189). Date of Publication: August 2011"

"TITLE","Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab""AUTHOR NAMES","Van Lümig P.P.M.","Driessen R.J.B.","Roelofs-Thijssen M.A.M.A.","Boezeman J.B.M.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2011) 165:2 (375-382). Date of Publication: August 2011"

"TITLE","Mycobacterium fortuitum infection following adalimumab treatment for psoriasis and subsequent complication-free treatment with alternate TNF-α blockers""AUTHOR NAMES","Chang M.B.","Sri J.C.","Driscoll M.","Gaspari A.A.""SOURCE","Journal of Drugs in Dermatology (2011) 10:8 (914-916). Date of Publication: August 2011"

"TITLE","Lymphomatoid drug reaction to ustekinumab""AUTHOR NAMES","Jung J.","Levin E.C.","Jarrett R.","Lu D.","Mann C.""SOURCE","Archives of Dermatology (2011) 147:8 (992-993). Date of Publication: August 2011"

"TITLE","Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience""AUTHOR NAMES","Fortea-Ormaechea J.I.","González-Lama Y.","Casis B.","Chaparro M.","López Serrano P.","Van Domselaar M.","Bermejo F.","Pajares R.","Ponferrada Á.","Vera M.I.","Martínez Montiel P.","Gisbert J.P.","Pérez-Calle J.L.","López San Román A.","Abreu L.","Menchén L.A.","Marn-Jimenez I.""SOURCE","Gastroenterologia y Hepatologia (2011) 34:7 (443-448). Date of Publication: August-September 2011"

"TITLE","Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis""AUTHOR NAMES","Marcella S.","Welsh B.","Foley P.""SOURCE","Australasian Journal of Dermatology (2011) 52:3 (e8-e11). Date of Publication: August 2011"

"TITLE","Acitretin for the treatment of psoriasis: An assessment of national trends""AUTHOR NAMES","Ghasri P.","Yentzer B.A.","Dabade T.S.","Feldman S.R.""SOURCE","Journal of Drugs in Dermatology (2011) 10:8 (873-877). Date of Publication: August 2011"

"TITLE","Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: Subanalysis of the CHAMPION study""AUTHOR NAMES","Saurat J.-H.","Langley R.G.","Reich K.","Unnebrink K.","Sasso E.H.","Kampman W.""SOURCE","British Journal of Dermatology (2011) 165:2 (399-406). Date of Publication: August 2011"

"TITLE","Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance""AUTHOR NAMES","Prignano F.","Ricceri F.","Pescitelli L.","Bonciani D.","Lotti T.""SOURCE","International Journal of Dermatology (2011) 50:8 (999-1001). Date of Publication: August 2011"

"TITLE","Secondary leprosy infection in a patient with psoriasis during treatment with infliximab""AUTHOR NAMES","Teixeira F.M.","Vasconcelos L.M.F.","Rola C.D.A.D.","Prata De Almeida T.L.","Valença J.T.","Nagao-Dias A.T.""SOURCE","Journal of Clinical Rheumatology (2011) 17:5 (269-271). Date of Publication: August 2011"

"TITLE","CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy""AUTHOR NAMES","Yildirim F.E.","Karaduman A.","Pinar A.","Aksoy Y.""SOURCE","International Journal of Dermatology (2011) 50:8 (948-955). Date of Publication: August 2011"

"TITLE","Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies""AUTHOR NAMES","McAleer M.A.","Bourke J.""SOURCE","Clinical and Experimental Dermatology (2011) 36:6 (638-640). Date of Publication: August 2011"

"TITLE","Inflammatory posterior interosseous nerve palsy in a patient with psoriatic arthropathy""AUTHOR NAMES","Ali E.","Colao R.","Gillespie P.","Colao C.B.""SOURCE","Journal of Plastic, Reconstructive and Aesthetic Surgery (2011) 64:8 (e205-e207). Date of Publication: August 2011"

"TITLE","Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis""AUTHOR NAMES","Çapkin E.","Karkucak M.","Yayli S.","Aydin Çapkin A.","Tosun M.""SOURCE","Journal of Clinical Rheumatology (2011) 17:5 (293-294). Date of Publication: August 2011"

"TITLE","Cost utility analysis based on a head-to-head phase 3 trial comparing ustekinumab and etanercept in patients with moderate-to-severe plaque psoriasis: A Canadian perspective""AUTHOR NAMES","Pan F.","Brazier N.C.","Shear N.H.","Jivraj F.","Schenkel B.","Brown R.""SOURCE","Value in Health (2011) 14:5 (652-656). Date of Publication: July-August 2011"

"TITLE","Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts""AUTHOR NAMES","Khraishi M.","MacDonald D.","Rampakakis E.","Vaillancourt J.","Sampalis J.S.""SOURCE","Clinical Rheumatology (2011) 30:7 (877-885). Date of Publication: July 2011"

"TITLE","New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab""AUTHOR NAMES","Van Rappard D.C.","Mooij J.E.","Baeten D.L.P.","Mekkes J.R.""SOURCE","British Journal of Dermatology (2011) 165:1 (194-198). Date of Publication: July 2011"

"TITLE","Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment""AUTHOR NAMES","Renzo L.D.","Saraceno R.","Schipani C.","Rizzo M.","Bianchi A.","Noce A.","Esposito M.","Tiberti S.","Chimenti S.","De Lorenzo A.""SOURCE","Dermatologic Therapy (2011) 24:4 (446-451). Date of Publication: July-August 2011"

"TITLE","Autoimmune-like syndromes during TNF blockade: Does infection have a role?""AUTHOR NAMES","Prinz J.C.""SOURCE","Nature Reviews Rheumatology (2011) 7:7 (429-434). Date of Publication: July 2011"

"TITLE","Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: Results from two phase III clinical trials""AUTHOR NAMES","Guenther L.","Han C.","Szapary P.","Schenkel B.","Poulin Y.","Bourcier M.","Ortonne J.P.","Sofen H.L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:7 (851-857). Date of Publication: July 2011"

"TITLE","Successful treatment of Von Zumbusch generalized pustular psoriasis with cyclosporine after eruption post etanercept injection in a PSO- patient""AUTHOR NAMES","Ephrem G.","Jour G.","Smith B.L.""SOURCE","Journal Medical Libanais (2011) 59:3 (168-169). Date of Publication: July-September 2011"

"TITLE","Gastric bypass surgery improves psoriasis""AUTHOR NAMES","Hossler E.W.","Maroon M.S.","Mowad C.M.""SOURCE","Journal of the American Academy of Dermatology (2011) 65:1 (198-200). Date of Publication: July 2011"

"TITLE","Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways""AUTHOR NAMES","Rácz E.","Prens E.P.","Kurek D.","Kant M.","De Ridder D.","Mourits S.","Baerveldt E.M.","Ozgur Z.","Van Ijcken W.F.J.","Laman J.D.","Staal F.J.","Van Der Fits L.""SOURCE","Journal of Investigative Dermatology (2011) 131:7 (1547-1558). Date of Publication: July 2011"

"TITLE","Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: The REPArE trial""AUTHOR NAMES","Gladman D.D.","Bombardier C.","Thorne C.","Haraoui B.","Khraishi M.","Rahman P.","Bensen W.","Syrotuik J.","Poulin-Costello M.""SOURCE","Journal of Rheumatology (2011) 38:7 (1355-1362). Date of Publication: July 2011"

"TITLE","Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? A case report and review of the literature""AUTHOR NAMES","Haddican M.M.","Koo J.Y.M.""SOURCE","Journal of the American Academy of Dermatology (2011) 65:1 (195-197). Date of Publication: July 2011"

"TITLE","""Paradoxical"" adverse effects caused by anti-tumor necrosis factor-alpha biological drugs: Appearance of psoriasis in a patient treated with infliximab for rheumatoid arthritis"

"AUTHOR NAMES","Satriano R.A.","Abbate G.","Esposito S.","Cassaglia B.","Piccolo V.","Baroni A.""SOURCE","Indian Journal of Dermatology, Venereology and Leprology (2011) 77:4 (536). Date of Publication: July-August 2011"

"TITLE","Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: Report of a case series with 144 patients""AUTHOR NAMES","Sánchez-Moya A.I.","Dauden E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:6 (730-733). Date of Publication: June 2011"

"TITLE","Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension""AUTHOR NAMES","Talamonti M.","Teoli M.","Botti E.","Spallone G.","Chimenti S.","Costanzo A.""SOURCE","Dermatology (2011) 222:3 (250-255). Date of Publication: June 2011"

"TITLE","Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis""AUTHOR NAMES","Martin S.","Feldman S.R.","Augustin M.","Szapary P.","Schenkel B.""SOURCE","Journal of Dermatological Treatment (2011) 22:3 (138-143). Date of Publication: June 2011"

"TITLE","Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors""AUTHOR NAMES","Wilson L.H.","Eliason M.J.","Leiferman K.M.","Hull C.M.","Powell D.L.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:6 (1221-1222). Date of Publication: June 2011"

"TITLE","Letter: A case of generalized guttate psoriasis induced by etanercept with relapse after abatacept""AUTHOR NAMES","Brigant F.","Clavel G.","Chatelain D.","Lok C.","Chaby G.""SOURCE","Dermatology Online Journal (2011) 17:6. Date of Publication: June 2011"

"TITLE","Ustekinumab for severe treatment-resistant psoriasis: A 24-week pilot study in Hong Kong Chinese""AUTHOR NAMES","Loo S.K.F.","Lau K.H.","Ho K.M.""SOURCE","Hong Kong Journal of Dermatology and Venereology (2011) 19:2 (59-64). Date of Publication: Summer 2011"

"TITLE","Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks""AUTHOR NAMES","Gambichler T.","Tigges C.","Scola N.","Weber J.","Skrygan M.","Bechara F.G.","Altmeyer P.","Kreuter A.""SOURCE","British Journal of Dermatology (2011) 164:6 (1383-1386). Date of Publication: June 2011"

"TITLE","Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis""AUTHOR NAMES","Zhou S.Y.","Shu C.","Korth-Bradley J.","Raible D.","Palmisano M.","Wadjula J.","Fatenejad S.","Bjornsson T.""SOURCE","Journal of Clinical Pharmacology (2011) 51:6 (864-875). Date of Publication: June 2011"

"TITLE","A case of psoriatic erythroderma successfully and rapidly treated with infliximab""AUTHOR NAMES","Ueda M.","Tanizaki H.","Kabashima K.","Matsumura Y.","Tanioka M.","Miyachi Y.","Matsui M.""SOURCE","Skin Research (2011) 10:3 (209-213). Date of Publication: June 2011"

"TITLE","Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods""AUTHOR NAMES","Eder L.","Chandran V.","Gladman D.D.""SOURCE","Journal of Rheumatology (2011) 38:6 (1066-1070). Date of Publication: June 2011"

"TITLE","Spondylodiscitis as the only clinical manifestation of the onset of psoriatic spondyloarthritis""AUTHOR NAMES","Bruzzese V.""SOURCE","Reumatismo (2011) 63:1 (38-43). Date of Publication: 2011"

"TITLE","Nail psoriasis: A retrospective study on the effectiveness of systemic treatments (classical and biological therapy)""AUTHOR NAMES","Sánchez-Regaña M.","Sola-Ortigosa J.","Alsina-Gibert M.","Vidal-Fernández M.","Umbert-Millet P.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:5 (579-588). Date of Publication: May 2011"

"TITLE","Weight-based adaptation of TNF-antagonist induction versus maintenance dose""AUTHOR NAMES","Navarini A.A.","Muster M.A.","Kolios A.G.A.","Fritsche P.","Glatz M.","French

L.E.","Trüeb R.M.""SOURCE","Case Reports in Dermatology (2011) 3:2 (124-129). Date of Publication: May-August"

"TITLE","Exacerbation and change of psoriasis morphology in a patient treated with ustekinumab""AUTHOR NAMES","Kerdel F.A.","Valeron-Almazán P.","Vitiello M.","Abuchar A.""SOURCE","Journal of Cutaneous Medicine and Surgery (2011) 15:3 (183-184). Date of Publication: May-June 2011"

"TITLE","Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris""AUTHOR NAMES","Gniadecki R.","Kragballe K.","Dam T.N.","Skov L.""SOURCE","British Journal of Dermatology (2011) 164:5 (1091-1096). Date of Publication: May 2011"

"TITLE","Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis""AUTHOR NAMES","Meyer A.","Chatelus E.","Wendling D.","Berthelot J.-M.","Dernis E.","Houvenagel E.","Morel J.","Richer O.","Schaeverbeke T.","Gottenberg J.-E.","Sibilia J.""SOURCE","Arthritis and Rheumatism (2011) 63:5 (1274-1280). Date of Publication: May 2011"

"TITLE","Dual role of anti-TNF therapy: Enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues""AUTHOR NAMES","Bosè F.","Raeli L.","Garutti C.","Frigerio E.","Cozzi A.","Crimi M.","Caprioli F.","Scavelli R.","Altomare G.","Geginat J.","Abrignani S.","Reali E.""SOURCE","Clinical Immunology (2011) 139:2 (164-176). Date of Publication: May 2011"

"TITLE","CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement""AUTHOR NAMES","Richetta A.G.","Mattozzi C.","Salvi M.","Giancristoforo S.","D'Epiro S.","Milana B.","Carboni V.","Zampetti M.","Calvieri S.","Morrone S.""SOURCE","European Journal of Dermatology (2011) 21:3 (344-348). Date of Publication: May-June 2011"

"TITLE","Comparative effectiveness analysis of tnf blockers in rheumatoid arthritis (RA) patients in a real-world setting""AUTHOR NAMES","Bonafede R.P.","Pearson D.","Babich J.","Chastek B.","Becker L.","Watson C.","Chaudhari S.","Harrison D.J.","Gandra S.R.""SOURCE","Value in Health (2011) 14:3 (A1-A2). Date of Publication: May 2011"

"TITLE","Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: A review""AUTHOR NAMES","Kamili Q.U.A.","Miner A.","Hapa A.","Menter A.""SOURCE","Journal of Drugs in Dermatology (2011) 10:5 (539-544). Date of Publication: May 2011"

"TITLE","Ustekinumab and herpes zoster""AUTHOR NAMES","Failla V.","Nikkels A.F.""SOURCE","Dermatology (2011) 222:2 (119-122). Date of Publication: May 2011"

"TITLE","Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis""AUTHOR NAMES","Lee H.-C.","Tsai T.-F.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:5 (1006-1007). Date of Publication: May 2011"

"TITLE","Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients""AUTHOR NAMES","Fabroni C.","Gori A.","Troiano M.","Prignano F.","Lotti T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:5 (549-553). Date of Publication: May 2011"

"TITLE","Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial""AUTHOR NAMES","Prinz J.C.","Fitzgerald O.","Boggs R.L.","Foehl J.","Robertson D.","Pedersen R.","Molta C.T.","Freundlich B.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:5 (559-564). Date of Publication: May 2011"

"TITLE","Erythrodermic psoriasis complicated by acute respiratory distress syndrome""AUTHOR NAMES","Al-Niaimi F.","Lyon C.C.""SOURCE","European Journal of Dermatology (2011) 21:3 (429-430). Date of Publication: May-June 2011"

"TITLE","Papillary thyroid carcinoma in a patient with severe psoriasis receiving adalimumab""AUTHOR NAMES","Lee J.J.","Mann J.A.","Blauvelt A.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:5 (999-1000). Date of Publication: May 2011"

"TITLE","Introducing the delayed retinoid burn: A case report and discussion of this potential risk of retinoid-phototherapy combination management""AUTHOR NAMES","Busse K.","Koo J.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:5 (1011-1012). Date of Publication: May 2011"

"TITLE","Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.""AUTHOR NAMES","Wu J.J.","Fleming K.F.""SOURCE","Cutis; cutaneous medicine for the practitioner (2011) 87:5 (249-250). Date of Publication: May 2011"

"TITLE","Necrolytic acral erythema""AUTHOR NAMES","Moellering J.R.C.""SOURCE","New England Journal of Medicine (2011) 364:15 (1479-1480). Date of Publication: 14 Apr 2011"

"TITLE","Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients""AUTHOR NAMES","Gambichler T.","Kobus S.","Kobus A.","Tigges C.","Scola N.","Altmeyer P.","Kreuter A.","Bechara F.G.","Skrygan M.""SOURCE","Regulatory Peptides (2011) 167:2-3 (163-166). Date of Publication: 11 Apr 2011"

"TITLE","Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry""AUTHOR NAMES","Salmon-Ceron D.","Tubach F.","Lortholary O.","Chosidow O.","Bretagne S.","Nicolas N.","Cuillerier E.","Fautrel B.","Michelet C.","Morel J.","Puéchal X.","Wendling D.","Lemann M.","Ravaud P.","Mariette X.""SOURCE","Annals of the Rheumatic Diseases (2011) 70:4 (616-623). Date of Publication: April 2011"

"TITLE","Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: A retrospective report of seven patients and brief review of the literature""AUTHOR NAMES","Fotiadou C.","Lazaridou E.","Ioannides D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2011) 25:4 (471-474). Date of Publication: April 2011"

"TITLE","Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: A retrospective analysis of 62 patients with psoriatic disease""AUTHOR NAMES","Cassano N.","Mastrandrea V.","Principi M.","Loconsole F.","De Tullio N.","Di Leo A.","Vena G.A.""SOURCE","Journal of Biological Regulators and Homeostatic Agents (2011) 25:2 (285-289). Date of Publication: April-June 2011"

"TITLE","Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study""AUTHOR NAMES","Strober B.E.","Poulin Y.","Kerdel F.A.","Langley R.G.","Gu Y.","Gupta S.R.","Okun M.M.","Papp K.A.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:4 (671-681). Date of Publication: April 2011"

"TITLE","Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: A case series""AUTHOR NAMES","Bhutani T.","Koo J.""SOURCE","Journal of Dermatological Treatment (2011) 22:2 (75-78). Date of Publication: April 2011"

"TITLE","Iatrogenic alopecia in adult patients treated with anti-tnf alpha therapy. A review of the French Pharmacovigilance database""AUTHOR NAMES","Poggi B.","Taugourdeau S.","Rouby F.","Astoul J.","Jean-Pastor M.""SOURCE","Fundamental and Clinical Pharmacology (2011) 25 SUPPL. 1 (41). Date of Publication: April 2011"

"TITLE","An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab""AUTHOR NAMES","Vender R.""SOURCE","Journal of Drugs in Dermatology (2011) 10:4 (396-402). Date of Publication: April 2011"

"TITLE","Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect""AUTHOR NAMES","Iborra M.","Beltrán B.","Bastida G.","Aguas M.","Nos P.""SOURCE","Journal of Crohn's and Colitis (2011) 5:2 (157-161). Date of Publication: April 2011"

"TITLE","Psoriatic arthritis successfully treated with ustekinumab after anti-TNF-alpha-induced lupus syndrome""AUTHOR NAMES","Lee M.","Haigh R.C.""SOURCE","Rheumatology (2011) 50 SUPPL. 3 (iii48). Date of Publication: April 2011"

"TITLE","Paternal exposure to methotrexate and pregnancy outcomes""AUTHOR NAMES","Beghin D.","Cournot M.-P.","Vauzelle C.","Elefant E.""SOURCE","Journal of Rheumatology (2011) 38:4 (628-632). Date of Publication: April 2011"

"TITLE","Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: A novel cause of noncicatricial alopecia""AUTHOR NAMES","Doyle L.A.","Sperling L.C.","Baksh S.","Lackey J.","Thomas B.","Vleugels R.A.","Qureshi A.A.","Velazquez E.F.""SOURCE","American Journal of Dermatopathology (2011) 33:2 (161-166). Date of Publication: April 2011"

"TITLE","Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: Efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial""AUTHOR NAMES","Leonardi C.","Langley R.G.","Papp K.","Tyring S.K.","Wasel N.","Vender R.","Unnebrink K.","Gupta S.R.","Valdecantos W.C.","Bagel J.""SOURCE","Archives of Dermatology (2011) 147:4 (429-436). Date of Publication: April 2011"

"TITLE","Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma""AUTHOR NAMES","Torii H.","Nakagawa H.""SOURCE","Journal of Dermatology (2011) 38:4 (310-323). Date of Publication: April 2011"

"TITLE","An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab in patients with moderate to severe palmar plantar psoriasis""AUTHOR NAMES","Wang A.C.","Kerensky T.A.","Au S.","Yaniv S.","Michelon M.","Andrews I.","Dumont N.","Gottlieb A.B.""SOURCE","Journal of Investigative Dermatology (2011) 131 SUPPL. 1 (S84). Date of Publication: April 2011"

"TITLE","Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin""AUTHOR NAMES","Meyer V.","Goerge T.","Luger T.A.","Beissert S.""SOURCE","Journal of Clinical and Aesthetic Dermatology (2011) 4:4. Date of Publication: April 2011"

"TITLE","Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis""AUTHOR NAMES","Bagel J.""SOURCE","Journal of Drugs in Dermatology (2011) 10:4 (366-371). Date of Publication: April 2011"

"TITLE","Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma.""AUTHOR NAMES","Torii H.","Nakagawa H.","Japanese Infliximab Study Investigators""SOURCE","The Journal of dermatology (2011) 38:4 (321-334). Date of Publication: Apr 2011"

"TITLE","Exaggerated imiquimod application site reactions in the context of systemic tumor necrosis factor-alpha inhibition: More than a coincidental occurrence?""AUTHOR NAMES","Saggini A.","Saraceno R.","Chimenti S.""SOURCE","International Journal of Immunopathology and Pharmacology (2011) 24:2 (509-515). Date of Publication: April-June 2011"

"TITLE","Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease""AUTHOR NAMES","Mocciaro F.","Orlando A.","Renna S.","Rizzuto M.R.","Cottone M.""SOURCE","Journal of Crohn's and Colitis (2011) 5:2 (173-174). Date of Publication: April 2011"

"TITLE","Cutaneous reactions to adalimumab administration""AUTHOR NAMES","Downes M.R.","Prendiville S.","Kiely C.","Lenane P.","Mulligan N.""SOURCE","Irish Medical Journal (2011) 104:4. Date of Publication: April 2011"

"TITLE","Inverse psoriasis: Case presentation and review""AUTHOR NAMES","Syed Z.U.","Khachemoune A.""SOURCE","American Journal of Clinical Dermatology (2011) 12:2 (143-146). Date of Publication: 2011"

"TITLE","Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan""AUTHOR NAMES","Chiu H.-Y.","Hsueh P.-R.","Tsai T.-F."

"SOURCE","British Journal of Dermatology (2011) 164:3 (553-559). Date of Publication: March 2011"

"TITLE","Frequency of thrombocytopenia in psoriasis patients treated with tumor necrosis factor-α inhibitors""AUTHOR NAMES","Chen M.","Holland M.J.","Mir M.R.","Wong M.G.","Kelley B.P.","Grim K.D.","Bhuchar S.S.","Hsu S.""SOURCE","Journal of Drugs in Dermatology (2011) 10:3 (280-284). Date of Publication: March 2011"

"TITLE","Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: A retrospective analysis of 17 patients""AUTHOR NAMES","Prignano F.","Ricceri F.","Pescitelli L.","Zanieri F.","Lotti T.""SOURCE","British Journal of Dermatology (2011) 164:3 (645-647). Date of Publication: March 2011"

"TITLE","Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: Induction of elevated serum adiponectin levels following therapy""AUTHOR NAMES","Shibata S.","Tada Y.","Hau C.","Tatsuta A.","Yamamoto M.","Kamata M.","Karakawa M.","Asano Y.","Mitsui H.","Sugaya M.","Kadono T.","Saeki H.","Kanda N.","Sato S.""SOURCE","British Journal of Dermatology (2011) 164:3 (667-670). Date of Publication: March 2011"

"TITLE","Moderate to severe psoriasis treated with infliximab - 53 patients: Patients profile, efficacy and adverse effects""AUTHOR NAMES","Duarte A.A.","Chehin F.B.""SOURCE","Anais Brasileiros de Dermatologia (2011) 86:2 (257-263). Date of Publication: Mar./Apr. 2011"

"TITLE","Increased risk of acute myocardial infarction in patients with psoriasis: A 5-year population-based study in Taiwan""AUTHOR NAMES","Lin H.-W.","Wang K.-H.","Lin H.-C.","Lin H.-C.""SOURCE","Journal of the American Academy of Dermatology (2011) 64:3 (495-501). Date of Publication: March 2011"

"TITLE","Influence of infliximab on keratinocyte apoptosis in psoriasis patients""AUTHOR NAMES","Raho G.","Vena G.A.","Bizzoca A.","Cassano N.","Garofalo E.","Congedo M.","Gennarini G.""SOURCE","Immunopharmacology and Immunotoxicology (2011) 33:1 (227-231). Date of Publication: March 2011"

"TITLE","Etanercept treatment for psoriatic disease""AUTHOR NAMES","Schabert V.F.","Harrison D.J.","Globe D.R.","Goodman S.","Burudpakdee C.""SOURCE","American Journal of Pharmacy Benefits (2011) 3:2 (e52-e58). Date of Publication: March/April 2011"

"TITLE","Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes""AUTHOR NAMES","Farrokhi F.","Taylor H.C.","McBride N.M.""SOURCE","Endocrine Practice (2011) 17:2 (306-307). Date of Publication: 1 Mar 2011"

"TITLE","TNF-blocking agents in juvenile psoriatic arthritis: Are they effective?""AUTHOR NAMES","Otten M.H.","Prince F.H.M.","Ten Cate R.","Van Rossum M.A.J.","Twilt M.","Hoppenreijs E.P.A.H.","Koopman-Keemink Y.","Oranje A.P.","De Waard-Van Der Spek F.B.","Gorter S.L.","Armbrust W.","Dolman K.M.","Wulffraat N.M.","Van Suijlekom-Smit L.W.A.""SOURCE","Clinical and Experimental Rheumatology (2011) 29:2 (456). Date of Publication: March-April 2011"

"TITLE","IL-1F5, -F6, -F8, and -F9: A novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression""AUTHOR NAMES","Johnston A.","Xing X.","Guzman A.M.","Riblett M.","Loyd C.M.","Ward N.L.","Wohn C.","Prens E.P.","Wang F.","Maier L.E.","Kang S.","Voorhees J.J.","Elder J.T.","Gudjonsson J.E.""SOURCE","Journal of Immunology (2011) 186:4 (2613-2622). Date of Publication: 15 Feb 2011"

"TITLE","Tolerability and safety of biological therapies for psoriasis in daily clinical practice: A study of 103 Italian patients""AUTHOR NAMES","Brunasso A.M.G.","Puntoni M.","Salvini C.","Delfino C.","Curcic P.","Gulia A.","Massone C.""SOURCE","Acta Dermato-Venereologica (2011) 91:1 (44-49). Date of Publication: 2011"

"TITLE","Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab""AUTHOR NAMES","Taxonera C.","Estellés J.","Fernández-Blanco I.","Merino O.","Marín-Jiménez I.","Barreiro-De Acosta M.","Saro C.","García-Sánchez V.","Gento E.","Bastida G.","Gisbert J.P.","Vera I.","Martinez-Montiel P.","Garcia-Morán S.","Sánchez M.C.","Mendoza J.L."

"SOURCE","Alimentary Pharmacology and Therapeutics (2011) 33:3 (340-348). Date of Publication: February 2011"

"TITLE","Infliximab-induced psoriasis in children with inflammatory bowel disease""AUTHOR NAMES","Hiremath G.","Duffy L.","Leibowitz I.""SOURCE","Journal of Pediatric Gastroenterology and Nutrition (2011) 52:2 (230-232). Date of Publication: February 2011"

"TITLE","Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: Are they effective?""AUTHOR NAMES","Otten M.H.","Prince F.H.M.","Ten Cate R.","Van Rossum M.A.J.","Twilt M.","Hoppenreijs E.P.A.H.","Koopman-Keemink Y.","Oranje A.P.","De Waard-van Der Spek F.B.","Gorter S.L.","Armbrust W.","Dolman K.M.","Wulffraat N.M.","Van Suijlekom-Smit L.W.A.""SOURCE","Annals of the Rheumatic Diseases (2011) 70:2 (337-340). Date of Publication: February 2011"

"TITLE","Adalimumab for moderate to severe chronic plaque psoriasis: Efficacy and safety of retreatment and disease recurrence following withdrawal from therapy""AUTHOR NAMES","Papp K.","Crowley J.","Ortonne J.-P.","Leu J.","Okun M.","Gupta S.R.","Gu Y.","Langley R.G.""SOURCE","British Journal of Dermatology (2011) 164:2 (434-441). Date of Publication: February 2011"

"TITLE","Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose ""escalation"" in patients losing response""AUTHOR NAMES","Chaparro M.","Panes J.","García V.","Mañosa M.","Esteve M.","Merino O.","Andreu M.","Gutierrez A.","Gomollón F.","Cabriada J.L.","Montoro M.A.","Mendoza J.L.","Nos P.","Gisbert J.P.""SOURCE","Journal of Clinical Gastroenterology (2011) 45:2 (113-118). Date of Publication: February 2011"

"TITLE","Resolved psoriasis lesions retain expression of a subset of disease-related genes""AUTHOR NAMES","Suárez-Farĩas M.","Fuentes-Duculan J.","Lowes M.A.","Krueger J.G.""SOURCE","Journal of Investigative Dermatology (2011) 131:2 (391-400). Date of Publication: February 2011"

"TITLE","Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis: Do bone resorption marker levels predict outcome of bone destruction in psoriatic arthritis?""AUTHOR NAMES","Taniguchi Y.","Kumon Y.","Shimamura Y.","Kobayashi S.","Terada Y.""SOURCE","Modern Rheumatology (2011) 21:1 (106-108). Date of Publication: February 2011"

"TITLE","Serum sepsis, not sickness""AUTHOR NAMES","Guidry M.M.","Drennan R.H.","Weise J.","Hamm L.L.""SOURCE","American Journal of the Medical Sciences (2011) 341:2 (88-91). Date of Publication: February 2011"

"TITLE","Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors""AUTHOR NAMES","Solomon A.J.","Spain R.I.","Kruer M.C.","Bourdette D.""SOURCE","Multiple Sclerosis Journal (2011) 17:12 (1472-1487). Date of Publication: December 2011"

"TITLE","Adverse reactions during biological drug therapy in psoriasis: Clinical series and a review of the literature""AUTHOR NAMES","Montesu M.A.","Addis G.M.","Satta R.","Cottoni F.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2011) 146:4 (273-281). Date of Publication: August 2011"

"TITLE","Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis""AUTHOR NAMES","Cummins E.","Asseburg C.","Punekar Y.S.","Shore E.","Morris J.","Briggs A.","Fenwick E.""SOURCE","Value in Health (2011) 14:1 (15-23). Date of Publication: January-February 2011"

"TITLE","A global approach to psoriatic patients through PASI score and Skindex-29""AUTHOR NAMES","Prignano F.","Ruffo G.","Ricceri F.","Pescitelli L.","Lotti T.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2011) 146:1 (47-52). Date of Publication: February 2011"

"TITLE","Childhood psoriasis: Analytic retrospective study in Saudi patients""AUTHOR NAMES","Alsuwaidan S.N.""SOURCE","Journal of the Saudi Society of Dermatology and Dermatologic Surgery (2011) 15:2 (57-61). Date of Publication: July 2011"

"TITLE","Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia"

"AUTHOR NAMES","Balato A.","Lembo S.","Cirillo T.","Megna M.","Raimondo A.","Di Costanzo L.""SOURCE","Case Reports in Dermatology (2011) 3:1 (60-63). Date of Publication: January-April 2011"

"TITLE","Clinical applicability of T-cell interferon-α release assay for tumour necrosis factor-α inhibitor therapy in severe psoriasis""AUTHOR NAMES","Chiang Y.Z.","Panting K.","Dever B.","Parslew R.A.G.""SOURCE","Clinical and Experimental Dermatology (2011) 36:1 (39-41). Date of Publication: January 2011"

"TITLE","Pustular psoriasis development after initial ustekinumab administration""AUTHOR NAMES","Gregoriou S.","Kazakos C.","Christofidou E.","Kontochristopoulos G.","Vakis G.","Rigopoulos D.""SOURCE","European Journal of Dermatology (2011) 21:1 (104-105). Date of Publication: January-February 2011"

"TITLE","Treatment of severe nail psoriasis with etanercept""AUTHOR NAMES","Coelho J.D.","Diamantino F.","Lestre S.","Ferreira A.M.""SOURCE","Indian Journal of Dermatology, Venereology and Leprology (2011) 77:1 (72-74). Date of Publication: January-February 2011"

"TITLE","Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial""AUTHOR NAMES","Kimball A.B.","Bensimon A.G.","Guerin A.","Yu A.P.","Wu E.Q.","Okun M.M.","Bao Y.","Gupta S.R.","Mulani P.M.""SOURCE","American Journal of Clinical Dermatology (2011) 12:1 (51-62). Date of Publication: 2011"

"TITLE","Modulation of toll-like receptors in psoriatic patients during therapy with adalimumab""AUTHOR NAMES","De Pità O.","Nardis C.","Lupi F.","Luci C.A.","Frezzolini A.","Pallotta S.""SOURCE","International Journal of Immunopathology and Pharmacology (2011) 24:1 (185-188). Date of Publication: January-March 2011"

"TITLE","Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage""AUTHOR NAMES","Gambichler T.","Tigges C.","Dith A.","Skrygan M.","Scola N.","Altmeyer P.","Kreuter A.""SOURCE","British Journal of Dermatology (2011) 164:1 (110-115). Date of Publication: January 2011"

"TITLE","Clinical, power Doppler sonography and histological assessment of the psoriatic plaque: Short-term monitoring in patients treated with etanercept""AUTHOR NAMES","Gutierrez M.","De Angelis R.","Bernardini M.L.","Filippucci E.","Goteri G.","Brandozzi G.","Lemme G.","Campanati A.","Grassi W.","Offidani A.""SOURCE","British Journal of Dermatology (2011) 164:1 (33-37). Date of Publication: January 2011"

"TITLE","Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): Case report and review of the literature""AUTHOR NAMES","Cuchacovich R.","Hagan J.","Khan T.","Richert A.","Espinoza L.R.""SOURCE","Clinical Rheumatology (2011) 30:1 (133-137). Date of Publication: January 2011"

"TITLE","Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: Role of immunosuppressants""AUTHOR NAMES","Quéreux G.","Renaut J.-J.","Peuvrel L.","Knol A.-C.","Brocard A.","Dréno B.""SOURCE","Acta Dermato-Venereologica (2010) 90:6 (616-620). Date of Publication: 2010"

"TITLE","Efficacy of ustekinumab in palmoplantar psoriasis""AUTHOR NAMES","Livideanu C.B.","Lahfa M.","Mazereeuw-Hautier J.","Paul C.""SOURCE","Dermatology (2010) 221:4 (321-323). Date of Publication: December 2010"

"TITLE","A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review""AUTHOR NAMES","Saougou I.","Papagoras C.","Markatseli T.E.","Voulgari P.V.","Drosos A.A.""SOURCE","Clinical Rheumatology (2010) 29:12 (1455-1459). Date of Publication: December 2010"

"TITLE","Reactivation of cutaneous psoriasis during abatacept therapy for spondyloarthropathy""AUTHOR NAMES","Florent A.","Albert C.","Giacchero D.","Roux C.","Euller-Ziegler L.""SOURCE","Joint Bone Spine (2010) 77:6 (626-627). Date of Publication: December 2010"

"TITLE","Analysis of efficacy and safety of therapy with TNF-α inhibitors in psoriasis vulgaris and psoriatic artritis""AUTHOR NAMES","Lesiak A.","Olejniczak I.","Sysa-Jȩdrzejowska A.","Zalewska-Janowska A.","Narbutt J."

"SOURCE","Dermatologia Kliniczna (2010) 12:4 (245-250). Date of Publication: 2010"

"TITLE","Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: Description of 3 cases and review of the literature""AUTHOR NAMES","Mourão A.F.","Rustin M.","Isenberg D.""SOURCE","Clinical and Experimental Rheumatology (2010) 28:3 (408-410). Date of Publication: 2010"

"TITLE","Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy""AUTHOR NAMES","Arenbergerova M.","Gkalpakiotis S.","Arenberger P.""SOURCE","International Journal of Dermatology (2010) 49:12 (1445-1449). Date of Publication: December 2010"

"TITLE","Claims data analysis of dosing and cost of TNF antagonists""AUTHOR NAMES","Gu N.Y.","Huang X.-Y.","Fox K.M.","Patel V.D.","Baumgartner S.W.","Chiou C.-F.""SOURCE","American Journal of Pharmacy Benefits (2010) 2:6 (351-359). Date of Publication: 2010"

"TITLE","Ustekinumab: Effective in a patient with severe recalcitrant generalized pustular psoriasis""AUTHOR NAMES","Daudén E.","Santiago-Et-Sánchez-Mateos D.","Sotomayor-López E.","García-Díez A.""SOURCE","British Journal of Dermatology (2010) 163:6 (1346-1347). Date of Publication: December 2010"

"TITLE","Infliximab for refractory ulcerative proctitis""AUTHOR NAMES","Peyrin-Biroulet L.""SOURCE","Practical Gastroenterology (2010) 34:12 (28-35). Date of Publication: December 2010"

"TITLE","Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy""AUTHOR NAMES","Rahier J.","Buche S.","Peyrin-Biroulet L.","Bouhnik Y.","Duclos B.","Louis E.","Papay P.","Allez M.","Cosnes J.","Cortot A.","Laharie D.","Reimund J.","Lémann M.","Delaporte E.","Colombel J.""SOURCE","Clinical Gastroenterology and Hepatology (2010) 8:12 (1048-1055). Date of Publication: December 2010"

"TITLE","Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists""AUTHOR NAMES","Brulhart L.","Nissen M.J.","Chevallier P.","Gabay C.""SOURCE","Joint Bone Spine (2010) 77:6 (625-626). Date of Publication: December 2010"

"TITLE","Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab""AUTHOR NAMES","Korsten P.","Sweiss N.J.","Nagorsnik U.","Niewold T.B.","Grne H.-J.","Gross O.","Mller G.A.""SOURCE","American Journal of Kidney Diseases (2010) 56:6 (e17-e21). Date of Publication: December 2010"

"TITLE","Sequential treatment with biologics: Switching from efalizumab to etanercept in 35 patients with high-need psoriasis""AUTHOR NAMES","Antoniou C.","Dessinioti C.","Vergou T.","Stratigos A.J.","Avgerinou G.","Kostaki M.","Katsambas A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2010) 24:12 (1413-1420). Date of Publication: December 2010"

"TITLE","Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event-free response days in the CHAMPION trial""AUTHOR NAMES","Reich K.","Signorovitch J.","Ramakrishnan K.","Yu A.P.","Wu E.Q.","Gupta S.R.","Bao Y.","Mulani P.M.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:6 (1011-1018). Date of Publication: December 2010"

"TITLE","Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy""AUTHOR NAMES","Johansen C.","Vinter H.","Soegaard-Madsen L.","Olsen L.R.","Steiniche T.","Iversen L.","Kragballe K.""SOURCE","British Journal of Dermatology (2010) 163:6 (1194-1204). Date of Publication: December 2010"

"TITLE","Mycobacterium marinum infection after infliximab therapy""AUTHOR NAMES","Alkhawaja S.","Tammam N.","Khalifa N.""SOURCE","Iranian Journal of Allergy, Asthma and Immunology (2010) 9:4 (255-257). Date of Publication: December 2010"

"TITLE","Drug-induced lichenoid dermatitis with histopathologic features of mycosis fungoides in a patient with psoriasis""AUTHOR NAMES","Wu J.","Vender R.","Jambrosic J.""SOURCE","Journal of Cutaneous Medicine and Surgery (2010) 14:6 (307-309). Date of Publication: December 2010"

"TITLE","A case of generalized psoriasiform and pustular eruption induced by infliximab: Evidence for skin-homing Th17 in the pathogenesis""AUTHOR NAMES","Teraki Y.","Tanaka S.","Hitomi K.","Izaki S.""SOURCE","British Journal of Dermatology (2010) 163:6 (1347-1351). Date of Publication: December 2010"

"TITLE","Clinical images: Multi-modality imaging monitoring of anti-tumor necrosis factor α treatment at the joint and skin level in psoriatic arthritis""AUTHOR NAMES","Gutierrez M.","De Angelis R.","Bertolazzi C.","Filippucci E.","Grassi W.","Filosa G.""SOURCE","Arthritis Care and Research (2010) 62:12 (3829). Date of Publication: December 2010"

"TITLE","Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis""AUTHOR NAMES","Zhu Y.W.","Mendelsohn A.","Pendley C.","Davis H.M.","Zhou H.""SOURCE","International Journal of Clinical Pharmacology and Therapeutics (2010) 48:12 (830-846). Date of Publication: December 2010"

"TITLE","Clinical images: Multi-modality imaging monitoring of anti-tumor necrosis factor α treatment at the joint and skin level in psoriatic arthritis""AUTHOR NAMES","Gutierrez M.","De Angelis R.","Bertolazzi C.","Filippucci E.","Grassi W.","Filosa G.""SOURCE","Arthritis and Rheumatism (2010) 62:12 (3829). Date of Publication: December 2010"

"TITLE","The efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of an open-labeled multicenter study""AUTHOR NAMES","Bunchuk N.V.","Rumyantseva O.A.","Loginova E.Yu.","Bochkova A.G.","Storozhakov G.I.","Ettinger O.A.","Kosyura S.D.","Kamalovo R.G.","Valishina L.M.""SOURCE","Terapevticheskii Arkhiv (2010) 82:10 (41-46). Date of Publication: 2010"

"TITLE","Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis""AUTHOR NAMES","Alabed I.B.","Qushmaq K.A.","Khan M.A.""SOURCE","Saudi Medical Journal (2010) 31:9 (1054-1056). Date of Publication: 2010"

"TITLE","Pharmacoeconomics of innovative medicines for treatment of psoriasis in Ukraine""AUTHOR NAMES","Zalis'ka O.","Mandrik O.""SOURCE","Value in Health (2010) 13:7 (A400). Date of Publication: November 2010"

"TITLE","Adalimumab for Crohns disease in clinical practice at Mayo clinic: The first 118 patients""AUTHOR NAMES","Swoger J.M.","Loftus Jr. E.V.","Tremaine W.J.","Faubion W.A.","Pardi D.S.","Kane S.V.","Hanson K.A.","Harmsen W.S.","Zinsmeister A.R.","Sandborn W.J.""SOURCE","Inflammatory Bowel Diseases (2010) 16:11 (1912-1921). Date of Publication: November 2010"

"TITLE","Ustekinumab for rapid treatment of nail psoriasis""AUTHOR NAMES","Rallis E.","Kintzoglou S.","Verros C.""SOURCE","Archives of Dermatology (2010) 146:11 (1315-1316). Date of Publication: November 2010"

"TITLE","Ustekinumab in the treatment of palmoplantar pustulosis""AUTHOR NAMES","Gerdes S.","Franke J.","Domm S.","Mrowietz U.""SOURCE","British Journal of Dermatology (2010) 163:5 (1116-1118). Date of Publication: November 2010"

"TITLE","The role of endothelial cell apoptosis in the effect of etanercept in psoriasis""AUTHOR NAMES","Avramidis G.","Krüger-Krasagakis S.","Krasagakis K.","Fragiadaki I.","Kokolakis G.","Tosca A.""SOURCE","British Journal of Dermatology (2010) 163:5 (928-934). Date of Publication: November 2010"

"TITLE","Efficacy and safety of etanercept in patients with psoriasis and hepatitis C""AUTHOR NAMES","Ventura F.","Gomes J.","Duarte M.D.L.","Fernandes J.C.","Brito C.""SOURCE","European Journal of Dermatology (2010) 20:6 (808-809). Date of Publication: November-December 2010"

"TITLE","ISMP adverse drug reactions - Severe rhabdomyolysis during sunitinib therapy - Meropenem-induced vanishing bile duct syndrome - Infliximab-induced lichen planopilaris - Papulopustular eruption associated with panitumumab - Serotonin syndrome with sertraline and

indomethacin - Review: Heparin-induced thrombocytopenia - Review: Amiodarone and thyroid dysfunction""AUTHOR NAMES","Shuster J.""SOURCE","Hospital Pharmacy (2010) 45:11 (822-827). Date of Publication: 1 Nov 2010"

"TITLE","Transient paresis of the right recurrent laryngeal nerve after treatment with etanercept for plaque-type psoriasis""AUTHOR NAMES","Fiala K.","Schierl M.","Breier F.","Feldmann R.","Sator P.G.""SOURCE","European Journal of Dermatology (2010) 20:6 (818-819). Date of Publication: November-December 2010"

"TITLE","[A case of psoriasis induced by infliximab treatment for Crohn's disease].""AUTHOR NAMES","Jwa Y.J.","Kim N.H.","Park H.J.","Park J.S.","Bae W.K.","Kim K.A.","Lee J.S.","Moon Y.S.""SOURCE","The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2010) 56:5 (324-328). Date of Publication: Nov 2010"

"TITLE","Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis""AUTHOR NAMES","Hueber W.","Patel D.D.","Dryja T.","Wright A.M.","Koroleva I.","Bruin G.","Antoni C.","Draelos Z.","Gold M.H.","Durez P.","Tak P.P.","Gomez-Reino J.J.","Foster C.S.","Kim R.Y.","Samson C.M.","Falk N.S.","Chu D.S.","Callanan D.","Nguyen Q.D.","Rose K.","Haider A.","Di Padova F.""SOURCE","Science Translational Medicine (2010) 2:52 Article Number: 52ra72. Date of Publication: 6 Oct 2010"

"TITLE","Adalimumab for psoriasis: Practical experience in a U.K. tertiary referral centre""AUTHOR NAMES","Warren R.B.","Brown B.C.","Lavery D.","Griffiths C.E.M.""SOURCE","British Journal of Dermatology (2010) 163:4 (859-862). Date of Publication: October 2010"

"TITLE","Cost-effectiveness of biological therapy in remission induction of moderate to severe plaque psoriasis""AUTHOR NAMES","Schmitt-Rau K.","Rosenbach T.","Radtke M.A.","Augustin M.""SOURCE","Dermatology (2010) 221:3 (236-242). Date of Publication: October 2010"

"TITLE","A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis""AUTHOR NAMES","Fonia A.","Jackson K.","Lereun C.","Grant D.M.","Barker J.N.W.N.","Smith C.H.""SOURCE","British Journal of Dermatology (2010) 163:4 (807-816). Date of Publication: October 2010"

"TITLE","Switching from etanercept to adalimumab is effective and safe: Results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept""AUTHOR NAMES","Van Lümig P.P.M.","Lecluse L.L.A.","Driessen R.J.B.","Spuls P.I.","Boezeman J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2010) 163:4 (838-846). Date of Publication: October 2010"

"TITLE","Cutaneous lupus erthyematosus and anti-TNF-α therapy: A case report with review of the literature""AUTHOR NAMES","Levine D.","Switlyk S.A.","Gottlieb A.""SOURCE","Journal of Drugs in Dermatology (2010) 9:10 (1283-1287). Date of Publication: October 2010"

"TITLE","Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations""AUTHOR NAMES","Lebwohl M.","Yeilding N.","Szapary P.","Wang Y.","Li S.","Zhu Y.","Reich K.","Langley R.G.","Papp K.A.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:4 (571-579). Date of Publication: October 2010"

"TITLE","Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report""AUTHOR NAMES","Caramaschi P.","Ravagnani V.","Bambara L.M.","Biasi D.""SOURCE","Joint Bone Spine (2010) 77:5 (484-485). Date of Publication: October 2010"

"TITLE","Infliximab treatment in two Chinese patients with psoriatic arthritis""AUTHOR NAMES","Xie X.","Chen J.-W.","Li F.","Tian J.","Gao J.-S.","Zhang D.""SOURCE","Journal of Zhejiang University: Science B (2010) 11:10 (779-782). Date of Publication: October 2010"

"TITLE","Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis""AUTHOR NAMES","Gottlieb A.","Feng J.","Harrison D.J.","Globe D.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:4 (580-586). Date of

Publication: October 2010"

"TITLE","Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: A randomized, placebo-controlled, phase II trial""AUTHOR NAMES","Kavanaugh A.","Menter A.","Mendelsohn A.","Shen Y.-K.","Lee S.","Gottlieb A.B.""SOURCE","Current Medical Research and Opinion (2010) 26:10 (2385-2392). Date of Publication: October 2010"

"TITLE","Infliximab-Induced Psoriaform Rash""AUTHOR NAMES","Goldstein J.","Levine J.""SOURCE","Clinical Gastroenterology and Hepatology (2010) 8:10 (A24). Date of Publication: October 2010"

"TITLE","Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis""AUTHOR NAMES","Vergou T.","Moustou A.E.","Stratigos A.J.","Katsambas A.","Antoniou C.","Maniateas A.","Vergou T.""SOURCE","International Journal of Dermatology (2010) 49:10 (1215-1217). Date of Publication: October 2010"

"TITLE","A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: A case report and literature review""AUTHOR NAMES","Gattu S.","Becker E.M.","Koo J.Y.M.""SOURCE","Journal of Drugs in Dermatology (2010) 9:10 (1277-1281). Date of Publication: October 2010"

"TITLE","Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy""AUTHOR NAMES","Słowińska M.","Kardynal A.","Warszawik O.","Czuwara J.","Rudnicka L.""SOURCE","Journal of Dermatological Case Reports (2010) 4:1 (15-17). Date of Publication: 2010"

"TITLE","Ustekinumab - Fully human IgG(1κ) monoclonal antibody for the treatment of moderate to severe plaque psoriasis in adults""AUTHOR NAMES","Sýkora J.""SOURCE","Farmaceuticky Obzor (2010) 79:7 (189-194). Date of Publication: 2010"

"TITLE","Neurological adverse events associated with anti-tumor necrosis factor alpha treatment""AUTHOR NAMES","Tristano A.G.""SOURCE","Journal of Neurology (2010) 257:9 (1421-1431). Date of Publication: September 2010"

"TITLE","Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: A literature review and potential mechanisms of action""AUTHOR NAMES","Carroll M.B.","Forgione M.A.""SOURCE","Clinical Rheumatology (2010) 29:9 (1021-1029). Date of Publication: September 2010"

"TITLE","Superimposed linear psoriasis unmasked by therapy with adalimumab""AUTHOR NAMES","Arnold A.W.","Happle R.","Itin P.H.""SOURCE","European Journal of Dermatology (2010) 20:5 (573-574). Date of Publication: September-October 2010"

"TITLE","Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: Effectiveness and safety results from an open-label study""AUTHOR NAMES","Gladman D.D.","Sampalis J.S.","Illouz O.","Guérette B.""SOURCE","Journal of Rheumatology (2010) 37:9 (1898-1906). Date of Publication: September 2010"

"TITLE","Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis""AUTHOR NAMES","Menter A.","Gordon K.B.","Leonardi C.L.","Gu Y.","Goldblum O.M.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:3 (448-456). Date of Publication: September 2010"

"TITLE","Infliximab-induced lichen planopilaris""AUTHOR NAMES","Fernández-Torres R.","Paradela S.","Valbuena L.","Fonseca E.""SOURCE","Annals of Pharmacotherapy (2010) 44:9 (1501-1503). Date of Publication: September 2010"

"TITLE","Treatment of pityriasis rubra pilaris with ustekinumab""AUTHOR NAMES","Wohlrab J.","Kreft B.""SOURCE","British Journal of Dermatology (2010) 163:3 (655-656). Date of Publication: September 2010"

"TITLE","Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes""AUTHOR NAMES","Tatlican S.","Arikok A.","Gulbahar O.","Eren C.","Cevirgen B.","Eskioglu F.""SOURCE","Journal of Dermatological Treatment (2010) 21:5 (306-310). Date of Publication:

September 2010"

"TITLE","Undifferentiated seronegative spondyloarthritis with inflammatory bowel disease and a family history of psoriasis. Sicca syndrome""AUTHOR NAMES","Marigliano N.","Galasso D.""SOURCE","Italian Journal of Medicine (2010) 4:3 (189-191). Date of Publication: September 2010"

"TITLE","Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report""AUTHOR NAMES","Baglieri F.","Scuderi G.""SOURCE","Dermatologic Therapy (2010) 23:5 (541-543). Date of Publication: September-October 2010"

"TITLE","Nail lichen planus: Successful treatment with etanercept""AUTHOR NAMES","Irla N.","Schneiter T.","Haneke E.","Yawalkar N.""SOURCE","Case Reports in Dermatology (2010) 2:3 (173-176). Date of Publication: September-December 2010"

"TITLE","Clinical management of psoriatic arthritis in Spain: The Calipso study""AUTHOR NAMES","López-Estebaranz J.L.","Zarco-Montejo P.","Escalas-Taberner J.","García-Rodríguez M.","García-Llorente J.F.","García-Calvo C.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:7 (629-636). Date of Publication: September 2010"

"TITLE","Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.""AUTHOR NAMES","Izzi S.","Francesconi F.","Visca P.","Altieri A.","De Mutiis C.","Trevisan G.","Bonifati C.""SOURCE","Dermatology online journal (2010) 16:5 (16). Date of Publication: 2010"

"TITLE","Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept""AUTHOR NAMES","Bissonnette R.","Bolduc C.","Poulin Y.","Guenther L.","Lynde C.W.","Maari C.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:2 (228-234). Date of Publication: 2010"

"TITLE","Autoimmune hepatitis in two psoriasis patients treated with inflixmab""AUTHOR NAMES","Goujon C.","Dahel K.","Bérard F.","Guillot I.","Gunera-Saad N.","Nicolas J.-F.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:2 (e43-e44). Date of Publication: 2010"

"TITLE","Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: Case series and literature overview""AUTHOR NAMES","Sarpel T.","Başaran S.","Akçam F.D.","Günaşti S.","Denli Y.""SOURCE","Turkish Journal of Rheumatology (2010) 25:2 (91-94). Date of Publication: 2010"

"TITLE","Thinking inside the box""AUTHOR NAMES","Jessel P.","Safdar N.","McCune W.J.","Saint S.","Kaul D.R.""SOURCE","New England Journal of Medicine (2010) 363:6 (574-579). Date of Publication: 5 Aug 2010"

"TITLE","The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab""AUTHOR NAMES","Papoutsaki M.","Talamonti M.","Giunta A.","Costanzo A.","Ruzzetti M.","Teoli M.","Chimenti S.""SOURCE","Dermatology (2010) 221:SUPPL. 1 (43-47). Date of Publication: August 2010"

"TITLE","Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis""AUTHOR NAMES","DiBonaventura M.D.","Wagner S.","Waters H.C.","Carter C.""SOURCE","Journal of Drugs in Dermatology (2010) 9:8 (938-944). Date of Publication: August 2010"

"TITLE","Tumor necrosis factor-α blockers in SAPHO syndrome""AUTHOR NAMES","Abdelghani K.B.","Dran D.G.","Gottenberg J.-E.","Morel J.","Sibilia J.","Combe B.""SOURCE","Journal of Rheumatology (2010) 37:8 (1699-1704). Date of Publication: August 2010"

"TITLE","Anti-TNF-α treatment: A possible promoter in endogenous uveitis observational report on six patients: Occurrence of uveitis following etanercept treatment""AUTHOR NAMES","Kakkassery V.","Mergler S.","Pleyer U.""SOURCE","Current Eye Research (2010) 35:8 (751-756). Date of Publication: August 2010"

"TITLE","A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment

in patients with moderate to severe psoriasis: The BELIEVE study""AUTHOR NAMES","Thaçi D.","Ortonne J.-P.","Chimenti S.","Ghislain P.-D.","Arenberger P.","Kragballe K.","Saurat J.-H.","Khemis A.","Sprøgel P.","Esslinger H.-U.","Unnebrink K.","Kupper H.""SOURCE","British Journal of Dermatology (2010) 163:2 (402-411). Date of Publication: August 2010"

"TITLE","Long-term safety and efficacy of etanercept in patients with psoriasis: An open-label study""AUTHOR NAMES","Leonardi C.","Strober B.","Gottlieb A.B.","Elewski B.E.","Ortonne J.-P.","Van De Kerkhof P.","Chiou C.-F.","Dunn M.","Jahreis A.""SOURCE","Journal of Drugs in Dermatology (2010) 9:8 (928-937). Date of Publication: August 2010"

"TITLE","Anti-infliximab antibody status and its relation to clinical response in psoriatic patients: A pilot study""AUTHOR NAMES","Adişen E.","Aral A.","Aybay C.","Gürer M.A.""SOURCE","Journal of Dermatology (2010) 37:8 (708-713). Date of Publication: August 2010"

"TITLE","Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: A retrospective analysis of the EXPRESS trial""AUTHOR NAMES","Reich K.","Ortonne J.-P.","Kerkmann U.","Wang Y.","Saurat J.-H.","Papp K.","Langley R.","Griffiths C.E.M.""SOURCE","Dermatology (2010) 221:2 (172-178). Date of Publication: August 2010"

"TITLE","Greater refill adherence to adalimumab therapy for patients using specialty versus retail pharmacies""AUTHOR NAMES","Liu Y.","Yang M.","Chao J.","Mulani P.M.""SOURCE","Advances in Therapy (2010) 27:8 (523-532). Date of Publication: August 2010"

"TITLE","Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment""AUTHOR NAMES","de Groot M.","Teunissen M.B.","Picavet D.I.","de Rie M.A.","Bos J.D.""SOURCE","Experimental Dermatology (2010) 19:8 (754-756). Date of Publication: August 2010"

"TITLE","Borreliosis mimicking lupus-like syndrome during infliximab treatment""AUTHOR NAMES","Molin S.","Ruzicka T.","Prinz J.C.""SOURCE","Clinical and Experimental Dermatology (2010) 35:6 (631-633). Date of Publication: August 2010"

"TITLE","Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis""AUTHOR NAMES","Prestinari F.","Ferguglia G.","Laria G.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (57-58). Date of Publication: 2010"

"TITLE","Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis""AUTHOR NAMES","Huo R.","Romanelli P.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (39-40). Date of Publication: 2010"

"TITLE","Beneficial neurological effects observed in a patient with psoriasis treated with Etanercept""AUTHOR NAMES","Bassi E.","De Filippi C.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (44-45). Date of Publication: 2010"

"TITLE","Onset of lichen planus during treatment with etanercept""AUTHOR NAMES","Musumeci M.L.","Lacarrubba F.","Micali G.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (55-56). Date of Publication: 2010"

"TITLE","A case of severe psoriasis with an apparent incomplete response to anti-tumour necrosis factor alpha treatment""AUTHOR NAMES","Agnusdei C.P.","Mastronardi C.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (41-43). Date of Publication: 2010"

"TITLE","Etanercept therapy for psoriasis in a patient with numerous comorbidities""AUTHOR NAMES","De Simone C.","Carbone A.","Caldarola G.""SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (49-50). Date of Publication: 2010"

"TITLE","A case of dystrophic Epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis""AUTHOR NAMES","Gubinelli E.","Angelo C.","Pacifico V."

"SOURCE","American Journal of Clinical Dermatology (2010) 11:SUPPL. 1 (53-54). Date of Publication: 2010"

"TITLE","Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist anakinra: Lack of correlation with IL1RN mutations""AUTHOR NAMES","Viguier M.","Guigue P.","Pagès C.","Smahi A.","Bachelez H.""SOURCE","Annals of Internal Medicine (2010) 153:1 (66-67). Date of Publication: 6 Jul 2010"

"TITLE","Ustekinumab in the treatment of severe rupioid psoriasis: A case report""AUTHOR NAMES","Nečas M.","Vašků V.""SOURCE","Acta Dermatovenerologica Alpina, Pannonica et Adriatica (2010) 19:2 (23-27). Date of Publication: July 2010"

"TITLE","Etanercept therapy in patients with psoriasis and concomitant HCV infection""AUTHOR NAMES","Garavaglia M.C.","Altomare G.""SOURCE","International Journal of Immunopathology and Pharmacology (2010) 23:3 (965-969). Date of Publication: July-September 2010"

"TITLE","Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept""AUTHOR NAMES","Cusano F.","Iannazzone S.S.","Riccio G.","Piccirillo F.""SOURCE","European Journal of Dermatology (2010) 20:4 (520). Date of Publication: July-August 2010"

"TITLE","Pityriasis rubra pilaris of the adult type i resolved after monotherapy with ustekinumab""AUTHOR NAMES","Bellutti M.","Bonnekoh B.","Gollnick H.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2010) 24 SUPPL. 4 (72). Date of Publication: July 2010"

"TITLE","Generalized pustular psoriasis in childhood""AUTHOR NAMES","De Oliveira S.T.","Maragno L.","Arnone M.","Takahashi M.D.F.","Romiti R.""SOURCE","Pediatric Dermatology (2010) 27:4 (349-354). Date of Publication: July-August 2010"

"TITLE","Successful treatment of hand and foot psoriasis with infliximab""AUTHOR NAMES","Di Lernia V.","Guareschi E.""SOURCE","Dermatology Online Journal (2010) 16:7. Date of Publication: July 2010"

"TITLE","Bell's palsy during etanercept treatment caused by neuroborreliosis""AUTHOR NAMES","Molin S.","Ruzicka T.","Prinz J.C.""SOURCE","British Journal of Dermatology (2010) 163:1 (228-230). Date of Publication: July 2010"

"TITLE","Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab""AUTHOR NAMES","Ursini F.","Naty S.","Mazzei V.","Spagnolo F.","Grembiale R.D.""SOURCE","International Immunopharmacology (2010) 10:7 (827-828). Date of Publication: July 2010"

"TITLE","Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the european group for blood and marrow transplantation""AUTHOR NAMES","Cesaro S.","Marsh J.","Tridello G.","Rovò A.","Maury S.","Montante B.","Masszi T.","Van Lint M.T.","Afanasyev B.","Iriondo Atienza A.","Bierings M.","Carbone C.","Doubek M.","Lanino E.","Sarhan M.","Risitano A.","Steinerova K.","Wahlin A.","Pegoraro A.","Passweg J.""SOURCE","Acta Haematologica (2010) 124:1 (19-22). Date of Publication: July 2010"

"TITLE","Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab""AUTHOR NAMES","Ursini F.","Succurro E.","Grembiale A.","Rudi S.","Grembiale R.D.","Arturi F.""SOURCE","International Journal of Immunopathology and Pharmacology (2010) 23:3 (961-963). Date of Publication: July-September 2010"

"TITLE","Changes in liver biochemistry during methotrexate use for inflammatory bowel disease""AUTHOR NAMES","Fournier M.R.","Klein J.","Minuk G.Y.","Bernstein C.N.""SOURCE","American Journal of Gastroenterology (2010) 105:7 (1620-1626). Date of Publication: July 2010"

"TITLE","Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspective""AUTHOR NAMES","Blank P.R.","Blank A.A.","Szucs T.D.""SOURCE","BMC Dermatology (2010) 10 Article Number: 4. Date of Publication: 25 Jun 2010"

"TITLE","Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: A relevant class-effect""AUTHOR NAMES","Garcovich S.","Burlando M.","Rongioletti F.","Garcovich A.","Parodi A.","Amerio P."

"SOURCE","Acta Dermato-Venereologica (2010) 90:3 (311-312). Date of Publication: 2010"

"TITLE","Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy""AUTHOR NAMES","Rudwaleit M.","Van den Bosch F.","Kron M.","Kary S.","Kupper H.""SOURCE","Arthritis Research and Therapy (2010) 12:3 Article Number: R117. Date of Publication: 16 Jun 2010"

"TITLE","Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis""AUTHOR NAMES","Langley R.G.","Strober B.E.","Gu Y.","Rozzo S.J.","Okun M.M.""SOURCE","British Journal of Dermatology (2010) 162:6 (1349-1358). Date of Publication: June 2010"

"TITLE","The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics""AUTHOR NAMES","Driessen R.J.B.","Bisschops L.A.","Adang E.M.M.","Evers A.W.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2010) 162:6 (1324-1329). Date of Publication: June 2010"

"TITLE","Letter: Long-term management of erythrodermic psoriasis with anti-TNF agents""AUTHOR NAMES","Romero-Maté A.","García-Donoso C.","Martinez-Morán C.","Hernández-Núñez A.","Borbujo J.""SOURCE","Dermatology Online Journal (2010) 16:6. Date of Publication: June 2010"

"TITLE","Infliximab for refractory ulcerative proctitis""AUTHOR NAMES","Bouguen G.","Roblin X.","Bourreille A.","Feier L.","Filippi J.","Nancey S.","Bretagne J.-F.","FlouriÉ B.","HÉbuterne X.","Bigard M.-A.","Siproudhis L.","Peyrin-Biroulet L.""SOURCE","Alimentary Pharmacology and Therapeutics (2010) 31:11 (1178-1185). Date of Publication: June 2010"

"TITLE","Clinical outcomes in patients with psoriasis following discontinuation of efalizumab due to suspension of marketing authorization""AUTHOR NAMES","Baniandrés O.","Pulido A.","Silvente C.","Suárez R.","Lázaro P.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:5 (423-429). Date of Publication: June 2010"

"TITLE","Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: Preliminary data""AUTHOR NAMES","Paradisi A.","Caldarola G.","Capizzi R.","Siciliano M.","Annichiarico E.","Vecchio F.M.","Amerio P.","De Simone C.""SOURCE","Journal of the American Academy of Dermatology (2010) 62:6 (1067-1069.e2). Date of Publication: June 2010"

"TITLE","Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection""AUTHOR NAMES","Nosotti L.","Francesconi F.","Izzi S.","Berardesca E.","Morrone A.","Bonifati C.""SOURCE","British Journal of Dermatology (2010) 162:6 (1408-1410). Date of Publication: June 2010"

"TITLE","Iatrogenic adrenal insufficiency associated with calcipotriol-betamethasone topical combination in psoriasis: Viewpoints in dermatology • Correspondence""AUTHOR NAMES","Giannitelli M.","Maza A.","Lahfa M.","Meyer N.","Livideanu C.","Paul C.""SOURCE","Clinical and Experimental Dermatology (2010) 35:4 (e167-e168). Date of Publication: June 2010"

"TITLE","Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis""AUTHOR NAMES","Thayer S.","Watson C.","Song R.","Globe D.R.","Harrison D.J.""SOURCE","Journal of Medical Economics (2010) 13:2 (228-235). Date of Publication: June 2010"

"TITLE","Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection: Clinical dermatology • Concise report""AUTHOR NAMES","Behnam S.E.","Hindiyeh R.","Fife D.J.","Jeffes III E.W.","Wu J.J.""SOURCE","Clinical and Experimental Dermatology (2010) 35:4 (397-398). Date of Publication: June 2010"

"TITLE","Paradoxical pustular psoriasis flare after infliximab therapy""AUTHOR NAMES","Leung Y.Y.","Ho K.M.""SOURCE","Hong Kong Journal of Dermatology and Venereology (2010) 18:2 (85-89). Date of Publication: Summer 2010"

"TITLE","Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab"

"AUTHOR NAMES","Kling M.C.","Larian A.A.","Scordi-Bello I.","Emer J.","Lebwohl M.G.""SOURCE","Archives of Dermatology (2010) 146:6 (651-654). Date of Publication: June 2010"

"TITLE","Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment: Viewpoints in dermatology • Correspondence""AUTHOR NAMES","O'Kane D.","Devereux C.E.","Walsh M.Y.","Hoey S.E.H.""SOURCE","Clinical and Experimental Dermatology (2010) 35:4 (e155-e156). Date of Publication: June 2010"

"TITLE","Clinical outcomes in patients with psoriasis following discontinuation of efalizumab due to suspension of marketing authorization""AUTHOR NAMES","Baniandrés O.","Pulido A.","Silvente C.","Suárez R.","Lázaro P.""SOURCE","Actas dermo-sifiliográficas (2010) 101:5 (421-427). Date of Publication: Jun 2010"

"TITLE","Anti-immunoglobulin e in the treatment of refractory atopic dermatitis""AUTHOR NAMES","Amrol D.""SOURCE","Southern Medical Journal (2010) 103:6 (554-558). Date of Publication: June 2010"

"TITLE","Rapid improvement of pyoderma gangrenosum after treatment with infliximab""AUTHOR NAMES","Chan J.L.","Graves M.S.","Cockerell C.J.","Pandya A.G.""SOURCE","Journal of Drugs in Dermatology (2010) 9:6 (702-704). Date of Publication: June 2010"

"TITLE","Paraneoplastic pemphigus due to high malignant non hodgkin lymphoma in a patient with pustular psoriasis treated with infliximab""AUTHOR NAMES","Schöberl A.","Allmacher C.","Flegl N.","Krahl B.","Krahl D.","Amon U.""SOURCE","Aktuelle Dermatologie (2010) 36:4 (129-132). Date of Publication: 2010"

"TITLE","Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis""AUTHOR NAMES","Braun J.","Rudwaleit M.","Kary S.","Kron M.","Wong R.L.","Kupper H.""SOURCE","Rheumatology (2010) 49:8 (1578-1589) Article Number: keq129. Date of Publication: August 2010"

"TITLE","Paradoxical reactions to targeted biological treatments: A way to treat and trigger?""AUTHOR NAMES","Brunasso A.M.G.","Laimer M.","Massone C.""SOURCE","Acta Dermato-Venereologica (2010) 90:2 (183-185). Date of Publication: 2010"

"TITLE","Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies""AUTHOR NAMES","Santos-Juanes J.","Coto-Segura P.","Mas-Vidal A.","Galache Osuna C.""SOURCE","British Journal of Dermatology (2010) 162:5 (1144-1146). Date of Publication: May 2010"

"TITLE","Pustular psoriasis, palmoplantar psoriasis, erythodermal psoriasis and etanercept""AUTHOR NAMES","López-Estebaranz J.L.","Ruiz-Genao D.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (35-39). Date of Publication: May 2010"

"TITLE","Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre""AUTHOR NAMES","Antoniou C.","Stefanaki I.","Stratigos A.","Moustou E.","Vergou T.","Stavropoulos P.","Avgerinou G.","Rigopoulos D.","Katsambas A.D.""SOURCE","British Journal of Dermatology (2010) 162:5 (1117-1123). Date of Publication: May 2010"

"TITLE","Psoriatic arthritis and etanercept""AUTHOR NAMES","Pedraz J.","Daudén E.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (26-34). Date of Publication: May 2010"

"TITLE","Psoriasiform skin reactions during treatment with etanercept""AUTHOR NAMES","Santos-Juanes J.","Galache C.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (106-110). Date of Publication: May 2010"

"TITLE","Etanercept. Other indications""AUTHOR NAMES","Hernanz J.M.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (111-116). Date of Publication: May 2010"

"TITLE","Predictors of infliximab failure after azathioprine withdrawal in crohn's disease treated with combination therapy""AUTHOR NAMES","Oussalah A.","Chevaux J.-B.","Fay R.","Sandborn W.J.","Bigard M.-A.","Peyrin-Biroulet L.""SOURCE","American Journal of Gastroenterology (2010) 105:5 (1142-1149). Date of Publication: May 2010"

"TITLE","Etanercept and infections""AUTHOR NAMES","Ribera M.","Leal L.","Luelmo J.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (70-76). Date of Publication: May 2010"

"TITLE","The safety of infliximab infusions in the community setting""AUTHOR NAMES","Ducharme J.","Pelletier C.","Zacharias R.""SOURCE","Canadian Journal of Gastroenterology (2010) 24:5 (307-311). Date of Publication: May 2010"

"TITLE","Intermittent use of etanercept in psoriasis""AUTHOR NAMES","Herrera E.","Alcaide A.J.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (18-25). Date of Publication: May 2010"

"TITLE","Transition of classical systemic treatments to etanercept""AUTHOR NAMES","Ferrándiz C.","Carrascosa J.M.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (45-49). Date of Publication: May 2010"

"TITLE","Etanercept in pregnancy and breast-feeding""AUTHOR NAMES","Borrego L.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (97-101). Date of Publication: May 2010"

"TITLE","Combined therapy with etanercept and systemic drugs or phototherapy""AUTHOR NAMES","Belinchón I.","Ballester I.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (40-44). Date of Publication: May 2010"

"TITLE","Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection""AUTHOR NAMES","Barco D.","Puig L.","Alomar A.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (77-81). Date of Publication: May 2010"

"TITLE","Etanercept and chronic infection by HCV and HBV""AUTHOR NAMES","Bordas X.","Martín-Sala S.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (82-87). Date of Publication: May 2010"

"TITLE","Etanercept and neoplasms""AUTHOR NAMES","García-Rabasco A.","Sánchez-Carazo J.L.","Esteve A.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (88-96). Date of Publication: May 2010"

"TITLE","The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial""AUTHOR NAMES","Menter A.","Augustin M.","Signorovitch J.","Yu A.P.","Wu E.Q.","Gupta S.R.","Bao Y.","Mulani P.""SOURCE","Journal of the American Academy of Dermatology (2010) 62:5 (812-818). Date of Publication: May 2010"

"TITLE","Etanercept and infection - Latent tuberculosis""AUTHOR NAMES","González-Sixto B.","Rodríguez-Prieto M.Á.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:SUPPL. 1 (62-69). Date of Publication: May 2010"

"TITLE","Circulating Th17, Th22, and Th1 cells are increased in psoriasis""AUTHOR NAMES","Kagami S.","Rizzo H.L.","Lee J.J.","Koguchi Y.","Blauvelt A.""SOURCE","Journal of Investigative Dermatology (2010) 130:5 (1373-1383). Date of Publication: May 2010"

"TITLE","Letter: Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy""AUTHOR NAMES","Izzi S.","Francesconi F.","Visca P.","Altieri A.","de Mutiis C.","Trevisan G.","Bonifati C.""SOURCE","Dermatology Online Journal (2010) 16:5. Date of Publication: May 2010"

"TITLE","Time and predictors of response to tumour necrosis factor-α blockers in psoriatic arthritis: An analysis of a longitudinal observational cohort""AUTHOR NAMES","Eder L.","Chandran V.","Schentag C.T.","Shen H.","Cook R.J.","Gladman D.D.""SOURCE","Rheumatology (2010) 49:7 (1361-1366) Article Number: keq091. Date of Publication: July 2010"

"TITLE","Successive sebopsoriasis, erysipelas and Koebner phenomenon""AUTHOR NAMES","Viguier M.","Bachelez H.""SOURCE","CMAJ (2010) 182:6 (E252). Date of Publication: 6 Apr 2010"

"TITLE","Cutaneous sarcoidosis occurring during anti-TNF-Alpha treatment: Report of two cases""AUTHOR NAMES","Dhaille F.","Viseux V.","Caudron A.","Dadban A.","Tribout C.","Boumier P.","Clabaut A.","Lok C.""SOURCE","Dermatology (2010) 220:3 (234-237). Date of Publication: April 2010"

"TITLE","Safety and efficacy of calcium folinate in psoriasis: An observational study""AUTHOR NAMES","Carlesimo M.","Mari E.","Arcese A.","De Angelis F.","Palese E.","Abruzzese C.","De Marco G.","Cattaruzza M.S.","Camplone G.""SOURCE","International Journal of Immunopathology and Pharmacology (2010) 23:2 (649-653). Date of Publication: April-June 2010"

"TITLE","Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs""AUTHOR NAMES","Atteno M.","Peluso R.","Costa L.","Padula S.","Iervolino S.","Caso F.","Sanduzzi A.","Lubrano E.","Del Puente A.","Scarpa R.""SOURCE","Clinical Rheumatology (2010) 29:4 (399-403). Date of Publication: April 2010"

"TITLE","Lupus induced by adalimumab: A new case report""AUTHOR NAMES","Bret S.","Nuccio A.","Roche C.","Wolf A.","De Biasi C.","Lightburne E.","Jean Pastor M.-J.","Morand J.-J.""SOURCE","Nouvelles Dermatologiques (2010) 29:4 PART 1 (206-208). Date of Publication: April 2010"

"TITLE","Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience""AUTHOR NAMES","Esposito M.","Giunta A.","Mazzotta A.","Babino G.","Talamonti M.","Chimenti M.S.","Chimenti S.""SOURCE","International Journal of Immunopathology and Pharmacology (2010) 23:2 (503-509). Date of Publication: April-June 2010"

"TITLE","Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: Results of a large population-based dutch cohort""AUTHOR NAMES","Wakkee M.","Herings R.M.C.","Nijsten T.""SOURCE","Journal of Investigative Dermatology (2010) 130:4 (962-967). Date of Publication: April 2010"

"TITLE","Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study""AUTHOR NAMES","Asahina A.","Nakagawa H.","Etoh T.","Ohtsuki M.""SOURCE","Journal of Dermatology (2010) 37:4 (299-310). Date of Publication: April 2010"

"TITLE","Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis""AUTHOR NAMES","Kimball A.B.","Guerin A.","Latremouille-Viau D.","Yu A.P.","Gupta S.","Bao Y.","Mulani P.""SOURCE","American Journal of Medicine (2010) 123:4 (350-357). Date of Publication: April 2010"

"TITLE","Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: Case report and literature review""AUTHOR NAMES","Poulin Y.","Thérien G.""SOURCE","Journal of Cutaneous Medicine and Surgery (2010) 14:2 (100-104). Date of Publication: April 2010"

"TITLE","New-onset psoriasis associated with etanercept therapy""AUTHOR NAMES","Chen L.-A.","Su L.-H.","Chang Y.-J.","Hsu Y.-L.","Tsai T.-H.""SOURCE","Journal of Dermatology (2010) 37:4 (378-380). Date of Publication: April 2010"

"TITLE","Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions""AUTHOR NAMES","Paul C.","Solignac M.""SOURCE","Annales de dermatologie et de vénéréologie (2010) 137:4 Suppl (13-15). Date of Publication: Apr 2010"

"TITLE","Differing effect of systemic anti psoriasis therapies on platelet physiology - a case report and review of literature""AUTHOR NAMES","Davidovici B.B.","Sullivan-Whalen M.M.","Gilleaudeau P.","Krueger J.G.""SOURCE","BMC Dermatology (2010) 10 Article Number: 2. Date of Publication: 31 Mar 2010"

"TITLE","Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors""AUTHOR NAMES","Wee J.S.","White J.M.L.","McFadden J.P.","White I.R."

"SOURCE","Contact Dermatitis (2010) 62:3 (165-169). Date of Publication: March 2010"

"TITLE","Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice""AUTHOR NAMES","Zabana Y.","Domènech E.","Mañosa M.","Garcia-Planella E.","Bernal I.","Cabré E.","Gassull M.A.""SOURCE","Alimentary Pharmacology and Therapeutics (2010) 31:5 (553-560). Date of Publication: March 2010"

"TITLE","Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Zhou H.","Hu C.","Zhu Y.","Lu M.","Liao S.","Yeilding N.","Davis H.M.""SOURCE","Journal of Clinical Pharmacology (2010) 50:3 (257-267). Date of Publication: March 2010"

"TITLE","Therapeutic hotline: Re-induction may be useful to manage psoriasis relapse during long-term maintenance treatment with infliximab: A retrospective analysis""AUTHOR NAMES","Vena G.","Loconsole F.","Mastrandrea V.","Buquicchio R.","Cassano N.""SOURCE","Dermatologic Therapy (2010) 23:2 (199-202). Date of Publication: March-April 2010"

"TITLE","Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial""AUTHOR NAMES","Sterry W.","Ortonne J.-P.","Kirkham B.","Brocq O.","Robertson D.","Pedersen R.D.","Estojak J.","Molta C.T.","Freundlich B.""SOURCE","BMJ (Online) (2010) 340:7741 (300) Article Number: c147. Date of Publication: 6 Feb 2010"

"TITLE","Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockers""AUTHOR NAMES","El Shabrawi-Caelen L.","La Placa M.","Vincenzi C.","Haidn T.","Muellegger R.","Tosti A.""SOURCE","Inflammatory Bowel Diseases (2010) 16:2 (182-183). Date of Publication: 2010"

"TITLE","Estimation of cost-of-illness in patients with psoriasis in Switzerland""AUTHOR NAMES","Navarini A.A.","Laffitte E.","Conrad C.","Piffaretti P.","Brock E.","Ruckdaeschel S.","Trüeb R.M.""SOURCE","Swiss Medical Weekly (2010) 140:5-6 (85-91). Date of Publication: 2 Feb 2010"

"TITLE","Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis""AUTHOR NAMES","Lecluse L.L.A.","Driessen R.J.B.","Spuls P.I.","De Jong E.M.G.J.","Stapel S.O.","Van Doorn M.B.A.","Bos J.D.","Wolbink G.-J.""SOURCE","Archives of Dermatology (2010) 146:2 (127-132). Date of Publication: February 2010"

"TITLE","A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis""AUTHOR NAMES","Chandran N.S.","Chong W.-S.""SOURCE","Australasian Journal of Dermatology (2010) 51:1 (29-31). Date of Publication: February 2010"

"TITLE","Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab""AUTHOR NAMES","Medkour F.","Babai S.","Chanteloup E.","Buffard V.","Delchier J.-C.","Le-Louet H.""SOURCE","Gastroenterologie Clinique et Biologique (2010) 34:2 (140-141). Date of Publication: February 2010"

"TITLE","Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions""AUTHOR NAMES","Van Den Bosch F.","Manger B.","Goupille P.","McHugh N.","Rødevand E.","Holck P.","Van Vollenhoven R.F.","Leirisalo-Repo M.","Fitzgerald O.","Kron M.","Frank M.","Kary S.","Kupper H.""SOURCE","Annals of the Rheumatic Diseases (2010) 69:2 (394-399). Date of Publication: February 2010"

"TITLE","Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis""AUTHOR NAMES","Griffiths C.E.M.","Strober B.E.","Van De Kerkhof P.","Ho V.","Fidelus-Gort R.","Yeilding N.","Guzzo C.","Xia Y.","Zhou B.","Li S.","Dooley L.T.","Goldstein N.H.","Menter A.""SOURCE","New England Journal of Medicine (2010) 362:2 (118-128). Date of Publication: 14 Jan 2010"

"TITLE","Generalized ostraceous psoriasis""AUTHOR NAMES","Arias-Santiago S.A.","Naranjo-Sintes R.""SOURCE","New England Journal of Medicine (2010) 362:2 (155). Date of Publication: 14 Jan 2010"

"TITLE","Cutaneous events during anti-TNF alpha therapy: A prospective observational study of 41 cases""AUTHOR NAMES","Bonnet N.","Guis S.","Koeppel M.-C.","Roudier J.","Grimaud J.-C.","Jean-Pastor M.-J.","Berbis P.""SOURCE","Annales de Dermatologie et de Venereologie (2010) 137:1 (12-20). Date of Publication: January 2010"

"TITLE","Autoimmunity by anti-tumour necrosis factor-alpha agents: The role of traditional therapies""AUTHOR NAMES","Antoniou C.","Moustou A.E.","Vergou T.","Stratigos A.","Kalambokas A.","Katsambas A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2010) 24:3 (356-357). Date of Publication: March 2010"

"TITLE","Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy""AUTHOR NAMES","Bardazzi F.","Balestri R.","Baldi E.","Antonucci A.","De Tommaso S.","Patrizi A.""SOURCE","Dermatologic Therapy (2010) 23:SUPPL. 1 (S14-S19). Date of Publication: January-February 2010"

"TITLE","The quality of life in Italian psoriatic patients treated with biological drugs""AUTHOR NAMES","Cozzani E.","Borrini V.","Pennella A.","Burlando M.","Cardo P.","Rebora A.","Parodi A.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2010) 145:6 (709-712). Date of Publication: December 2010"

"TITLE","Treating psoriasis with etanercept in Italian clinical practice: Prescribing practices and duration of remission following discontinuation""AUTHOR NAMES","Arcese A.","Aste N.","Bettacchi A.","Camplone G.","Cantoresi F.","Caproni M.","Damico D.","Fabbri P.","Filosa G.","Galluccio A.","Hansel K.","Lisi P.","Micali G.","Musumeci M.L.","Nicolini M.","Parodi A.","Patania M.","Pezza M.","Potenza C.","Richetta A.","Simonacci M.","Trevisan P.","Valenti G.","Calvieri S.""SOURCE","Clinical Drug Investigation (2010) 30:8 (507-516). Date of Publication: 2010"

"TITLE","Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities""AUTHOR NAMES","Prignano F.","Pescitelli L.","Ricceri F.","Lotti T.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2010) 24:5 (555-560). Date of Publication: May 2010"

"TITLE","Lymphomatoid contact dermatitis to baby wipes""AUTHOR NAMES","Mendese G.","Beckford A.","Demierre M.-F.""SOURCE","Archives of Dermatology (2010) 146:8 (934-935). Date of Publication: August 2010"

"TITLE","Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial""AUTHOR NAMES","Torii H.","Nakagawa H.""SOURCE","Journal of Dermatological Science (2010) 59:1 (40-49). Date of Publication: July 2010"

"TITLE","Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: Results from the PHOENIX 1 trial""AUTHOR NAMES","Lebwohl M.","Papp K.","Han C.","Schenkel B.","Yeilding N.","Wang Y.","Krueger G.G.""SOURCE","British Journal of Dermatology (2010) 162:1 (137-146). Date of Publication: January 2010"

"TITLE","Long-term safety and efficacy of etanercept in the treatment of psoriasis""AUTHOR NAMES","Zaragoza V.","Pérez A.","Sánchez J.L.","Oliver V.","Martínez L.","Alegre V.""SOURCE","Actas Dermo-Sifiliograficas (2010) 101:1 (47-53). Date of Publication: January 2010/February 2010"

"TITLE","Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial""AUTHOR NAMES","Langley R.G.","Feldman S.R.","Han C.","Schenkel B.","Szapary P.","Hsu M.-C.","Ortonne J.-P.","Gordon K.B.","Kimball A.B.""SOURCE","Journal of the American Academy of Dermatology (2010) 63:3 (457-465). Date of Publication: September 2010"

"TITLE","Treatment of psoriasis with anti-TNF drugs during pregnancy: Case report and review of the literature""AUTHOR NAMES","Puig L.","Barco D.","Alomar A.""SOURCE","Dermatology (2010) 220:1 (71-76). Date of Publication: January 2010"

"TITLE","Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: A pooled analysis of randomized clinical trials""AUTHOR NAMES","Mease P.J.","Signorovitch J.","Yu A.P.","Wu E.Q.","Gupta S.R.","Bao Y.","Mulani P.M.""SOURCE","Dermatology (2010) 220:1 (1-7). Date of Publication: January 2010"

"TITLE","Treatment of nail psoriasis with adalimumab: An open label unblinded study: ORIGINAL ARTICLE""AUTHOR NAMES","Rigopoulos D.","Gregoriou S.","Lazaridou E.","Belyayeva E.","Apalla Z.","Makris M.","Katsambas A.","Ioannides D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2010) 24:5 (530-534). Date of Publication: May 2010"

"TITLE","Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study""AUTHOR NAMES","Saougou I.","Markatseli T.E.","Voulgari P.V.","Drosos A.A.""SOURCE","Joint Bone Spine (2010) 77:4 (325-329). Date of Publication: July 2010"

"TITLE","Unusual presentation of tuberculosis in an infliximab-treated patient - Which is the correct TB screening before starting a biologic?""AUTHOR NAMES","Gori A.","Fabroni C.","Prignano F.","Lotti T.""SOURCE","Dermatologic Therapy (2010) 23:SUPPL. 1 (S1-S3). Date of Publication: January-February 2010"

"TITLE","Posttraumatic psoriatic osteitis of the frontal bone successfully treated with etanercept. Report of a case""AUTHOR NAMES","Fournié B.","Zabraniecki L.","Lemaire O.","Plaut-Gaty M.-A.","Poix-Jover E.""SOURCE","Joint Bone Spine (2010) 77:1 (78-80). Date of Publication: January 2010"

"TITLE","Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis""AUTHOR NAMES","Stewart L.","Howat A.","Coulson I.""SOURCE","Archives of Dermatology (2010) 146:10 (1193-1194). Date of Publication: October 2010"

"TITLE","A severe complication of anti-TNF αlfa treatment""AUTHOR NAMES","Fabroni C.","Gori A.","Prignano F.","Lotti T.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2010) 145:6 (775-777). Date of Publication: December 2010"

"TITLE","Transient and reversible thrombocytopenia in a psoriatic patient treated with etanercept""AUTHOR NAMES","Balato N.","Gallo L.","Gaudiello F.","Chiurazzi F.","Ayala F.""SOURCE","Journal of Dermatological Treatment (2010) 21:2 (117-118). Date of Publication: March 2010"

"TITLE","Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy""AUTHOR NAMES","Ul Ain Kamili Q.","Menter A.""SOURCE","Journal of Drugs in Dermatology (2010) 9:1 (57-60). Date of Publication: January 2010"

"TITLE","Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis""AUTHOR NAMES","Diluvio L.","Romiti M.L.","Angelini F.","Campione E.","Rossi P.","Prinz J.C.","Chimenti S.","Lamioni A.""SOURCE","British Journal of Dermatology (2010) 162:4 (895-897). Date of Publication: April 2010"

"TITLE","Adalimumab-induced autoimmune hepatitis""AUTHOR NAMES","Adar T.","Mizrahi M.","Pappo O.","Scheiman-Elazary A.","Shibolet O.""SOURCE","Journal of Clinical Gastroenterology (2010) 44:1 (e20-e22). Date of Publication: January 2010"

"TITLE","Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A 'class effect' of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?""AUTHOR NAMES","Rallis E.","Korfitis C.","Stavropoulou E.","Papaconstantis M.""SOURCE","Journal of Dermatological Treatment (2010) 21:1 (3-5). Date of Publication: January 2010"

"TITLE","Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?""AUTHOR NAMES","Gandhi R.K.","Pickup T.","Sheth P.B.""SOURCE","Archives of Dermatology (2010) 146:10 (1151-1152). Date of Publication: October 2010"

"TITLE","Sarcoidosis during infliximab therapy for Crohn's disease""AUTHOR NAMES","Takahashi H.","Kaneta K.","Honma M.","Ishida-Yamamoto A.","Ashida T.","Kohgo

Y.","Ohsaki Y.","Iizuka H.""SOURCE","Journal of Dermatology (2010) 37:5 (471-474). Date of Publication: May 2010"

"TITLE","Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: The different pathological mechanisms""AUTHOR NAMES","Quarta L.","Corrado A.","D'Onofrio F.","Maruotti N.","Cantatore F.P.""SOURCE","Rheumatology International (2010) 30:10 (1367-1370). Date of Publication: August 2010"

"TITLE","Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept""AUTHOR NAMES","Poulin Y.""SOURCE","Journal of Cutaneous Medicine and Surgery (2009) 13:4 (221-225). Date of Publication: 2009"

"TITLE","Infliximab in the treatment of plaque type psoriasis""AUTHOR NAMES","Saraceno R.","Saggini A.","Pietroleonardo L.","Chimenti S.""SOURCE","Clinical, Cosmetic and Investigational Dermatology (2009) 2 (27-37). Date of Publication: 2009"

"TITLE","New biologic: Ustekinumab""SOURCE","Formulary (2009) 44:11 (320). Date of Publication: 2009"

"TITLE","Biological therapy for psoriasis: Practical experience at a French dermatology unit""AUTHOR NAMES","Saccomani C.","Penz S.","Guerre-Schmidt R.","Riou M.-O.","Pelletier F.","Puzenat E.","Mermet I.","Levang J.","Humbert P.","Aubin F.""SOURCE","Annales de Dermatologie et de Venereologie (2009) 136:12 (877-882). Date of Publication: December 2009"

"TITLE","Adalimumab for psoriasis patients who are non-responders to etanercept: Open-label prospective evaluation""AUTHOR NAMES","Martyn-Simmons C.L.","Green L.","Ash G.","Groves R.W.","Smith C.H.","Barker J.N.W.N.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:12 (1394-1397). Date of Publication: December 2009"

"TITLE","Rapid remission of psoriasis with reversible leucopenia after two injections with adalimumab""AUTHOR NAMES","Jordan J.","Bieber T.","Wilsmann-Theis D.""SOURCE","Clinical and Experimental Dermatology (2009) 34:8 (e1004-e1005). Date of Publication: December 2009"

"TITLE","Topical 8-methoxypsoralen increases the efficacy of narrowband ultraviolet B in psoriasis""AUTHOR NAMES","Seckin D.","Usta I.","Yazici Z.","Senol A.""SOURCE","Photodermatology Photoimmunology and Photomedicine (2009) 25:5 (237-241). Date of Publication: 2009"

"TITLE","Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases""AUTHOR NAMES","Burmester G.R.","Mease P.","Dijkmans B.A.C.","Gordon K.","Lovell D.","Panaccione R.","Perez J.","Pangan A.L.""SOURCE","Annals of the Rheumatic Diseases (2009) 68:12 (1863-1869). Date of Publication: December 2009"

"TITLE","Adalimumab treatment of a patient with psoriasis suppurativa Hallopeau associated osteoarthropathy""AUTHOR NAMES","Mueller R.B.","Ogilvie A.","Schwarz S.","Kern P.","Schett G.","Sticherling M.""SOURCE","Clinical and Experimental Rheumatology (2009) 27:5 (887). Date of Publication: 2009"

"TITLE","Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study""AUTHOR NAMES","Mazzotta A.","Esposito M.","Schipani C.","Chimenti S.""SOURCE","Journal of Dermatological Treatment (2009) 20:6 (354-358). Date of Publication: December 2009"

"TITLE","Blasch-kolinear psoriasis revealed by infliximab therapy""AUTHOR NAMES","Sfia M.","Roth-Mall B.","Tortel M.-C.","Guillaume J.-C.","Cribier B.""SOURCE","Annales de Dermatologie et de Venereologie (2009) 136:12 (898-903). Date of Publication: December 2009"

"TITLE","Coarctation of the aorta in an infant exposed to etanercept in utero""AUTHOR NAMES","Hemmati I.","Ensworth S.","Shojania K.""SOURCE","Journal of Rheumatology (2009) 36:12 (2848). Date of Publication: December 2009"

"TITLE","Our clinic experience with infliximab in cases with moderate-severe psoriasis: A

retrospective study""AUTHOR NAMES","Başkan E.B.","Öztürk Z.Y.","Erdem H.","Saricaoǧlu H.""SOURCE","Turkderm Deri Hastaliklari ve Frengi Arsivi (2009) 43:3 (95-99). Date of Publication: 2009"

"TITLE","Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: The CRYSTEL study""AUTHOR NAMES","Daudén E.","Griffiths C.E.M.","Ortonne J.-P.","Kragballe K.","Molta C.T.","Robertson D.","Pedersen R.","Estojak J.","Boggs R.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:12 (1374-1382). Date of Publication: December 2009"

"TITLE","Acitretin narrow-band TL-01 phototherapy but not etanercept treatment improves a localized inflammatory linear verrucous epidermal naevus with concomitant psoriasis""AUTHOR NAMES","Özdemir M.","Mevlitoǧlu I.","Balevi A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:12 (1453-1454). Date of Publication: December 2009"

"TITLE","Efalizumab-induced thrombocytopenia: Report of relapse after re-administration""AUTHOR NAMES","Kiorpelidou D.","Tsiouri G.","Gaitanis G.","Akritidis N.","Bassukas I.D.""SOURCE","Clinical and Experimental Dermatology (2009) 34:8 (e914-e916). Date of Publication: December 2009"

"TITLE","Adalimumab in the management of palmoplantar psoriasis""AUTHOR NAMES","Ghate J.V.","Alspaugh C.D.""SOURCE","Journal of Drugs in Dermatology (2009) 8:12 (1136-1139). Date of Publication: December 2009"

"TITLE","Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab""AUTHOR NAMES","Markatseli T.E.","Kaltsonoudis E.S.","Voulgari P.V.","Zioga A.","Drosos A.A.""SOURCE","Clinical and Experimental Rheumatology (2009) 27:6 (996-998). Date of Publication: 2009"

"TITLE","Acquired dermal melanocytosis of the hand at the site of treated psoriasis""AUTHOR NAMES","Kelley B.P.","Doherty S.D.","Calame A.","Hsu S.""SOURCE","Dermatology Online Journal (2009) 15:12 Article Number: 2. Date of Publication: December 2009"

"TITLE","Anti-NuMA antibodies in a psoriatic patient: considerations about clinical relevance and effect of infliximab treatment.""AUTHOR NAMES","Tampoia M.","Mastrandrea V.","Cassano N.","Vena G.A.""SOURCE","Immunopharmacology and immunotoxicology (2009) 31:1 (127-129). Date of Publication: 2009"

"TITLE","Chest pain as presenting symptom of staphyloccocus aureus epidural abscess associated with anti-tumor necrosis factor and methotrexate therapy""AUTHOR NAMES","Vasoo S.","Gurnani P.","Agustin T.","Lee J.","Singh K.""SOURCE","Journal of Clinical Rheumatology (2009) 15:8 (396-398). Date of Publication: December 2009"

"TITLE","Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: A 5-year prevalence study""AUTHOR NAMES","Wakkee M.","Meijer W.","Neumann H.A.M.","Herings R.M.C.","Nijsten T.""SOURCE","Acta Dermato-Venereologica (2009) 89:5 (476-483). Date of Publication: 2009"

"TITLE","Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement""AUTHOR NAMES","Van Lingen R.G.","Van Erp P.E.J.","Seyger M.M.B.","De Jong E.M.G.J.","De Boer-van Huizen R.T.","Driessen R.J.B.","Van De Kerkhof P.C.M.""SOURCE","Acta Dermato-Venereologica (2009) 89:5 (518-520). Date of Publication: 2009"

"TITLE","Patterns of biologic agent use in older males with inflammatory diseases: An institution-focused, observational post-marketing study""AUTHOR NAMES","Tran S.","Hooker R.S.","Cipher D.J.","Reimold A.""SOURCE","Drugs and Aging (2009) 26:7 (607-615). Date of Publication: 2009"

"TITLE","Treatment of severe psoriasis with infliximab: Report of two cases""AUTHOR NAMES","Peternel S.","Prpić-Massari L.","Guina T.","Novak S.","Brajac I.","Kaštelan M.""SOURCE","Acta Dermatovenerologica Croatica (2009) 17:3 (204-208). Date of Publication: 2009"

"TITLE","Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease""AUTHOR NAMES","Karmiris K.","Paintaud G.","Noman M.","Magdelaine-Beuzelin C.","Ferrante M.","Degenne D.","Claes K.","Coopman T.","Van Schuerbeek N.","Van Assche G.","Vermeire S.","Rutgeerts P."

"SOURCE","Gastroenterology (2009) 137:5 (1628-1640). Date of Publication: November 2009"

"TITLE","Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis""AUTHOR NAMES","Coaccioli S.","Panaccione A.","Biondi R.","Sabatini C.","Landucci P.","Del Giorno R.","Fantera M.","Mondo A.M.","Di Cato L.","Paladini A.","Fatati G.","Puxeddu A.""SOURCE","Clinica Terapeutica (2009) 160:6 (467-471). Date of Publication: November-December 2009"

"TITLE","Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab""AUTHOR NAMES","Richetta A.G.","Maiani E.","Carlomagno V.","Carboni V.","Mattozzi C.","Giancristoforo S.","Calvieri S.""SOURCE","Dermatologic Therapy (2009) 22:SUPPL. 1 (S16-S18). Date of Publication: November 2009"

"TITLE","Marked improvement in nail psoriasis during treatment with adalimumab""AUTHOR NAMES","Irla N.","Yawalkar N.""SOURCE","Dermatology (2009) 219:4 (353-356). Date of Publication: November 2009"

"TITLE","Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept""AUTHOR NAMES","Ortonne J.-P.","Taïeb A.","Ormerod A.D.","Robertson D.","Foehl J.","Pedersen R.","Molta C.","Freundlich B.""SOURCE","British Journal of Dermatology (2009) 161:5 (1190-1195). Date of Publication: November 2009"

"TITLE","Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes""AUTHOR NAMES","Zaba L.C.","Suárez-Fariñas M.","Fuentes-Duculan J.","Nograles K.E.","Guttman-Yassky E.","Cardinale I.","Lowes M.A.","Krueger J.G.""SOURCE","Journal of Allergy and Clinical Immunology (2009) 124:5 (1022-1030.e395). Date of Publication: November 2009"

"TITLE","Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: A functional magnetic resonance imaging study""AUTHOR NAMES","Kleyn C.E.","McKie S.","Ross A.R.","Montaldi D.","Gregory L.J.","Elliott R.","Isaacs C.L.","Anderson I.M.","Richards H.L.","Deakin J.F.W.","Fortune D.G.","Griffiths C.E.M.""SOURCE","Journal of Investigative Dermatology (2009) 129:11 (2613-2619). Date of Publication: November 2009"

"TITLE","Chronic Herpes Simplex Scleritis: Characterization of 9 Cases of an Underrecognized Clinical Entity""AUTHOR NAMES","Bhat P.V.","Jakobiec F.A.","Kurbanyan K.","Zhao T.","Foster C.S.""SOURCE","American Journal of Ophthalmology (2009) 148:5 (779-789.e2). Date of Publication: November 2009"

"TITLE","Facial granulomatous nodules during etanercept treatment for psoriasis""AUTHOR NAMES","Samimi M.","Lorette G.","Machet L.","de Muret A.","Watier H.","Maruani A.""SOURCE","International Journal of Dermatology (2009) 48:9 (1025-1027). Date of Publication: 2009"

"TITLE","Adalimumab treatment for severe recalcitrant chronic plaque psoriasis""AUTHOR NAMES","Ryan C.","Kirby B.","Collins P.","Rogers S.""SOURCE","Clinical and Experimental Dermatology (2009) 34:7 (784-788). Date of Publication: October 2009"

"TITLE","Nontuberculous mycobacteria infections and anti-tumor necrosis factor-α therapy""AUTHOR NAMES","Winthrop K.L.","Chang E.","Yamashita S.","Iademarco M.F.","LoBue P.A.""SOURCE","Emerging Infectious Diseases (2009) 15:10 (1556-1561). Date of Publication: October 2009"

"TITLE","Generalized pustular psoriasis induced by systemic glucocorticosteroids: Four cases and recommendations for treatment""AUTHOR NAMES","Brenner M.","Molin S.","Ruebsam K.","Weisenseel P.","Ruzicka T.","Prinz J.C.""SOURCE","British Journal of Dermatology (2009) 161:4 (964-966). Date of Publication: October 2009"

"TITLE","Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: Comparison of an interferon-γ release assay vs. tuberculin skin test""AUTHOR NAMES","Laffitte E.","Janssens J.P.","Roux-Lombard P.","Thielen A.M.","Barde C.","Marazza G.","Panizzon R.G.","Saurat J.-H.""SOURCE","British Journal of Dermatology (2009) 161:4 (797-800). Date of Publication: October 2009"

"TITLE","Economic burden of psoriasis compared to the general population and stratified by disease severity"

"AUTHOR NAMES","Yu A.P.","Tang J.","Xie J.","Wu E.Q.","Gupta S.R.","Bao Y.","Mulani P.M.""SOURCE","Current Medical Research and Opinion (2009) 25:10 (2429-2438). Date of Publication: October 2009"

"TITLE","Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study""AUTHOR NAMES","Mazzotta A.","Esposito M.","Costanzo A.","Chimenti S.""SOURCE","American Journal of Clinical Dermatology (2009) 10:5 (319-324). Date of Publication: 2009"

"TITLE","Circulating CD4+CD25FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients""AUTHOR NAMES","Quaglino P.","Ortoncelli M.","Comessatti A.","Ponti R.","Novelli M.","Bergallo M.","Costa C.","Cicchelli S.","Savoia P.","Bernengo M.G.""SOURCE","Dermatology (2009) 219:3 (250-258). Date of Publication: October 2009"

"TITLE","Ustekinumab for the treatment of moderate to severe psoriasis.""AUTHOR NAMES","Gospodarevskaya E.","Picot J.","Cooper K.","Loveman E.","Takeda A.""SOURCE","Health technology assessment (Winchester, England) (2009) 13 Suppl 3 (61-66). Date of Publication: Oct 2009"

"TITLE","Efficacy of adalimumab in moderate-to-severe pediatric crohn's disease""AUTHOR NAMES","Viola F.","Civitelli F.","Di Nardo G.","Barbato M.B.","Borrelli O.","Oliva S.","Conte F.","Cucchiara S.""SOURCE","American Journal of Gastroenterology (2009) 104:10 (2566-2571). Date of Publication: October 2009"

"TITLE","Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab""AUTHOR NAMES","Bouguen G.","Trouilloud I.","Siproudhis L.","Oussalah A.","Bigard M.-A.","Bretagne J.-F.","Peyrin-Biroulet L.""SOURCE","Alimentary Pharmacology and Therapeutics (2009) 30:7 (749-756). Date of Publication: October 2009"

"TITLE","Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis""AUTHOR NAMES","Reich K.","Segaert S.","Van De Kerkhof P.","Durian C.","Boussuge M.P.","Paolozzi L.","Wajdula J.","Boggs R.""SOURCE","Dermatology (2009) 219:3 (239-249). Date of Publication: October 2009"

"TITLE","Severe psoriasis, morbid obesity and bariatric surgery""AUTHOR NAMES","Pérez-Pérez L.","Allegue F.","Caeiro J.L.","Fabeiro A. Zulaica J.M.""SOURCE","Clinical and Experimental Dermatology (2009) 34:7 (e421-e422). Date of Publication: October 2009"

"TITLE","Jaundice in a patient treated with etanercept""AUTHOR NAMES","Rodríguez Gil F.J.","Martínez Crespo J.J.","García Belmonte D.","Nicolás de Prado I.N.","de Prado Serrano R.""SOURCE","Gastroenterologia y Hepatologia (2009) 32:8 (584-585). Date of Publication: October 2009"

"TITLE","TNFα and its receptors in psoriatic skin, before and after treatment with etanercept""AUTHOR NAMES","Caldarola G.","De Simone C.","Carbone A.","Tulli A.","Amerio P.","Feliciani C.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:4 (961-966). Date of Publication: October-December 2009"

"TITLE","Development of bullous pemphigoid during treatment of psoriasis with adalimumab""AUTHOR NAMES","Stausbøl-Grøn B.","Deleuran M.","Sommer Hansen E.","Kragballe K.""SOURCE","Clinical and Experimental Dermatology (2009) 34:7 (e285-e286). Date of Publication: October 2009"

"TITLE","Predictive factors of eczema-like eruptions among patients without cutaneous psoriasis receiving infliximab: A cohort study of 92 patients""AUTHOR NAMES","Esmailzadeh A.","Yousefi P.","Farhi D.","Bachmeyer C.","Cosnes J.","Berenbaum F.","Duriez P.","Aractingi S.","Khosrotehrani K.""SOURCE","Dermatology (2009) 219:3 (263-267). Date of Publication: October 2009"

"TITLE","Reduced libido and erectile dysfunction: Rarely reported side-effects of methotrexate""AUTHOR NAMES","Wylie G.","Evans C.D.","Gupta G.""SOURCE","Clinical and Experimental Dermatology (2009) 34:7 (e234). Date of Publication: October 2009"

"TITLE","Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with efalizumab""AUTHOR NAMES","Saraceno R.","Scotto G.","Chiricozzi A.","Chimenti S.""SOURCE","Acta Dermato-Venereologica (2009) 89:4 (412-413). Date of Publication: 2009"

"TITLE","Large plaque psoriasis. Are masterly formulae still a therapeutic alternative?""AUTHOR NAMES","Domínguez M.A.","Márquez Palencia C.E.""SOURCE","Dermatologia Revista Mexicana (2009) 53:5 (251-255). Date of Publication: September-October 2009"

"TITLE","Successful adalimumab desensitization after generalized urticaria and rhinitis""AUTHOR NAMES","Rodríguez-Jiménez B.","Domínguez-Ortega J.","González-Herrada C.","Kindelan-Recarte C.","Loribo-Bueno P.","Garrido-Peño N.""SOURCE","Journal of Investigational Allergology and Clinical Immunology (2009) 19:3 (246-247). Date of Publication: 2009"

"TITLE","Gilbert's syndrome triggered by etanercept and adalimumab treatments""AUTHOR NAMES","Ruiz-Villaverde R.","Navarro-Pérez V.","Sánchez-Cano D.""SOURCE","Piel (2009) 24:7 (402-403). Date of Publication: September 2009"

"TITLE","Generalized pustular psoriasis: Treatment. With etanercept""AUTHOR NAMES","Palomo Arellano A.","Torres Iglesias L.M.","Cervigón González I.","Gil Pascual B.""SOURCE","Medicina Cutanea Ibero-Latino-Americana (2009) 37:5 (224-226). Date of Publication: September-October 2009"

"TITLE","Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines""AUTHOR NAMES","Nast A.","Erdmann R.","Hofelich V.","Reytan N.","Orawa H.","Sterry W.","Rzany B.""SOURCE","Archives of Dermatological Research (2009) 301:8 (553-559). Date of Publication: September 2009"

"TITLE","Annual Scientific Meeting of the Hong Kong Society of Dermatology and Venereology 2009 (Part 1)""AUTHOR NAMES","Chu E.C.Y.","Chung A.C.K.","Ng S.C.","Lai D.Y.K.","Wat M.Y.M.","Au A.W.M.""SOURCE","Hong Kong Journal of Dermatology and Venereology (2009) 17:3 (157-163). Date of Publication: Autumn 2009"

"TITLE","Pityriasis rosea during etanercept therapy""AUTHOR NAMES","Guarneri C.","Polimeni G.","Nunnari G.""SOURCE","European Review for Medical and Pharmacological Sciences (2009) 13:5 (383-387). Date of Publication: September-October 2009"

"TITLE","Immunological therapy in severe pustular psoriasis""AUTHOR NAMES","Valero González S.","Díaz De Santiago A.","Montero Hernández E.","Bilbao Garay J.""SOURCE","Revista Clinica Espanola (2009) 209:8 (404-405). Date of Publication: September 2009"

"TITLE","Peripheral neuropathy in two patients with psoriasis in treatment with infliximab""AUTHOR NAMES","Eguren C.","Ley B.D.","Daudén E.","García-Diez A.","Losada M.""SOURCE","Muscle and Nerve (2009) 40:3 (488-489). Date of Publication: September 2009"

"TITLE","The infectious profiles of anti-tumor necrosis factor agents in a Thai population: A retrospective study a the university-based hospital""AUTHOR NAMES","Suwannalai P.","Auethavekiat P.","Udomsubpayakul U.","Janvitayanujit S.""SOURCE","International Journal of Rheumatic Diseases (2009) 12:2 (118-124). Date of Publication: 2009"

"TITLE","Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: A retrospective study""AUTHOR NAMES","Fouache D.","Goëb V.","Massy-Guillemant N.","Avenel G.","Bacquet-Deschryver H.","Kozyreff-Meurice M.","Ménard J.-F.","Muraine M.","Savoye G.","Le Loët X.","Tharasse C.","Vittecoq O.""SOURCE","Rheumatology (2009) 48:7 (761-764). Date of Publication: 2009"

"TITLE","Long term treatment of psoriasis with TNF-alpha antagonists:Occurrence of malignant melanoma""AUTHOR NAMES","Kowalzick L.","Eickenscheidt L.","Komar M.","Schaarschmidt E.""SOURCE","Hautarzt (2009) 60:8 (655-657). Date of Publication: August 2009"

"TITLE","Etanercept in severe, recalcitrant psoriasis: Clinical response, safety profile and predictors of response based on a single institution's experience""AUTHOR NAMES","Antoniou C.","Dessinioti C.","Stratigos A.","Avgerinou G.","Stavropoulos P.","Katsambas A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:8 (979-982). Date of Publication: August 2009"

"TITLE","Arthralgia as an adverse event to infliximab: A reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept"

"AUTHOR NAMES","Moustou A.E.","Stratigos A.J.","Vergou T.","Gregoriou S.","Georgala S.","Danopoulou I.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:8 (968-969). Date of Publication: August 2009"

"TITLE","Tanning beds as an alternative for psoriasis when office-based phototherapy is not accessible""AUTHOR NAMES","Yentzer B.A.","Feldman S.R.""SOURCE","Journal of Dermatological Treatment (2009) 20:4 (238-240). Date of Publication: August 2009"

"TITLE","Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis""AUTHOR NAMES","Luger T.A.","Barker J.","Lambert J.","Yang S.","Robertson D.","Foehl J.","Molta C.T.","Boggs R.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:8 (896-904). Date of Publication: August 2009"

"TITLE","Treatment of psoriasis with efalizumab in patients with hepatitis C viral infection: Report of five cases""AUTHOR NAMES","Gisondi P.","Prignano F.","Grossi P.","Lotti T.","Girolomoni G.""SOURCE","Dermatology (2009) 219:2 (158-161). Date of Publication: August 2009"

"TITLE","Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French research axed on tolerance of biotherapies registry""AUTHOR NAMES","Tubach F.","Salmon D.","Ravaud P.","Allanore Y.","Goupille P.","Bréban M.","Pallot-Prades B.","Pouplin S.","Sacchi A.","Chichemanian R.M.","Bretagne S.","Emilie D.","Lemann M.","Lorthololary O.","Mariette X.""SOURCE","Arthritis and Rheumatism (2009) 60:7 (1884-1894). Date of Publication: July 2009"

"TITLE","Lichen planus-like eruptions: An emerging side effect of tumor necrosis factor-α antagonists""AUTHOR NAMES","Asarch A.","Gottlieb A.B.","Lee J.","Masterpol K.S.","Scheinman P.L.","Stadecker M.J.","Massarotti E.M.","Bush M.L.""SOURCE","Journal of the American Academy of Dermatology (2009) 61:1 (104-111). Date of Publication: July 2009"

"TITLE","Adalimumab treats psoriasis in patients previously treated with etanercept: A case series""AUTHOR NAMES","Yamauchi P.S.","Mau N.""SOURCE","Journal of the American Academy of Dermatology (2009) 61:1 (158-160). Date of Publication: July 2009"

"TITLE","Psoriasiform and pustular eruption induced by etanercept and infliximab""AUTHOR NAMES","Kuhara T.","Watanabe D.","Iwahori Y.","Tamada Y.","Yamamura M.","Matsumoto Y.""SOURCE","European Journal of Dermatology (2009) 19:4 (388-389). Date of Publication: July-August 2009"

"TITLE","Efalizumab for the treatment of pityriasis rubra pilaris: Experience in three patients""AUTHOR NAMES","Sinha A.","Natarajan S.""SOURCE","British Journal of Dermatology (2009) 161 SUPPL. 1 (15). Date of Publication: July 2009"

"TITLE","Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma""AUTHOR NAMES","Chong B.F.","Wong H.K.""SOURCE","Clinical and Experimental Dermatology (2009) 34:5 (e11-e13). Date of Publication: July 2009"

"TITLE","Serum levels of transforming growth factor-β1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs""AUTHOR NAMES","Kallimanis P.G.","Xenos K.","Markantonis S.L.","Stavropoulos P.","Margaroni G.","Katsambas A.","Avgerinou G.""SOURCE","Clinical and Experimental Dermatology (2009) 34:5 (582-586). Date of Publication: July 2009"

"TITLE","Adalimumab in the management of palmoplantar psoriasis""AUTHOR NAMES","Ghate J.V.","Alspaugh C.D.""SOURCE","Dermatology Online Journal (2009) 15:7 Article Number: 15. Date of Publication: July 2009"

"TITLE","Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: A case report""AUTHOR NAMES","Prignano F.","Zanieri F.","Milani S.","Lotti T."

"SOURCE","Dermatologic Therapy (2009) 22:4 (386-390). Date of Publication: July-August 2009"

"TITLE","Splenic tuberculosis during psoriasis treatment with infliximab""AUTHOR NAMES","Fortaleza G.T.D.M.","Brito M.D.F.D.M.","Dos Santos J.B.","Figueiredo A.R.","Gomes P.""SOURCE","Anais Brasileiros de Dermatologia (2009) 84:4 (420-424). Date of Publication: July-August 2009"

"TITLE","Psoriasis induced by infliximab in a patient suffering from Crohn's disease""AUTHOR NAMES","Manni E.","Barachini P.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:3 (841-844). Date of Publication: July-September 2009"

"TITLE","Hematogenous spinal infection in Central Greece""AUTHOR NAMES","Sakkas L.I.","Davas E.M.","Kapsalaki E.","Boulbou M.","Makaritsis K.","Alexiou I.","Tsikrikas T.","Stathakis N.""SOURCE","Spine (2009) 34:15 (E513-E518). Date of Publication: 1 Jul 2009"

"TITLE","Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis""AUTHOR NAMES","Kluger N.","Girard C.","Guillot B.","Bessis D.""SOURCE","Acta Dermato-Venereologica (2009) 89:3 (332-334). Date of Publication: 2009"

"TITLE","Epidemiological study of psoriasis in the national health insurance database in Taiwan""AUTHOR NAMES","Chang Y.-T.","Chen T.-J.","Liu P.-C.","Chen Y.-C.","Chen Y.-J.","Huang Y.-L.","Jih J.-S.","Chen C.-C.","Lee D.-D.","Wang W.-J.","Lin M.-W.","Liu H.-N.""SOURCE","Acta Dermato-Venereologica (2009) 89:3 (262-266). Date of Publication: 2009"

"TITLE","Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients""AUTHOR NAMES","Campione E.","Mazzotta A.","Paternò E.J.","Diluvio L.","Prinz J.C.","Chimenti S.""SOURCE","Acta Dermato-Venereologica (2009) 89:3 (288-291). Date of Publication: 2009"

"TITLE","Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers""AUTHOR NAMES","Costanzo A.","Talamonti M.","Botti E.","Spallone G.","Papoutsaki M.","Chimenti S.""SOURCE","Dermatology (2009) 219:1 (48-53). Date of Publication: June 2009"

"TITLE","Efalizumab treatment of psoriasis vulgaris: A cohort study in outpatient clinical practice""AUTHOR NAMES","Puig L.","Roé E.","García-Navarro X.","Corella F.","Alomar A.""SOURCE","Clinical and Experimental Dermatology (2009) 34:4 (469-475). Date of Publication: June 2009"

"TITLE","Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau""AUTHOR NAMES","Rubio C.","Martin M.A.","Sánchez D.M.A.","Vidaurrazaga C.","Casado M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:6 (707-708). Date of Publication: June 2009"

"TITLE","Sequential histological and immunohistochemical assessment of proliferation and apoptotic markers during treatment of psoriasis with antitumor necrosis factor α (infliximab)""AUTHOR NAMES","Gómez-Mateo C.","Ávalos-Peralta S.P.","Ríos-Martín J.J.","Carrizosa-Esquivel A.M.","González-Cámpora R.","Camacho-Martínez F.""SOURCE","Actas Dermo-Sifiliograficas (2009) 100:5 (420-424). Date of Publication: June 2009"

"TITLE","Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection""AUTHOR NAMES","Conde-Taboada A.","Muñoz J.P.","Campos Muñoz L.","López-Bran E.""SOURCE","Journal of the American Academy of Dermatology (2009) 60:6 (1077-1080). Date of Publication: June 2009"

"TITLE","Generalized pustular psoriasis of pregnancy treated with infliximab""AUTHOR NAMES","Sheth N.","Greenblatt D.T.","Acland K.","Barker J.","Teixeira F.""SOURCE","Clinical and Experimental Dermatology (2009) 34:4 (521-522). Date of Publication: June 2009"

"TITLE","Occurrence of plantar pustular psoriasis during treatment with infliximab""AUTHOR NAMES","English P.L.","Vender R.""SOURCE","Journal of Cutaneous Medicine and Surgery (2009) 13:1 (40-42). Date of Publication: 2009"

"TITLE","Thrombocytopenia associated with the use of anti-tumor necrosis factor-α agents for

psoriasis""AUTHOR NAMES","Brunasso A.M.G.","Massone C.""SOURCE","Journal of the American Academy of Dermatology (2009) 60:5 (781-785). Date of Publication: May 2009"

"TITLE","Psoriasis associated with ulcerative colitis and Crohn's disease""AUTHOR NAMES","Cohen A.D.","Dreiher J.","Birkenfeld S.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:5 (561-565). Date of Publication: May 2009"

"TITLE","Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response""AUTHOR NAMES","Rakkhit T.","Panko J.M.","Christensen T.E.","Wong B.","Nelson T.","Papenfuss J.","Hansen C.B.","Callis-Duffin K.","Krueger G.G.""SOURCE","British Journal of Dermatology (2009) 160:5 (1083-1089). Date of Publication: May 2009"

"TITLE","Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus""AUTHOR NAMES","Wambier C.G.","Foss-Freitas M.C.","Paschoal R.S.","Tomazini M.V.","Simão J.C.","Foss M.C.","Foss N.T.""SOURCE","Journal of the American Academy of Dermatology (2009) 60:5 (883-885). Date of Publication: May 2009"

"TITLE","Effect of immunosuppression on patients undergoing bariatric surgery""AUTHOR NAMES","Gagné D.J.","Papasavas P.K.","Dovec E.A.","Urbandt J.E.","Caushaj P.F.""SOURCE","Surgery for Obesity and Related Diseases (2009) 5:3 (339-345). Date of Publication: May 2009/June 2009"

"TITLE","Development of familial benign chronic pemphigus in a patient undergoing treatment with efalizumab for psoriasis""AUTHOR NAMES","Santos-Juanes J.","Coto-Segura P.","Saavedra J.","Laviano S.","Galache C.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:5 (605-606). Date of Publication: May 2009"

"TITLE","Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis""AUTHOR NAMES","O'Shea F.D.","Haroon N.","Salonen D.C.","Inman R.D.""SOURCE","Nature Clinical Practice Rheumatology (2009) 5:3 (171-173). Date of Publication: 2009"

"TITLE","Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-a-blocker therapy""AUTHOR NAMES","Lozeron P.","Denier C.","Lacroix C.","Adams D.""SOURCE","Archives of Neurology (2009) 66:4 (490-497). Date of Publication: April 2009"

"TITLE","Sonographic monitoring of psoriatic plaque""AUTHOR NAMES","Gutierrez M.","Filippucci E.","Bertolazzi C.","Grassi W.""SOURCE","Journal of Rheumatology (2009) 36:4 (850-851). Date of Publication: April 2009"

"TITLE","Long-term safety of infliximab for the treatment of inflammatory bowel disease: A single-centre cohort study""AUTHOR NAMES","Fidder H.","Schnitzler F.","Ferrante M.","Noman M.","Katsanos K.","Segaert S.","Henckaerts L.","Van Assche G.","Vermeire S.","Rutgeerts P.""SOURCE","Gut (2009) 58:4 (501-508). Date of Publication: April 2009"

"TITLE","Management of spondyloarthritis in ambulatory medicine""AUTHOR NAMES","León Vázquez F.","Sanz Rodrigo C.""SOURCE","Medicine (2009) 10:30 (2014-2020). Date of Publication: April 2009"

"TITLE","Proteinuria in a patient using adalimumab for psoriasis""AUTHOR NAMES","Ingraffea A.","Pedvis-Leftick A.""SOURCE","Journal of Dermatology (2009) 36:4 (249-250). Date of Publication: April 2009"

"TITLE","Certolizumab use in pregnancy""AUTHOR NAMES","Oussalah A.","Bigard M.-A.","Peyrin-Biroulet L.""SOURCE","Gut (2009) 58:4 (608). Date of Publication: April 2009"

"TITLE","Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy""AUTHOR NAMES","Pomerantza R.G.","Mody E.","Husni M.E.","Qureshi A.A.""SOURCE","Journal of Drugs in Dermatology (2009) 8:4 (406-412). Date of Publication: April 2009"

"TITLE","Efalizumab therapy for psoriasis in patients with inadequate responses to etanercept""AUTHOR NAMES","Kramer J.M.","Turner J.E."

"SOURCE","American Journal of Clinical Dermatology (2009) 10:2 (134-140). Date of Publication: 2009"

"TITLE","Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate""AUTHOR NAMES","Warren R.B.","Brown B.C.","Carmichael A.J.","Griffiths C.E.M.""SOURCE","Clinical and Experimental Dermatology (2009) 34:3 (415-416). Date of Publication: April 2009"

"TITLE","Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study""AUTHOR NAMES","Koc E.","Tunca M.","Akgul E.O.","Akar A.","Kurt Y.","Kurumlu Z.","Erbil K.","Kilic S.""SOURCE","Journal of Dermatology (2009) 36:4 (191-196). Date of Publication: April 2009"

"TITLE","Multiple basal cell carcinomas after etanercept treatment for psoriasis""AUTHOR NAMES","Maire C.","Delesalle F.","Carpentier O.","Lequint P.","Delaporte E.","Thomas P.""SOURCE","Annales de Dermatologie et de Venereologie (2009) 136:4 (355-359). Date of Publication: April 2009"

"TITLE","Angiogenesis in psoriatic skin and its modifications after administration of etanercept: Videocapillaroscopic, histological and immunohistochemical evaluation""AUTHOR NAMES","Campanati A.","Goteri G.","Simonetti O.","Ganzetti G.","Giuliodori K.","Giuliano A.","Sabato S.","Stramazzotti D.","Gulini E.","Dusi D.","De Blasio S.","Fabris G.","Offidani A.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:2 (371-377). Date of Publication: April-June 2009"

"TITLE","Non-randomized pilot study on the evaluation of the quality of life and psychosocial stress before and after systemic therapy in patients affected by moderate to severe psoriasis""AUTHOR NAMES","Panigalli S.","Coccarielli D.","Germi L.","Trevisan G.P.","Veller-Fornasa C.""SOURCE","Journal of Biological Regulators and Homeostatic Agents (2009) 23:2 (111-117). Date of Publication: April-June 2009"

"TITLE","Recall injection-site reactions to etanercept in a patient with psoriasis""AUTHOR NAMES","Papadavid E.","Makris M.","Dalamaga M.","Kalogeromitros D.","Stavrianeas N.""SOURCE","Clinical and Experimental Dermatology (2009) 34:3 (414-415). Date of Publication: April 2009"

"TITLE","Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis""AUTHOR NAMES","Prignano F.","Ricceri F.","Bianchi B.","Lotti T.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:2 (379-387). Date of Publication: April-June 2009"

"TITLE","Leukemic phase of follicular lymphoma after treatment with etanercept in a patient with psoriasis""AUTHOR NAMES","Ganguly S.""SOURCE","American Journal of Clinical Dermatology (2009) 10:2 (125-126). Date of Publication: 2009"

"TITLE","Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept""AUTHOR NAMES","Daulat S.","Detweiler J.G.","Pandya A.G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:4 (483-484). Date of Publication: April 2009"

"TITLE","Development of primary varicella infection during infliximab treatment for psoriasis""AUTHOR NAMES","Balato N.","Gaudiello F.","Balato A.","Ayala F.""SOURCE","Journal of the American Academy of Dermatology (2009) 60:4 (709-710). Date of Publication: April 2009"

"TITLE","Ophthalmic tacrolimus cream for the treatment of immunological corneal ulcers""AUTHOR NAMES","Dávila-Fajardo C.L.","Cabeza Barrera J.","Vallejo Rodríguez I.","García Serrano J.L.""SOURCE","Farmacia Hospitalaria (2009) 33:2 (112-113). Date of Publication: April 2009"

"TITLE","Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide""AUTHOR NAMES","Srinivasan S.","Schiffer C.A.""SOURCE","Leukemia Research (2009) 33:4 (561-564). Date of Publication: April 2009"

"TITLE","Palmoplantar psoriasis: A paradoxical adverse reaction induced by adalimumab""AUTHOR NAMES","Bordel-Gómez M.T.","Sánchez-Estella J.","Martínez-González O.","Cardeñoso-Álvarez M.E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:4 (444-445).

Date of Publication: April 2009"

"TITLE","Alefacept treatment for refractory chronic extensive GVHD""AUTHOR NAMES","Shapira M.Y.","Abdul-Hai A.","Resnick I.B.","Bitan M.","Tsirigotis P.","Aker M.","Gesundheit B.","Slavin S.","Or R.""SOURCE","Bone Marrow Transplantation (2009) 43:4 (339-343). Date of Publication: 2009"

"TITLE","Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease""AUTHOR NAMES","Ávila Álvarez A.","García-Alonso L.","Solar Boga A.","García-Silva J.""SOURCE","Anales de Pediatria (2009) 70:3 (278-281). Date of Publication: March 2009"

"TITLE","Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort""AUTHOR NAMES","Dalaker M.","Bonesrønning J.H.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:3 (277-282). Date of Publication: March 2009"

"TITLE","Three-year registry data on biological treatment for psoriasis: The influence of patient characteristics on treatment outcome""AUTHOR NAMES","Driessen R.J.B.","Boezeman J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2009) 160:3 (670-675). Date of Publication: March 2009"

"TITLE","Increasing use of more potent treatments for psoriasis""AUTHOR NAMES","Strowd L.C.","Yentzer B.A.","Fleischer Jr. A.B.","Feldman S.R.""SOURCE","Journal of the American Academy of Dermatology (2009) 60:3 (478-481). Date of Publication: March 2009"

"TITLE","Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: Analysis of nationwide experience in Scotland (2004-2008)""AUTHOR NAMES","Ho G.T.","Mowat A.","Potts L.","Cahill A.","Mowat C.","Lees C.W.","Hare N.C.","Wilson J.A.","Boulton-Jones R.","Priest M.","Watts D.A.","Shand A.G.","Arnott I.D.","Russell R.K.","Wilson D.C.","Morris A.J.","Satsangi J.""SOURCE","Alimentary Pharmacology and Therapeutics (2009) 29:5 (527-534). Date of Publication: March 2009"

"TITLE","First case report of adalimumab-induced psoriasis in Crohn's disease""AUTHOR NAMES","Harris M.D.","Richards R.""SOURCE","American Journal of Gastroenterology (2009) 104:3 (792-793). Date of Publication: March 2009"

"TITLE","Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: A randomized-controlled trial""AUTHOR NAMES","Caproni M.","Antiga E.","Melani L.","Volpi W.","Del Bianco E.","Fabbri P.""SOURCE","Journal of Clinical Immunology (2009) 29:2 (210-214). Date of Publication: March 2009"

"TITLE","Urticaria due to etanercept in a patient with psoriatic arthritis""AUTHOR NAMES","Borrás-Blasco J.","Gracia-Perez A.","Rosique-Robles J.D.","Nuñez-Cornejo C.","Casterá M.D.E.","Abad F.J.""SOURCE","Southern Medical Journal (2009) 102:3 (304-305). Date of Publication: March 2009"

"TITLE","Infliximab-induced pustular psoriasis in a patient with Crohn's disease""AUTHOR NAMES","Monteagudo Sánchez B.","Cabanillas M.","Ortiz- S.","Gallego-Ojea J.C.""SOURCE","Gastroenterologia y Hepatologia (2009) 32:3 (175-176). Date of Publication: March 2009"

"TITLE","Care of patients with psoriasis: An audit of U.K. services in secondary care""AUTHOR NAMES","Eedy D.J.","Griffiths C.E.M.","Chalmers R.J.G.","Ormerod A.D.","Smith C.H.","Barker J.N.W.N.","Potter J.","Ingham J.","Lowe D.","Burge S.""SOURCE","British Journal of Dermatology (2009) 160:3 (557-564). Date of Publication: March 2009"

"TITLE","Psoriasis vulgaris: How effective and safe is the calcineurin inhibitor voclosporin?""AUTHOR NAMES","Ecker-Schlipf B.""SOURCE","Arzneimitteltherapie (2009) 27:3 (97-98). Date of Publication: March 2009"

"TITLE","Acrodermatitis continua resistant to etanercept: Therapeutic challenge and Unfortunate outcome""AUTHOR NAMES","Gokdemir G.","Kutlu S.","Köşlü A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:3 (345-347). Date of Publication: March 2009"

"TITLE","Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial"

"AUTHOR NAMES","Gottlieb A.","Menter A.","Mendelsohn A.","Shen Y.-K.","Li S.","Guzzo C.","Fretzin S.","Kunynetz R.","Kavanaugh A.""SOURCE","The Lancet (2009) 373:9664 (633-640). Date of Publication: 20090221/27"

"TITLE","Efalizumab: A review of its use in the management of chronic moderate-to-severe plaque psoriasis""AUTHOR NAMES","Frampton J.E.","Plosker G.L.""SOURCE","American Journal of Clinical Dermatology (2009) 10:1 (51-72). Date of Publication: 2009"

"TITLE","Cancer in arthritis patients after anti-tumour necrosis factor therapy""AUTHOR NAMES","Dreyer L.","Mellemkjaer L.","Hetland M.L.""SOURCE","Ugeskrift for laeger (2009) 171:7 (506-511). Date of Publication: 9 Feb 2009"

"TITLE","Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Zhu Y.","Hu C.","Lu M.","Liao S.","Marini J.C.","Yohrling J.","Yeilding N.","Davis H.M.","Zhou H.""SOURCE","Journal of Clinical Pharmacology (2009) 49:2 (162-175). Date of Publication: February 2009"

"TITLE","Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: Results from the British Society for Rheumatology Biologies Register""AUTHOR NAMES","Harrison M.J.","Dixon W.G.","Watson K.D.","King Y.","Groves R.","Hyrich K.L.","Symmons D.P.M.""SOURCE","Annals of the Rheumatic Diseases (2009) 68:2 (209-215). Date of Publication: February 2009"

"TITLE","Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies""AUTHOR NAMES","Driessen R.J.B.","Boezeman J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","Journal of Dermatological Treatment (2009) 20:1 (42-47). Date of Publication: February 2009"

"TITLE","Adalimumab for Crohn's disease with intolerance or lost response to infliximab: A 3-year single-centre experience""AUTHOR NAMES","Oussalah A.","Babouri A.","Chevaux J.-B.","Stancu L.","Trouilloud I.","Bensenane M.","Boucekkine T.","Bigard M.-A.","Peyrin-Biroulet L.""SOURCE","Alimentary Pharmacology and Therapeutics (2009) 29:4 (416-423). Date of Publication: February 2009"

"TITLE","Hidradenitis suppurativa managed with adalimumab""AUTHOR NAMES","Yamauchi P.S.","Mau N.""SOURCE","Journal of Drugs in Dermatology (2009) 8:2 (181-183). Date of Publication: February 2009"

"TITLE","Efficacy and safety of Ustekinumab, a human monoclonal interleukin-12/-23 monoclonal antibody, in patients with psoriasis: Results from the randomised, double-blind, placebo-controlled phase-III-trials PHOENIX 1 and PHOENIX 2""AUTHOR NAMES","Reich K.""SOURCE","Aktuelle Dermatologie (2009) 35:1-2 (29-34). Date of Publication: February 2009"

"TITLE","Economic evaluation of etanercept in the management of chronic plaque psoriasis""AUTHOR NAMES","Lloyd A.","Reeves P.","Conway P.","Reynolds A.","Baxter G.""SOURCE","British Journal of Dermatology (2009) 160:2 (380-386). Date of Publication: February 2009"

"TITLE","Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate""AUTHOR NAMES","Darabi K.","Jaiswal R.","Hostetler S.","Bechtel M.","Zirwas M.""SOURCE","Journal of Drugs in Dermatology (2009) 8:2 (175-178). Date of Publication: February 2009"

"TITLE","Infliximab-induced acne: A new case and review of published reports""AUTHOR NAMES","Steels E.","Peretz A.","Vereecken P.""SOURCE","Journal of Dermatological Treatment (2009) 20:1 (59-60). Date of Publication: February 2009"

"TITLE","A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis""AUTHOR NAMES","Kitamura G.","Mehr N.","Anderson N.","Sirichotiratana M.""SOURCE","Dermatology Online Journal (2009) 15:2 Article Number: 11. Date of Publication: February 2009"

"TITLE","Erythroderma in two patients with psoriasis upon discontinuation of efalizumab

treatment""AUTHOR NAMES","Kop E.N.","Korver J.E.M.","Van Ruysevelt D.","De Jong E.M.G.J.","Van Der Valk P.G.","Van De Kerkhof P.C.M.""SOURCE","Journal of Dermatological Treatment (2009) 20:1 (67-69). Date of Publication: February 2009"

"TITLE","Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis""AUTHOR NAMES","Newell E.L.","Jain S.","Stephens C.","Martland G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2009) 23:2 (230-231). Date of Publication: February 2009"

"TITLE","Psoriasis in a tattoo""AUTHOR NAMES","Kluger N.","Debu A.","Girard C.","Bessis D.","Guillot B.""SOURCE","Presse Medicale (2009) 38:2 (338-339). Date of Publication: February 2009"

"TITLE","Biologic therapies for psoriasis: Practical experience in a U.K. tertiary referral centre""AUTHOR NAMES","Warren R.B.","Brown B.C.","Lavery D.","Ashcroft D.M.","Griffiths C.E.M.""SOURCE","British Journal of Dermatology (2009) 160:1 (162-169). Date of Publication: January 2009"

"TITLE","Tuberculosis and tumour necrosis factor-α inhibitor therapy: A report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians""AUTHOR NAMES","Perlmutter A.","Mittal A.","Menter A.""SOURCE","British Journal of Dermatology (2009) 160:1 (8-15). Date of Publication: January 2009"

"TITLE","Possibilities and limits for treating psoriasis with biologics. Case reports""AUTHOR NAMES","Süß A.","Colsman A.","Simon J.C.","Sticherling M.""SOURCE","Hautarzt (2009) 60:1 (51-57). Date of Publication: January 2009"

"TITLE","A multicenter open-label experience on the response on psoriasis to adalimumab and effect of dose escalation in non-responders: The aphrodite project""AUTHOR NAMES","Vena G.A.","Galluccio A.","De Simone C.","Mastrandrea V.","Buquicchio R.","La Greca S.","Dattola S.","Puglisi Guerra A.","Donato L.","Cantoresi F.","De Pita O.","Pezza M.","D'Agostino M.","Vernaci R.","Miracapillo A.","Velenti G.","Cassano N.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:1 (227-233). Date of Publication: January/March 2009"

"TITLE","Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis""AUTHOR NAMES","Esposito M.","Mazzotta A.","Saraceno R.","Schipani C.","Chimenti S.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:1 (219-225). Date of Publication: January/March 2009"

"TITLE","Efficacy of cyclosporine in the treatment of a case of infliximab-induced erythrodermic psoriasis""AUTHOR NAMES","Bruzzese V.","Pepe J.""SOURCE","International Journal of Immunopathology and Pharmacology (2009) 22:1 (235-238). Date of Publication: January/March 2009"

"TITLE","Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept""AUTHOR NAMES","Wolf P.","Hofer A.","Legat F.J.","Bretterklieber A.","Weger W.","Salmhofer W.","Kerl H.""SOURCE","British Journal of Dermatology (2009) 160:1 (186-189). Date of Publication: January 2009"

"TITLE","Long-term efficacy and safety of calcipotriol/betamethasone dipropionate in the treatment of psoriasis""AUTHOR NAMES","Girolomoni G.","Pugliarello S.""SOURCE","Journal of Plastic Dermatology (2009) 5:1 (69-74). Date of Publication: January/March 2009"

"TITLE","Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept""AUTHOR NAMES","Lafaille P.","Bouffard D.","Provost N.""SOURCE","Archives of Dermatology (2009) 145:1 (94-95). Date of Publication: January 2009"

"TITLE","Digital vasculitis: A late complication of anti-tumour necrosis factor alpha therapy""AUTHOR NAMES","Mangat P.","Whittle S.","Cleland L.","Limaye V.""SOURCE","Clinical Rheumatology (2008) 27:12 (1593-1595). Date of Publication: 2008"

"TITLE","ILVEN: Is it psoriasis? Debate based on successful treatment with etanercept""AUTHOR NAMES","Renner R.","Colsman A.","Sticherling M.""SOURCE","Acta Dermato-Venereologica (2008) 88:6 (631-632). Date of Publication: 2008"

"TITLE","Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - A therapeutic challenge""AUTHOR NAMES","Kucharekova M.","Winnepenninckx V.","Frank J.","Poblete-Gutiérrez P.""SOURCE","International Journal of Dermatology (2008) 47:SUPPL. 1 (25-28). Date of Publication: 2008"

"TITLE","Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: A cross-sectional study""AUTHOR NAMES","Davaine A.C.","Saraux A.","Prigent S.","Kupfer-Bessaguet I.","Roswag D.","Plantin P.","Schoenlaub P.","Talarmin F.","Zagnoli A.","Misery L.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:12 (1471-1477). Date of Publication: December 2008"

"TITLE","Biologic therapy(TNF-α antagonists)-induced psoriasis: A cytokine imbalance between TNF-α and IFN-α?""AUTHOR NAMES","Cuchacovich R.","Espinoza C.G.","Virk Z.","Espinoza L.R.""SOURCE","Journal of Clinical Rheumatology (2008) 14:6 (353-356). Date of Publication: December 2008"

"TITLE","Efficacy of a day-care program in the treatment of psoriasis""AUTHOR NAMES","Zhang J.","Adam D.N.","Stebbing E.","Gerbrandt J.","Lui H.","Shapiro J.","Zhou Y.""SOURCE","Journal of Cutaneous Medicine and Surgery (2008) 12:5 (211-216). Date of Publication: 2008"

"TITLE","Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab""AUTHOR NAMES","Yawalkar N.","Hunger R.E.""SOURCE","Dermatology (2009) 218:1 (79-83). Date of Publication: December 2008"

"TITLE","Efficacy and safety of continuous versus paused etanercept teatment in patients with moderate-to-severe psoriasis over 54 weeks: The CRYSTEL study""AUTHOR NAMES","Ortonne J.-P.","Griffiths C.E.M.","Daudén E.","Strohal R.","Robertson D.","Pedersen R.","Molta C.","Freundlich B.""SOURCE","Expert Review of Dermatology (2008) 3:6 (657-665). Date of Publication: 2008"

"TITLE","Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population""AUTHOR NAMES","Wu E.Q.","Feldman S.R.","Chen L.","Kaltenboeck A.","Yu A.P.","Gupta S.R.","Laitinen D.","Willian M.K.""SOURCE","Current Medical Research and Opinion (2008) 24:12 (3493-3501). Date of Publication: 2008"

"TITLE","Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations.""AUTHOR NAMES","Menter A.","Reich K.","Gottlieb A.B.","Bala M.","Li S.","Hsu M.C.","Guzzo C.","Diels J.","Gelfand J.M.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:12 (1137-1146). Date of Publication: Dec 2008"

"TITLE","Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab""AUTHOR NAMES","Brunasso A.M.G.","Delfino C.","Massone C.""SOURCE","Dermatology (2009) 218:1 (73-74). Date of Publication: December 2008"

"TITLE","Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection""AUTHOR NAMES","Alcaide A.J.","Barrera M.V.","Habicheyn S.","López N.","Mendiola M.V.","Herrera E.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:12 (1514-1516). Date of Publication: December 2008"

"TITLE","EBV-associated smooth muscle neoplasms: Solid tumors arising in the presence of immunosuppression and autoimmune diseases""AUTHOR NAMES","Moore Dalal K.","Antonescu C.R.","DeMatteo R.P.","Maki R.G.""SOURCE","Sarcoma (2008) 2008 Article Number: 859407. Date of Publication: 2008"

"TITLE","Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis: Evidence from the psocare project""AUTHOR NAMES","Naldi L.","Addis A.","Chimenti S.","Giannetti A.","Picardo M.","Tomino C.","Maccarone M.","Chatenoud L.","Bertuccio P.","Caggese E.","Cuscito R.","Venegoni M.""SOURCE","Dermatology (2008) 217:4 (365-373). Date of Publication: November 2008"

"TITLE","Psoriasis disappearance after the first phase of an oncologic treatment: A serendipity case report""AUTHOR NAMES","Cagiano R.","Bera I.","Vermesan D.","Flace R.","Sabatini R.","Bottalico

L.","Auteri P.","Santacroce L.""SOURCE","Clinica Terapeutica (2008) 159:6 (421-425). Date of Publication: November/December 2008"

"TITLE","Cutaneous adverse effects of biological therapies for psoriasis""AUTHOR NAMES","Roé E.","Puig L.","Corella F.","García-Navarro X.","Alomar A.""SOURCE","European Journal of Dermatology (2008) 18:6 (693-699). Date of Publication: November/December 2008"

"TITLE","Angiokeratoma induced by injection of etanercept for psoriasis""AUTHOR NAMES","Bathelier E.","Gunera-Saad N.","Bérard F.","Nicolas J.-F.""SOURCE","Journal of the American Academy of Dermatology (2008) 59:5 SUPPL. (S124-S125). Date of Publication: November 2008"

"TITLE","Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver""AUTHOR NAMES","Piel S.","Dissemond J.""SOURCE","Journal of the American Academy of Dermatology (2008) 59:5 SUPPL. (S117-S118). Date of Publication: November 2008"

"TITLE","Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.""AUTHOR NAMES","Hamilton T.K.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:11 (1089-1093). Date of Publication: Nov 2008"

"TITLE","Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: A randomized controlled trial with open-label extension""AUTHOR NAMES","Van De Kerkhof P.C.M.","Segaert S.","Lahfa M.","Luger T.A.","Karolyi Z.","Kaszuba A.","Leigheb G.","Camacho F.M.","Forsea D.","Zang C.","Boussuge M.P.","Paolozzi L.","Wajdula J.""SOURCE","British Journal of Dermatology (2008) 159:5 (1177-1185). Date of Publication: November 2008"

"TITLE","A case of infliximab-induced psoriasis""AUTHOR NAMES","Richetta A.G.","Mattozzi C.","Carlomagno V.","Maiani E.","Carboni V.","Giancristoforo S.","D'Epiro S.","Bruni F.","Calvieri S.""SOURCE","Dermatology Online Journal (2008) 14:11 Article Number: 9. Date of Publication: November 2008"

"TITLE","Reduced watery diarrhea during pregnancy in a psoriasis patient with lymphocytic colitis""AUTHOR NAMES","Wiedermann C.J.","Zagler B.""SOURCE","Zeitschrift fur Gastroenterologie (2008) 46:11 (1275-1277). Date of Publication: November 2008"

"TITLE","A case report of generalized pustulosis with systemic manifestations requiring burn intensive care unit admission""AUTHOR NAMES","Pomahac B.","Lim J.","Liu A.""SOURCE","Journal of Burn Care and Research (2008) 29:6 (1004-1008). Date of Publication: November/December 2008"

"TITLE","Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy""AUTHOR NAMES","Bodur H.","Seçkin Ü.","Eser F.","Ergül G.","Seçkin S.""SOURCE","Rheumatology International (2008) 29:1 (107-110). Date of Publication: November 2008"

"TITLE","The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy""AUTHOR NAMES","Zachariae C.","Mørk N.-J.","Reunala T.","Lorentzen H.","Falk E.","Karvonen S.-L.","Johannesson A.","Claŕeus B.","Skov L.","Mørk G.","Walker S.","Qvitzau S.""SOURCE","Acta Dermato-Venereologica (2008) 88:5 (495-501). Date of Publication: 2008"

"TITLE","Cytomegalovirus complicating biological immunosuppressive therapy in two patients with psoriasis receiving treatment with etanercept or efalizumab""AUTHOR NAMES","Petersen B.","Lorentzen H.""SOURCE","Acta Dermato-Venereologica (2008) 88:5 (523-524). Date of Publication: 2008"

"TITLE","Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study""AUTHOR NAMES","Revicki D.A.","Menter A.","Feldman S.","Kimel M.","Harnam N.","Willian M.K.""SOURCE","Health and Quality of Life Outcomes (2008) 6 Article Number: 75. Date of Publication: 2 Oct 2008"

"TITLE","Recurrent hyperglycemia during adalimumab treatment in a patient with psoriasis""AUTHOR NAMES","Wu J.-J.","Tsai T.-F.""SOURCE","Archives of Dermatology (2008) 144:10 (1403-1404). Date of Publication: October 2008"

"TITLE","Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: A single-centre experience""AUTHOR NAMES","Oussalah A.","Laclotte C.","Chevaux J.-B.","Bensenane M.","Babouri A.","Serre A.-A.","Boucekkine T.","Roblin X.","Bigard M.-A.","Peyrin-Biroulet L.""SOURCE","Alimentary Pharmacology and Therapeutics (2008) 28:8 (966-972). Date of Publication: October 2008"

"TITLE","Infliximab for the treatment of severe pustular psoriasis: 6 Years later""AUTHOR NAMES","Varma R.","Cantrell W.","Elmets C.","Elewski B.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:10 (1253-1254). Date of Publication: October 2008"

"TITLE","Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis""AUTHOR NAMES","Kaye J.A.","Li L.","Jick S.S.""SOURCE","British Journal of Dermatology (2008) 159:4 (895-902). Date of Publication: October 2008"

"TITLE","Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: An exploratory analysis from the aphrodite data""AUTHOR NAMES","Cassano N.","Galluccio A.","De Simone C.","Loconsole F.","Massimino S.D.","Plumari A.","Dattola S.","Guerra A.P.","Donato L.","Cantoresi F.","De Pità O.","Fenizi G.","Altamura V.","Congedo M.","Pellicano R.","Vena G.A.""SOURCE","Journal of Biological Regulators and Homeostatic Agents (2008) 22:4 (233-237). Date of Publication: October/December 2008"

"TITLE","Efficacy of adalimumab in plaque psoriasis: experience on 28 patients.""AUTHOR NAMES","Ardigò M.","Giuliani A.","de Felice C.","Mastroianni A.","Berardesca E.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:10 (935-939). Date of Publication: Oct 2008"

"TITLE","Recurrent varicella in an adult psoriasis patient treated with etanercept""AUTHOR NAMES","Becart S.","Segaert S.""SOURCE","Dermatology (2008) 217:3 (260-261). Date of Publication: October 2008"

"TITLE","Etanercept in the treatment of palmoplantar pustulosis.""AUTHOR NAMES","Bissonnette R.","Poulin Y.","Bolduc C.","Maari C.","Provost N.","Syrotuik J.","Poulin-Costello C.M.","Nigen S.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:10 (940-946). Date of Publication: Oct 2008"

"TITLE","Cutaneous lesions in the legs of a patient with psoriasis in infliximab and methotrexate treatment""AUTHOR NAMES","Loureiro Martínez M.","Concheiro Cao J.""SOURCE","Piel (2008) 23:8 (433-434). Date of Publication: October 2008"

"TITLE","Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.""AUTHOR NAMES","Egnatios G.","Warthan M.M.","Pariser R.","Hood A.F.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:10 (975-977). Date of Publication: Oct 2008"

"TITLE","Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study""AUTHOR NAMES","Van Lingen R.G.","De Jong E.M.G.J.","Berends M.A.M.","Seyger M.M.B.","Van Erp P.E.J.","Van De Kerkhof P.C.M.""SOURCE","Journal of Dermatological Treatment (2008) 19:5 (284-287). Date of Publication: 2008"

"TITLE","'Coral reef' psoriasis: A marker of resistance to topical treatment""AUTHOR NAMES","Feldman S.R.","Brown K.L.","Heald P.""SOURCE","Journal of Dermatological Treatment (2008) 19:5 (257-258). Date of Publication: 2008"

"TITLE","Efalizumab in the treatment of psoriasis: When comorbidity is an issue""AUTHOR NAMES","Prignano F.","Buggiani G.","Lotti T.""SOURCE","Dermatologic Therapy (2008) 21:SUPPL. 2 (S25-S29). Date of Publication: September/October 2008"

"TITLE","Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab""AUTHOR NAMES","Paltiel M.","Gober L.M.","Deng A.","Mikdashi J.","Alexeeva I.","Saini S.S.","Gaspari A.A.""SOURCE","Archives of Dermatology (2008) 144:9 (1190-1194). Date of Publication: September

2008"

"TITLE","Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment""AUTHOR NAMES","De Oliveira J.P.","Levy A.","Morel P.","Guibal F.""SOURCE","Journal of Dermatology (2008) 35:9 (575-580). Date of Publication: September 2008"

"TITLE","Low-dose etanercept therapy in moderate to severe psoriasis in Korean""AUTHOR NAMES","Na J.I.","Kim J.H.","Park K.C.","Youn S.W.""SOURCE","Journal of Dermatology (2008) 35:8 (484-490). Date of Publication: September 2008"

"TITLE","Clinical experience with etanercept in the treatment of psoriasis""AUTHOR NAMES","Martín González B.","Sánchez-Carazo J.L.","Pérez-Ferriols A.","Laguna C.","Oliver V.","Alegre V.""SOURCE","Actas Dermo-Sifiliograficas (2008) 99:7 (540-545). Date of Publication: 1 Sep 2008"

"TITLE","Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis""AUTHOR NAMES","Bongiorno M.R.","Pistone G.","Doukaki S.","Aricò M.""SOURCE","Dermatologic Therapy (2008) 21:SUPPL. 2 (S15-S20). Date of Publication: September/October 2008"

"TITLE","Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis""AUTHOR NAMES","Feldman S.R.","Gottlieb A.B.","Bala M.","Wu Y.","Eisenberg D.","Guzzo C.","Li S.","Dooley L.T.","Menter A.""SOURCE","British Journal of Dermatology (2008) 159:3 (704-710). Date of Publication: September 2008"

"TITLE","Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis""AUTHOR NAMES","Driessen R.J.B.","De Jong E.M.G.J.","De Rie M.A.","Salemink G.W.","Van De Kerkhof P.C.M.""SOURCE","British Journal of Dermatology (2008) 159:3 (760-761). Date of Publication: September 2008"

"TITLE","Palmoplantar pustular psoriasis: Successful therapy with efalizumab after non-response to infliximab""AUTHOR NAMES","Wozel G.G.","Vitéz L.","Meurer M.""SOURCE","Acta Dermatovenerologica Alpina, Pannonica et Adriatica (2008) 17:3 (133-136). Date of Publication: September 2008"

"TITLE","A photo quiz to hone dermatologic skills""AUTHOR NAMES","Kaplan D.L.""SOURCE","Consultant (2008) 48:10 (754-756+759-760). Date of Publication: September 2008"

"TITLE","Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving Infliximab: A case report""AUTHOR NAMES","Justice E.A.","Khan S.Y.","Logan S.","Jobanputra P.""SOURCE","Journal of Medical Case Reports (2008) 2 Article Number: 282. Date of Publication: 26 Aug 2008"

"TITLE","Long-term efficacy of adalimumab in generalized pustular psoriasis""AUTHOR NAMES","Zangrilli A.","Papoutsaki M.","Talamonti M.","Chimenti S.""SOURCE","Journal of Dermatological Treatment (2008) 19:3 (185-187). Date of Publication: 2008"

"TITLE","Menorrhagia and severe menstrual pain related to the use of adalimumab in a psoriatic""AUTHOR NAMES","Scheinfeld N.""SOURCE","Journal of Dermatological Treatment (2008) 19:3 (188-189). Date of Publication: 2008"

"TITLE","Psoriasis vulgaris associated with acne vulgaris: Differential effects of biologicals?""AUTHOR NAMES","Colsman A.","Sticherling M.""SOURCE","Acta Dermato-Venereologica (2008) 88:4 (418-419). Date of Publication: 2008"

"TITLE","Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients""AUTHOR NAMES","Gerloni V.","Pontikaki I.","Gattinara M.","Fantini F.""SOURCE","Annals of the Rheumatic Diseases (2008) 67:8 (1145-1152). Date of Publication: August 2008"

"TITLE","Letter to the editor""AUTHOR NAMES","Lucas A.","Belinchón I.","Pérez-Crespo M.","Mataix J.","Betlloch I.""SOURCE","Australasian Journal of Dermatology (2008) 49:3 (173-174). Date of Publication: August 2008"

"TITLE","Psoriasiform lesions induced by tumour necrosis factor antagonists: A skin-deep medical conundrum"

"AUTHOR NAMES","Carter J.D.","Gerard H.C.","Hudson A.P.""SOURCE","Annals of the Rheumatic Diseases (2008) 67:8 (1181-1183). Date of Publication: August 2008"

"TITLE","From biologic to biologic to biologic: Lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis""AUTHOR NAMES","Yip L.","Harrison S.","Foley P.""SOURCE","Australasian Journal of Dermatology (2008) 49:3 (152-155). Date of Publication: August 2008"

"TITLE","Long-term control with etanercept (Enbrel®) of a severe acrodermatitis continua of hallopeau refractory to infliximab (Remicade®)""AUTHOR NAMES","Thielen A.-M.","Barde C.","Marazza G.","Saurat J.-H.""SOURCE","Dermatology (2008) 217:2 (137-139). Date of Publication: August 2008"

"TITLE","Etanercept combined with methotrexate for high-need psoriasis""AUTHOR NAMES","Driessen R.J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2008) 159:2 (460-463). Date of Publication: August 2008"

"TITLE","Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis""AUTHOR NAMES","Strober B.","Teller C.","Yamauchi P.","Miller J.L.","Hooper M.","Yang Y.-C.","Dann F.""SOURCE","British Journal of Dermatology (2008) 159:2 (322-330). Date of Publication: August 2008"

"TITLE","First manifestation of psoriasis vulgaris in tumor necrosis factor receptor-associated periodic syndrome during treatment with etanercept""AUTHOR NAMES","Boms S.","Sehr T.","Jappe U.","Enk A.""SOURCE","Hautarzt (2008) 59:8 (653-655). Date of Publication: August 2008"

"TITLE","Evaluation of the efficacy and safety of infliximab on psoriatic nails: An unblinded, nonrandomized, open-label study""AUTHOR NAMES","Rigopoulos D.","Gregoriou S.","Stratigos A.","Larios G.","Korfitis C.","Papaioannou D.","Antoniou C.","Ioannides D.""SOURCE","British Journal of Dermatology (2008) 159:2 (453-456). Date of Publication: August 2008"

"TITLE","Gastric MALT lymphoma in a patient receiving infliximab for psoriasis""AUTHOR NAMES","Girard C.","Guillot B.","Bessis D.""SOURCE","British Journal of Dermatology (2008) 159:2 (497-498). Date of Publication: August 2008"

"TITLE","Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action""AUTHOR NAMES","Collamer A.N.","Guerrero K.T.","Henning J.S.","Battafarano D.F.""SOURCE","Arthritis Care and Research (2008) 59:7 (996-1001). Date of Publication: 15 Jul 2008"

"TITLE","Type I reaction of Hansen's disease with exposure to adalimumab: A case report""AUTHOR NAMES","Oberstein E.M.","Kromo O.","Tozman E.C.""SOURCE","Arthritis Care and Research (2008) 59:7 (1040-1043). Date of Publication: 15 Jul 2008"

"TITLE","Long-term management of generalized pustular psoriasis with infliximab: Case series""AUTHOR NAMES","Routhouska S.B.","Sheth P.B.","Korman N.J.""SOURCE","Journal of Cutaneous Medicine and Surgery (2008) 12:4 (184-188). Date of Publication: July/August 2008"

"TITLE","Balneotherapy for chronic plaque psoriasis at Comano spa in Trentino, Italy""AUTHOR NAMES","Peroni A.","Gisondi P.","Zanoni M.","Girolomoni G.""SOURCE","Dermatologic Therapy (2008) 21:SUPPL. 1 (S31-S38). Date of Publication: July/August 2008"

"TITLE","Severe recalcitrant nail psoriasis responding dramatically to infliximab: Report of two patients""AUTHOR NAMES","Hussain W.","Coulson I.","Owen C.""SOURCE","Clinical and Experimental Dermatology (2008) 33:4 (520-522). Date of Publication: July 2008"

"TITLE","Urticarial vasculitis due do infliximab""AUTHOR NAMES","Goulão J.","Cunha H.","Anes I.","Bártolo E.","Furtado C.","Serrano P.","Brandão F.M.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:7 (882-883). Date of Publication: July 2008"

"TITLE","Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: Effect of immune-targeted antipsoriatic therapies""AUTHOR NAMES","Van Lingen R.G.","Körver J.E.M.","Van De Kerkhof P.C.M.","Berends M.A.M.","Van Rens D.W.A.","Langewouters A.M.","Boezeman J.B.M.","Seyger M.M.B.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2008) 159:1 (91-96). Date of Publication: July 2008"

"TITLE","Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment""AUTHOR NAMES","Cordiali-Fei P.","Ardigò M.","Mastroianni A.","Giuliani A.","D'Agosto G.","Bordignon V.","Trento E.","Vento A.","Berardesca E.""SOURCE","International Journal of Immunopathology and Pharmacology (2008) 21:3 (643-649). Date of Publication: July/September 2008"

"TITLE","Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis""AUTHOR NAMES","Esposito M.","Saraceno R.","Schipani C.","Di Marcantonio D.","Bianchi L.","Chimenti S.""SOURCE","Journal of Infection (2008) 57:1 (90-92). Date of Publication: July 2008"

"TITLE","Psychiatric issues in dermatology, Part 1: Atopic dermatitis and psoriasis""AUTHOR NAMES","Levenson J.L.""SOURCE","Primary Psychiatry (2008) 15:7 (35-38). Date of Publication: July 2008"

"TITLE","Etanercept as a possible trigger of fatal pulmonary fibrosis""AUTHOR NAMES","Díez Piña J.M.","Gómez Ó.V.","Alises S.M.","García Jiménez J.D.","Álvarez D.Á.","Bolado M.P.R.""SOURCE","Archivos de Bronconeumologia (2008) 44:7 (393-395). Date of Publication: July 2008"

"TITLE","Effective control of psoriasis by etanercept in a patient with HCV-related diseases""AUTHOR NAMES","Piccolo D.","Di Cesare A.","Fargnoli M.C.","Paoloni M.","Vecchiotti S.","Peris K.""SOURCE","European Journal of Dermatology (2008) 18:4 (459-460). Date of Publication: July/August 2008"

"TITLE","Infliximab""AUTHOR NAMES","Herrera E.","Habicheyn S.""SOURCE","Actas dermo-sifiliográficas (2008) 99 Suppl 4 (7-13). Date of Publication: Jul 2008"

"TITLE","Our experience with infliximab in reclacitrant cases of psoriasis""AUTHOR NAMES","Pereiro Jr. M.","González-Vilas D.","Sánchez-Aguilar D.","Toribio J.""SOURCE","Actas dermo-sifiliográficas (2008) 99 Suppl 4 (43-47). Date of Publication: Jul 2008"

"TITLE","Induction of pustular lesions during infliximab therapy for Crohn's disease""AUTHOR NAMES","Pérez-Pérez L.","Caeiro J.-L.","Fabeiro J.-M.","Allegue F.","Zulaica A.""SOURCE","Acta Dermato-Venereologica (2008) 88:3 (292-293). Date of Publication: 2008"

"TITLE","Patch testing a patient with allergic contact hand dermatitis who is taking infliximab""AUTHOR NAMES","Rosmarin D.","Bush M.","Scheinman P.L.""SOURCE","Journal of the American Academy of Dermatology (2008) 59:1 (145-147). Date of Publication: July 2008"

"TITLE","Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)""AUTHOR NAMES","Papp K.A.","Langley R.G.","Lebwohl M.","Krueger G.G.","Szapary P.","Yeilding N.","Guzzo C.","Hsu M.-C.","Wang Y.","Li S.","Dooley L.T.","Reich K.""SOURCE","The Lancet (2008) 371:9625 (1675-1684). Date of Publication: 20080517/23"

"TITLE","Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)""AUTHOR NAMES","Leonardi C.L.","Kimball A.B.","Papp K.A.","Yeilding N.","Guzzo C.","Wang Y.","Li S.","Dooley L.T.","Gordon K.B.""SOURCE","The Lancet (2008) 371:9625 (1665-1674). Date of Publication: 20080517/23"

"TITLE","Severe generalized exanthema due to etanercept given for severe plaque psoriasis""AUTHOR NAMES","Gonzalo-Garijo M.A.","Pérez-Calderón R.","Fernández-Durán D.D.A.""SOURCE","Annals of Allergy, Asthma and Immunology (2008) 100:6 (621-622). Date of Publication: June 2008"

"TITLE","Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists""AUTHOR NAMES","Patel V.","Horn E.J.","Lobosco S.J.","Fox K.M.","Stevens S.R.","Lebwohl M.""SOURCE","Journal of the American Academy of Dermatology (2008) 58:6 (964-969). Date of Publication: June 2008"

"TITLE","Onset of psoriatic arthritis in patients treated with efalizumab for moderate to

severe psoriasis""AUTHOR NAMES","Viguier M.","Richette P.","Aubin F.","Beylot-Barry M.","Lahfa M.","Bedane C.","Delesalle F.","Richard-Lallemand M.-A.","Delaporte E.","Dubertret L.","Bardin T.","Bachelez H.""SOURCE","Arthritis and Rheumatism (2008) 58:6 (1796-1802). Date of Publication: June 2008"

"TITLE","Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab""AUTHOR NAMES","Borrás-Blasco J.","Gracia-Perez A.","Nuñez-Cornejo C.","Rosique-Robles J.D.","Mateu-Puchades A.","Casterá M.D.E.","Rubio-Fabra M.""SOURCE","Journal of Clinical Pharmacy and Therapeutics (2008) 33:3 (321-325). Date of Publication: June 2008"

"TITLE","Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: A 24-week, randomized, controlled, investigator-blinded pilot trial""AUTHOR NAMES","Gisondi P.","Del Giglio M.","Cotena C.","Girolomoni G.""SOURCE","British Journal of Dermatology (2008) 158:6 (1345-1349). Date of Publication: June 2008"

"TITLE","Infliximab in severe active ankylosing spondylitis with spinal ankylosis""AUTHOR NAMES","Cheung P.P.M.","Tymms K.E.","Wilson B.J.","Shadbolt B.","Brook A.S.","Dorai Raj A.K.","Khoo K.B.K.""SOURCE","Internal Medicine Journal (2008) 38:6 A (396-401). Date of Publication: June 2008"

"TITLE","Etanercept in the management of nail psoriasis""AUTHOR NAMES","Aguilar-García G.","Vilanova-Mateu A.","Dulanto-Campos C.","Naranjo-Sintes R.""SOURCE","Piel (2008) 23:6 (33). Date of Publication: 1 Jun 2008"

"TITLE","A case of myiasis in a patient with psoriasis from Turkey""AUTHOR NAMES","Dagci H.","Zeyrek F.","Gerzile Y.K.","Sahin S.B.","Yagci S.","Uner A.""SOURCE","Parasitology International (2008) 57:2 (239-241). Date of Publication: June 2008"

"TITLE","Alefacept for moderate to severe atopic dermatitis: A pilot study in adults""AUTHOR NAMES","Moul D.K.","Routhouska S.B.","Robinson M.R.","Korman N.J.""SOURCE","Journal of the American Academy of Dermatology (2008) 58:6 (984-989). Date of Publication: June 2008"

"TITLE","Palmoplantar pustular psoriasis: Successful therapy with efalizumab after non-response to infliximab""AUTHOR NAMES","Wozel G.","Vitéz L.""SOURCE","Acta Dermato-Venereologica (2008) 88:2 (169-170). Date of Publication: 2008"

"TITLE","Onset or exacerbation of cutaneous psoriasis during TNFα antagonist therapy""AUTHOR NAMES","Wendling D.","Balblanc J.-C.","Briançon D.","Brousse A.","Lohse A.","Deprez P.","Humbert P.","Aubin F.""SOURCE","Joint Bone Spine (2008) 75:3 (315-318). Date of Publication: May 2008"

"TITLE","Combining systemic retinoids with biologic agents for moderate to severe psoriasis""AUTHOR NAMES","Smith E.C.A.","Riddle C.","Menter M.A.","Lebwohl M.""SOURCE","International Journal of Dermatology (2008) 47:5 (514-518). Date of Publication: May 2008"

"TITLE","Psoriasis treatment with etanercept and efalizumab: Clinical strategies influencing treatment outcome""AUTHOR NAMES","Driessen R.J.B.","Berends M.A.M.","Boezeman J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","British Journal of Dermatology (2008) 158:5 (1098-1106). Date of Publication: May 2008"

"TITLE","Efficacy of etanercept in psoriatic patients previously treated with infliximab""AUTHOR NAMES","Pitarch G.","Sánchez-Carazo J.L.","Mahiques L.","Oliver V.""SOURCE","Dermatology (2008) 216:4 (312-316). Date of Publication: May 2008"

"TITLE","Etanercept at different dosages in the treatment of generalized pustular psoriasis: A case series""AUTHOR NAMES","Esposito M.","Mazzotta A.","Casciello C.","Chimenti S.""SOURCE","Dermatology (2008) 216:4 (355-360). Date of Publication: May 2008"

"TITLE","Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-α therapy""AUTHOR NAMES","Antoniou C.","Kosmadaki M.G.","Stratigos A.J.","Katsambas A.D.""SOURCE","Dermatology (2008) 216:4 (364-365). Date of Publication: May 2008"

"TITLE","Biologic response modifier therapy for psoriatic ocular inflammatory disease""AUTHOR NAMES","Huynh N.","Cervantes-Castaneda R.A.","Bhat P.","Gallagher M.J.","Foster C.S.""SOURCE","Ocular Immunology and Inflammation (2008) 16:3 (89-93). Date of Publication: May

2008"

"TITLE","Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: Continuous versus interrupted treatment""AUTHOR NAMES","Gelfand J.M.","Kimball A.B.","Mostow E.N.","Chiou C.-F.","Patel V.","Xia H.A.","Freundlich B.","Stevens S.R.""SOURCE","Value in Health (2008) 11:3 (400-407). Date of Publication: May/June 2008"

"TITLE","Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)""AUTHOR NAMES","Antoni C.E.","Kavanaugh A.","Van Der Heijde D.","Beutler A.","Keenan G.","Zhou B.","Kirkham B.","Tutuncu Z.","Burmester G.R.","Schneider U.","Fürst D.E.","Molitor J.","Keystone E.","Gladman D.D.","Manger B.","Wassenberg S.","Weier R.","Wallace D.J.","Weisman M.H.","Kalden J.R.","Smolen J.S.""SOURCE","Journal of Rheumatology (2008) 35:5 (869-876). Date of Publication: May 2008"

"TITLE","Efalizumab: Results of a 3-year continuous dosing study for the long-term control of psoriasis""AUTHOR NAMES","Leonardi C.","Menter A.","Hamilton T.","Caro I.","Xing B.","Gottlieb A.B.""SOURCE","British Journal of Dermatology (2008) 158:5 (1107-1116). Date of Publication: May 2008"

"TITLE","Alopecia areata universalis elicited during treatment with adalimumab""AUTHOR NAMES","Pelivani N.","Hassan A.S.","Braathen L.R.","Hunger R.E.","Yawalkar N.""SOURCE","Dermatology (2008) 216:4 (320-323). Date of Publication: May 2008"

"TITLE","Lichenoid reaction induced by adalimumab""AUTHOR NAMES","De Simone C.","Caldarola G.","D'agostino M.","Rotoli M.","Capizzi R.","Amerio P.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:5 (626-627). Date of Publication: May 2008"

"TITLE","Tinea versicolor associated with etanercept therapy""AUTHOR NAMES","Levy M.S.","Polsky D.","Davidson A.","Strober B.E.""SOURCE","Journal of the American Academy of Dermatology (2008) 58:5 SUPPL. 1 (S99-S100). Date of Publication: May 2008"

"TITLE","Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept""AUTHOR NAMES","Lahbabi I.","Adamski H.","Le Jean S.","Cannieux V.","Polard E.","Chevrant-Breton J.""SOURCE","Annales de Dermatologie et de Venereologie (2008) 135:5 (409-410). Date of Publication: May 2008"

"TITLE","QuantiFERON®-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor α therapy""AUTHOR NAMES","Desai N.","Raste Y.","Cooke N.T.","Harland C.C.""SOURCE","British Journal of Dermatology (2008) 158:5 (1137-1138). Date of Publication: May 2008"

"TITLE","Complete remission of severe scleritis and psoriasis in a patient with active Crohn's disease using modulen IBD as an exclusive immunomodulating diet""AUTHOR NAMES","Triantafillidis J.K.","Mantzaris G.","Stamataki A.","Asvestis K.","Malgarinos G.","Gikas A.""SOURCE","Journal of Clinical Gastroenterology (2008) 42:5 (550-551). Date of Publication: May-June 2008"

"TITLE","Psoriatic arthritis and arthroplasty: A review of the literature""AUTHOR NAMES","Iofin I.","Levine B.","Badlani N.","Klein G.R.","Jaffe W.L.""SOURCE","Bulletin of the NYU Hospital for Joint Diseases (2008) 66:1 (41-48). Date of Publication: 2008"

"TITLE","Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results""AUTHOR NAMES","Braun-Moscovici Y.","Markovits D.","Rozin A.","Toledano K.","Nahir A.M.","Balbir-Gurman A.""SOURCE","Israel Medical Association Journal (2008) 10:4 (277-281). Date of Publication: April 2008"

"TITLE","Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis""AUTHOR NAMES","Saraceno R.","Schipani C.","Mazzotta A.","Esposito M.","Di Renzo L.","De Lorenzo A.","Chimenti S.""SOURCE","Pharmacological Research (2008) 57:4 (290-295). Date of Publication: April 2008"

"TITLE","Psoriasis induced by anti-TNF probably not so uncommon""AUTHOR NAMES","Bosch R.I.","Amo N.D.V.D.","Manteca C.F.","Cortina E.L.","Polo R.G.","Courel L.G.""SOURCE","Journal of Clinical Rheumatology (2008) 14:2 (128). Date of Publication: April 2008"

"TITLE","Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab""AUTHOR NAMES","Mañosa M.","Domènech E.","Marín L.","Olivé A.","Zabana Y.","Cabré E.","Gassull M.A.""SOURCE","Gut (2008) 57:4 (559). Date of Publication: April 2008"

"TITLE","Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy""AUTHOR NAMES","Genovese M.C.","Schiff M.","Luggen M.","Becker J.-C.","Aranda R.","Teng J.","Li T.","Schmidely N.","Le Bars M.","Dougados M.""SOURCE","Annals of the Rheumatic Diseases (2008) 67:4 (547-554). Date of Publication: April 2008"

"TITLE","Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: Experience from an urban arthritis clinic""AUTHOR NAMES","Mor A.","Bingham III C.O.","Kishimoto M.","Izmirly P.M.","Greenberg J.D.","Reddy S.","Rosenthal P.B.""SOURCE","Annals of the Rheumatic Diseases (2008) 67:4 (462-465). Date of Publication: April 2008"

"TITLE","Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus""AUTHOR NAMES","Mikhail M.","Weinberg J.M.","Smith B.L.""SOURCE","Archives of Dermatology (2008) 144:4 (453-456). Date of Publication: April 2008"

"TITLE","Onset of psoriasis induced by infliximab""AUTHOR NAMES","Bal A.","Gurcay E.","Aydog E.","Umay E.","Tatlican S.","Cakci A.""SOURCE","Journal of Clinical Rheumatology (2008) 14:2 (128-129). Date of Publication: April 2008"

"TITLE","Generalized pustular psoriasis and cryptogenic organizing pneumonia""AUTHOR NAMES","Webber N.K.","Elston C.M.","O'Toole E.A.""SOURCE","British Journal of Dermatology (2008) 158:4 (853-854). Date of Publication: April 2008"

"TITLE","Sustained Clinical Response and High Infliximab Survival in Psoriatic Arthritis Patients: A 3-year Long-Term Study""AUTHOR NAMES","Voulgari P.V.","Venetsanopoulou A.I.","Exarchou S.A.","Alamanos Y.","Tsifetaki N.","Drosos A.A.""SOURCE","Seminars in Arthritis and Rheumatism (2008) 37:5 (293-298). Date of Publication: April 2008"

"TITLE","Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: Results of the 2005 Spring US National Psoriasis Foundation Survey""AUTHOR NAMES","Ciocon D.H.","Horn E.J.","Kimball A.B.""SOURCE","American Journal of Clinical Dermatology (2008) 9:2 (111-117). Date of Publication: 2008"

"TITLE","Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: Report on five cases""AUTHOR NAMES","Mössner R.","Thaci D.","Mohr J.","Pätzold S.","Bertsch H.P.","Krüger U.","Reich K.""SOURCE","Archives of Dermatological Research (2008) 300:3 (101-105). Date of Publication: March 2008"

"TITLE","Tumor necrosis factor-a antagonist-induced psoriasis: Yet another paradox in medicine""AUTHOR NAMES","Aslanidis S.","Pyrpasopoulou A.","Douma S.","Triantafyllou A.""SOURCE","Clinical Rheumatology (2008) 27:3 (377-380). Date of Publication: March 2008"

"TITLE","Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-α therapy: A case series of four patients and guidelines for management [13]""AUTHOR NAMES","Papadavid E.","Gazi S.","Dalamaga M.","Stavrianeas N.","Ntelis V.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:3 (380-382). Date of Publication: March 2008"

"TITLE","Anti-tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis: A retrospective cohort study""AUTHOR NAMES","Gisondi P.","Cotena C.","Tessari G.","Girolomoni G.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:3 (341-344).

Date of Publication: March 2008"

"TITLE","Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)""AUTHOR NAMES","Saurat J.-H.","Stingl G.","Dubertret L.","Papp K.","Langley R.G.","Ortonne J.-P.","Unnebrink K.","Kaul M.","Camez A.""SOURCE","British Journal of Dermatology (2008) 158:3 (558-566). Date of Publication: March 2008"

"TITLE","Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: Results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Revicki D.","Willian M.K.","Saurat J.-H.","Papp K.A.","Ortonne J.-P.","Sexton C.","Camez A.""SOURCE","British Journal of Dermatology (2008) 158:3 (549-557). Date of Publication: March 2008"

"TITLE","Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Revicki D.A.","Willian M.K.","Menter A.","Saurat J.-H.","Harnam N.","Kaul M.""SOURCE","Dermatology (2008) 216:3 (260-270). Date of Publication: March 2008"

"TITLE","Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: Results of an open-label, single-arm pilot study""AUTHOR NAMES","Tsai T.F.","Liu M.T.","Liao Y.H.","Licu D.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:3 (345-352). Date of Publication: March 2008"

"TITLE","Rapid response of nail psoriasis to etanercept""AUTHOR NAMES","Rallis E.","Stavropoulou E.","Rigopoulos D.","Verros C.""SOURCE","Journal of Rheumatology (2008) 35:3 (544-545). Date of Publication: March 2008"

"TITLE","Successful use of etanercept in type I pityriasis rubra pilaris [13]""AUTHOR NAMES","Seckin D.","Tula E.","Ergun T.""SOURCE","British Journal of Dermatology (2008) 158:3 (642-644). Date of Publication: March 2008"

"TITLE","A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy""AUTHOR NAMES","Saraceno R.","Citarella L.","Spallone G.","Chimenti S.""SOURCE","Clinical and Experimental Dermatology (2008) 33:2 (154-155). Date of Publication: March 2008"

"TITLE","Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab""AUTHOR NAMES","Santos-Juanes J.","Coto P.","Mallo S.","Galache C.","Sánchez Del Río J.","Torre J.C.""SOURCE","Dermatology (2008) 216:3 (279). Date of Publication: March 2008"

"TITLE","When there is no single best biological agent: Psoriasis and psoriatic arthritis in the same patient responding to two different biological agents""AUTHOR NAMES","Adişen E.","Karaca F.","Gürer M.A.""SOURCE","Clinical and Experimental Dermatology (2008) 33:2 (164-166). Date of Publication: March 2008"

"TITLE","Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.""AUTHOR NAMES","Kircik L.","Bagel J.","Korman N.","Menter A.","Elmets C.A.","Koo J.","Yang Y.C.","Chiou C.F.","Dann F.","Stevens S.R.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:3 (245-253). Date of Publication: Mar 2008"

"TITLE","The Enigmatic Development of Psoriasis and Psoriasiform Lesions During Anti-TNF Therapy: A Review""AUTHOR NAMES","Grinblat B.","Scheinberg M.""SOURCE","Seminars in Arthritis and Rheumatism (2008) 37:4 (251-255). Date of Publication: February 2008"

"TITLE","Ethical perspectives in neurology""AUTHOR NAMES","Kass J.""SOURCE","CONTINUUM Lifelong Learning in Neurology (2008) 14:1 (205-210). Date of Publication: February 2008"

"TITLE","Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year"

"AUTHOR NAMES","Rich P.","Griffiths C.E.M.","Reich K.","Nestle F.O.","Scher R.K.","Li S.","Xu S.","Hsu M.-C.","Guzzo C.""SOURCE","Journal of the American Academy of Dermatology (2008) 58:2 (224-231). Date of Publication: February 2008"

"TITLE","Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis""AUTHOR NAMES","Yamauchi P.S.","Lowe N.J.""SOURCE","International Journal of Dermatology (2008) 47:2 (202-204). Date of Publication: February 2008"

"TITLE","Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity [17]""AUTHOR NAMES","Bassukas I.D.","Hyphantis T.","Gamvroulia C.","Gaitanis G.","Mavreas V.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:2 (257-258). Date of Publication: February 2008"

"TITLE","My clinical experience with efalizumab in the Hospital of Conxo""AUTHOR NAMES","Vázquez-Veiga H.A.","Seoane-Pose M.J.","Fernández-Blanco M.T.""SOURCE","Actas Dermo-Sifiliograficas (2008) 99:SUPPL.1 (62-69). Date of Publication: 15 Jan 2008"

"TITLE","Clinical experience with efalizumab in the Hospital of Cruces""AUTHOR NAMES","Martinez De Lagran Alvarez De Arcaya Z.","González Hermosa M.R.","Díaz-Pérez J.L.""SOURCE","Actas Dermo-Sifiliograficas (2008) 99:SUPPL.1 (74-81). Date of Publication: 15 Jan 2008"

"TITLE","Economic evaluation of a prior authorization program for biologic response modifiers""AUTHOR NAMES","Sun S.X.","Jing Y.","Aruru M.","Lee K.Y.""SOURCE","Drug Benefit Trends (2008) 20:1 (26-31). Date of Publication: January 2008"

"TITLE","Acneiform eruption following anti-TNF-alpha treatment: a report of three cases.""AUTHOR NAMES","Sun G.","Wasko C.A.","Hsu S.""SOURCE","Journal of drugs in dermatology : JDD (2008) 7:1 (69-71). Date of Publication: Jan 2008"

"TITLE","Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial""AUTHOR NAMES","Menter A.","Tyring S.K.","Gordon K.","Kimball A.B.","Leonardi C.L.","Langley R.G.","Strober B.E.","Kaul M.","Gu Y.","Okun M.","Papp K.""SOURCE","Journal of the American Academy of Dermatology (2008) 58:1 (106-115). Date of Publication: January 2008"

"TITLE","Infliximab then efalizumab, the 'hit and run' approach does not work""AUTHOR NAMES","Barde C.","Thielen A.M.","Saurat J.-H.""SOURCE","Dermatology (2008) 216:2 (171-172). Date of Publication: January 2008"

"TITLE","Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept""AUTHOR NAMES","Costa L.A.","Belinchón I.","Betlloch I.","Pérez-Crespo M.","Mataix J.""SOURCE","Dermatology Online Journal (2008) 14:1 Article Number: 11. Date of Publication: January 2008"

"TITLE","Infliximab in recalcitrant generalized pustular arthropatic psoriasis""AUTHOR NAMES","Vieira Serrão V.","Martins A.","Lopes M.J.P.""SOURCE","European Journal of Dermatology (2008) 18:1 (71-73). Date of Publication: January/February 2008"

"TITLE","Treatment of idiopathic pyoderma gangrenosum with infliximab: Induction dosing regimen or on-demand therapy?""AUTHOR NAMES","Adişen E.","Öztaş M.","Gürer M.A.""SOURCE","Dermatology (2008) 216:2 (163-165). Date of Publication: January 2008"

"TITLE","Severe neutrophilia induced by infliximab for psoriasis [19]""AUTHOR NAMES","De Oliveira J.P.","Levy A.","Morel P.","Guibal F.""SOURCE","British Journal of Dermatology (2008) 158:1 (200-201). Date of Publication: January 2008"

"TITLE","Type III juvenile pityriasis rubra pilaris: A successful treatment with infliximab [12]""AUTHOR NAMES","Ruzzetti M.","Saraceno R.","Carboni I.","Papoutsaki M.","Chimenti S.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2008) 22:1 (117-118). Date of Publication: January 2008"

"TITLE","Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile"

"AUTHOR NAMES","Queiro R.","Moreno P.","Sarasqueta C.","Alperi M.","Riestra J.L.","Ballina J.""SOURCE","Clinical and Experimental Rheumatology (2008) 26:1 (125-128). Date of Publication: January/February 2008"

"TITLE","DRESS syndrome caused by efalizumab""AUTHOR NAMES","White J.M.L.","Smith C.H.","Robson A.","Ash G.","Barker J.N.W.N.""SOURCE","Clinical and Experimental Dermatology (2008) 33:1 (50-52). Date of Publication: January 2008"

"TITLE","Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis""AUTHOR NAMES","Revicki D.A.","Willian M.K.","Menter A.","Gordon K.B.","Kimball A.B.","Leonardi C.L.","Langley R.G.","Kimel M.","Okun M.""SOURCE","Journal of Dermatological Treatment (2007) 18:6 (341-350). Date of Publication: 2007"

"TITLE","Psoriasiform eruptions during anti-TNF-α treatment: Psoriasis or not? [5]""AUTHOR NAMES","Seneschal J.","Lepreux S.","Milpied B.","Schaeverbeke T.","Taïeb A.""SOURCE","Archives of Dermatology (2007) 143:12 (1593-1595). Date of Publication: December 2007"

"TITLE","Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey""AUTHOR NAMES","Horn E.J.","Fox K.M.","Patel V.","Chiou C.-F.","Dann F.","Lebwohl M.""SOURCE","Journal of the American Academy of Dermatology (2007) 57:6 (957-962). Date of Publication: December 2007"

"TITLE","Biologic therapeutics in the treatment of psoriasis. Part 2: Practical considerations""AUTHOR NAMES","Langley R.G.","Gupta A.K.","Cherman A.M.","Inniss K.A.""SOURCE","Journal of Cutaneous Medicine and Surgery (2007) 11:4 (145-149). Date of Publication: 2007"

"TITLE","Diffused suberitrodermic psoriasis induced by infliximab""AUTHOR NAMES","Bruzzese V.""SOURCE","Reumatismo (2007) 59:4 (328-331). Date of Publication: 2007"

"TITLE","Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis [5]""AUTHOR NAMES","Stinco G.","Piccirillo F.","Patrone P.""SOURCE","British Journal of Dermatology (2007) 157:6 (1273-1274). Date of Publication: December 2007"

"TITLE","Pneumocystis jiroveci pneumonia in an infant treated with oral steroids; all-trans retinoic acid as a cause of respiratory failure; dronabinol-induced gynecomastia; neutrophilic dermatitis seen with bortezomib; unfavorable smell with a selective serotonin reuptake inhibitor; aloe vera-induced hepatitis; pulmonary sarcoidosis attributed to etanercept; serious adverse drug events reported to the ...""AUTHOR NAMES","Shuster J.""SOURCE","Hospital Pharmacy (2007) 42:12 (1104-1107). Date of Publication: December 2007"

"TITLE","Severe psoriasis in an African American woman treated with infliximab therapy for 6 years""AUTHOR NAMES","May J.","Hogan D.""SOURCE","International Journal of Dermatology (2007) 46:12 (1312). Date of Publication: December 2007"

"TITLE","Successful treatment of severe psoriatic natal cleft fissuring with tissue adhesive [2]""AUTHOR NAMES","Smith V.H.","Jones S.K.""SOURCE","British Journal of Dermatology (2007) 157:6 (1269-1270). Date of Publication: December 2007"

"TITLE","Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus""AUTHOR NAMES","Martínez-Abundis E.","Reynoso-Von Drateln C.","Hernández-Salazar E.","González-Ortiz M.""SOURCE","Archives of Dermatological Research (2007) 299:9 (461-465). Date of Publication: November 2007"

"TITLE","Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau""AUTHOR NAMES","Adisşen E.","Öztasş M.","Gürer M.A.""SOURCE","International Journal of Dermatology (2007) 46:11 (1205-1207). Date of Publication: November 2007"

"TITLE","Infliximab-induced palmoplantar pustulosis in a patient with crohn disease [3]""AUTHOR NAMES","Sladden M.J.","Clarke P.J.","Wettenhall J.""SOURCE","Archives of Dermatology (2007) 143:11 (1449). Date of Publication: November 2007"

"TITLE","TNF-á inhibitor etanercept and hematologic malignancies: Report of a case and review of the literature""AUTHOR NAMES","Nair B.","Raval G.","Mehta P.""SOURCE","American Journal of Hematology (2007) 82:11 (1022-1024). Date of Publication: November 2007"

"TITLE","Treatment of necrobiosis lipoidica with pioglitazone""AUTHOR NAMES","Boyd A.S.""SOURCE","Journal of the American Academy of Dermatology (2007) 57:5 SUPPL. (S120-S121). Date of Publication: November 2007"

"TITLE","Pustular psoriasis induced by infliximab [10]""AUTHOR NAMES","Martínez-Morán C.","Sanz-Muñoz C.","Morales-Callaghan A.M.","Torrero V.","Miranda-Romero A.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2007) 21:10 (1424-1426). Date of Publication: November 2007"

"TITLE","Skin cancer in psoriatic arthritis treated with anti-TNF therapy [6]""AUTHOR NAMES","Sheppard J.","Raza K.","Buckley C.D.""SOURCE","Rheumatology (2007) 46:10 (1622-1623). Date of Publication: October 2007"

"TITLE","Patient profiles in psoriatic disease: a case-based approach.""AUTHOR NAMES","Wiatrowski M.","Furfaro N.""SOURCE","Dermatology nursing / Dermatology Nurses' Association (2007) Suppl (5-19; quiz 20-21). Date of Publication: Oct 2007"

"TITLE","Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor α with etanercept""AUTHOR NAMES","Mahiques Santos L.","Pitarch G.","Sánchez-Carazo J.L.","Pérez-Ferriols A.","Soriano C.J.","Alegre V.""SOURCE","Actas Dermo-Sifiliograficas (2007) 98:8 (539-544). Date of Publication: 1 Oct 2007"

"TITLE","Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab [16]""AUTHOR NAMES","Vestergaard C.","Deleuran M.","Kragballe K.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2007) 21:9 (1272-1274). Date of Publication: October 2007"

"TITLE","Effect of Etanercept on insulin sensitivity in nine patients with psoriasis""AUTHOR NAMES","Marra M.","Campanati A.","Testa R.","Sirolla C.","Bonfigli A.R.","Franceschi C.","Marchegiani F.","Offidani A.""SOURCE","International Journal of Immunopathology and Pharmacology (2007) 20:4 (731-736). Date of Publication: October/December 2007"

"TITLE","Prevention of recurrent aphthous stomatitis by efalizumab (Raptiva®) [27]""AUTHOR NAMES","Zribi H.","Crickx B.","Descamps V.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2007) 21:9 (1286-1287). Date of Publication: October 2007"

"TITLE","Acute onset of rash and oligoarthritis""AUTHOR NAMES","Shedd A.D.","Reddy S.G.","Meffert J.J.","Kraus E.W.""SOURCE","Journal of Family Practice (2007) 56:10 (811-814). Date of Publication: October 2007"

"TITLE","Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.""AUTHOR NAMES","Di Nuzzo S.","Zanni M.","De Panfilis G.""SOURCE","Journal of drugs in dermatology : JDD (2007) 6:10 (1046-1047). Date of Publication: Oct 2007"

"TITLE","Instability of topical ciclosporin emulsion for nail psoriasis [4]""AUTHOR NAMES","Prins A.M.A.","Vos K.","Franssen E.J.F.""SOURCE","Dermatology (2007) 215:4 (362-363). Date of Publication: October 2007"

"TITLE","Anti-TNF-α therapy in pressure urticaria. Successful use of infliximab in drug-resistant delayed pressure urticaria""AUTHOR NAMES","Debus D.","Jacobi A.","Paul E.""SOURCE","Allergo Journal (2007) 16:7 (507-511). Date of Publication: October 2007"

"TITLE","Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease [4]""AUTHOR NAMES","Umeno J.","Matsumoto T.","Jo Y.","Ichikawa M.","Urabe K.","Iida M.""SOURCE","Inflammatory Bowel Diseases (2007) 13:9 (1188-1189). Date of Publication: September 2007"

"TITLE","Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-α inhibition [13]""AUTHOR NAMES","Wachter T.","Murach W.M.","Bröcker E.-B.","Schön M.P."

"SOURCE","British Journal of Dermatology (2007) 157:3 (627-629). Date of Publication: September 2007"

"TITLE","Remission of photosensitivity following treatment of psoriasis vulgaris with tumour necrosis factor inhibitors [12]""AUTHOR NAMES","Viguier M.","Jeanmougin M.","Begon E.","Verola O.","Dubertret L.","Bachelez H.""SOURCE","British Journal of Dermatology (2007) 157:3 (625-627). Date of Publication: September 2007"

"TITLE","Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis""AUTHOR NAMES","Reich K.","Nestle F.O.","Wu Y.","Bala M.","Eisenberg D.","Guzzo C.","Li S.","Dooley L.T.","Griffiths C.E.M.""SOURCE","European Journal of Dermatology (2007) 17:5 (381-386). Date of Publication: September/October 2007"

"TITLE","Effective therapy with anti-TNF-α in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions""AUTHOR NAMES","Cordiali-Fei P.","Trento E.","D'Agosto G.","Bordignon V.","Mussi A.","Ardigò M.","Mastroianni A.","Vento A.","Solivetti F.","Berardesca E.","Ensoli F.""SOURCE","Annals of the New York Academy of Sciences (2007) 1110 (578-589). Date of Publication: September 2007"

"TITLE","Cutaneous adverse reaction to infliximab: Report of psoriasis developing in 3 patients""AUTHOR NAMES","Severs G.A.","Lawlor T.H.","Purcell S.M.","Adler D.J.","Thompson R.""SOURCE","Cutis (2007) 80:3 (231-237). Date of Publication: September 2007"

"TITLE","An unusual Koebner phenomenon secondary to PPD with pustular and arthropathic psoriasis [1]""AUTHOR NAMES","Şahin G.Ö.","Akyol M.","Özçelik S.""SOURCE","European Journal of Dermatology (2007) 17:5 (446). Date of Publication: September/October 2007"

"TITLE","Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics""AUTHOR NAMES","Papoutsaki M.","Chimenti M.-S.","Costanzo A.","Talamonti M.","Zangrilli A.","Giunta A.","Bianchi L.","Chimenti S.""SOURCE","Journal of the American Academy of Dermatology (2007) 57:2 (269-275). Date of Publication: August 2007"

"TITLE","Another paradox in Crohn's disease: New onset of psoriasis in a patient receiving tumor necrosis factor-α antagonist [4]""AUTHOR NAMES","Angelucci E.","Cocco A.","Viscido A.","Vernia P.","Caprilli R.""SOURCE","Inflammatory Bowel Diseases (2007) 13:8 (1059-1061). Date of Publication: August 2007"

"TITLE","Coexistent psoriasis and lupus erythematosus treated with alefacept""AUTHOR NAMES","Berthelot C.","Nash J.","Duvic M.""SOURCE","American Journal of Clinical Dermatology (2007) 8:1 (47-50). Date of Publication: 2007"

"TITLE","Infliximab in the treatment of psoriasis in patients previously treated with etanercept""AUTHOR NAMES","Haitz K.A.","Kalb R.E.""SOURCE","Journal of the American Academy of Dermatology (2007) 57:1 (120-125). Date of Publication: July 2007"

"TITLE","Use of biological agents in patients with moderate to severe psoriasis: A cohort-based perspective""AUTHOR NAMES","Jones-Caballero M.","Unaeze J.","Peñas P.F.","Stern R.S.""SOURCE","Archives of Dermatology (2007) 143:7 (846-850). Date of Publication: July 2007"

"TITLE","Psoriasiform and pustular eruption induced by infliximab""AUTHOR NAMES","Takahashi H.","Hashimoto Y.","Ishida-Yamamoto A.","Ashida T.","Kohgo Y.","Iizuka H.""SOURCE","Journal of Dermatology (2007) 34:7 (468-472). Date of Publication: July 2007"

"TITLE","Re-induction as a possible alternative modality of dose escalation of infliximab: A prospective evaluation in a small series of psoriatic patients""AUTHOR NAMES","Cassano N.","Puglisi Guerra A.","Malara C.","Loconsole F.","Galluccio A.","Pezza M.","Vena G.A.""SOURCE","International Journal of Immunopathology and Pharmacology (2007) 20:3 (647-650). Date of Publication: July/September 2007"

"TITLE","Severe bout of cutaneous psoriasis in a patient with psoriasic arthritis undergoing treatment with infliximab [2]""AUTHOR NAMES","Uriarte Itzazelaia E.","Hernando I.","Prada A.","Alonso A.""SOURCE","Clinical and Experimental Rheumatology (2007) 25:4 (659). Date of Publication: July/August 2007"

"TITLE","Success of goeckerman treatment in 2 patients with psoriasis not responding to biological drugs [6]""AUTHOR NAMES","Soares T.F.","Davis M.D.P.""SOURCE","Archives of Dermatology (2007) 143:7 (950-951). Date of Publication: July 2007"

"TITLE","Interferon-α as an Effective Treatment for Noninfectious Posterior Uveitis and Panuveitis""AUTHOR NAMES","Plskova J.","Greiner K.","Forrester J.V.""SOURCE","American Journal of Ophthalmology (2007) 144:1 (55-61.e2). Date of Publication: July 2007"

"TITLE","Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination.""AUTHOR NAMES","Ricotti C.","Kerdel F.A.""SOURCE","Journal of drugs in dermatology : JDD (2007) 6:7 (738-740). Date of Publication: Jul 2007"

"TITLE","Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice""AUTHOR NAMES","Berends M.A.M.","Driessen R.J.B.","Langewouters A.M.G.","Boezeman J.B.","Van De Kerkhof P.C.M.","De Jong E.M.G.J.""SOURCE","Journal of Dermatological Treatment (2007) 18:2 (76-83). Date of Publication: 2007"

"TITLE","Exacerbation of pityriasis rubra pilaris under efalizumab therapy""AUTHOR NAMES","Klein A.","Szeimies R.-M.","Landthaler M.","Karrer S.""SOURCE","Dermatology (2007) 215:1 (72-75). Date of Publication: June 2007"

"TITLE","The role of the quantiFERON-TB gold test as screening prior to administration of tumor necrosis factor inhibitors [13]""AUTHOR NAMES","Martinez L.C.","Harrison-Balestra C.","Caeiro J.P.","Nousari C.H.""SOURCE","Archives of Dermatology (2007) 143:6 (809-810). Date of Publication: June 2007"

"TITLE","Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis""AUTHOR NAMES","Tyring S.","Gordon K.B.","Poulin Y.","Langley R.G.","Gottlieb A.B.","Dunn M.","Jahreis A.""SOURCE","Archives of Dermatology (2007) 143:6 (719-726). Date of Publication: June 2007"

"TITLE","Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis""AUTHOR NAMES","Marzo-Ortega H.","McGonagle D.","Rhodes L.A.","Tan A.L.","Conaghan P.G.","O'Connor P.","Tanner S.F.","Fraser A.","Veale D.","Emery P.""SOURCE","Annals of the Rheumatic Diseases (2007) 66:6 (778-781). Date of Publication: June 2007"

"TITLE","Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection""AUTHOR NAMES","Linardaki G.","Katsarou O.","Ioannidou P.","Karafoulidou A.","Boki K.""SOURCE","Journal of Rheumatology (2007) 34:6 (1353-1355). Date of Publication: June 2007"

"TITLE","Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau""AUTHOR NAMES","Weisshaar E.","Diepgen T.L.""SOURCE","JDDG - Journal of the German Society of Dermatology (2007) 5:6 (489-492). Date of Publication: June 2007"

"TITLE","Hidradenitis suppurativa. Response to treatment with infliximab""AUTHOR NAMES","Pedraz Muñoz J.","Daudén E.","Pérez-Gala S.","Goiriz-Valdés R.","Fernández-Peñas P.","García-Diez A.""SOURCE","Actas Dermo-Sifiliograficas (2007) 98:5 (325-331). Date of Publication: June 2007"

"TITLE","Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies""AUTHOR NAMES","Fulchiero Jr. G.J.","Salvaggio H.","Drabick J.J.","Staveley-O'Carroll K.","Billingsley E.M.","Marks J.G.","Helm K.F.""SOURCE","Journal of the American Academy of Dermatology (2007) 56:5 SUPPL. (S65-S67). Date of Publication: May 2007"

"TITLE","Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept? [8]""AUTHOR NAMES","Ahmad K.","McDonnell T.J.","Rogers S."

"SOURCE","Clinical and Experimental Dermatology (2007) 32:3 (329). Date of Publication: May 2007"

"TITLE","Two years of experience with etanercept in recalcitrant psoriasis""AUTHOR NAMES","Ahmad K.","Rogers S.""SOURCE","British Journal of Dermatology (2007) 156:5 (1010-1014). Date of Publication: May 2007"

"TITLE","Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy""AUTHOR NAMES","Genovese M.C.","Mease P.J.","Thomson G.T.D.","Kivitz A.J.","Perdok R.J.","Weinberg M.A.","Medich J.","Sasso E.H.""SOURCE","Journal of Rheumatology (2007) 34:5 (1040-1050). Date of Publication: May 2007"

"TITLE","Treatment of pustular psoriasis with infliximab""AUTHOR NAMES","Weishaupt C.","Metze D.","Luger T.A.","Ständer S.""SOURCE","JDDG - Journal of the German Society of Dermatology (2007) 5:5 (397-400). Date of Publication: May 2007"

"TITLE","Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial""AUTHOR NAMES","Shikiar R.","Heffernan M.","Langley R.G.","Willian M.K.","Okun M.M.","Revicki D.A.""SOURCE","Journal of Dermatological Treatment (2007) 18:1 (25-31). Date of Publication: 2007"

"TITLE","Adverse skin reactions to infliximab in the treatment of intraocular inflammation""AUTHOR NAMES","Wegscheider B.J.","El-Shabrawi L.","Weger M.","Ardjomand N.","Hermann J.","Aberer E.","El-Shabrawi Y.""SOURCE","Eye (2007) 21:4 (547-549). Date of Publication: April 2007"

"TITLE","Long-term treatment of plaque psoriasis with efalizumab: An Italian experience""AUTHOR NAMES","Costanzo A.","Peris K.","Talamonti M.","Di Cesare A.","Fargnoli M.C.","Botti E.","Chimenti S.""SOURCE","British Journal of Dermatology (2007) 156:SUPPL. 2 (17-23). Date of Publication: April 2007"

"TITLE","A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis""AUTHOR NAMES","Moore A.","Gordon K.B.","Kang S.","Gottlieb A.","Freundlich B.","Xia H.A.","Stevens S.R.""SOURCE","Journal of the American Academy of Dermatology (2007) 56:4 (598-603). Date of Publication: April 2007"

"TITLE","Occurrence of psoriasis in a patient presenting Shulman fasciitis treated with infliximab""AUTHOR NAMES","Cavailhes A.","Ingen-Housz-Oro S.","Djennane S.","Rafaa M.","Fiszenson-Albala F.","Weber N.","Sigal-Grinberg M.""SOURCE","Annales de Dermatologie et de Venereologie (2007) 134:4 (363-367). Date of Publication: April 2007"

"TITLE","Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis [3]""AUTHOR NAMES","Seneschal J.","Lepreux S.","Bouyssou-Gauthier M.-L.","Heliot-Hosten I.","Economu A.","Dehais J.","Schaeverbeke T.","Taïeb A.""SOURCE","Acta Dermato-Venereologica (2007) 87:1 (77-80). Date of Publication: 2007"

"TITLE","Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists""AUTHOR NAMES","Lee H.-H.","Song I.-H.","Friedrich M.","Gauliard A.","Detert J.","Röwert J.","Audring H.","Kary S.","Burmester G.-R.","Sterry W.","Worm M.""SOURCE","British Journal of Dermatology (2007) 156:3 (486-491). Date of Publication: March 2007"

"TITLE","Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers""AUTHOR NAMES","Goiriz R.","Daudén E.","Pérez-Gala S.","Guhl G.","García-Díez A.""SOURCE","Clinical and Experimental Dermatology (2007) 32:2 (176-179). Date of Publication: March 2007"

"TITLE","Successful treatment of delayed pressure urticaria with anti-TNF-α""AUTHOR NAMES","Magerl M.","Philipp S.","Manasterski M.","Friedrich M.","Maurer M.""SOURCE","Journal of Allergy and Clinical Immunology (2007) 119:3 (752-754). Date of Publication: March 2007"

"TITLE","Systemic immunomodulatory therapy in severe dry eye secondary to inflammation""AUTHOR NAMES","Cordero-Coma M.","Anzaar F.","Sobrin L.","Foster C.S."

"SOURCE","Ocular Immunology and Inflammation (2007) 15:2 (99-104). Date of Publication: March/April 2007"

"TITLE","Infliximab-induced skin reaction with visceral manifestations and high levels of anti-DNA antibodies""AUTHOR NAMES","Jeudy G.","Dutronc Y.","Galliot-Repkat C.","Dupuis J.","Jolimoy G.","Lambert D.","Collet E.""SOURCE","Annales de Dermatologie et de Venereologie (2007) 134:3 (268-271). Date of Publication: March 2007"

"TITLE","Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial.""AUTHOR NAMES","Kimball A.B.","Jackson J.M.","Sobell J.M.","Boh E.E.","Grekin S.","Pharmd E.B.","Woolley J.M.","Xia H.A.","Chiou C.F.","Stevens S.R.""SOURCE","Journal of drugs in dermatology : JDD (2007) 6:3 (299-306). Date of Publication: Mar 2007"

"TITLE","Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions""AUTHOR NAMES","De Gannes G.C.","Ghoreishi M.","Pope J.","Russell A.","Bell D.","Adams S.","Shojania K.","Martinka M.","Dutz J.P.""SOURCE","Archives of Dermatology (2007) 143:2 (223-231). Date of Publication: February 2007"

"TITLE","Onset of psoriasis during treatment with TNF-α antagonists: A report of 3 cases [6]""AUTHOR NAMES","Ubriani R.","Van Voorhees A.S.""SOURCE","Archives of Dermatology (2007) 143:2 (270-272). Date of Publication: February 2007"

"TITLE","New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: A class effect?""AUTHOR NAMES","Roux C.H.","Brocq O.","Leccia N.","Giacchero D.","Breuil V.","Albert C.","Lacour J.","Perrin C.","Euler-Ziegler L.""SOURCE","Journal of Rheumatology (2007) 34:2 (434-437). Date of Publication: February 2007"

"TITLE","Psoriasis induced by tumor necrosis factor-α antagonist therapy: A case series""AUTHOR NAMES","Cohen J.D.","Bournerias I.","Buffard V.","Paufler A.","Chevalier X.","Bagot M.","Claudepierre P.""SOURCE","Journal of Rheumatology (2007) 34:2 (380-385). Date of Publication: February 2007"

"TITLE","Infliximab-induced acne: Report of two cases [19]""AUTHOR NAMES","Bassi E.","Poli F.","Charachon A.","Claudepierre P.","Revuz J.""SOURCE","British Journal of Dermatology (2007) 156:2 (402-403). Date of Publication: February 2007"

"TITLE","A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: Evidence for efficacy and high incidence of biological autoimmunity""AUTHOR NAMES","Poulalhon N.","Begon E.","Lebbé C.","Lioté F.","Lahfa M.","Bengoufa D.","Morel P.","Dubertret L.","Bachelez H.""SOURCE","British Journal of Dermatology (2007) 156:2 (329-336). Date of Publication: February 2007"

"TITLE","Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial""AUTHOR NAMES","Gladman D.D.","Mease P.J.","Ritchlin C.T.","Choy E.H.S.","Sharp J.T.","Ory P.A.","Perdok R.J.","Sasso E.H.""SOURCE","Arthritis and Rheumatism (2007) 56:2 (476-488). Date of Publication: February 2007"

"TITLE","Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis""AUTHOR NAMES","Hutmacher M.M.","Nestorov I.","Ludden T.","Zitnik R.","Banfield C.""SOURCE","Journal of Clinical Pharmacology (2007) 47:2 (238-248). Date of Publication: February 2007"

"TITLE","Infliximab in refractory psoriatic arthritis with severe psoriasis: A 2-year experience [1]""AUTHOR NAMES","Voulgari P.V.","Venetsanopoulou A.I.","Epagelis E.K.","Alamanos Y.","Takalou I.","Drosos A.A.""SOURCE","Annals of the Rheumatic Diseases (2007) 66:2 (270-271). Date of Publication: February 2007"

"TITLE","Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept) [7]""AUTHOR NAMES","Kasche A.","Pfab F.","Hein R.","Athanasiadis G.I.","Ollert M.","Ring J.","Eberlein-könig B.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2007) 21:2 (255-257). Date of Publication: February 2007"

"TITLE","Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment""AUTHOR NAMES","Tektonidou M.G.","Serelis J.","Skopouli F.N.""SOURCE","Clinical Rheumatology (2007) 26:2 (258-260). Date of Publication: February 2007"

"TITLE","Treatment of psoriasis with adalimumab""AUTHOR NAMES","Pitarch G.","Sanchez-Carazo J.L.","Mahiques L.","Perez-Ferriols M.A.","Fortea J.M.""SOURCE","Clinical and Experimental Dermatology (2007) 32:1 (18-22). Date of Publication: January 2007"

"TITLE","The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis""AUTHOR NAMES","Cassell S.E.","Bieber J.D.","Rich P.","Tutuncu Z.N.","Lee S.J.","Kalunian K.C.","Wu C.W.","Kavanaugh A.""SOURCE","Journal of Rheumatology (2007) 34:1 (123-129). Date of Publication: January 2007"

"TITLE","Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis""AUTHOR NAMES","Elewski B.","Leonardi C.","Gottlieb A.B.","Strober B.E.","Simiens M.A.","Dunn M.","Jahreis A.""SOURCE","British Journal of Dermatology (2007) 156:1 (138-142). Date of Publication: January 2007"

"TITLE","Diffuse psoriasis plaque type and infliximab: Our experience and review of literature""AUTHOR NAMES","Lemme G.","Campanati A.","Paolinelli M.","Offidani A.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2007) 142:1 (9-14). Date of Publication: February 2007"

"TITLE","A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis""AUTHOR NAMES","Menter A.","Feldman S.R.","Weinstein G.D.","Papp K.","Evans R.","Guzzo C.","Li S.","Dooley L.T.","Arnold C.","Gottlieb A.B.""SOURCE","Journal of the American Academy of Dermatology (2007) 56:1 (31.e1-31.e15). Date of Publication: January 2007"

"TITLE","Acute myelogenous leukemia in a patient receiving etanercept for psoriasis""AUTHOR NAMES","Bachmeyer C.","Thiolière B.","Khosrotehrani K.","Cattan E.""SOURCE","Journal of the American Academy of Dermatology (2007) 56:1 (169-170). Date of Publication: January 2007"

"TITLE","Efalizumab-induced aseptic meningitis [15]""AUTHOR NAMES","Kluger N.","Girard C.","Gonzalez V.","Guillot B.","Bessis D.""SOURCE","British Journal of Dermatology (2007) 156:1 (189-191). Date of Publication: January 2007"

"TITLE","Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients""AUTHOR NAMES","Jansson A.","Renner E.D.","Ramser J.","Mayer A.","Haban M.","Meindl A.","Grote V.","Diebold J.","Jansson V.","Schneider K.","Belohradsky B.H.""SOURCE","Rheumatology (2007) 46:1 (154-160). Date of Publication: January 2007"

"TITLE","Psoriatic onycho-pachydermo periostitis""AUTHOR NAMES","Srivastava M.","Solomon G.","Strober B.""SOURCE","Dermatology Online Journal (2007) 13:1 Article Number: 20. Date of Publication: January 2007"

"TITLE","Polyarticular arthritis secondary to Mycobacterium bovis infection: An unusual clinical presentation""AUTHOR NAMES","Cachafeiro-Vilar A.","García-Padilla C.","Reyes E.","Hernández-Molina G.""SOURCE","Joint Bone Spine (2007) 74:1 (107-109). Date of Publication: January 2007"

"TITLE","Pulmonary sarcoidosis developing during infliximab therapy""AUTHOR NAMES","O'Shea F.D.","Marras T.K.","Inman R.D.""SOURCE","Arthritis Care and Research (2006) 55:6 (978-981). Date of Publication: 15 Dec 2006"

"TITLE","Animation as a useful tool for assessing functional status in psoriatic arthritis""AUTHOR NAMES","Nomura T.","Kodama K.","Nishimura M.","Abe M.","Onozuka T.","Shimizu H.""SOURCE","Journal of Dermatological Science (2006) 44:3 (172-174). Date of Publication: December 2006"

"TITLE","Adalimumab-induced urticaria""AUTHOR NAMES","George S.J.","Anderson H.L.","Hsu S.""SOURCE","Dermatology Online Journal (2006) 12:2 Article Number: 4. Date of Publication: 2006"

"TITLE","Alopecia areata during treatment with biologic agents [5]"

"AUTHOR NAMES","Tosti A.","Pazzaglia M.","Starace M.","Bellavista S.","Vincenzi C.","Tonelli G.""SOURCE","Archives of Dermatology (2006) 142:12 (1653-1654). Date of Publication: 2006"

"TITLE","Use of etanercept for psoriatic arthritis in the dermatology clinic: The Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study""AUTHOR NAMES","Gottlieb A.B.","Kircik L.","Eisen D.","Jackson J.M.","Boh E.E.","Strober B.E.","Frankel E.","Xia H.A.","Stevens S.R.""SOURCE","Journal of Dermatological Treatment (2006) 17:6 (343-352). Date of Publication: December 2006"

"TITLE","Our experience with etanercept in the treatment of psoriasis""AUTHOR NAMES","Kokelj F.","Tothova S.M.","Patamia M.","Trevisan G.""SOURCE","Acta Dermatovenerologica Croatica (2006) 14:4 (241-245). Date of Publication: 2006"

"TITLE","High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life""AUTHOR NAMES","De Felice C.","Mazzotta A.","Esposito M.","Bianchi L.","Chimenti S.""SOURCE","Journal of Dermatological Treatment (2006) 17:6 (355-358). Date of Publication: December 2006"

"TITLE","Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy""AUTHOR NAMES","Markham T.","Mathews C.","Rogers S.","Mullan R.","Bresnihan B.","FitzGerald O.","Veale D.J.","Fearon U.""SOURCE","British Journal of Dermatology (2006) 155:6 (1191-1196). Date of Publication: December 2006"

"TITLE","New-onset, debilitating arthritis in psoriasis patients receiving efalizumab""AUTHOR NAMES","Myers W.A.","Najarian D.","Gottlieb A.B.""SOURCE","Journal of Dermatological Treatment (2006) 17:6 (353-354). Date of Publication: December 2006"

"TITLE","Pyoderma vegetans associated with severe psoriatic arthritis: Good response to etanercept""AUTHOR NAMES","Carrera C.","Mascaró Jr. J.M.","Moreno-Romero J.A.","Iranzo P.","Palou J.","Zamora E.","Herrero C.""SOURCE","Dermatology (2007) 214:1 (77-81). Date of Publication: December 2006"

"TITLE","Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.""AUTHOR NAMES","Tubach F.","Ravaud P.","Salmon-Céron D.","Petitpain N.","Brocq O.","Grados F.","Guillaume J.C.","Leport J.","Roudaut A.","Solau-Gervais E.","Lemann M.","Mariette X.","Lortholary O.""SOURCE","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2006) 43:10 (e95-100). Date of Publication: 15 Nov 2006"

"TITLE","Development of new-onset psoriasis while on anti-TNFα treatment [1]""AUTHOR NAMES","Matthews C.","Rogers S.","FitzGerald O.""SOURCE","Annals of the Rheumatic Diseases (2006) 65:11 (1529-1530). Date of Publication: November 2006"

"TITLE","Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept)""AUTHOR NAMES","Cecchi R.","Bartoli L.""SOURCE","Dermatology Online Journal (2006) 12:7. Date of Publication: Nov 2006"

"TITLE","Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept""AUTHOR NAMES","Myers W.","Newman M.","Katz B.","Gottlieb A.B.""SOURCE","Journal of the American Academy of Dermatology (2006) 55:5 SUPPL. (S127-S128). Date of Publication: November 2006"

"TITLE","Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report [6]""AUTHOR NAMES","Bang B.","Gniadecki R.""SOURCE","Acta Dermato-Venereologica (2006) 86:5 (456-457). Date of Publication: 2006"

"TITLE","Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: Three further cases and current overview""AUTHOR NAMES","Pirard D.","Arco D.","Debrouckere V.","Heenen M.""SOURCE","Dermatology (2006) 213:3 (182-186). Date of Publication: October 2006"

"TITLE","Henoch-Schönlein purpura after etanercept therapy for psoriasis""AUTHOR NAMES","Lee A.","Kasama R.","Evangelisto A.","Elfenbein B.","Falasca G.""SOURCE","Journal of Clinical Rheumatology (2006) 12:5 (249-251). Date of Publication: October 2006"

"TITLE","A distinct inflammatory gene expression profile in patients with psoriatic arthritis""AUTHOR NAMES","Stoeckman A.K.","Baechler E.C.","Ortmann W.A.","Behrens T.W.","Michet C.J.","Peterson E.J.""SOURCE","Genes and Immunity (2006) 7:7 (583-591). Date of Publication: October 2006"

"TITLE","Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study""AUTHOR NAMES","Gordon K.B.","Langley R.G.","Leonardi C.","Toth D.","Menter M.A.","Kang S.","Heffernan M.","Miller B.","Hamlin R.","Lim L.","Zhong J.","Hoffman R.","Okun M.M.""SOURCE","Journal of the American Academy of Dermatology (2006) 55:4 (598-606). Date of Publication: October 2006"

"TITLE","Initial experience with routine administration of etanercept in psoriasis""AUTHOR NAMES","De Groot M.","Appelman M.","Spuls P.I.","De Rie M.A.","Bos J.D.""SOURCE","British Journal of Dermatology (2006) 155:4 (808-814). Date of Publication: October 2006"

"TITLE","Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis""AUTHOR NAMES","Nestorov I.","Zitnik R.","DeVries T.","Nakanishi A.M.","Wang A.","Banfield C.""SOURCE","British Journal of Clinical Pharmacology (2006) 62:4 (435-445). Date of Publication: October 2006"

"TITLE","Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients""AUTHOR NAMES","Malaviya R.","Sun Y.","Tan J.K.","Wang A.","Magliocco M.","Yao M.","Krueger J.G.","Gottlieb A.B.""SOURCE","Journal of the American Academy of Dermatology (2006) 55:4 (590-597). Date of Publication: October 2006"

"TITLE","Psoriasis onset during infliximab treatment: Description of two cases""AUTHOR NAMES","Volpe A.","Caramaschi P.","Carletto A.","Pieropan S.","Bambara L.M.","Biasi D.""SOURCE","Rheumatology International (2006) 26:12 (1158-1160). Date of Publication: October 2006"

"TITLE","Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis.""AUTHOR NAMES","Malaviya R.","Sun Y.","Tan J.K.","Magliocco M.","Gottlieb A.B.""SOURCE","Journal of drugs in dermatology : JDD (2006) 5:9 (890-893). Date of Publication: Oct 2006"

"TITLE","The appearance of pustular psoriasis during antitumor necrosis factor therapy [2]""AUTHOR NAMES","Goncalves D.P.","Laurindo I.","Scheinberg M.A.""SOURCE","Journal of Clinical Rheumatology (2006) 12:5 (262). Date of Publication: October 2006"

"TITLE","Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva®) [5]""AUTHOR NAMES","Thielen A.M.","Barde C.","Saurat J.H.""SOURCE","British Journal of Dermatology (2006) 155:4 (846-847). Date of Publication: October 2006"

"TITLE","The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study""AUTHOR NAMES","Shikiar R.","Willian M.K.","Okun M.M.","Thompson C.S.","Revicki D.A.""SOURCE","Health and Quality of Life Outcomes (2006) 4 Article Number: 71. Date of Publication: 27 Sep 2006"

"TITLE","Psoriasis induced by infliximab: A paradoxical event [4]""AUTHOR NAMES","González-López M.A.","Blanco-Alonso R.","Yáñez-Diaz S.","Fernández-Llaca H.""SOURCE","Medicina Clinica (2006) 127:8 (316). Date of Publication: 2 Sep 2006"

"TITLE","Adverse events from systemic therapies for psoriasis are common in clinical practice""AUTHOR NAMES","Pearce D.J.","Higgins K.B.","Stealey K.H.","Balkrishnan R.","Crane M.M.","Camacho F.","Fleischer Jr. A.B.","Feldman S.R.""SOURCE","Journal of Dermatological Treatment (2006) 17:5 (288-293). Date of Publication: 1 Sep 2006"

"TITLE","Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis""AUTHOR NAMES","Bhosle M.J.","Feldman S.R.","Camacho F.T.","Whitmire J.T.","Nahata M.C.","Balkrishnan R.""SOURCE","Journal of Dermatological Treatment (2006) 17:5 (294-301). Date of Publication: 1 Sep 2006"

"TITLE","Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasis"

"AUTHOR NAMES","Neimann A.L.","Hodinka R.L.","Joshi Y.B.","Elkan M.","Van Voorhees A.S.","Gelfand J.M.""SOURCE","European Journal of Dermatology (2006) 16:5 (548-552). Date of Publication: September/October 2006"

"TITLE","Three years' experience with infliximab in recalcitrant psoriasis""AUTHOR NAMES","Ahmad K.","Rogers S.""SOURCE","Clinical and Experimental Dermatology (2006) 31:5 (630-633). Date of Publication: September 2006"

"TITLE","Etanercept for the treatment of psoriasis in the elderly""AUTHOR NAMES","Militello G.","Xia A.","Stevens S.R.","Van Voorhees A.S.""SOURCE","Journal of the American Academy of Dermatology (2006) 55:3 (517-519). Date of Publication: September 2006"

"TITLE","Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices""AUTHOR NAMES","Gottlieb A.B.","Mease P.J.","Jackson J.M.","Eisen D.","Xia H.A.","Asare C.","Stevens S.R.""SOURCE","Journal of Dermatological Treatment (2006) 17:5 (279-287). Date of Publication: 1 Sep 2006"

"TITLE","Biological treatment in rheumatic diseases: Results from a longitudinal surveillance: Adverse events""AUTHOR NAMES","Konttinen L.","Honkanen V.","Uotila T.","Pöllänen J.","Waahtera M.","Romu M.","Puolakka K.","Vasala M.","Karjalainen A.","Luukkainen R.","Nordström D.C.""SOURCE","Rheumatology International (2006) 26:10 (916-922). Date of Publication: August 2006"

"TITLE","Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment""AUTHOR NAMES","Anstey A.V.","Kragballe K.""SOURCE","International Journal of Dermatology (2006) 45:8 (970-975). Date of Publication: August 2006"

"TITLE","Anti-TNF-α-induced psoriasis: Case report of an unusual adverse event [1]""AUTHOR NAMES","Aslanidis S.","Pyrpasopoulou A.","Leontsini M.","Zamboulis C.""SOURCE","International Journal of Dermatology (2006) 45:8 (982-983). Date of Publication: August 2006"

"TITLE","Severe plaque psoriasis cum pustulatione - Significant improvement by treatment with efalizumab (Raptiva®)""AUTHOR NAMES","Thiel W.","Kowalzick L.""SOURCE","Aktuelle Dermatologie (2006) 32:8-9 (379-381). Date of Publication: Aug 2006"

"TITLE","Epidemiological investigation on a suggestive case of Legionella pneumonia and public health implications""AUTHOR NAMES","Borella P.","Marchesi I.","Boccia S.","Amore R.","Cagarelli R.","Casolari C.","Marchegiano P.""SOURCE","Scandinavian Journal of Infectious Diseases (2006) 38:8 (725-728). Date of Publication: August 2006"

"TITLE","Clinical experience with infliximab among Filipino patients with rheumatic diseases""AUTHOR NAMES","Navarra S.V.","Raso A.-A.","Lichauco J.J.","Tan P.P.""SOURCE","APLAR Journal of Rheumatology (2006) 9:2 (150-156). Date of Publication: Aug 2006"

"TITLE","Anti-tumor necrosis factor-α-induced psoriasis""AUTHOR NAMES","Sari I.","Akar S.","Birlik M.","Sis B.","Onen F.","Akkoc N.""SOURCE","Journal of Rheumatology (2006) 33:7 (1411-1414). Date of Publication: July 2006"

"TITLE","Treatment of erythrodermic psoriasis with etanercept""AUTHOR NAMES","Esposito M.","Mazzotta A.","De Felice C.","Papoutsaki M.","Chimenti S.""SOURCE","British Journal of Dermatology (2006) 155:1 (156-159). Date of Publication: July 2006"

"TITLE","Infliximab for severe, treatment-resistant psoriasis: A prospective, open-label study""AUTHOR NAMES","Smith C.H.","Jackson K.","Bashir S.J.","Perez A.","Chew A.L.","Powell A.M.","Wain M.","Barker J.N.W.N.""SOURCE","British Journal of Dermatology (2006) 155:1 (160-169). Date of Publication: July 2006"

"TITLE","Treatment of plaque psoriasis by sequential therapy with two 'biologics': The 'hit and run' approach, a report of two cases [3]""AUTHOR NAMES","Barde C.","Thielen A.-M.","Kuenzli S.","Saurat J.-H.""SOURCE","British Journal of Dermatology (2006) 155:1 (211-213). Date of Publication: July 2006"

"TITLE","Failure of two TNF-alpha blockers to influence the course of alopecia areata.""AUTHOR NAMES","Abramovits W.","Losornio M.""SOURCE","Skinmed (2006) 5:4 (177-181). Date of Publication: 2006 Jul-Aug"

"TITLE","Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: A randomized controlled trial""AUTHOR NAMES","Reich K.","Nestle F.O.","Papp K.","Ortonne J.-P.","Wu Y.","Bala M.","Evans R.","Guzzo C.","Li S.","Dooley L.T.","Griffiths C.E.M.""SOURCE","British Journal of Dermatology (2006) 154:6 (1161-1168). Date of Publication: June 2006"

"TITLE","Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept""AUTHOR NAMES","Krell J.M.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:6 (1099-1101). Date of Publication: June 2006"

"TITLE","Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy""AUTHOR NAMES","Markham T.","Mullan R.","Golden-Mason L.","Rogers S.","Bresnihan B.","FitzGerald O.","Fearon U.","Veale D.J.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:6 (1003-1012). Date of Publication: June 2006"

"TITLE","Etanercept therapy in two patients with psoriasis and concomitant hepatitis C""AUTHOR NAMES","De Simone C.","Paradisi A.","Capizzi R.","Carbone A.","Siciliano M.","Amerio P.L.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:6 (1102-1104). Date of Publication: June 2006"

"TITLE","Tumor necrosis factor-α inhibition and VATER association: A causal relationship?""AUTHOR NAMES","Carter J.D.","Valeriano J.","Vasey F.B.""SOURCE","Journal of Rheumatology (2006) 33:5 (1014-1017). Date of Publication: May 2006"

"TITLE","Hepatitis: A rare, but important, complication of infliximab therapy for psoriasis [8]""AUTHOR NAMES","Wahie S.","Alexandroff A.","Reynolds N.J.""SOURCE","Clinical and Experimental Dermatology (2006) 31:3 (460-461). Date of Publication: May 2006"

"TITLE","Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals""AUTHOR NAMES","Bovenschen H.J.","Tjioe M.","Vermaat H.","De Hoop D.","Witteman B.M.J.","Janssens R.W.A.","Stoof T.J.","Van De Kerkhof P.C.M.""SOURCE","British Journal of Dermatology (2006) 154:5 (880-884). Date of Publication: May 2006"

"TITLE","Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study""AUTHOR NAMES","Mease P.J.","Gladman D.D.","Keystone E.C.""SOURCE","Arthritis and Rheumatism (2006) 54:5 (1638-1645). Date of Publication: May 2006"

"TITLE","Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy [7]""AUTHOR NAMES","Cassano N.","Coviello C.","Loconsole F.","Miracapillo A.","Vena G.A.""SOURCE","European Journal of Dermatology (2006) 16:3 (316-317). Date of Publication: May/June 2006"

"TITLE","How to treat nail psoriasis? When must systemic drugs be used to treat nail lichen planus?""AUTHOR NAMES","Duhard E.""SOURCE","Nouvelles Dermatologiques (2006) 25:5 II (13-18). Date of Publication: May 2006"

"TITLE","Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease [3]""AUTHOR NAMES","Iizuka M.","Konno S.","Horie Y.","Itou H.","Shindo K.","Watanabe S.""SOURCE","Gut (2006) 55:5 (744-745). Date of Publication: May 2006"

"TITLE","Conjugal transformed mycosis fungoides: The unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma""AUTHOR NAMES","Schmidt A.N.","Robbins J.B.","Greer J.P.","Zic J.A.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:5 SUPPL. 1 (S202-S205). Date of Publication: May 2006"

"TITLE","Novel combination regimens: Biologics and acitretin for the treatment of psoriasis - A case series""AUTHOR NAMES","Conley J.","Nanton J.","Dhawan S.","Pearce D.J.","Feldman S.R.""SOURCE","Journal of Dermatological Treatment (2006) 17:2 (86-89). Date of Publication: April

2006"

"TITLE","Psoriasis treatment in the United States at the end of the 20th century""AUTHOR NAMES","Pearce D.J.","Stealey K.H.","Balkrishnan R.","Fleischer Jr. A.B.","Feldman S.R.""SOURCE","International Journal of Dermatology (2006) 45:4 (370-374). Date of Publication: April 2006"

"TITLE","Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Updated results from an ongoing trial""AUTHOR NAMES","Gottlieb A.B.","Hamilton T.","Caro I.","Kwon P.","Compton P.G.","Leonardi C.L.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:4 SUPPL. (S154-S163). Date of Publication: April 2006"

"TITLE","Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept""AUTHOR NAMES","Mease P.J.","Kivitz A.J.","Burch F.X.","Siegel E.L.","Cohen S.B.","Ory P.","Salonen D.","Rubenstein J.","Sharp J.T.","Dunn M.","Tsuji W.""SOURCE","Journal of Rheumatology (2006) 33:4 (712-721). Date of Publication: April 2006"

"TITLE","Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis""AUTHOR NAMES","Kavanaugh A.","Antoni C.","Krueger G.G.","Yan S.","Bala M.","Dooley L.T.","Beutler A.","Guzzo C.","Gladman D.""SOURCE","Annals of the Rheumatic Diseases (2006) 65:4 (471-477). Date of Publication: April 2006"

"TITLE","New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists""AUTHOR NAMES","Kary S.","Worm M.","Audring H.","Huscher D.","Renelt M.","Sörensen H.","Ständer E.","Maaß U.","Lee H.","Sterry W.","Burmester G.-R.""SOURCE","Annals of the Rheumatic Diseases (2006) 65:3 (405-407). Date of Publication: March 2006"

"TITLE","Efficacy of etanercept in an integrated multistudy database of patients with psoriasis""AUTHOR NAMES","Gordon K.","Korman N.","Frankel E.","Wang H.","Jahreis A.","Zitnik R.","Chang T.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S101-S111). Date of Publication: March 2006"

"TITLE","Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis""AUTHOR NAMES","Krüger-Krasagakis S.","Galanopoulos V.K.","Giannikaki L.","Stefanidou M.","Tosca A.D.""SOURCE","British Journal of Dermatology (2006) 154:3 (460-466). Date of Publication: March 2006"

"TITLE","Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial""AUTHOR NAMES","Krueger G.G.","Elewski B.","Papp K.","Wang A.","Zitnik R.","Jahreis A.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S112-S119). Date of Publication: March 2006"

"TITLE","Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database""AUTHOR NAMES","Gottlieb A.B.","Leonardi C.L.","Goffe B.S.","Ortonne J.-P.","Van Der Kerkhof P.C.M.","Zitnik R.","Nakanishi A.","Jahreis A.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S92-S100). Date of Publication: March 2006"

"TITLE","Efficacy of infliximab in patients with moderate and severe psoriasis treated with infliximab (Remicade®)""AUTHOR NAMES","Valdés A M.D.P.","Schroeder H F.","Roizen G V.","Honeyman M J.","Sánchez M L.""SOURCE","Revista Medica de Chile (2006) 134:3 (326-331). Date of Publication: March 2006"

"TITLE","Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patients.""AUTHOR NAMES","Krathen R.A.","Berthelot C.N.","Hsu S.""SOURCE","Journal of drugs in dermatology : JDD (2006) 5:3 (251-254). Date of Publication: Mar 2006"

"TITLE","Chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) in psoriasis""AUTHOR NAMES","Sridhar J.","Desylva P.L.K.","Singh Y.D.""SOURCE","Indian Journal of Dermatology, Venereology and Leprology (2006) 72:2 (133-135). Date of Publication: 1 Mar 2006"

"TITLE","Case reports of etanercept in inflammatory dermatoses""AUTHOR NAMES","Norman R.","Greenberg R.G.","Jackson J.M.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S139-S142). Date of Publication: March 2006"

"TITLE","Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept [2]""AUTHOR NAMES","Yamauchi P.S.","Lowe N.J.","Gindi V.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S121-S122). Date of Publication: March 2006"

"TITLE","A novel therapeutic approach to erythema annulare centrifugum [6]""AUTHOR NAMES","Minni J.","Sarro R.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:3 SUPPL. 2 (S134-S135). Date of Publication: March 2006"

"TITLE","Resolving granuloma annulare with etanercept [4]""AUTHOR NAMES","Shupack J.","Siu K.""SOURCE","Archives of Dermatology (2006) 142:3 (394-395). Date of Publication: March 2006"

"TITLE","Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor α inhibitors""AUTHOR NAMES","Deng A.","Harvey V.","Sina B.","Strobel D.","Badros A.","Junkins-Hopkins J.M.","Samuels A.","Oghilikhan M.","Gaspari A.""SOURCE","Archives of Dermatology (2006) 142:2 (198-202). Date of Publication: February 2006"

"TITLE","Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy""AUTHOR NAMES","Gordon K.B.","Gottlieb A.B.","Leonardi C.L.","Elewski B.E.","Wang A.","Jahreis A.","Zitnik R.""SOURCE","Journal of Dermatological Treatment (2006) 17:1 (9-17). Date of Publication: February 2006"

"TITLE","Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A""AUTHOR NAMES","Gül U.","Gönül M.","Kiliç A.","Erdem R.","Çakmak S.K.","Gündüz H.""SOURCE","Clinical Therapeutics (2006) 28:2 (251-254). Date of Publication: February 2006"

"TITLE","Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection [4]""AUTHOR NAMES","Rokhsar C.","Rabhan N.","Cohen S.R.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:2 (361-362). Date of Publication: February 2006"

"TITLE","Infliximab associated new-onset psoriasis.""AUTHOR NAMES","Adams D.R.","Buckel T.","Sceppa J.A.""SOURCE","Journal of drugs in dermatology : JDD (2006) 5:2 (178-179). Date of Publication: Feb 2006"

"TITLE","Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial""AUTHOR NAMES","Tyring S.","Gottlieb A.","Papp K.","Gordon K.","Leonardi C.","Wang A.","Lalla D.","Woolley M.","Jahreis A.","Zitnik R.","Cella D.","Krishnan R.""SOURCE","Lancet (2006) 367:9504 (29-35). Date of Publication: 7 Jan 2006"

"TITLE","Etanercept and demyelinating disease in a patient with psoriasis""AUTHOR NAMES","Sukal S.A.","Nadiminti L.","Granstein R.D.""SOURCE","Journal of the American Academy of Dermatology (2006) 54:1 (160-164). Date of Publication: January 2006"

"TITLE","Sequential treatment of psoriasis with infliximab followed by cyclosporin: Preliminary results of an open-label prospective study""AUTHOR NAMES","Vena G.A.","Cassano N.","Loconsole F.","Malara G.","Sciarrone C.","Guerra A.P.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2006) 141:3 (221-225). Date of Publication: June 2006"

"TITLE","Once-weekly administration of high-dosage etanercept in patients with plaque psoriasis: Results of a pilot experience (power study)""AUTHOR NAMES","Cassano N.","Loconsole F.","Galluccio A.","Miracapillo A.","Pezza M.","Vena G.A.""SOURCE","International Journal of Immunopathology and Pharmacology (2006) 19:1 (225-229). Date of Publication: January/March 2006"

"TITLE","A case of recurrent generalized pustular psoriasis treated with a combination of infliximab with methotrexate and retinoid""AUTHOR NAMES","Kim S.Y.","Kim G.M.","Kim S.-Y.""SOURCE","Korean Journal of Dermatology (2006) 44:1 (67-70). Date of Publication: Jan 2006"

"TITLE","Etanercept for psoriasis in the pediatric population: Experience in nine patients""AUTHOR NAMES","Hawrot A.C.","Metry D.W.","Theos A.J.","Levy M.L.""SOURCE","Pediatric Dermatology (2006) 23:1 (67-71). Date of Publication: January 2006"

"TITLE","Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis""AUTHOR NAMES","Bianchi L.","Giunta A.","Papoutsaki M.","Costanzo A.","Chimenti S.""SOURCE","Giornale Italiano di Dermatologia e Venereologia (2006) 141:1 (73-78). Date of Publication: February 2006"

"TITLE","Atypical CD8(+) cutaneous T-cell lymphoma after immunomodulatory therapy""AUTHOR NAMES","Berthelot C.","Cather J.","Jones D.","Duvic M.""SOURCE","Clinical Lymphoma and Myeloma (2006) 6:4 (329-332). Date of Publication: January 2006"

"TITLE","Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis [4]""AUTHOR NAMES","Pallotta P.","Cianchini G.","Ruffelli M.","Puddu P.""SOURCE","Rheumatology (2006) 45:1 (116-117). Date of Publication: January 2006"

"TITLE","Infliximab in recalcitrant severe atopic eczema associated with contact allergy""AUTHOR NAMES","Cassano N.","Loconsole F.","Coviello C.","Vena G.A.""SOURCE","International Journal of Immunopathology and Pharmacology (2006) 19:1 (237-240). Date of Publication: January/March 2006"

"TITLE","Biological therapy in psoriatic arthritis - Our experience with etanercept""AUTHOR NAMES","Raffayová H.","Rovenský J.","Máliš F.""SOURCE","Rheumatologia (2005) 19:4 (163-167). Date of Publication: 2005"

"TITLE","Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis [7]""AUTHOR NAMES","Heikkilä H.","Ranki A.","Cajanus S.","Karvonen S.-L.""SOURCE","Archives of Dermatology (2005) 141:12 (1607-1610). Date of Publication: December 2005"

"TITLE","Patient-reported outcomes of psoriasis improvement with etanercept therapy: Results of a randomized phase III trial""AUTHOR NAMES","Krueger G.G.","Langley R.G.","Finlay A.Y.","Griffiths C.E.M.","Woolley J.M.","Lalla D.","Jahreis A.""SOURCE","British Journal of Dermatology (2005) 153:6 (1192-1199). Date of Publication: December 2005"

"TITLE","Safety and efficacy study on etanercept in patients with plaque psoriasis [11]""AUTHOR NAMES","Costanzo A.","Mazzotta A.","Papoutsaki M.","Nisticò S.","Chimenti S.""SOURCE","British Journal of Dermatology, Supplement (2005) 152:1 (187-189). Date of Publication: 2005"

"TITLE","Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis""AUTHOR NAMES","Zargari O.""SOURCE","Dermatology Online Journal (2005) 11:3 Article Number: 21. Date of Publication: 2005"

"TITLE","Etanercept for psoriasis: Two case reports""AUTHOR NAMES","Fidalgo A.","Baptista J.","Rocha Páris F.","Caldas Lopes L.","Ferreira A.""SOURCE","International Journal of Clinical Pharmacology Research (2005) 25:4 (159-163). Date of Publication: 2005"

"TITLE","Infliximab and nephrotic syndrome""AUTHOR NAMES","Chin G.","Luxton G.","Harvey J.M.""SOURCE","Nephrology Dialysis Transplantation (2005) 20:12 (2824-2826). Date of Publication: December 2005"

"TITLE","Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis.""AUTHOR NAMES","Zargari O.""SOURCE","Dermatology online journal (2005) 11:3 (21). Date of Publication: 2005"

"TITLE","Scaly red plaques on dorsal part of hand""AUTHOR NAMES","Levine N.""SOURCE","Geriatrics (2005) 60:12 (17). Date of Publication: December 2005"

"TITLE","The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis""AUTHOR NAMES","Don B.R.","Spin G.","Nestorov I.","Hutmacher M.","Rose A.","Kaysen G.A.""SOURCE","Journal of Pharmacy and Pharmacology (2005) 57:11 (1407-1413). Date of Publication: 2005"

"TITLE","Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.""AUTHOR NAMES","Lowes M.A.","Turton J.A.","Krueger J.G.","Barnetson R.S.""SOURCE","BMC dermatology (2005) 5 Article Number: 9. Date of Publication: 2005"

"TITLE","Distal lower extremity paresthesia and foot drop developing during adalimumab therapy""AUTHOR NAMES","Berthelot C.N.","George S.J.","Hsu S.""SOURCE","Journal of the American Academy of Dermatology (2005) 53:5 SUPPL. (S260-S262). Date of Publication: November 2005"

"TITLE","The role of lesional T cells in recalcitrant psoriasis during infliximab therapy""AUTHOR NAMES","Bovenschen H.J.","Van De Kerkhof P.C.M.","Gerritsen W.J.","Seyger M.M.B.""SOURCE","European Journal of Dermatology (2005) 15:6 (454-458). Date of Publication: November/December 2005"

"TITLE","Onset of flexural psoriasis during infliximab treatment for Crohn's disease [6]""AUTHOR NAMES","Peramiquel L.","Puig L.","Dalmau J.","Ricart E.","Roé E.","Alomar A.""SOURCE","Clinical and Experimental Dermatology (2005) 30:6 (713-714). Date of Publication: November 2005"

"TITLE","Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment [8]""AUTHOR NAMES","Nikas S.N.","Voulgari P.V.","Takalou I.P.","Katsimbri P.","Drosos A.A.""SOURCE","Annals of the Rheumatic Diseases (2005) 64:11 (1665-1667). Date of Publication: November 2005"

"TITLE","Open-label 24-month study evaluating infliximab therapy in patients with psoriatic spondyloarthropathy""AUTHOR NAMES","Scali J.J.","Kaminsky A.","Salomón J.","Visentini S.","Dancziger E.""SOURCE","Annals of the New York Academy of Sciences (2005) 1051 (543-550). Date of Publication: 2005"

"TITLE","Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial""AUTHOR NAMES","Reich K.","Nestle F.O.","Papp K.","Ortonne J.-P.","Evans R.","Guzzo C.","Li S.","Dooley L.T.","Griffiths C.E.M.""SOURCE","Lancet (2005) 366:9494 (1367-1374). Date of Publication: 15 Oct 2005"

"TITLE","Infliximab for the treatment of psoriasis: Clinical experience at the State University of New York at Buffalo""AUTHOR NAMES","Kalb R.E.","Gurske J.""SOURCE","Journal of the American Academy of Dermatology (2005) 53:4 (616-622). Date of Publication: October 2005"

"TITLE","Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial""AUTHOR NAMES","Mease P.J.","Gladman D.D.","Ritchlin C.T.","Ruderman E.M.","Steinfeld S.D.","Choy E.H.S.","Sharp J.T.","Ory P.A.","Perdok R.J.","Weinberg M.A.""SOURCE","Arthritis and Rheumatism (2005) 52:10 (3279-3289). Date of Publication: October 2005"

"TITLE","Psoriatic onychopachydermoperiostitis: Improvement with etanercept [10]""AUTHOR NAMES","Dans M.","Hivnor C.","Van Voorhees A.S.""SOURCE","British Journal of Dermatology (2005) 153:4 (858-859). Date of Publication: October 2005"

"TITLE","Therapy-resistant psoriasis treated with alefacept and subsequent narrow band ultraviolet B phototherapy with total clearing of psoriasis""AUTHOR NAMES","Scheinfeld N.""SOURCE","Dermatology Online Journal (2005) 11:2 Article Number: 7. Date of Publication: 2005"

"TITLE","Refractory psoriasis treatment with etanercept""AUTHOR NAMES","Mahiques Santos L.","Martínez-Menchón T.","Sánchez Carazo J.L.","Pérez-Ferriols A.","Soriano Navarr C.J.","Fortea Baixauli J.M.""SOURCE","Medicina Clinica (2005) 125:10 (371-373) Article Number: 102.960. Date of Publication: 24 Sep 2005"

"TITLE","Cytokine profiles during infliximab monotherapy in psoriatic arthritis""AUTHOR NAMES","Mastroianni A.","Minutilli E.","Mussi A.","Bordignon V.","Trento E.","D'Agosto G.","Cordiali-Fei P.","Berardesca E.""SOURCE","British Journal of Dermatology (2005) 153:3 (531-536). Date of Publication: September 2005"

"TITLE","Case report: Infliximab treatment for recalcitrant psoriasis and psoriatic arthritis""AUTHOR NAMES","San Filippo J.","Kalb R.E.""SOURCE","Cosmetic Dermatology (2005) 18:9 (645-646). Date of Publication: Sep 2005"

"TITLE","Efalizumab for the treatment of moderate to severe plaque psoriasis""AUTHOR NAMES","Jordan J.K.""SOURCE","Annals of Pharmacotherapy (2005) 39:9 (1476-1482). Date of Publication: September 2005"

"TITLE","Long term infliximab treatment for severe psoriatic arthritis: Evidence of sustained clinical and radiographic response""AUTHOR NAMES","Rinaldi F.","Provenzano G.","Termini A.","Spinello M.","La Seta F.""SOURCE","Annals of the Rheumatic Diseases (2005) 64:9 (1375-1376). Date of Publication: September 2005"

"TITLE","Pustular skin lesions in patients treated with infliximab: Report of two cases""AUTHOR NAMES","Starmans-Kool M.J.F.","Peeters H.R.M.","Houben H.H.M.L.""SOURCE","Rheumatology International (2005) 25:7 (550-552). Date of Publication: September 2005"

"TITLE","Infliximab in treatment of severe psoriatic arthritis""AUTHOR NAMES","Consorte Loyola A.J.","Wirth Chaibub S.C.","Miranda De Castro L.C.","Ximenes A.C.""SOURCE","Anais Brasileiros de Dermatologia (2005) 80:5 (535-537). Date of Publication: September/October 2005"

"TITLE","Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: A case series""AUTHOR NAMES","Lowes M.A.","Turton J.A.","Krueger J.G.","Barnetson R.St.C.""SOURCE","BMC Dermatology (2005) 5 Article Number: 9. Date of Publication: 18 Aug 2005"

"TITLE","Granulomatous lung disease occurring during etanercept treatment""AUTHOR NAMES","Phillips K.","Weinblatt M.""SOURCE","Arthritis Care and Research (2005) 53:4 (618-620). Date of Publication: 15 Aug 2005"

"TITLE","TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques""AUTHOR NAMES","Gottlieb A.B.","Chamian F.","Masud S.","Cardinale I.","Abello M.V.","Lowes M.A.","Chen F.","Magliocco M.","Krueger J.G.""SOURCE","Journal of Immunology (2005) 175:4 (2721-2729). Date of Publication: 15 Aug 2005"

"TITLE","Psoriasis induced by anti-tumor necrosis factor therapy: A paradoxical adverse reaction""AUTHOR NAMES","Sfikakis P.P.","Iliopoulos A.","Elezoglou A.","Kittas C.","Stratigos A.""SOURCE","Arthritis and Rheumatism (2005) 52:8 (2513-2518). Date of Publication: August 2005"

"TITLE","Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin [4]""AUTHOR NAMES","Tobin A.M.","Kirby B.""SOURCE","British Journal of Dermatology (2005) 153:2 (445-446). Date of Publication: August 2005"

"TITLE","Etanercept and psoriasis, from clinical studies to real life""AUTHOR NAMES","Jacob S.E.","Sergay A.","Kerdel F.A.""SOURCE","International Journal of Dermatology (2005) 44:8 (688-691). Date of Publication: August 2005"

"TITLE","Infliximab""AUTHOR NAMES","Mealy N.E.","Bayés M.""SOURCE","Drugs of the Future (2005) 30:8 (845-846). Date of Publication: Aug 2005"

"TITLE","Infliximab improves signs and symptoms of psoriatic arthritis: Results of the IMPACT 2 trial""AUTHOR NAMES","Antoni C.","Krueger G.G.","De Vlam K.","Birbara C.","Beutler A.","Guzzo C.","Zhou B.","Dooley L.T.","Kavanaugh A.""SOURCE","Annals of the Rheumatic Diseases (2005) 64:8 (1150-1157). Date of Publication: August 2005"

"TITLE","Mycosis fungoides-associated follicular mucinosis under adalimumab [2]""AUTHOR NAMES","Dalle S.","Balme B.","Berger F.","Hayette S.","Thomas L.""SOURCE","British Journal of Dermatology (2005) 153:1 (207-208). Date of Publication: July 2005"

"TITLE","Etanercept, anticytokines and mania""AUTHOR NAMES","Kaufman K.R.""SOURCE","International Clinical Psychopharmacology (2005) 20:4 (239-241). Date of Publication: July 2005"

"TITLE","BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis.

Report of a working party of the British Society for Rheumatology""AUTHOR NAMES","Keat A.","Barkham N.","Bhalla A.","Gaffney K.","Marzo-Ortega H.","Paul S.","Rogers F.","Somerville M.","Sturrock R.","Wordsworth P.""SOURCE","Rheumatology (2005) 44:7 (939-947). Date of Publication: July 2005"

"TITLE","Successful infliximab therapy of psoriasis vulgaris and psoriatic arthritis in a patient with cirrhosis [5]""AUTHOR NAMES","Lehnen M.","Franckson T.","Knab J.","Hoeft D.","Grabbe S.","Dissemond J.""SOURCE","British Journal of Dermatology (2005) 153:1 (212-214). Date of Publication: July 2005"

"TITLE","Generalized pustular psoriasis following withdrawal of short-term cyclosporin therapy for psoriatic arthritis [15]""AUTHOR NAMES","Hong S.-B.","Kim N.-I.""SOURCE","Journal of the European Academy of Dermatology and Venereology (2005) 19:4 (522-523). Date of Publication: July 2005"

"TITLE","Psoriatic arthritis in a military aviator""AUTHOR NAMES","Sulit D.J.","Clarke J.E.""SOURCE","Aviation Space and Environmental Medicine (2005) 76:7 I (684-688). Date of Publication: July 2005"

"TITLE","Modern modified 'ultra' Goeckerman therapy: A PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies""AUTHOR NAMES","Lee E.","Koo J.""SOURCE","Journal of Dermatological Treatment (2005) 16:2 (102-107). Date of Publication: 2005"

"TITLE","Chronic psoriasis""AUTHOR NAMES","Tate B.""SOURCE","Medicine Today (2005) 6:6 (73-76). Date of Publication: Jun 2005"

"TITLE","A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction""AUTHOR NAMES","Papp K.A.","Tyring S.","Lahfa M.","Prinz J.","Griffiths C.E.M.","Nakanishi A.M.","Zitnik R.","Van De Kerkhof P.C.M.""SOURCE","British Journal of Dermatology (2005) 152:6 (1304-1312). Date of Publication: June 2005"

"TITLE","Differential expression of phosphorylated NF-κB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept""AUTHOR NAMES","Lizzul P.F.","Aphale A.","Malaviya R.","Sun Y.","Masud S.","Dombrovskiy V.","Gottlieb A.B.""SOURCE","Journal of Investigative Dermatology (2005) 124:6 (1275-1283). Date of Publication: June 2005"

"TITLE","Therapy-resistant psoriasis: Increase of skin disorder during treatment with infliximab""AUTHOR NAMES","Bovenschen H.J.","Seyger M.M.B.","Van De Kerkhof P.C.M.","Van Der Valk P.G.M.""SOURCE","Nederlands Tijdschrift voor Dermatologie en Venereologie (2005) 15:5 (245-246). Date of Publication: Jun 2005"

"TITLE","Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: A double-blind, multicentre, randomized, dose-finding trial""AUTHOR NAMES","Gottlieb A.B.","Griffiths C.E.M.","Ho V.C.","Lahfa M.","Mrowietz U.","Murrell D.F.","Ortonne J.-P.","Todd G.","Cherill R.","Marks I.","Emady-Azar S.","Paul C.F.""SOURCE","British Journal of Dermatology (2005) 152:6 (1219-1227). Date of Publication: June 2005"

"TITLE","Early videocapillaroscopic changes of the psoriatic skin after anti-tumour necrosis factor alpha treatment [3]""AUTHOR NAMES","De Angelis R.","Gasparini S.","Bugatti L.","Filosa G.""SOURCE","Dermatology (2005) 210:3 (241-243). Date of Publication: 2005"

"TITLE","Efficacy of treatment of patients with spondyloarthropathies with infliximab""AUTHOR NAMES","Głowska A.","Wiland P.","Szechiński J.""SOURCE","Polskie Archiwum Medycyny Wewnetrznej (2005) 113:1 (42-47). Date of Publication: 2005"

"TITLE","Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: A double-blind placebo-controlled trial""AUTHOR NAMES","Feldman S.R.","Gordon K.B.","Bala M.","Evans R.","Li S.","Dooley L.T.","Guzzo C.","Patel K.","Menter A.","Gottlieb A.B.""SOURCE","British Journal of Dermatology (2005) 152:5 (954-960). Date of Publication: May 2005"

"TITLE","Unexpected onset of psoriasis during infliximab treatment: Comment on the article by Beuthien et al [1] (multiple letters)"

"AUTHOR NAMES","Grinblat B.","Scheinberg M.","Beuthien W.","Mellinghoff H.-U.","Loske K.-D.","Von Kempis J.""SOURCE","Arthritis and Rheumatism (2005) 52:4 (1333-1334). Date of Publication: April 2005"

"TITLE","Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)""AUTHOR NAMES","Antoni C.E.","Kavanaugh A.","Kirkham B.","Tutuncu Z.","Burmester G.R.","Schneider U.","Furst D.E.","Molitor J.","Keystone E.","Gladman D.","Manger B.","Wassenberg S.","Weier R.","Wallace D.J.","Weisman M.H.","Kalden J.R.","Smolen J.""SOURCE","Arthritis and Rheumatism (2005) 52:4 (1227-1236). Date of Publication: April 2005"

"TITLE","Remission and time of resolution of nail psoriasis during infliximab therapy [27]""AUTHOR NAMES","Bianchi L.","Bergamin A.","De Felice C.","Capriotti E.","Chimenti S.""SOURCE","Journal of the American Academy of Dermatology (2005) 52:4 (736-737). Date of Publication: April 2005"

"TITLE","Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy [14]""AUTHOR NAMES","Eisendle K.","Fritsch P.""SOURCE","British Journal of Dermatology (2005) 152:3 (585-586). Date of Publication: March 2005"

"TITLE","A case of SAPHO syndrome in a palmoplantar pustulosis patient""AUTHOR NAMES","Kwon O.-E.","Kim H.-S.","Sim S.-J.","Song K.-H.","Kim K.-H.""SOURCE","Korean Journal of Dermatology (2005) 43:2 (239-243). Date of Publication: Feb 2005"

"TITLE","Safety and efficacy study on etanercept in patients with plaque psoriasis [11]""AUTHOR NAMES","Costanzo A.","Mazzotta A.","Papoutsaki M.","Nisticò S.","Chimenti S.""SOURCE","British Journal of Dermatology (2005) 152:1 (187-189). Date of Publication: January 2005"

"TITLE","Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab""AUTHOR NAMES","Bongartz T.","Härle P.","Friedrich S.","Karrer S.","Vogt T.","Seitz A.","Müller-Ladner U.""SOURCE","Arthritis and Rheumatism (2005) 52:1 (280-282). Date of Publication: January 2005"

"TITLE","Eczematous drug eruption after infliximab [1]""AUTHOR NAMES","Dumont-Berset M.","Laffitte E.","Gerber C.","Dudler J.","Panizzon R.G.""SOURCE","British Journal of Dermatology (2004) 151:6 (1272-1273). Date of Publication: December 2004"

"TITLE","Population pharmacokinetic modeling of subcutaneously administered etanercept in patients with psoriasis""AUTHOR NAMES","Nestorov I.","Zitnik R.","Ludden T.""SOURCE","Journal of Pharmacokinetics and Pharmacodynamics (2004) 31:6 (463-490). Date of Publication: December 2004"

"TITLE","Rapid onset of cutaneous squamous cell carcinoma of the penis in a patient with psoriasis on etanercept therapy [1]""AUTHOR NAMES","Fryrear II R.S.","Wiggins A.K.","Sangueza O.","Yosipovitch G.""SOURCE","Journal of the American Academy of Dermatology (2004) 51:6 (1026). Date of Publication: December 2004"

"TITLE","Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab""AUTHOR NAMES","Garrity J.A.","Coleman A.W.","Matteson E.L.","Eggenberger E.R.","Waitzman D.M.""SOURCE","American Journal of Ophthalmology (2004) 138:6 (925-930). Date of Publication: December 2004"

"TITLE","Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.""AUTHOR NAMES","Goedkoop A.Y.","Kraan M.C.","Picavet D.I.","de Rie M.A.","Teunissen M.B.","Bos J.D.","Tak P.P.""SOURCE","Arthritis research & therapy (2004) 6:4 (R326-334). Date of Publication: 2004"

"TITLE","Treatment of severe refractory psoriasis with infliximab""AUTHOR NAMES","Santos L.M.","Martínez-Menchón T.","Carazo J.L.S.","Martínez V.O.","Navarro C.J.S.","Baixauli J.M.F.""SOURCE","Medicina Clinica (2004) 123:17 (657-658). Date of Publication: 13 Nov 2004"

"TITLE","Absence of a clinically relevant interaction between etanercept and digoxin""AUTHOR NAMES","Zhou H.","Parks V.","Patat A.","Le Coz F.","Simcoe D.","Korth-Bradley J.""SOURCE","Journal of Clinical Pharmacology (2004) 44:11 (1244-1251). Date of Publication:

November 2004"

"TITLE","Enbrel (etanercept).""AUTHOR NAMES","Abramovits W.","Arrazola P.","Gupta A.K.""SOURCE","Skinmed (2004) 3:6 (333-335). Date of Publication: 2004 Nov-Dec"

"TITLE","Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial""AUTHOR NAMES","Gottlieb A.B.","Evans R.","Li S.","Dooley L.T.","Guzzo C.A.","Baker D.","Bala M.","Marano C.W.","Menter A.""SOURCE","Journal of the American Academy of Dermatology (2004) 51:4 (534-542). Date of Publication: October 2004"

"TITLE","Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases""AUTHOR NAMES","Magliocco M.A.","Gottlieb A.B.""SOURCE","Journal of the American Academy of Dermatology (2004) 51:4 (580-584). Date of Publication: October 2004"

"TITLE","Infliximab monotherapy for refractory psoriasis: Preliminary results""AUTHOR NAMES","Cassano N.","Loconsole F.","Amoruso A.","Coviello C.","Filieri M.","Filotico R.","Del Vecchio S.","Vena G.A.""SOURCE","International Journal of Immunopathology and Pharmacology (2004) 17:3 (373-380). Date of Publication: September/December 2004"

"TITLE","Fulminant cytomegaloviral pneumonia after infliximab in a patient with Crohn disease""AUTHOR NAMES","Kak V.","Havlichek Jr. D.""SOURCE","Infectious Diseases in Clinical Practice (2004) 12:5 (311-313). Date of Publication: Sep 2004"

"TITLE","Class I topical corticosteroid use by psoriasis patients in an academic practice""AUTHOR NAMES","Pearce D.J.","Spencer L.","Hu J.","Balkrishnan R.","Fleischer Jr. A.B.","Feldman S.R.""SOURCE","Journal of Dermatological Treatment (2004) 15:4 (235-238). Date of Publication: 2004"

"TITLE","Successful treatment of Von Zumbusch pustular psoriasis with infliximab""AUTHOR NAMES","Trent J.T.","Kerdel F.A.""SOURCE","Journal of Cutaneous Medicine and Surgery (2004) 8:4 (224-228). Date of Publication: August 2004"

"TITLE","Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab""AUTHOR NAMES","Chew A.-L.","Bennett A.","Smith C.H.","Barker J.","Kirkham B.""SOURCE","British Journal of Dermatology (2004) 151:2 (492-496). Date of Publication: August 2004"

"TITLE","Psoriatic lesions induced by antitumour necrosis factor-α treatment: Two cases [1]""AUTHOR NAMES","Dereure O.","Guillot B.","Jorgensen C.","Cohen J.-D.","Combes B.","Guilhou J.-J.""SOURCE","British Journal of Dermatology (2004) 151:2 (506-507). Date of Publication: August 2004"

"TITLE","Use of infliximab in the treatment of psoriasis [1]""AUTHOR NAMES","Lee M.R.","Cooper A.J.""SOURCE","Australasian Journal of Dermatology (2004) 45:3 (193-195). Date of Publication: August 2004"

"TITLE","A red, scaly rash: How to recognize and treat psoriasis""AUTHOR NAMES","Cayce K.A.","Carroll C.L.","Pearce D.J.","Feldman S.R.""SOURCE","Journal of Clinical Outcomes Management (2004) 11:7 (463-474). Date of Publication: Jul 2004"

"TITLE","Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression""AUTHOR NAMES","Mease P.J.","Kivitz A.J.","Burch F.X.","Siegel E.L.","Cohen S.B.","Ory P.","Salonen D.","Rubenstein J.","Sharp J.T.","Tsuji W.""SOURCE","Arthritis and Rheumatism (2004) 50:7 (2264-2272). Date of Publication: July 2004"

"TITLE","Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis""AUTHOR NAMES","Goedkoop A.Y.","Kraan M.C.","Teunissen M.B.M.","Picavet D.I.","De Rie M.A.","Bos J.D.","Tak P.P.""SOURCE","Annals of the Rheumatic Diseases (2004) 63:7 (769-773). Date of Publication: July 2004"

"TITLE","Pustular psoriasis induced by infliximab.""AUTHOR NAMES","Thurber M.","Feasel A.","Stroehlein J.","Hymes S.R."

"SOURCE","Journal of drugs in dermatology : JDD (2004) 3:4 (439-440). Date of Publication: 2004 Jul-Aug"

"TITLE","Inflximab (Remicade®) for acute, severe pustular and erythrodermic psoriasis [13]""AUTHOR NAMES","Lisby S.","Gniadecki R.""SOURCE","Acta Dermato-Venereologica (2004) 84:3 (247-248). Date of Publication: 2004"

"TITLE","Treatment of recalcitrant pustular psoriasis with infliximab: Effective reduction of chemokine expression""AUTHOR NAMES","Benoit S.","Toksoy A.","Bröcker E.-B.","Gillitzer R.","Goebeler M.""SOURCE","British Journal of Dermatology (2004) 150:5 (1009-1012). Date of Publication: May 2004"

"TITLE","Serum sickness due to infliximab in a patient with psoriasis.""AUTHOR NAMES","Krishnan R.S.","Hsu S.""SOURCE","Journal of drugs in dermatology : JDD (2004) 3:3 (305-308). Date of Publication: 2004 May-Jun"

"TITLE","Etanercept for the treatment of psoriasis: combination therapy with other modalities.""AUTHOR NAMES","Strober B.E.","Clarke S.""SOURCE","Journal of drugs in dermatology : JDD (2004) 3:3 (270-272). Date of Publication: 2004 May-Jun"

"TITLE","SAPHO syndrome treated with pamidronate: An open-label study of 10 patients""AUTHOR NAMES","Amital H.","Applbaum Y.H.","Aamar S.","Daniel N.","Rubinow A.""SOURCE","Rheumatology (2004) 43:5 (658-661). Date of Publication: May 2004"

"TITLE","Visceral leishmaniasis related to infliximab administration [6]""AUTHOR NAMES","Romaní-Costa V.","Sánchez C.","Moyá F.","Estany C.""SOURCE","Enfermedades Infecciosas y Microbiologia Clinica (2004) 22:5 (310). Date of Publication: May 2004"

"TITLE","Infliximab monotherapy in psoriasis: A case of rapid clinical and histological response""AUTHOR NAMES","Vincek V.","Jacob S.E.","Nassiri M.","Herbert L.M.","Nadji M.","Kerdel F.A.""SOURCE","International Journal of Dermatology (2004) 43:4 (303-308). Date of Publication: April 2004"

"TITLE","Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab [10]""AUTHOR NAMES","Bartke U.","Venten I.","Kreuter A.","Gabbay S.","Altmeyer P.","Brockmeyer N.H.""SOURCE","British Journal of Dermatology (2004) 150:4 (784-786). Date of Publication: April 2004"

"TITLE","Successful Treatment of Psoriasis and Psoriatic Arthritis with Etanercept and Methotrexate in a Patient Newly Unresponsive to Infliximab [6]""AUTHOR NAMES","Strober B.E.""SOURCE","Archives of Dermatology (2004) 140:3 (366). Date of Publication: March 2004"

"TITLE","Treatment of refractory psoriatic arthritis with infliximab: A 12 month observational study of 16 patients""AUTHOR NAMES","Feletar M.","Brockbank J.E.","Schentag C.T.","Lapp V.","Gladman D.D.""SOURCE","Annals of the Rheumatic Diseases (2004) 63:2 (156-161). Date of Publication: February 2004"

"TITLE","Treatment of recalcitrant psoriasis with infliximab""AUTHOR NAMES","Revenga F.","Juanb A.","Ros I.","Nadal C.","Taberner R.""SOURCE","Actas Dermo-Sifiliograficas (2004) 95:1 (44-50). Date of Publication: Jan 2004"

"TITLE","Immunospecific Therapy in IBD: Rationale and Practical Application""AUTHOR NAMES","Papachristou G.","Plevy S.""SOURCE","Practical Gastroenterology (2004) 28:1 (18-30). Date of Publication: Jan 2004"

"TITLE","Efalizumab: A new biologic therapy for the control of chronic plaque psoriasis""AUTHOR NAMES","Tam J.W.","Lee G.J.","Song J.C.""SOURCE","Formulary (2004) 39:1 (20-39). Date of Publication: Jan 2004"

"TITLE","Psoriasiform Eruption Induced by Infliximab""AUTHOR NAMES","Verea M.M.","Del Pozo J.","Yebra-Pimentel M.T.","Porta A.","Fonseca E.""SOURCE","Annals of Pharmacotherapy (2004) 38:1 (54-57). Date of Publication: January 2004"

"TITLE","Retrospective analysis of the treatment of psoriasis of the palms and soles""AUTHOR NAMES","Spuls P.I.","Hadi S.","Rivera L.","Lebwohl M.""SOURCE","Journal of Dermatological Treatment (2003) 14:SUPPL. 2 (21-25). Date of Publication: 2003"

"TITLE","Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab""AUTHOR NAMES","Rongioletti F.","Borenstein M.","Kirsner R.","Kerdel F.""SOURCE","Journal of Dermatological Treatment (2003) 14:4 (222-225). Date of Publication: December 2003"

"TITLE","A Randomized Trial of Etanercept as Monotherapy for Psoriasis""AUTHOR NAMES","Gottlieb A.B.","Matheson R.T.","Lowe N.","Krueger G.G.","Kang S.","Goffe B.S.","Gaspari A.A.","Ling M.","Weinstein G.D.","Nayak A.","Gordon K.B.","Zitnik R.","Naldi L.""SOURCE","Archives of Dermatology (2003) 139:12 (1627-1632). Date of Publication: December 2003"

"TITLE","Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea""AUTHOR NAMES","Gach J.E.","Berth-Jones J.""SOURCE","Journal of Dermatological Treatment (2003) 14:4 (226-228). Date of Publication: December 2003"

"TITLE","Etanercept as Monotherapy in Patients with Psoriasis""AUTHOR NAMES","Leonardi C.L.","Powers J.L.","Matheson R.T.","Goffe B.S.","Zitnik R.","Wang A.","Gottlieb A.B.""SOURCE","New England Journal of Medicine (2003) 349:21 (2014-2022). Date of Publication: 20 Nov 2003"

"TITLE","Infliximab for the treatment of hidradenitis suppurativa""AUTHOR NAMES","Lebwohl B.","Sapadin A.N.""SOURCE","Journal of the American Academy of Dermatology (2003) 49:5 SUPPL. (S275-S276). Date of Publication: November 2003"

"TITLE","Successful Treatment of Recalcitrant Palmoplantar Psoriasis with Etanercept""AUTHOR NAMES","Weinberg J.M.""SOURCE","Cutis (2003) 72:5 (396-398). Date of Publication: November 2003"

"TITLE","Infliximab-induced remission of extensive plaque psoriasis""AUTHOR NAMES","Amital H.","Ingber A.","Rubinow A.""SOURCE","Israel Medical Association Journal (2003) 5:11 (827-828). Date of Publication: November 2003"

"TITLE","Infliximab for hidradenitis suppurativa""AUTHOR NAMES","Sullivan T.P.","Welsh E.","Kerdel F.A.","Burdick A.E.","Kirsner R.S.""SOURCE","British Journal of Dermatology (2003) 149:5 (1046-1049). Date of Publication: November 2003"

"TITLE","Etanercept-induced systemic lupus erythematosus""AUTHOR NAMES","Swale V.J.","Perrett C.M.","Denton C.P.","Black C.M.","Rustin M.H.A.""SOURCE","Clinical and Experimental Dermatology (2003) 28:6 (604-607). Date of Publication: November 2003"

"TITLE","Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment""AUTHOR NAMES","Labarca C.","Massardo L.","García P.I.","Jacobelli S.""SOURCE","Revista médica de Chile (2003) 131:10 (1157-1164). Date of Publication: Oct 2003"

"TITLE","Use of Infliximab, an Anti-Tumor Necrosis Alpha Antibody, for Inflammatory Dermatoses""AUTHOR NAMES","Drosou A.","Kirsner R.S.","Welsh E.","Sullivan T.P.","Kerdel F.A.""SOURCE","Journal of Cutaneous Medicine and Surgery (2003) 7:5 (382-386). Date of Publication: September/October 2003"

"TITLE","Efficacy of infliximab in resistant psoriatic arthritis""AUTHOR NAMES","Salvarani C.","Cantini F.","Olivieri I.","Macchioni P.","Padula A.","Niccoli L.","Catanoso M.G.","Lo Scocco G.","Boiardi L.""SOURCE","Arthritis Care and Research (2003) 49:4 (541-545). Date of Publication: 15 Aug 2003"

"TITLE","Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis""AUTHOR NAMES","Stokes D.G.","Kremer J.M.""SOURCE","Seminars in Arthritis and Rheumatism (2003) 33:1 (1-18). Date of Publication: August 2003"

"TITLE","CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab""AUTHOR NAMES","Mahé E.","Descamps V.","Grossin M.","Fraitag S.","Crickx B.""SOURCE","British Journal of Dermatology (2003) 149:1 (170-173). Date of Publication: 1 Aug 2003"

"TITLE","Striking and rapid improvement of plaque psoriasis with infliximab: A report of two cases"

"AUTHOR NAMES","Al-Salem I.H.""SOURCE","Dermatology (2003) 207:1 (54-56). Date of Publication: 2003"

"TITLE","Successful treatment of pustular psoriasis of von Zumbusch with anti-tumor necrosis factor α antibody""AUTHOR NAMES","Kowalzick L.","Mischke D.","Blum R.","Iliev D.""SOURCE","Aktuelle Dermatologie (2003) 29:7 (289-292). Date of Publication: 1 Jul 2003"

"TITLE","Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis""AUTHOR NAMES","Gottlieb A.B.","Chaudhari U.","Mulcahy L.D.","Li S.","Dooley L.T.","Baker D.G.""SOURCE","Journal of the American Academy of Dermatology (2003) 48:6 (829-835). Date of Publication: 1 Jun 2003"

"TITLE","The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.""AUTHOR NAMES","Gottlieb A.B.","Chaudhari U.","Baker D.G.","Perate M.","Dooley L.T.""SOURCE","Journal of drugs in dermatology : JDD (2003) 2:3 (260-266). Date of Publication: Jun 2003"

"TITLE","Psoriasis vulgaris and arthritis psoriatica gravis mutilans""AUTHOR NAMES","Vrzǒogić P.","Pašić A.","Podobnik-Takač T.""SOURCE","Acta Dermatovenerologica Croatica (2003) 11:1 (22-28). Date of Publication: 2003"

"TITLE","Treatment of severe recalcitrant plaque psoriasis with single-dose intravenous tumour necrosis factor-alpha antibody (infliximab)""AUTHOR NAMES","Chan J.J.","Gebauer K.""SOURCE","Australasian Journal of Dermatology (2003) 44:2 (116-120). Date of Publication: May 2003"

"TITLE","Treatment of severe psoriasis with infliximab and methotrexate""AUTHOR NAMES","Dalaker M.","Bonesrønning J.H.""SOURCE","Tidsskrift for den Norske Laegeforening (2003) 123:8 (1070-1071). Date of Publication: 10 Apr 2003"

"TITLE","Cutaneous ulceration with methotrexate""SOURCE","Prescrire International (2003) 12:64 (59-60). Date of Publication: April 2003"

"TITLE","Secondary amyloidosis complicating arthropatic psoriasis""AUTHOR NAMES","García-Arpa M.","García-Donoso C.","Isarría Marcos M.J.","Vanaclocha Sebastián F.","Rodríguez-Peralto J.L.","Iglesias Díez L.""SOURCE","Actas Dermo-Sifiliograficas (2003) 94:2 (121-122). Date of Publication: Mar 2003"

"TITLE","Anemia with proton-pump inhibitor; Psoriasis flare-ups with selective Serotonin reuptake inhibitor; Exacerbation of tuberculosis due to infliximab therapy; Hepatitis seen with celecoxib; Thalidomide-associated deep vein thrombosis and pulmonary embolism; Chronic ADRs associated with hepatitis B vaccination; Neurologic disorders with MMR vaccines?""AUTHOR NAMES","Shuster J.""SOURCE","Hospital Pharmacy (2003) 38:2 (112-117+128). Date of Publication: 1 Feb 2003"

"TITLE","Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris""AUTHOR NAMES","Gottlieb A.B.","Masud S.","Ramamurthi R.","Abdulghani A.","Romano P.","Chaudhari U.","Dooley L.T.","Fasanmade A.A.","Wagner C.L.""SOURCE","Journal of the American Academy of Dermatology (2003) 48:1 (68-75). Date of Publication: 1 Jan 2003"

"TITLE","Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab""AUTHOR NAMES","Cauza E.","Spak M.","Cauza K.","Hanusch-Enserer U.","Dunky A.","Wagner E.""SOURCE","Rheumatology International (2002) 22:6 (227-232). Date of Publication: 2002"

"TITLE","Infliximab for the treatment of severe pustular psoriasis [1]""AUTHOR NAMES","Elewski B.E.""SOURCE","Journal of the American Academy of Dermatology (2002) 47:5 (796-797). Date of Publication: 1 Nov 2002"

"TITLE","Lymphocytic colitis: Clinical features, treatment, and outcomes""AUTHOR NAMES","Pardi D.S.","Ramnath V.R.","Loftus Jr. E.V.","Tremaine W.J.","Sandborn W.J.""SOURCE","American Journal of Gastroenterology (2002) 97:11 (2829-2833). Date of Publication: 1 Nov 2002"

"TITLE","Open-label study of infliximab treatment for psoriatic arthritis: Clinical and magnetic resonance imaging measurements of reduction of inflammation""AUTHOR NAMES","Antoni C.","Dechant C.","Lorenz P.D.H.-M.","Wendler J.","Ogilvie A.","Lueftl M.","Kalden-Nemeth D.","Kalden J.R.","Manger B.""SOURCE","Arthritis Care and Research (2002) 47:5 (506-512). Date of Publication: 15 Oct 2002"

"TITLE","Psoriasis: Response to high-dose intravenous immunoglobulin in three patients""AUTHOR NAMES","Gurmin V.","Mediwake R.","Fernando M.","Whittaker S.","Rustin M.H.A.","Beynon H.L.C.""SOURCE","British Journal of Dermatology (2002) 147:3 (554-557). Date of Publication: 2002"

"TITLE","Juvenile spondyloarthropathies and related arthritis""AUTHOR NAMES","Bukulmez H.","Colbert R.A.""SOURCE","Current Opinion in Rheumatology (2002) 14:5 (531-535). Date of Publication: September 2002"

"TITLE","Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type""AUTHOR NAMES","Newland M.R.","Weinstein A.","Kerdel F.""SOURCE","International Journal of Dermatology (2002) 41:7 (449-452). Date of Publication: 2002"

"TITLE","Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab""AUTHOR NAMES","Schopf R.E.","Aust H.","Knop J.""SOURCE","Journal of the American Academy of Dermatology (2002) 46:6 (886-891). Date of Publication: 1 Jun 2002"

"TITLE","The effectiveness of tumor necrosis factor α antibody (infliximab) in treating recalcitrant psoriasis: A report of 2 cases""AUTHOR NAMES","O'Quinn R.P.","Miller J.L.""SOURCE","Archives of Dermatology (2002) 138:5 (644-648). Date of Publication: May 2002"

"TITLE","Response of severe psoriasis to infliximab [4]""AUTHOR NAMES","Mang R.","Stege H.","Ruzicka T.","Krutmann J.""SOURCE","Dermatology (2002) 204:2 (156-157). Date of Publication: 2002"

"TITLE","Dermatological complications of etanercept therapy for rheumatoid arthritis [3]""AUTHOR NAMES","Misery L.","Perrot J.-L.","Gentil-Perret A.","Pallot-Prades B.","Cambazard F.","Alexandre C.""SOURCE","British Journal of Dermatology (2002) 146:2 (334-335). Date of Publication: 2002"

"TITLE","Etanercept for severe psoriasis and psoriatic arthritis: Observations on combination therapy""AUTHOR NAMES","Iyer S.","Yamauchi P.","Lowe N.J.""SOURCE","British Journal of Dermatology (2002) 146:1 (118-121). Date of Publication: 2002"

"TITLE","Dermatology""AUTHOR NAMES","Kuenzli S.","Lübbe J.""SOURCE","Medecine et Hygiene (2002) 60:2375 (89-96). Date of Publication: 16 Jan 2002"

"TITLE","The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseases""AUTHOR NAMES","Ricart E.","Bouma G.","Salvador Peña A.""SOURCE","Drugs of Today (2002) 38:11 (725-744). Date of Publication: 1 Jan 2002"

"TITLE","Psoriasis and psoriatic arthritis, axial type""AUTHOR NAMES","White K.L.""SOURCE","Dermatology Online Journal (2001) 7:2 (11d). Date of Publication: 2001"

"TITLE","Editorial comments""SOURCE","Journal of the American Osteopathic Association (2001) 101:8 (481-482). Date of Publication: 2001"

"TITLE","Improvement of pyoderma gangrenosum and psoriasis associated with crohn disease with anti-tumor necrosis factor α monoclonal antibody""AUTHOR NAMES","Tan M.-H.","Gordon M.","Lebwohl O.","George J.","Lebwohl M.G.""SOURCE","Archives of Dermatology (2001) 137:7 (930-933). Date of Publication: 2001"

"TITLE","Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: A recombinant tumor necrosis factor α receptor: Fc fusion protein""AUTHOR NAMES","Zeltser R.","Valle L.","Tanck C.","Holyst M.M.","Ritchlin C.","Gaspari A.A.""SOURCE","Archives of Dermatology (2001) 137:7 (893-899). Date of Publication: 2001"

"TITLE","Anti-tumor necrosis factor α therapy in psoriatic arthritis and psoriasis""AUTHOR NAMES","Girolomoni G.","Abeni D.""SOURCE","Archives of Dermatology (2001) 137:6 (784-785). Date of Publication: 2001"

"TITLE","Infliximab ""turns off"" T cells in psoriasis""SOURCE","Pharmaceutical Journal (2001) 266:7152 (804). Date of Publication: 16 Jun 2001"

"TITLE","Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial""AUTHOR NAMES","Chaudhari U.","Romano P.","Mulcahy L.D.","Dooley L.T.","Baker D.G.","Gottlieb A.B.""SOURCE","Lancet (2001) 357:9271 (1842-1847). Date of Publication: 9 Jun 2001"

"TITLE","Successful therapy of psoriatic arthritis with a TNF-alpha antibody (Infliximab)""AUTHOR NAMES","Megahed M.","Grewe M.","Ruzicka T.","Neuse W.","Sterry W.","Mang R.","Stege H.","Plettenberg H.","Krutmann J.""SOURCE","H+G Zeitschrift fur Hautkrankheiten (2001) 76:4 (232-234). Date of Publication: 2001"

"TITLE","Psoriatic arthritis - Emerging concepts""AUTHOR NAMES","Patel S.","Veale D.","FitzGerald V.O.","McHugh N.J.""SOURCE","Rheumatology (2001) 40:3 (243-246). Date of Publication: 2001"

"TITLE","Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate""AUTHOR NAMES","Kirby B.","Marsland A.M.","Carmichael A.J.","Griffiths C.E.M.""SOURCE","Clinical and Experimental Dermatology (2001) 26:1 (27-29). Date of Publication: 2001"

"TITLE","Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial""AUTHOR NAMES","Mease P.J.","Goffe B.S.","Metz J.","Vanderstoep A.","Finck B.","Bürge D.J.""SOURCE","Lancet (2000) 356:9227 (385-390). Date of Publication: 29 Jul 2000"

"TITLE","Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: An open pilot study""AUTHOR NAMES","Van Den Bosch F.","Kruithof E.","Baeten D.","De Keyser F.","Mielants H.","Veys E.M.""SOURCE","Annals of the Rheumatic Diseases (2000) 59:6 (428-433). Date of Publication: 2000"

"TITLE","Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions""AUTHOR NAMES","Oh C.J.","Das K.M.","Gottlieb A.B.""SOURCE","Journal of the American Academy of Dermatology (2000) 42:5 I (829-830). Date of Publication: 2000"

"TITLE","Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis""AUTHOR NAMES","Aboulafia D.M.","Bundow D.","Wilske K.","Ochs U.I.""SOURCE","Mayo Clinic Proceedings (2000) 75:10 (1093-1098). Date of Publication: 2000"